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VSUMMARY
Involving cancer patients in treatment decision-making is considered to be gold 
standard practice, yet there are limited data on the views of cancer doctors.
The first stage of this thesis identified Australian cancer doctors’ usual approach to 
decision-making and comfort with different decision-making styles when discussing 
treatment with patients. Barriers and facilitators to patient involvement were 
investigated.
A response rate of 59% resulted in 624 complete surveys. Most cancer doctors 
reported using shared decision-making (SDM) and being most comfortable with this 
approach. Differences were apparent between high comfort with SDM and less 
frequent usual practice. Specialisation in breast or urological cancer compared to 
other cancers, high new patient caseload and female gender were independently 
associated with increased likelihood of use of SDM. Insufficient information and 
time at first consultation were the most frequent barriers. Less experienced 
physicians more commonly reported system barriers, while trust and being 
accompanied at the consultation were most helpful.
Stage two used qualitative methodology to explore influences on doctors’ decision­
making styles with patients and consequences of involvement with a subset of the 
sample.
Three main themes emerged. Critical features of involving patients in treatment 
decisions included the doctor/patient relationship, eliciting preferences and 
information exchange. Factors which motivate doctors to involve patients were 
influenced by disease, patient, doctor and society characteristics. Consequences of 
involvement include improved doctor/patient relationship, increased consultation 
time and acquiring new skills in eliciting preferences and communicating complex 
information. Decision responsibility, meaning accountability for the decision, may 
also be shifted by involving patients in treatment decisions.
Australian cancer doctors report discrepancies between their comfort with and use of 
SDM. Cancer doctors suggest that the context, impact and effects of involvement 
influence their support of this, with doctors experiencing difficulties involving 
patients in treatment decisions. Yet support for interventions and strategies to 
enhance patient involvement is limited.
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SECTION ONE
INTRODUCTION AND REVIEW OF 
THE LITERATURE
2CHAPTER ONE
INTRODUCTION
1.1 History of approaches to decision-making
Decision-making in medicine has traditionally been seen as the arena of the doctor. 
As the expert, the doctor has been seen as the one with the knowledge and 
responsibility to make treatment decisions. This Hippocratic tradition of medicine is 
founded on a paternalistic model, with a guiding moral principle of beneficence, the 
duty of the doctor where possible to do good where possible (Robison 1979; 
Plueckhahn 1994).
The late twentieth century has seen the emergence of patient autonomy and patient 
rights as competing ethical principles in patient care (Rosner 2004). The traditional 
paternalistic model has been challenged by the increased importance placed on the 
ethos of autonomy in the medical setting, with the anti-paternalistic argument 
asserting that paternalism contravenes the rights of the individual and inhibits choice 
(Beauchamp and Childress 2001). Childress writes that one of the true criticisms of 
paternalism is the increased power that this model of care gives to healthcare 
professionals and the state. In the domain of healthcare decision-making, the 
paternalistic model allows the doctor to override the patient’s right of self- 
determination by asserting that he/she can make the best decision for the patient 
(Robison 1979; Beauchamp and Childress 2001). Hayry (1991) suggests that a 
fundamental problem with medical paternalism is that while the doctor has factual
medical knowledge, he or she is not necessarily knowledgeable about their patients’ 
personal values and expectations and therefore may not make the ‘best’ decision for 
the individual patient. Subsequently, the principle of patient autonomy may better 
protect patient rights and facilitate optimal outcomes.
Autonomy is one of the four moral principles particularly relevant to medicine and is 
defined as the right of individuals to make decisions on their own behalf (Hâyry 
1991; Plueckhahn 1994; Beauchamp and Childress 2001). Autonomy in the 
healthcare context is described by Garfield in (Shotton 1997) as the right to determine 
one’s own life and medical treatment, having been informed as much as is feasible, 
and to be respected as a person (Quill and Brody 1996). This description 
encompasses the right of competent patients to commence, continue or terminate 
treatment, even when their choice challenges health professionals’ beneficence (such 
as in situations where patients refuse life-sustaining therapy). The World Medical 
Association outlined the rights of patients in 1981 in the Declaration of Lisbon, 
defining informed consent as the patient’s right to accept or refuse treatment after 
receiving adequate information (Plueckhahn 1994). The principles of informed 
consent are now widely accepted in the medical world, encompassing the revelation 
of pertinent information, the subsequent understanding of that information by the 
patient, followed by a voluntary decision and granting of permission to proceed with 
the treatment or therapy being discussed (Beauchamp and Childress 2001). The 
principle of informed consent, closely aligned with the principle of autonomy, has
now been embodied in charters and rulings, such as the Declaration of Helsinki in 
1964, and again in 1996 and 2000.
The principle of autonomy has come to the fore in healthcare due to the progress of 
medicine. Increased specialisation, the increased availability of treatment options and 
diagnostic tests, the reduced role of the family doctor and the high profile of health 
issues in the media have each contributed to this change, in line with the move to a 
progressively more consumerist society, (Skene and Millwood 1997). Expectations 
of the public to be informed have also increased over recent years, while there is a 
decrease in acceptance of medical paternalism, reflected in the reference to patients as 
consumers in literature concerning medical ethics and healthcare (Shotton 1997). 
The patients’ rights movement supports autonomy, control and patient challenge to 
medical authority (Quill and Brody 1996; Strum 1997). Also contributing to this 
changing environment is the increased availability of the internet, the increased 
access to tertiary education and the activity of the media over the last 50 years, which 
has made a plethora of information readily accessible to the general public (Strum 
1997). With this knowledge, some patients now enter consultations very differently 
to patients who previously had no way of accessing such medical knowledge, 
diagnostic information or awareness of treatment availability.
1.2 Legal issues
The changing role of the patient in healthcare has been reflected through a number of 
legal proceedings, namely where lack of information provision to patients concerning 
possible outcomes prior to medical intervention, and a resulting poor outcome has
brought about successful challenges to the definition of informed consent prior to the 
1970s (Laine and Davidoff 1996). In law, consent was defined through the often- 
cited 1957 Bolam case in the United Kingdom (UK). This case determined that 
doctors were required to provide information to patients which a “responsible body of 
doctors would regard as appropriate”. A case in the High Court of Australia, Rogers 
versus Whittaker (1992), challenged the Bolam process of consent and asserted the 
importance of communication of material risk and the significance this may have to 
individual patients (Campbell-Tiech 2003). In Australia, the High Court outlined two 
requirements of medical practitioners in gaining the consent of their patients to 
procedures. Firstly, the doctor must inform the patient of the procedure or therapy to 
be performed and secondly, the doctor is required to provide the patient with material 
information concerning the planned therapy. Failure to meet the first requirement 
could result in liability in terms of trespass or assault; failure to meet the second 
requirement would leave the doctor liable for negligence in failing to meet his or her 
duty of care (Hayry 1991; Skene and Millwood 1997; Protection 2003). The same 
High Court went further in the Chappel versus Hart case (1998) in supporting a 
patient’s comprehensive right to know. Through these high profile cases, informed 
consent has become embodied in law as a patient right (Campbell-Tiech 2003).
In the United States, law suits that sought to determine whether informed consent had 
been achieved appeared to support paternalistic behaviour of the medical community 
by summoning doctors as expert witnesses in such cases. The expert witnesses were 
required to assist in determining whether sufficient information had been given to the
patients. By using just doctors in this instance, doctors themselves were able to 
govern how much information a patient should receive. However in recent years 
‘■expert’ witnesses have included laypeople, illustrating the shift toward respecting 
the autonomy and rights of patients (Frosch and Kaplan 1999).
A number of high profile scandals concerning healthcare have reduced the confidence 
of the general public in the medical profession, thus producing enquiring, question­
asking patients (Charles, Gafni et al. 1999; Coulter and Dunn 2002). In 2004 the UK 
Prime Minister used the phrase “end of medical paternalism” to define a new 
approach to medical practice. This new approach aims to encourage patients to 
participate in treatment decisions (Dean 2004). These recent developments reinforce 
the notion that it is ethically sound that people should be informed and should be able 
to participate in and influence decisions about their own healthcare (Entwistle 2000).
1.3 Models of decision-making
Treatment decision-making models in healthcare are generally described in terms of 
the roles taken by the participants, the doctor and the patient, in the interaction and 
the resulting treatment decision (Emanuel and Emanuel 1992; Wirtz, Cribb et al. 
2006). The first model discussed below portrays the doctor/clinician as the controller
of the situation.
71.3.1 Paternalistic model
The paternalistic model is characterised by the patient playing a passive role in any 
communication with the clinician (Charles, Gafni et al. 1997), stemming from the 
sick role first alluded to in the literature by Parsons in 1951, as cited by Charles et al 
(1997). The patient, in this ‘sick role’, was obligated to recover from their illness by 
adhering to the treatments prescribed by their doctor/clinician and was relieved of any 
responsibility in their family during their sickness, clearly assuming a passive stance 
in relation to the expert doctor. Some advantages of the paternalistic model 
highlighted in the literature are its protective nature in relieving the family and patient 
of consideration of treatments which had only a minimal possibility of success (Quill 
and Brody 1996). Disadvantages now acknowledged are the difficulty 
doctors/clinicians may have in eliciting patients’ preferences and subsequent 
identification of their best interests. For example the effect of bias based on gender, 
ethnicity and socio-economic status, and the possibility of patients not being able to 
make decisions due to ignorance of their medical status can each impact a patient’s 
best interest (Quill and Brody 1996). Interestingly, as early as 1956, Szasz and 
Hollander suggested that the physician-patient relationship was changing.
1.3.2 Informed model
The next model to enter the medical decision-making literature has been described 
under a variety of different titles, including the informative model, the consumer 
model and the model of independent choice (Marzuk 1985; Emanuel and Emanuel 
1992; Quill and Brody 1996). The informed model of decision-making in healthcare
8was a response to the imbalance of information exchanged between doctor and 
patient in the paternalistic model and was formulated to embrace the legal 
requirements of informed consent which surfaced in the 1970s (Emanuel and 
Emanuel 1992; Charles, Gafni et al. 1997; Sheridan, Harris et al. 2004). This model 
focuses on the premise of information sharing, in the main part from the doctor to the 
patient, but giving the patient the two main ingredients necessary for decision­
making: information and preferences (Levine, Gafni et al. 1992). Information 
gathering by the patient is stated by Charles et al (1997) to be the catalyst for 
empowerment as a decision maker. In the informed model the patient is in control of 
the decision-making, a complete role reversal for the doctor who can be excluded 
from any discussion of decisions once he or she has provided the relevant 
information. This information, as hypothesised by Charles et al (1997), could even 
be in a multi-media format, which means the doctor does not even need to be present 
when a decision regarding treatment in made. The independent choice and consumer 
models are described similarly in the literature to the informed model with the 
doctor’s role being mainly as information providers in terms of treatment options and 
evidence-based information on outcomes (Marzuk 1985; Emanuel and Emanuel 
1992; Quill and Brody 1996). The model promotes a truly patient-centred approach 
in that the patient is not exposed to any bias on the part of the clinician; the doctor’s 
recommendations do not feature in the consultation. The human face of the clinician 
is considered to be superfluous, with their experience and values unnecessary and 
even a hindrance to the patient’s decision-making (Quill and Brody 1996), implying
that any recommendation or expression of past experience in similar situations by the 
clinician is unwelcome.
9
One major stumbling block for this model in modern healthcare is the potential for 
patients sanctioning an indefinite continuation of treatment considered futile by the 
medical establishment (Quill and Brody 1996). Other criticisms of the informed 
model focus on the reduction of the clinician to information giver only, with the 
dangers of this approach being the de-skilling of health professionals, as well as the 
abandonment of the patient who may feel insufficiently knowledgeable, skilled or 
emotionally capable of making a decision (Emanuel and Emanuel 1992; Quill and 
Cassel 1995).
A variant of the informed model is that of enhanced autonomy. This model can be 
viewed as a reaction to the concern that the informed or independent choice model 
blurred the concepts of autonomy and independence (Quill and Brody 1996). Key 
components of this model are free discussion and exchange of information 
concerning treatment options, their risks, benefits and chances of success according 
to the evidence, the preferences and values of both parties, and recommendations 
based on this information (Quill and Brody 1996). This model places high value on 
the importance of the relationship between the doctor and patient and significant 
others, in contrast to the purely patient-centred nature of the independent choice 
model. The importance placed on the doctor-patient dialogue is illustrated by the 
emphasis given to the doctor’s skills of active listening, acknowledging and
considering the patient’s perspective and considering this perspective when making 
any treatment recommendations (Quill and Brody 1996). Quill and Brody (1996) 
state that treatment decisions are improved when made by the patient assisted by an 
experienced and knowledgeable doctor. This model lies at the autonomous end of the 
spectrum of the informed model of decision-making. The model permits the clinician 
to discuss treatment options and allows the patient to make a decision based on the 
expertise and advice of the clinician in terms of his or her medical knowledge (Quill 
and Brody 1996).
1.3.3 Interpretive model
In the interpretive model, the doctor takes the lead in informing the patient and 
guiding them towards a treatment choice by gathering information from the patient 
and deciphering his or her values (Emanuel and Emanuel 1992). The defining 
characteristic of this model, versus the paternalistic and informed models, is the 
emphasis on the discussion of what is important to the patient and the necessary skills 
required by the doctor to do this. An extreme example of this model is the ‘physician 
as agent’ model.
The agency or ‘physician as agent’ model as described by Charles et al (1997) lies at 
the paternalistic end of the spectrum of the informed models of decision-making, with 
the aim being to correct the informational imbalance of the paternalistic model, but 
with the clinician controlling the decision-making once the patient has divulged
personal values and preferences. Information and preferences are in the power of one 
of the participants in the decision-making process. However though the doctor makes 
the decision, the process is not regarded as paternalistic, as the decision is likely to be 
the same decision as the one the patient would have made (Gafni, Charles et al. 
1998). Shared decision-making has some similarities with interpretive decision­
making, as both models acknowledge the importance of discovering the patient’s 
values (Wirtz, Cribb et al. 2006)
1.3.4 Sh ared decision-making
One of the earliest descriptions of what we now might recognise as a shared decision­
making model was a deliberative model (Emanuel and Emanuel 1992). Shared 
decision-making is seen as the middle ground between paternalism and informed 
decision-making (Edwards, Evans et al. 2003), and is considered an important 
component of patient-centred care. Patient-centred care supports the notion of 
sharing and the clinician must have the ability to empower patients, to share power 
within their relationship with patients, emphasising that this entails a change to the 
traditional view of a doctor-patient relationship (Stewart, Brown et al. 2003).
1.4 Concepts of shared decision-making 
1.4.1 Partnership
In Eddy’s analysis of shared decision-making, he describes a two step process, facts 
and preferences, where the patient’s values determine the final decision (Eddy 1990).
The challenges for the clinician are to prevent their patients from misunderstanding 
the facts, leading to misinterpretation of risk or value, and for the clinician to avoid 
imposing his or her own preferences onto the patient. One central idea in shared 
decision-making is that of equal contribution, where both doctor and patient are equal 
partners in the decision process (Gattellari, Butow et al. 2001). This notion of 
partnership and of power being interchangeable in the doctor-patient relationship is 
also used to describe shared decision-making (Trevena and Barratt 2003).
1.4.2 Information exchange
Emanuel and Emanuel (1992) allude to the need for clinicians to provide information 
concerning the clinical status of the patient alongside clarification of what each or 
any treatment option would mean for the patient. Feldman-Stewart et al (2000) 
define shared decision-making as the means of assisting patients in treatment 
decision-making, by providing comprehensible information and in aiding the patient 
through the cognitive processes that result in a treatment decision. A number of 
researchers have defined information sharing as key to the process of shared decision­
making (Gattellari, Butow et al. 2001). In the context of treatment decision-making, 
the most important information is often referred to as risk communication, which 
permits any management decisions to be based on knowledge by both parties of the 
choices and possible outcomes of those choices (Elwyn, Edwards et al. 1999). 
Coulter (2003) asserts that shared decision-making requires clinicians to present 
patients with information concerning diagnosis, prognosis, treatment options and 
their outcome probabilities. In order to practise shared decision-making, the
information needs to be entirely comprehendible by patients (Edwards, Elwyn et al.
2001).
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1.4.3 Eliciting preferences
Coulter (1997; 2003) states that as well as providing information, the clinician should 
allow patients to express their preferences for involvement in any decision-making 
and treatment choice. Having elicited the patient’s preferences, the doctor should 
then modify their consultation style in response to the patient’s chosen decision­
making role. This definition and interpretation is essential to avoid forcing some 
patients to participate in a process when they prefer not to.
1.4.4 Negotiation and agreemeni
Agreement between clinician and patient is highlighted as a marker of a shared 
decision process by Stewart (1995). She suggests that empowerment to be involved 
and support of the patient throughout the decision-making process to reach 
agreement, gives rise to positive outcomes. Shared decision-making is defined by 
Frosch as a discussion of treatment options by the doctor and patient, followed by an 
agreed selection of one which fits the preferences of the patient (Frosch and Kaplan 
1999). In their critical analysis of treatment decision-making models, Wirtz, Cribb 
and Barber (2006) posit that negotiation has been a neglected component of shared 
decision-making, with minimal explanation about how clinicians can facilitate this 
crucial aspect of their communication with patients.
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1.4.5 Implementation
Consistent with the characteristics of shared decision-making outlined above, three 
important goals have been identified for doctors to achieve during their interactions 
with patients; establish a good interpersonal relationship; facilitate information 
exchange; and facilitate patient involvement in decision-making (Ong, de Haes et al. 
1995). Towle and Godolphin (1999) developed an informed shared decision-making 
competency list to assist doctors in their discussions with patients which consists of 
the following; establishing a partnership; eliciting preferences for information and 
involvement; acknowledging and responding to patient’s views;, outlining choices 
and providing the research evidence to support or refute these; discussion of possible 
outcomes, good and bad; decision negotiation and further planning. In their research 
to produce this framework, competencies for patients were also suggested by patient 
educators and patients themselves, namely: defining the preferred relationship and 
location of the clinician to establish and develop that relationship; ability to enunciate 
and communicate health issues, expectation and preferences to the clinician; and 
accessing information and skills to comprehend and evaluate this; capability to 
discuss, negotiate and manage differences of opinion; and capacity to form an agreed 
plan for treatment.
1.5 Models of shared decision-making
Several authors have attempted to explicate models of shared decision-making. 
Ratzan (1996) discusses a model of effective healthcare decision-making based on 
the principles of workable integrative negotiation and illustrates the process to
achieve this through the acronym COAST, Communication, Options, Alternatives, 
Standards and Trust. The model he presents is illustrated as a circular process, 
beginning with communication which incorporates the identification of standpoints 
and an agenda, and listening to the other parties involved. Options are put on the 
table through continued dialogue, and alternatives are explored by identifying those 
that are available and realistic. The Standards stage concerns coming to an agreed 
goal and the sharing of information of what can be expected according to pertinent 
evidence. Trust is included as a two-way arrow feeding into communication, 
illustrating that unless trust between parties is established through honesty and 
openness, decisions may often be short-lived. This model emphasises the substantial 
role of communication in shared decision-making.
A model of shared decision-making in the context of patients with life-threatening 
disease and different treatment options has been described by Charles, Gafni et al 
(1997) This outlines four essential characteristics:
□ Two people at least are involved in the decision-making process
□ Both patient and doctor take part in the treatment decision-making
□ There is a two-way flow of information between the clinician and the patient
□ A treatment decision is made when both the clinician and the patient agree on the
most appropriate treatment.
These four characteristics demonstrate collaboration between doctor and patient 
through information, personal value and preference exchange about potential 
treatment options. However these essential characteristics do not imply that they are 
all that is required. For example, as Charles, Gafni and Whelan state, there are many 
situations in which more than two parties are involved. Examples of these situations 
include a newly diagnosed breast cancer patient who consults a medical oncologist, 
radiation oncologist and a surgeon in addition to her general practitioner. Likewise, 
in situations of serious illness, significant others of the patient are often involved in 
making treatment decisions every step of the way.
One of the major challenges in implementing shared decision-making is the second 
step outlined above, namely ensuring that both parties participate in the process. As 
Charles, Gafni et al (1997) assert, shared decision-making is extremely difficult for 
the patient to instigate and requires the doctor to be supportive of this approach. 
Doctors are therefore faced with the task of creating a consultation environment in 
which the patient senses that his or her role is valued, and that his or her views and 
concerns about potential treatment options and outcomes are welcome. The doctor 
also needs to acquire skills to elicit preferences from the patient as well as 
communicate complex information concerning risks and benefits, probabilities of 
treatment success or failure. Similarly, the patient needs to embrace this approach 
too. The substantial literature devoted to patient information and involvement 
preferences is described in more detail below. A key but somewhat hidden point 
raised by this model is the assertion that shared decision-making has occurred if both
the patient and the doctor are satisfied with the level of involvement they have 
achieved.
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Information sharing is fundamental to shared decision-making and it would be 
surprising to find any doctor who did not endorse this aspect of their role. However, 
the model requires that the patient also contributes information, including details of 
their illness or information they may have obtained from other sources such as from 
internet sites, friends or disease-related pamphlets and consumer groups. The 
gleaning of information from the patient serves to assist the patient and clinician to 
communicate and comprehend each others’ values and preferences and thereby 
developing mutual trust and respect. The final component described by Charles, 
Gafni and Whelan is that of agreement by both (or more) parties to the decision 
reached. This consensus is a defining feature of shared decision-making. The model 
accepts that the treatment decided upon may not necessarily be the option that either 
participant considers to be the optimum, but it is the one which both support and 
acknowledge responsibility for.
Following further research with breast cancer patients and doctors. Charles, Gafni 
and Whelan (1999) added to their model The resulting new framework illustrated 
three stages of the decision-making process: information exchange; deliberation; and 
deciding on which treatment to implement. This updated model was reported to be 
more user-friendly, both as a teaching tool for doctors and also to assist them in 
identifying their own and their patients’ preferences for involvement in the process.
Further, the authors acknowledged the dynamism of decision-making and the 
likelihood that preferences of either party change along the process, either within a 
consultation or at subsequent meetings. In 2003, the model was refined yet further, 
emphasising the importance of doctor facilitation of shared decision-making, by 
encouraging patients to take sufficient time to make decisions, tailoring information 
to patients’ needs and reinforcing the importance of patients’ values in determining 
the optimal treatment (Charles, Whelan et al. 2003).
In response to existing models of shared decision-making, Siminoff and Step (2005) 
present a Communication Model of Shared decision-making (CMSDM). This 
interpretation of shared decision-making seeks to hone in on the vital role that 
communication and the doctor-patient relationship play in the process and 
particularly relates the process to treatment decision making with cancer patients. 
Criticism of prior models targets the lack of emphasis on the different behaviours and 
roles that participants engage in. The model comprises three factors based on four 
underlying assumptions. The factors are: patient and doctor communication 
antecedents; the communication climate; and the treatment decision. The first 
underlying assumption is that both parties bring their own experience, skills and 
characteristics to the encounter and are receptive to verbal and non-verbal cues in 
order to achieve goals such as information exchange, relationship establishment and 
knowledge gain. Second, the communication includes not only the verbalised topics 
but also non-verbal transfer of information about roles and values. Third, Siminoff 
and Step (2005) endorse the physician’s role in setting the climate for this patient
interaction. They assert that even though a patient may be assertive, the nature of the 
interaction in a new environment and the doctor’s greater familiarity with the 
language of illness means that the patient is unlikely to feel sufficiently confident to 
direct the encounter. Thus the responsibility lies with the doctor to engage with the 
patient and allow them to function as they would like to. The final assumption is that 
the patient is capable of identifying and informing the clinician of the active, 
collaborative or passive role he or she prefers to play in the decision. It is important 
to re-emphasise here that shared decision-making is a process and is not solely 
concerned with the decision.
1.6 Why use shared decision-making?
Shared decision-making is a process which in many respects is a response to and 
acknowledgement of the right of patients to be informed of potential healthcare 
interventions and to choose between them. Reflecting on the philosophy of patient- 
centred care, the patient clearly has a role to play in this process, but the value which 
clinicians bring to the process above and beyond information giving should not be 
ignored. Shared decision-making is often seen as the optimal model due to both 
health professionals and patients not wanting to relinquish or accept sole 
responsibility for a treatment decision (Sculpher, Gafni et al. 2002). From the 
clinician’s perspective, shared decision-making is a useful way of presenting to 
patients the reality that outcomes medicine is not certain. Thus shared decision­
making is particularly promoted in instances where there is more than one clinically 
reasonable treatment option, or where there is a reasonable degree of uncertainty
about the benefit of a particular intervention (Kaplan 2004; Whitney, McGuire et al. 
2004). It also allows clinicians the possibility of abrogating responsibility for 
decisions which they do not consider wise or where the outcome is not the success 
hoped for. In addition, there has been increasing acknowledgement of the differing 
attitudes of patients to the amount of risk they consider acceptable (Sculpher, Gafni et 
al. 2002; Thewes, Meiser et al. 2005). Shared decision-making is seen as a method of 
allowing both the perspective of the patient and of the doctor to be discussed and 
given equal value (Whitney 2003). However, not all stakeholders see shared 
decisions as appropriate in all settings all the time, although much of the debate 
revolves around the use of the word “shared” and definitions that overlap with other 
decision-making model descriptions, rather than the model itself (Elwyn, Edwards et 
al. 1999).
1.7 When is shared decision-making appropriate?
Some authors consider shared decision-making unrealistic in healthcare (McNutt 
2004). Others suggest that shared decision-making is only possible when real options 
are available and the doctor is happy to allow the patient to be involved in the process 
(Whitney, McGuire et al. 2004). According to Whitney, shared decision-making is 
only feasible in medical decisions of low certainty, with either high or low risk, 
where there are two or more alternatives. Thus the appropriateness of shared 
decision-making may vary according to the diagnosis, the type of decision being 
made, and the context (for example, General Practice versus specialist care). Patients 
may prefer to be the decision maker in family planning or for treatment decisions
about chronic but not life threatening disease situations, while in instances that are 
considered urgent or life threatening, or in diseases where the outcome of choices will 
be more significant such as in cancer, patients may prefer the clinician to take the 
lead (Edwards, Evans et al. 2003). Edwards asserts that a shared decision is more 
likely in contexts where decisions may affect risk of diseases such as hypertension or 
ischaemic heart disease at a later stage, or when deciding about screening where the 
risk and benefit of the intervention need to be considered by the doctor and the 
patient (Edwards, Evans et al. 2003).
Murray, Charles and Gafni (2006) discuss adaptation of their original model to the 
General Practice setting. The differences identified between General Practice and 
doctors specialising in life-threatening illness are listed as: patient characteristics; 
multi-faceted symptoms; the doctor-patient relationship; the role of the doctor; and 
the responsibility for the wider population.
As a consequence of these different characteristics, General Practitioners face patients 
with a multitude of problems. Therefore the first stage of any shared decision­
making process needs to be the identification of the problem to be discussed and an 
agenda to reach the agreed starting point at which the shared decision-making 
framework commences. This stage may or may not be complex and can be tackled 
using the principles of information sharing, negotiation and decision-making.
The types of decisions made in general practice can be very different from those for 
which the original framework was developed. Often decisions in primary care are in 
a chronic environment where decisions are not binding as compared to, for example, 
surgical decisions faced by breast cancer patients. Typically treatment decisions can 
be postponed, and/or revisited with minimal consequences. A further model variation 
for general practice is the recognition of the information and sources which a patient 
might bring. In the acute setting, physicians were labelled by Charles et al (1999) as 
the information givers, whereas in general practice the authors acknowledge that the 
role of the GP includes direction of the patient to seek information from other 
sources. Additionally, in primary care the participant in the process who carries out 
the decision is usually the patient, not the General Practitioner (GP). For example, it 
is the patient who takes the prescribed antibiotics at home rather than being admitted 
to hospital for surgery or chemotherapy performed by a health professional. As 
Murray, Charles and Gafni (2006) emphasise this additional responsibility for the 
patient is perhaps further endorsement of the need for the patient to fully understand 
the treatment program decided upon, precisely one of the benefits of using a shared 
decision-making approach.
The shared treatment decision-making model has also been discussed for the chronic 
disease context, specifically diabetes (Montori, Gafni et al. 2006). This setting differs 
in that patients are not faced with one decision but rather a series of decisions, each 
with costs and benefits within or outside medical parameters (Watt 2000). The goals 
revolve around management of the condition instead of the possibility of cure or
restoration to wellness as in the cancer or general practice setting. Often decisions 
are multi-faceted, such as taking medications appropriately and adjusting lifestyle, 
and are implemented as in general practice outside of a healthcare facility. The 
success of decision implementation depends on the behaviour of the patient. 
Montori, Gafni and Charles (2006) suggest that patients experienced in their disease 
can determine success by communicating foreseeable problems with a treatment plan 
in discussion with their clinician; the idea is that with this shared knowledge and 
understanding, the treatment plans chosen have a greater chance of success.
Having presented the conceptual understanding of shared decision-making and the 
context in which it has been developed, it is important to examine the existing 
evidence to support such an approach. As has been described above, shared decision­
making is an approach which requires at least two participants, a patient and a doctor. 
It is therefore important to consider the evidence that either party endorses or 
demands this approach.
1.8 Patient preferences for involvement and styles of decision-making 
1.8.1 What do patients want?
As the concept of shared decision-making has gathered support from health 
professionals, it has become important to ascertain what the patient wants. Is there 
support from patients for this model of decision-making? A number of studies have 
explored patient preferences for involvement and produced variable results.
Involvement in decision-making has been described by three phases: acquiring 
knowledge; discussion of options; making the decision. Preferences for involvement 
acknowledge that patients may vary their preferences according to the three stages of 
the process (Levinson, Kao et al. 2005). Similarly, what patients want must 
distinguish between their preferences for information and preferences for decision­
making responsibility (Fallowfield 2001).
1.8.2 Information preferences
Most studies reveal a strong desire for maximum information amongst patients. In an 
Australian study of 65 female cancer patients, over 80% wanted to receive as many 
details as possible and more than 85% wanted as much information as possible, both 
before and after their initial consultations with their oncologists (Brown, Butow et al. 
2004). Similarly, in a survey of over 2000 cancer patients in the UK, Jenkins, et al, 
(2001) found that the vast majority wanted maximum information(Schofield, Elwyn 
et al. 2003). Beisecker and Beisecker also reported that participants wanted to 
receive full information about their medical situation, but they felt that the doctor was 
the correct person to make a final decision (Beisecker and Beisecker 1990). Despite 
their desire for information, participants in this study did not display any information­
seeking behaviours when consulting with their clinician. Ogden’s study of 
components of patient-centredness with general practice patients showed that patients 
rated all information items as more important than the doctors (Ogden, Ambrose et al.
2002).
Other studies have also shown that information needs are greater than the need or 
wish to be involved in decision-making (Strull, Lo et al. 1984; Ende, Kazis et al. 
1989; Degner, Kristjanson et al. 1997; Vick and Scott 1998). In one study, 41% of
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participants wanted more information than they received from their doctors, yet the 
doctors in this study overestimated, 78% compared to 53%, the wish of their patients 
to participate in decisions (Strull, Lo et al. 1984). Ende’s study also showed a high 
patient desire for information, 79.5 out of 100 compared to a score of 33.2 out of 100 
for participation in decision-making (Ende, Kazis et al. 1989). Vick’s study of 
General Practice consultations in Scotland showed that the desire for a lot of 
information was much higher than the wish to be the actual decision maker (Vick and 
Scott 1998).
In cancer patients, information needs have been found to be similar, regardless of the 
cancer site. Breast and colorectal cancer patients, in a study by Beaver, all reported 
chances of cure and spread of disease and treatment choices as the most important 
information items they wanted to receive (Beaver, Bogg et al. 1999). Similar 
information priorities have also been reported in prostate cancer (Davison, Degner et 
al. 1995).
1.8.3 Discussion preferences
A population-based survey in 2002 in the United States showed that 96% of 
participants wanted to be offered choices and be able to express their opinion to their
doctors (Levinson, Kao et al. 2005). Strull (1984) highlighted a discrepancy in 
clinicians’ perception of their patients’ wish to discuss treatments, with 29% of the 
doctors underestimating this preference. Being able to talk to the doctor, defined by 
the doctor listening to what the patient has to say, was rated as the most important 
feature of the doctor-patient relationship in another Scottish study which surveyed 
consecutive General Practice patients (Vick and Scott 1998). This study used 
hypothetical scenarios with different consultation and communication attributes for 
the participants to choose from.
1.8.4 Decision-making preferences
Involvement preferences of patients with cancer have varied, perhaps because of 
different disease types and stages in the samples involved. However, in most studies, 
a majority of patients prefer shared decision-making to passivity or complete 
autonomy. In Brown’s study, decisional preferences were lower than preferences for 
information, with 52% wising to share the decision equally with their doctor, 16% 
wishing to make the decision themselves but strongly considering the doctor’s 
opinion, and 27% wishing the doctor to make the decision but with consideration of 
their needs and priorities (Brown, Butow et al. 2004). Studies of breast cancer 
patients report that from 48% (Beaver, Luker et al. 1996) to 66% (Degner, 
Kristjanson et al. 1997); to 89% (Bruera, Willey et al. 2002) want to play an active or 
a shared role in decision-making. A study in lung cancer patients revealed that 57% 
wished to play an active or collaborative role in decision-making about treatments 
(Davidson, Brundage et al. 1999). Gwede et al (2005) reported in a study of prostate
cancer patients that 63% preferred an active role in decision-making, 29% preferred a 
collaborative role and just 9% preferred a passive role. Beaver, Bogg and Luker 
(1999) reported that there were differences in involvement preferences of patients 
with different cancer types; 78% of colorectal cancer patients preferred a passive role 
compared to 52% of breast cancer patients. Studies of heterogeneous samples of 
cancer patients have reported 41% (Degner and Sloan 1992), 69% (Blanchard, 
Labrecque et al. 1988) and 88% (Keating, Guadagnoli et al. 2002) preferred a 
collaborative or active role. In another study, participation in decision-making was 
broken down into knowledge, options and decision, with 52% preferring to leave 
final decisions to the doctor (Levinson, Kao et al. 2005). In a United States study of 
2,197 patients with chronic disease, 69% of participants preferred that their doctors 
make any medical decisions (Arora and McHorney 2000), however this preference 
was dependent on patient characteristics, with older age predicting more passivity and 
higher education and female gender predictive of a desire for a more active role. 
Survey results of patient preferences for involvement outlined above do point to 
changes over time, with a shift from 40-70% of samples preferring collaboration or 
an active role reported up to 1999, to 68-89% of samples in survey reported after 
2002.
1.8.5 Predictors o f in volvement preferen ces 
1.8.5.1 Knowledge
Fallowfield asserts that participation in decision-making by patients is not possible 
unless they receive quality information and comprehend what they are given
(Fallowfield 2001). Fallowfield et al (2003) also suggested that the low percentage 
(20%) in their breast cancer cohort who preferred an active role in decision-making 
may have been related to poor knowledge due to the assessment being completed 
prior to participants being informed about definitive diagnosis, prognosis or possible 
treatment. Indeed, Elwyn and colleagues suggest it is unreasonable for patients to 
express preferences for decision-making without having sufficient information about 
the pros and cons about the choices which they may have (Elwyn, Edwards et al. 
1999). One conclusion drawn by Guadagnoli and Ward’s review supports the notion 
that patients’ wish for involvement is increased when their knowledge of available 
options is increased (Guadagnoli and Ward 1998).
While patients’ interpretation of decision-making participation can be constrained by 
their own lack of knowledge of the options available, these options may not be 
known to them due to system limitations, such as clinical practice guidelines within 
which their doctor may practice or time pressures in a busy clinic setting (Entwistle, 
Watt et al. 2004). If patients are to be supported and encouraged to participate in 
decision-making, health authorities need to embrace and fund strategies which 
encourage this (Entwistle 2000). However there is potential for conflict particularly 
in public-funded health systems where the need for adequate resources is constantly 
high on the political agenda and where the promotion of patient choice may raise 
public expectations.
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1.8.5.2 Demographics
Age and education level have been found to correlate with desire for patient 
participation (Cassileth, Zupkis et al. 1980; Ende, Kazis et al. 1989; Degner and 
Sloan 1992; Thompson, Pitts et al. 1993; Arora and McHorney 2000; Orsino, 
Cameron et al. 2003). Younger people, those with more education and women show 
more inclination towards a collaborative or active role in decision-making than older 
people, those with less education, and men (Degner and Sloan 1992; Arora and 
McHorney 2000; Levinson, Kao et al. 2005). The gender effect may be influenced 
by the type of cancer and the role of the consumer and women’s movement in 
advocating choice in surgical treatment of breast cancer (Degner and Sloan 1992).
1.8.5.3 Disease severity
Clearly, the severity of the disease and the potential benefits and costs of treatment 
may influence patient and doctor attitudes to shared decision-making. The severity of 
illness has been shown to have varying effects on patient and doctor involvement 
preferences. Studies have reported that the more serious the illness, the less patients’ 
preference for participation in decision-making (Ende, Kazis et al. 1989). In one 
study, 25% of participants with ‘serious’ illness wanted full information about their 
illness but did not want to be involved in treatment decisions (Blanchard et al, 1988). 
These patients were generally male, older and sicker. Participants with ‘benign’ 
disease showed more enthusiasm for participation in treatment decisions, with 69% 
preferring an active or shared role (Degner and Sloan 1992; Beaver, Luker et al. 
1996). Similarly, in a prospective study, patients whose disease worsened altered
their involvement preference towards greater passivity (Butow, Maclean et al. 1997). 
In contrast, a more recent study found that the desire to participate in decision­
making increased along the disease trajectory, with 76% of end stage renal patients 
preferring to have an active or shared role in decisions (Orsino, Cameron et al. 2003).
Additional predictors of patient involvement include the psychological factors such as 
anxiety, self-efficacy and locus of control. Data reporting the link between these 
factors and patients preferences for involvement in decision making is limited, 
although these factors are alluded to in studies identifying improved psychological 
outcomes as a result of greater involvement.
1.9 Impact of decisional involvement and style on patient outcomes 
1.9.1 Enhanced patient satisfaction
Many studies report that patient decisional involvement improves patient outcomes 
including higher satisfaction, greater compliance and improved psychological 
wellbeing. Several studies have explored the match between patient and doctor 
preferences. Jahng et al (2005) reported agreement on involvement preferences 
between doctor and patient showed strong correlation with patients’ satisfaction. 
This study also found that matched patient and clinician preferences for the highest 
patient involvement produced the highest mean patient satisfaction levels. 
Satisfaction was not reduced when the doctor desired active involvement but the 
patient did not, nor when both patient and doctor preferred a passive patient role.
Similarly, when patients’ preferred involvement and actual role in decision-making 
matched, patients were significantly more satisfied with treatment choice and with the 
amount of information they received (Keating, Guadagnoli et al. 2002).
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Other studies have shown that satisfaction is highest when doctors actively encourage 
patients to participate regardless of the patients’ participation preferences (Golin, 
DiMatteo et al. 2002) Actually taking an active role in decision-making was found in 
another study to correlate with perceived receipt of sufficient information and 
satisfaction with the consultation (Lam, Fielding et al. 2003). Similarly, cancer 
patients who reported sharing decisions were significantly more satisfied with the 
consultation, regardless of their initial preference for involvement (Gattellari, Butow 
et al. 2001). Greater patient satisfaction has also been noted in encounters with 
doctors who displayed an increased participatory style (Kaplan, Greenfield et al. 
1996). Doctors who have had specific interviewing technique training, or who were 
primary care trained, were reported as displaying a consultation style which embraced 
patient involvement and which subsequently left patients more satisfied (Kaplan, 
Greenfield et al. 1996). These studies suggest that given appropriate support, patients 
may find value in a shared decision-making approach, even if they initially feel 
unable to be actively involved in their treatment decisions.
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1.9.2 Impro ved physiological o utcomes
Improved patient physical health outcomes have been reported in studies where 
patients played an active role in decisions about their treatment (Morris and Ingham 
1988; Morris and Royle 1988). Greater adherence to treatment plans was 
demonstrated in patients who were more involved in the decision about their 
treatment (Kaplan, Greenfield et al. 1996). Similarly, Jahng et al (2005) reported 
agreement on involvement preferences between doctor and patient showed strong 
correlation with adherence and health perception. Involving diabetic patients in 
decisions led to increased adherence to treatment regimes resulting in improved 
diabetic health (Anderson, Funnell et al. 1995). Patients with diabetic ulcer disease, 
randomised to receive an intervention which encouraged and coached them to 
increase their involvement in decisions about their care, showed fewer physical and 
role limitations two months on (Greenfield, Kaplan et al. 1985). Communication 
style was found to effect clinical outcome in a group of Austrian cardiac patients, 
with an empowering style taught in a communication skills program reducing the 
length of hospitalisation and increasing the patient rated quality of care (Trummer, 
Mueller et al. 2006)
1.9.3 Enhanced psychological wellbeing
Some studies suggest that shared decision-making leads to enhanced psychological 
outcomes. For women with breast cancer being offered a treatment choice or seeing 
a surgeon who encouraged choice correlated with better patient psychological 
outcomes, including lower levels of depression, (Morris and Ingham 1988; Morris
and Royle 1988; Fallowfield, Hall et al. 1990; Fallowfield, Hall et al. 1994). 
However, this significant difference was not documented three years post operatively 
(Fallowfield, Hall et al. 1994). Anxiety levels were found to be lower in educated 
patients who believed they had participated in decision-making, and in those patients 
who reported a passive coping style but had received information or had been 
involved in decision-making (Margalith and Shapiro 1997). However, a study of 
initial consultations of 96 cancer patients in the Netherlands showed no significant 
relationship between the clinicians’ communication behaviour and patients’ quality of 
life (Ong, Visser et al. 2000). Communication behaviours here allude to the 
instrumental (information giving, question asking) and socio-economic (social 
behaviour, concern, verbal attentiveness and negative talk) clusters identified in the 
Roter Interaction Analysis System (RIAS) (Ong, Visser et al. 1998), which do not 
exactly correspond with behaviours designed to encourage shared decision-making.
1.10 Match between current practice and models
As has been outlined above, there have been a number of conceptual models of 
shared decision-making outlined in the literature along with evidence of benefit from 
use of these models. However the implementation of these ideas into current practice 
is not well documented (Sculpher, Gafni et al. 2002). A number of studies in recent 
years have sought to document patient involvement in decision-making in practice 
and explore whether patients benefit from achieving their desired preference. Shared 
decision-making in practice is still uncommon (Elwyn, Edwards et al. 1999; Holmes-
Rovner, Valade et al. 2000).
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1.10.1 Practice evidence
1.10.1.1 Coding studies
A number of studies have reported evidence of shared decision-making based on 
analysis of audio recordings of real consultations in outpatient clinics or general 
practice surgeries. Coding schemes aim to identify presence of shared decision­
making or presence of elements identified as shared decision-making behaviours. 
Therefore the scores aimed for are the highest, implying that all elements which 
signify shared or collaborative decision-making were present in the consultation. 
Analysis was completed in most cases using verbatim transcriptions of the 
consultations. Most studies reveal a low level of adherence to shared decision­
making.
Brown et al (2004) reported analysis of 59 consultations between cancer patients and 
ten Australian oncologists. The main aim of the study was to identify the quality of 
informed consent by patients considering entering clinical trials. As part of the study, 
the consultation content was coded. Fourteen elements were selected which 
epitomised a shared decision-making framework; the presence or absence and quality 
of these elements in the consultation audio recordings were coded. Shared decision­
making was introduced in only 24% of oncology consultations, but this component 
was rated as poor in 75%; preferences for involvement were checked in 10%, and 
information preferences were checked in 40% (Brown, Butow et al. 2004). Choice 
between standard treatment and no treatment was explicitly offered in only 19% of 
consultations and an explicit choice was presented between standard treatment and
clinical trial participation in 32%. Decisional delay was offered in 78% of 
consultations. Understanding was verified on one occasion in 46% of consultations, 
but was rated poorly in 76% of cases. Understanding was verified more than once in 
15% of consultations. Questions were invited in 60% of consultations; however this 
invitation was rated as poor on 70% of occasions. Thus some but not all elements of 
shared decision-making models were present in most of these consultations, but a 
high level of skill was rarely displayed.
An analysis of audio-taped cancer consultations by Ford, Fallowfield and Lewis 
(1996) in the UK aimed to identify the content of the doctor-patient interaction when 
bad news was given. Analyses were completed using the R1AS. Twelve clinician 
and eight patient categories were identified: emotional responsiveness; partnership 
building; open and closed questions; biomedical and psychosocial information 
giving; and biomedical and psychosocial counselling. Patient clinician ratios were 
calculated identifying the direction of the consultation; i.e. patient or clinician-led; 
patient centeredness; and clinician-patient psycho-social exchange versus biomedical 
exchange. These ratios, in particular patient centeredness, provide some insight into 
the collaborative nature of the consultations despite not actually measuring shared 
decision-making itself. Patient-centeredness was measured by dividing the total 
utterances of all patient questions, psycho-social and lifestyle content and doctor 
partnership building statements by total doctor closed questions and total biomedical 
information giving for doctor and patient. The ratio was 0.33 for the first
consultation and 0.41 at the follow up consultation, demonstrating that patient- 
centeredness was not the norm.
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In an analysis of 118 audio-taped consultations with advanced cancer patients 
discussing treatment options, just 14% were given information about life expectancy 
with and without treatment, 57% were not given any prognostic information, and 
acknowledgement of trade-offs, one of the characteristics of informed treatment 
decision-making, was presented in 60% of the consultations (Gattellari, Voigt et al. 
2002). Patient comprehension was checked in just 10% of the consultations, and 
even though patients’ views were expressed in 75% of cases in only a third were 
these opinions invited by the doctor.
Similar results have been obtained in studies of general practice consultations. 
Kinnersley, Stott, Peters and Harvey (1999) audio-taped 143 general practice 
consultations to identify patient-centeredness using the Measurement of Patient 
Centered Communication (Brown, Stewart et al. 1986; Levenstein, McCracken et al. 
1986; Brown, Stewart et al. 2003). This method provides scores for understanding 
patients’ disease and illness, integrated understanding of the whole person and 
finding common ground through doctor expressions and the interaction. The mean 
score for the General Practitioners was 0.51; score range was from 0-1, with a score 
nearer 1 indicating greater patient centeredness.
A study identifying the existence of informed decision-making in outpatient practice 
used a bank of 1057 audiotapes of outpatient consultations in the practices of General 
Practitioners, general internists, orthopaedic and general surgeons (Braddock III, 
Edwards et al. 1999). Elements of informed decision-making were analysed using 
content analysis only. Nine percent of consultations achieved the criteria for 
informed decision-making. Basic decisions, described as decisions to undergo a 
laboratory test, were more likely to be informed (17%) than complex decisions such 
as prostate cancer screening (0.5%). For all types of decisions, discussion of 
alternatives was present in 11% of consultations, discussion of pros and cons in 8% 
and mention of uncertainties in 4%. Checking patient understanding featured the 
least, 1%, although this was higher for complex decisions (7%).
Design of an instrument to measure the extent to which doctors involve patients in 
decision-making incorporated analysis of 186 general practice consultations with 21 
different General Practitioners in the UK (Elwyn, Edwards et al. 2003). The 
OPTION tool which was developed to measure evidence of shared decision-making, 
uses a five-point Likert scale (strongly agree to strongly disagree) for 12 items 
identified as required components of a shared decision-making consultation. 
Existence of clinical equipoise, listing of options and explanation of pros and cons 
were coded as strongly disagree for 71%, 72% and 71% of consultations respectively. 
Coders strongly disagreed that doctors explored patient expectations and concerns in 
70% and 59% of consultations respectively. The mean score for shared decision-
making was 17 on a scale of 1-100, signifying that in this cohort, patients rarely 
experienced a shared decision-making consultation.
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Ford, Schofield and Hope (2006) analysed 149 videotaped consultations with 13 
General Practitioners in the UK to identify types of decisions and the skills displayed 
by doctors to meet the preferences of their patients. Video analysis was completed 
using the Oxbridge Rating Scale (ORS), a measure of ten items, four of which 
represent effectiveness and six of which represent skills, scores given on a five-point 
Likert scale for each item (0 = not at all, 4 = very effectively). Mean score for the 
effectiveness elements was reported as 8.6 (maximum score 16) and the mean score 
of 11.9 (maximum score 24) for the skills elements. This study also measured 
congruence and grouped the 13 participating doctors into two consultation styles; 
congruent, defined as doctors who displayed flexible styles and who were able to 
alter their approach, or rigid, doctors who persisted with either a doctor-led style or a 
shared style regardless of the preferences of the patient.
With the exception of Elwyn et al (2003), shared decision-making has been identified 
through elements of the process rather than examination of the whole process. 
However it is clear in all these studies that shared decision-making or elements 
described as characteristics or requirements for a shared decision in the models have 
not been identified as prevalent in current practice. Of course, this is not necessarily 
a bad thing, since not all patients desire involvement. A Norwegian study 
demonstrated the complexity of this issue. They focused on palliative care cancer
patients and used semi-structured interviews to identify the role played when 
discussing continuation or not of ‘active’ treatment (Friedrichsen, Strang et al. 2000). 
Participants’ perception of their participation was described by three subcategories; 
verbal passivity, verbal activity and interpretive activity. Participants indicated that 
their verbally passive stance was intentional in some cases in order to avoid hearing 
undesired information, verbal activeness was described as communicating a clear 
wish for information whilst in other circumstances it signified distress or 
misunderstanding. Consequently, it may be important to look at the match between 
patient preferences and patient involvement.
1.10.2 Patient reported decision-making styles
Much literature has identified the type of decision-making experienced by patients 
through their reports post consultation, most commonly using the five-point 
involvement preferences scale developed by Degner and Sloan (1988; 1992). This 
scale, whilst originally designed to elicit involvement preferences, is commonly used 
as a descriptive tool to report what actually happened. Often these two results have 
been compared to determine whether patient preferences have been met. Many of 
these studies show that many patients do not achieve their desired level of 
involvement (Gattellari, Butow et al. 2001; Bruera, Willey et al. 2002; Davison,
Gleave et al. 2002).
The study which included videotaping of consultations described above also included 
patient reports of the style of consultation that they perceived they had experienced 
(Ford, Schofield et al. 2003). This perception was measured using a validated 
enablement scale (Howie, Heaney et al. 1999) as well as Degner’s involvement 
preference scale. The results for this study show that 47% of patients considered that 
the doctor made the decision, 39% that the decision was shared and 14% that they 
made the decision. The patients experienced their preferred level of involvement in 
64% of consultations for doctor-led, 53% for shared and 41% for patient-led 
decision-making.
In another study which asked patients to recall their preferences for involvement and 
their actual involvement, 33% perceived the doctor had made the decision, 43% that 
the doctor had made the decision but considered their opinion, 9% recalled a shared 
decision and 14% recalled making the decision after considering the doctor’s views 
(Davidson, Brundage et al. 1999). A discrepancy in 29% of cases was found, with all 
cases showing that patients were less involved than they would have desired. The 
participants recalled their actual role a median of eight months after treatment in this 
study.
In another study breast cancer patients who had recently undergone surgical treatment 
were asked to recall the role they had played in the recent treatment decision 
(Keating, Guadagnoli et al. 2002). Actual roles recalled were described to 
participants as: surgeon "decided what should be done and did it"; "presented his or
her recommendations to you to accept or reject"; "discussed alternatives with you and 
the two of you decided together how to proceed"; or "presented all available options 
and allowed you to decide". The majority (40%) recalled that they had made the 
decision once all options were presented - a patient-led role. A third (33%) reported a 
collaborative experience, whilst 27% recalled being presented with a doctor-led 
experience either being presented with a recommendation to accept or reject or where 
the surgeon outlined treatment and proceeded. Comparison of actual roles with 
preferred roles showed that just under half of patients (49%) reported experiencing a 
role which they desired in decision-making, with 25% being less active and 26% 
being more active than desired (Keating, Guadagnoli et al. 2002).
A study with breast cancer patients has shown that the reported involvement 
preferences of the patient and the perceived preference of the clinician was only 
matched in 42% of cases (Bruera, Willey et al. 2002).
1. 10.3 Limitations in measuring shared decision-making
A number of issues are raised when measuring whether shared decision-making 
occurred in consultations. Coding systems described above imply expectation of a 
high score, but there is a lack of standard or norms for what should be expected in 
shared decision-making scales. Many of the studies reported above use the scale 
developed by Degner et al (1992) which asks who made the decision, yet there is a
view as raised by Elwyn et al (2003) that shared decision-making is not only about 
who makes the decision., but rather about the process of the decision making.
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The evidence above clearly demonstrates that for the most part, patients’ involvement 
preferences are not being met and a suggested reason for this is that research and 
interventions developed for patients have raised the patients’ expectations. Clinicians 
have not been prepared for these new patient expectations and indeed limited 
evidence documents the views of doctors to involving their patients in decision­
making and treatment discussions.
1.11 Barriers to shared decision-making
A number of studies have identified barriers to involving patients in decision­
making. These barriers can be grouped as; practical issues, doctor competence, 
patient difficulties and doctor support.
1.11.1 Practical issues
The barrier most commonly reported was shortage of time. The models and 
competencies of shared decision-making and the steps along this process take time. 
Say and Thompson (2003) state that the establishment of a partnership is required for 
patients’ views and values to be given significance. According to Sainio et al (2001) 
health professionals who are friendly, and with whom patients are familiar, enable 
patients to be more involved in their own care. However, informing patients
adequately, finding time to develop rapport and to discuss options within the 
consultation are cited as problems for many health professionals (Sainio, Eriksson et 
al. 2001; Stapleton, Kirkham et al. 2002; Stevenson 2003). In a Canadian survey of 
breast cancer doctors, participants were asked to report the extent to which they found 
listed items a difficulty to the treatment decision-making process. Insufficient time to 
spend with the patient was the greatest barrier with 64% reporting they encountered 
this often or almost always in their practice (Charles, Gafni et al. 2004).
Another study of providing information by issuing evidence-based leaflets to patients 
found that lack of time due to competing clinical responsibilities was one of the 
prevailing barriers to doctor-patient discussions and the effective use of a valued 
resource (Stapleton, Kirkham et al. 2002).
Finally, a study in the United States evaluated the implementation of a multi-media 
shared decision-making program across three hospitals. Recruitment to the program 
depended on referral by the clinician and over seven months only 24 patients were 
referred to use the system (Holmes-Rovner, Valade et al. 2000). The primary 
explanation for this low recruitment was the intense time pressure felt by the 
physicians involved in the study: supplementary staff were required to assist with 
identification and enrolment of patients and this was just not practicable in the 
already understaffed environment.
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Whilst time is cited as an issue there is little evidence that this is true. Interventions 
to increase patient involvement have not increased consultation time (Greenfield, 
Kaplan et al. 1985). Some authors have asserted that in the short term, more time 
might be needed to conduct detailed consultations discussing risks and benefits, but 
that this time will be valued later when follow up consultations could be more concise 
due to the understanding gained initially (Edwards, Elwyn et al. 2002).
Another practical difficulty cited by some studies has been timely access to evidence 
required to adequately inform patients. For example, provision of accurate data was 
described as a difficulty by General Practitioners, who noted that particularly as a 
generalist, they cannot be abreast of the latest research and guidelines in all areas of 
their varied practice. For this reason, participants in that particular study posited that 
shared decision-making was more suited to specialists (Elwyn, Edwards et al. 1999). 
However it was suggested that provision of accurate information there and then could 
be overcome by follow-up consultations, as participants stated it was rare for 
decisions to be made within one consultation.
1.11.2 Doctor competence
Patients stated that some obstacles to being involved stemmed from the doctors, 
particularly their tendency to treat patients as objects and to behave in an automated 
manner, and their inability to effectively communicate information (Sainio, Eriksson 
et al. 2001). In Say and Thompson’s review (2003), doctors’ ability to explain
relative and absolute risk was raised. Some doctors present information in a manner 
which makes their treatment preference appear the best option (Lelie 2000) even if 
evidence of other treatments is comparable. In Charles, Gafni and Whelan’s (2004) 
survey of breast cancer doctors, only 5% of oncologists and 3.6% of surgeons 
reported that they often/almost always experienced difficulties in framing treatment 
options for patients. Yet General Practitioners’ communications skills and views 
towards patient involvement showed participants felt that patients misunderstood 
some fundamental messages of the consultations when they reviewed their own 
consultations (Stevenson 2003). Thistlethwaite et al’s (2002) study of junior doctors 
in the UK reported the doctors’ knowledge of treatment options or lack of knowledge 
may prevent options being discussed and consequently a shared process being 
achieved. In the study by Elwyn et al (1999), General Practice registrars suggested 
that shared decision-making, requiring the ability to know all the options, was 
especially challenging for generalists.
1.11.3 Patient difficulties
Patients who do not wish to be involved, often labelled ‘passive patients’ have been 
cited widely as a barrier to shared decision-making (Elwyn, Edwards et al. 1999; 
Sainio, Eriksson et al. 2001; Say and Thomson 2003). Sainio et al (2001) reported 
that encouragement to participate can overcome this barrier. However, insufficient 
information and resources to assist clinicians to increase and educate patients about 
involvement has also been listed as a barrier to the process (Say and Thomson 2003). 
These findings are supported by the results of the survey by Charles et al (2004),
which found reported that surgeons and oncologists most frequently cited patient 
anxiety (49%, 38%), misconceptions about their disease (41%, 39%) and lack of 
understanding (42%, 38%) as barriers to the successful implementation of shared 
decision-making.
1.11.4 Doctor support
Lack of doctor commitment to the process is an important barrier to using a shared 
decision-making approach. Physicians may not wish to practice in such a style due to 
habit or the belief that involving patients in decisions is not appropriate. A number of 
studies have alluded to the belief that shared decision-making is not feasible due to a 
lack of treatment options to choose between. Many doctors (and patients) do not 
recognise “no treatment” as a reasonable option, and thus consider many medical 
situations as not being subject to choice.
The support of shared decision-making, in particular by surgeons in the Canadian 
survey (Charles, Gafni et al. 2004), was suggested by the authors to be somewhat 
surprising, despite the barriers listed above, and may well be due to breast cancer care 
being a specialty in which the involvement of the patient has had a great deal of 
media coverage stemming from the highly motivated women’s and consumer 
movements in this arena (Charles, Gafni et al. 2004). It is not known whether 
clinicians treating other cancers have similar views to those of the breast cancer 
doctors in Canada. This gap and avenue for more research was highlighted in the
discussion of the results. Currently there are no data on Australian oncologists’ views 
about shared decision-making. It is not clear whether there are cross-cultural 
differences in attitudes. Australian doctors may not share the views of Canadian 
cancer doctors. No studies have explored predictors of doctor views or practice, in 
order to identify sub-groups who may have either useful experience to offer, or who 
may benefit from intervention.
1.11.5 Facilitators
Potential facilitators or ways to overcome barriers to shared decision-making have 
been explored. Sainio’s qualitative study with breast cancer patients identified three 
factors which assisted patients to be involved in decision-making, namely time, 
encouragement and being treated as an equal (Sainio, Eriksson et al. 2001). Eighty- 
four percent or more of breast cancer doctors rated emotional support from 
family/others, patient being accompanied in the consultation, patient being 
emotionally ready for a role in decision-making, patient wanting to participate, 
patient having adequate knowledge for the consultation and patient trust in the doctor 
as almost always or very helpful by (Charles, Gafni et al. 2004).
Some authors have suggested that the move towards a multi-disciplinary team 
approach, involving collaboration with other health professionals to plan care, has 
increased the opportunity and the relevance of shared decision-making (Stevenson, 
Barry et al. 2000). Elwyn et al (2000) concluded that development of clinician skills
and encouragement to implement these skills can be achieved through policy, 
education and professional development. In Charles’ survey of breast cancer doctors, 
respondents were asked to define the meaning of shared decision-making as well as 
identify which of four presented examples they felt most illustrated a shared decision. 
The results showed that breast cancer doctors demonstrated a good understanding of 
shared decision-making and used the language of the framework to describe their 
own perception. The authors concluded that the consensus they reported is helpful in 
planning potential training for clinicians in a shared approach (Charles, Whelan et al. 
2003; Charles, Gafni et al. 2004). It is not known what barriers Australian doctors 
perceive to implementing shared decision-making or what might facilitate their 
greater use of this approach.
1.12 Interventions to increase patient involvement
Entwistle (2000) outlines four strategies for supporting patients’ participation in 
decisions about their healthcare: development of skills of health professionals; 
development of skills and comprehension of the local healthcare system by the 
general public; development and use of interventions to encourage active role playing 
by patients; and development, dissemination, supply and accreditation of information 
resources and services.
Collaborative relationships between patient and clinician are vital for a shared 
decision-making environment and achievement of this requires skilled and effective
communication between the doctor and the patient (Sepucha, Belkora et al. 2000). In 
the cancer context, patient anxiety and unexpressed concerns can hinder the 
information flow and involvement of patients in decision-making (Boyle, Robinson et 
al. 2004). Tools or strategies have been developed to better prepare patients for the 
consultation by empowering the patient to improve their communication skills 
(Greenfield, Kaplan et al. 1985; Greenfield, Kaplan et al. 1988) Using another 
approach, Sepucha, Belkora et al (2000) evaluated an intervention consisting of a 
preparation visit with a trained researcher who assisted the patient in organising 
questions and concerns, and who then accompanied the patient into the consultation, 
assisted the doctor and patient to create an agenda, facilitated discussion and kept a 
record of the consultation for the patient to take home. This pilot study showed the 
intervention increased the decision quality score, increased agreement between 
physicians and patients and increased patient satisfaction with the consultation.
1.12.1 Communication skills
Communication skills training has been a neglected part of medical education despite 
being considered a core clinical skill (Fallowfield, Jenkins et al. 2002). A number of 
programs have been devised to improve the communication skills of the clinicians in 
the area of treatment decision-making with their patients. Jenkins et al (2005) 
developed and evaluated a communication skills program for clinicians in gaining 
consent to clinical trials, which incorporates training in facilitating patient 
involvement. The course was run over two days and included four video modules 
depicting varying scenarios. Participants were videotaped before and after the course
in simulated consultations. A high number of communication behaviours improved 
significantly after the course, as did clinicians’ confidence in their ability to discuss 
and explain clinical trials. Participants expressed a wholehearted satisfaction with the 
course and recommended it to fellow health professionals.
Elwyn and colleagues report a communication skills training intervention designed 
for General Practitioners in the UK. The training consisted of four three-hour 
workshops focussing on shared decision-making and risk communication (Elwyn, 
Edwards et al. 2004). Participating doctors were allocated to the shared decision­
making and the risk communication in two phases and consultations with patients 
were audio-taped and analysed for skills and competencies covered in the workshops. 
Results of this study showed an increase in patient involvement in treatment decision­
making, increased doctor perceived patient satisfaction with information and with the 
doctor and increased agreement between doctor and patient (Elwyn, Edwards et al. 
2004).
A video-conferencing system using a trained standardised patient, who also evaluated 
performance, was developed and tested with orthopaedic surgeons in the United 
States (Clever, Novack et al. 2003). Skills examined included involving the patient in 
decision-making, information on clinical issues, surgery and alternatives to surgery, 
including risks and benefits. The ‘patient’ fed back to the surgeons about the five key 
criteria and, if certain elements were missed during the role play and suggested ways 
of introducing them in the scenario. 86% of participants would recommend the
program as a means of learning shared decision-making skills. The use of this 
conferencing technology also makes this program feasible for practitioners regardless 
of geographic location.
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One difficulty with any training program is the ability to monitor outcomes and their 
durability, and to remove any barriers to implementation of newly acquired skills. In 
a study in Wales with General Practitioners, participants reported using the risk 
communication tools up to six times on average in the following month (Edwards and 
Elwyn 2004). Fallowfield and her group asked participants in an intensive three-day 
communication skill course and the control group to complete self assessment after 
three months and found significant and improved differences in their communication 
behaviours (Jenkins and Fallowfield 2002; Fallowfield, Jenkins et al. 2003). One 
strategy to optimise the effect of communication skills training has been the addition 
of consolidation sessions over a three-month period following the basic session. 
Significant differences were seen in assessment at six months, with the group who 
received the consolidation sessions showing more acknowledgements, more empathy, 
and more negotiation (Razavi, Merckaert et al. 2003).
1.12.2 Decision A ids
Decision aids are standardised, evidence-based tools to aid achievement of an 
informed, value-based choice among treatment options, one of these which could be 
watching and waiting (O'Connor, Graham et al. 2005). O’Connor has been at the
forefront of developing decision aids as a method of presenting and comparing 
treatment preferences, survival and quality of life using trade-offs for patients facing 
difficult decisions (O'Connor, Drake et al. 1999). Decision aids are not intended to 
replace the doctor, but rather to supplement doctor-patient interaction and allow 
patients to reflect personally on their choices and the results of these, as well as to 
acknowledge what is important to them and to share this with the health professional 
(O'Connor, Graham et al. 2005). A Cochrane systematic review identified 34 
randomised trials of decision aids and reported positive outcomes compared to 
standard care in knowledge, patient comprehension of probable outcomes, agreement 
between personal values and choices made, decisional conflict and the number of 
patients who could not make a decision (O’Connor AM, Stacey D et al. 2003). 
Anxiety was not increased in those patients who participated in decision-making.
A number of studies have evaluated decision aids in a variety of practice settings. 
For example, a randomised trial of a decision aid for cancer patients considering 
adjuvant chemotherapy produced significant results in terms of improved knowledge 
of their disease and the treatment options available, as well as improved satisfaction 
with the decision-making itself (Whelan, Sawka et al. 2003). A randomised trial of 
112 men in general practice with benign prostatic hypertrophy tested the efficacy of 
an interactive multimedia program, booklet and printed summary, and found the 
intervention acceptable to doctors and patients; reported participation in decision­
making by the patients was higher and decisional conflict was lower in the
intervention group, whilst levels of anxiety, health status and costs showed no 
difference (Murray, Davis et al. 2001).
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Kennedy (2003) in his review on how best decision aids should be evaluated, asserts 
that much of the assessment of current decision aids uses measures testing 
knowledge, awareness of treatment decisions and the process of decision-making 
rather than measuring the concordance between the treatment choice and the patients’ 
expressed values.
1.12.3 Feeding back preferences to clinicians
A few studies have investigated the value of identifying patient preferences for 
information and involvement prior to consultations. A study in the UK randomised 
doctors to either receive, or not, questionnaires completed by their patients which 
covered information requirements and attitudes to participating in a clinical trial 
(Fleissig, Jenkins et al. 2001). Results showed no difference in the information 
exchange between doctor and patient in either study arm, further only one out of the 
15 doctors referred to the preferences recorded by the patient in each consultation, 
while nine of the other doctors discussed preferences briefly and occasionally. 
Conclusions drawn were that doctors were unlikely to deviate from their usual 
manner of discussing treatments with patients, either due to difficulty or because they
felt their routine ensured that all issues were covered.
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Another study involved the use of a computerised intervention devised and tested 
with breast cancer patients to elicit information and decision-making preferences 
prior to the consultation in a randomised controlled trial (Davison and Degner 2002). 
Following completion of the assessments, participants in the computer arm were 
given a printout of their involvement and information preferences and coached by the 
nurse to encourage them to achieve their preferred role and focus information 
requests on those topics most important to them. Almost 75% of participants 
achieved their preferred participation role; however a higher proportion of the 
intervention group assumed a more passive role than the control group. The authors 
suggest this may have been due to increased expectations of the role they could play 
in their consultation and subsequent reporting of a more passive experience when 
expectations were not met.
1.12.4 Question prompt lists
Question prompt lists/sheets are simple tools designed to aid the patient in obtaining 
the information he or she may want by listing questions pertinent to their consultation 
and facilitating the patient to raise these during the consultation (Butow, Dunn et al. 
1994; Brown, Butow et al. 1999; Brown, Butow et al. 2001; Clayton, Butow et al. 
2003; McJannett, Butow et al. 2003). Patients who received question prompt lists 
asked significantly more questions, particularly about difficult and emotional subjects 
such as prognosis. They also rated the helpfulness of written material and 
communication with the doctor higher, and recorded lower anxiety scores post receipt 
of the question prompt list (Bruera, Sweeney et al. 2003; Clayton, Butow et al. 2003).
Endorsement of the question prompt list by the doctor was found in another study to 
increase the number of questions asked and improve patient recall of information; 
another positive outcome in terms of implementation was that the intervention 
decreased the consultation length (Brown, Butow et al. 2001). Bruera’s study 
comparing a question prompt sheet with a general information sheet also found no 
increase in consultation duration (Bruera, Sweeney et al. 2003).
1.12.5 Audio-recording consultations
The value of audio-recording consultations has been explored in a number of studies 
and has been proven of value in allowing patients to clarify details of the 
consultation, as well as to give further opportunity to absorb the plethora of 
information given in any consultation (Deutsch 1992; Ford, Fallowfield et al. 1995; 
Scott, Entwistle et al. 2001; Tattersall and Butow 2002). Patients given an audiotape 
of their consultation have also been more satisfied with their outpatient visit and 
recalled more specific information (Bruera, Pituskin et al. 1999). A survey in 
Australia of oncologists and surgeons, however, showed that 79% and 89% 
respectively never offered an audiotape of consultations to their patients (McConnell, 
Butow et al. 1999). When asked if they thought audiotapes should be offered, the 
majority of General Practitioners, oncologists and surgeons stated that they should 
not (73%, 39% and 66% respectively). Reasons for these views were listed as 
intrusive, preventive of free discussion, cumbersome, no benefit and not supported by 
patients, legal and confidentiality issues, reviewing of tape by patients cannot be
monitored and pertinent points may be missed or misunderstood and non-verbal 
communication is excluded.
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Other information interventions have included patient information booklets, summary 
sheets and videotapes for patients to read or view in their own time. A randomised 
controlled trial, comparing a video with written information for cancer patients 
receiving radiotherapy, demonstrated no difference in patient anxiety prior to 
commencing radiotherapy between the two groups (Harrison, Dey et al. 2001). 
Another study reported significantly better outcomes in patients who received a video 
versus booklet, with reduced anxiety and increased satisfaction as well as 81% of the 
participants in the video arm finding it helpful. However, 5% reported that the extra 
information caused them more concern (Thomas, Daly et al. 2000).
The majority of these interventions have demonstrated positive outcomes, yet as 
discussed above, many patients still fail to achieve their involvement preferences, or, 
as suggested by a number of authors, interventions which empower patients also raise 
their expectations which clinicians then fail to meet (Davison and Degner 2002; 
Butow, Devine et al. 2004). This hypothesis reinforces a potential barrier to shared 
decision-making being the lack of support for this approach from doctors. If the 
doctor does not endorse shared decision-making, facilitate patient involvement in the 
consultation, or use decision aids or question prompt lists, the likelihood of the 
patient achieving shared decision-making is vastly reduced, regardless of their initial 
preferences. Clinicians who do not wish to relinquish their power in the consultation
as regards reaching a decision pose a problem for patients who wish to be involved in 
discussion about treatment options (Whitney 2003). To a major extent, patient 
involvement in decision-making is dependent on the support of the medical 
practitioner (Stevenson 2003).
1.13 Doctors’ views on shared decision-making
While many studies have explored patients’ preferences for decision-making roles, 
few studies have asked doctors their views on this issue or practice, despite the fact 
that the support of clinicians and endorsement of tools is integral to the 
implementation of interventions. Much of the current literature concerning doctors’ 
views on shared decision-making has been completed in the general practice 
environment or in breast cancer.
A UK study sought to identify the importance of patient-centred behaviour according 
to General Practitioners and patients (Ogden, Ambrose et al. 2002). Sixty-four 
General Practitioners and 410 patients completed questionnaires rating each element 
on a five-point Likert scale where 1= not important and 5= totally important. Overall 
the General Practitioners believed the majority of patient-centred behaviours were 
very important; mean scores were > 4 for all items except for “allowing the patient to 
make the final decision”. Involving patients in decisions about treatment recorded 
the highest mean score, 4.46. General Practitioners in this study supported involving 
patients in decision-making but they were less enthusiastic about allowing patients
full decisional control. Patients in this study also rated being involved in decisions 
highly, with a mean score of 4.37 and had comparable scores with the doctors for 
items concerning patient involvement.
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A small qualitative study, identifying the views of 12 pre-registration House Officers 
in hospital and General Practice settings regarding involving patients in management 
decisions and their experiences of this approach produced three themes 
(Thistlethwaite 2002);
□ Hospital-based clinicians use a more paternalistic approach
□ Using a patient-centred approach more important in primary care
□ Sharing information is more likely in general practice than in hospital.
Essentially, this small group of junior doctors expressed positive attitudes towards the 
concept of shared decision-making, seeing it as beneficial to both clinicians and 
patients; however, this attitude was tempered by hesitancy regarding its successful 
implementation. These doctors reported that they had had little opportunity to see 
this approach used in practice, particularly in the acute hospital setting. Consequently 
they experienced few occasions to learn such skills from senior colleagues.
The attitudes of 11 General Practitioners to shared decision-making in the UK were 
explored in two focus groups through reference to a model of shared decision-making 
(Charles, Gafni et al. 1997) and analysis of previously recorded and transcribed 
consultations conducted by the focus group participants (Stevenson 2003). The
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consultations included a discussion of medications by the General Practitioner and 
the patient and four key components of shared decision-making were scored, namely:
□ Two participants involved, clinician and patient
□ Information shared by both participants
□ Both participants work to a consensus on preferred treatment
□ An agreement is reached on treatment to implement
Overall the General Practitioners did not express negative comments about shared 
decision-making, although one focus group noted that some doctors are 
uncomfortable with patients expressing their own opinions about treatment or having 
a fixed view on what treatment they wish to receive. The General Practitioners 
expressed difficulty in knowing how and when shared decision-making had actually 
taken place and when decision sharing is appropriate and feasible.
Attitudes to involving patients in decision-making were collected in a study in the 
UK evaluating the effect of training General Practitioners in risk communication and 
shared decision-making and documenting changes as participants went through the 
program (Edwards and Elwyn 2004). Participants included 20 General Practitioners 
each with one to ten years as a principal in their practice, average age of 38yrs. 
Measures aimed to elicit attitudes regarding the importance of involving patients in 
decision-making, the importance of patients responding positively to this approach, 
their frequency of involving patients in the decision and the importance of the
General Practitioners own competence in this approach. Scores were on five-point 
scale (1= most important/highest, 5=lowest/not important). Results showed that 
General Practitioners reported involving their patients in decision-making prior to the 
training program less often (mean score 2.6) than they did post training (mean score 
2.2). The importance of involving patients at baseline (mean score 2.1), increased 
post training (mean score 1.7), however how long this effect lasts is unknown.
A further qualitative study in the United States using semi-structured interviews with 
53 academic and private practice physicians from primary care and surgical 
specialties identified three primary justifications for involving patients in decision­
making; respect for autonomy, beneficence and self-interest (McGuire, McCullough 
et al. 2005). The majority of doctors in this study preferred the role of the doctor as 
an expert who educates patients and directs the decision-making process. Some of 
the participants supported a collaborative relationship with their patients, however 
many saw a reduced role for patients if there was only one reasonable medical choice. 
Treatment decisions with no clear best answer or with moral dimensions were 
deemed particularly appropriate for increased or full patient control.
A recent study reporting attitudes to shared decision-making is based on 41 
Norwegian General Practitioners (Carlsen and Aakvik 2006). General Practitioners’ 
preferences for their decision-making role were scored on a six point scale, a score of 
6 indicating a preference for sharing. Overall the mean score for General 
Practitioners was 4.31, with the male GP score being slightly lower than female GP
score 4.26 and 4.41 respectively. Sixty-six percent of the sample was male. These 
results show a high support and preference for shared decision-making amongst 
Norwegian General Practitioners.
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A study exploring the appropriateness of involving patients in decision-making and 
the skills and methods required to facilitate such practice used focus groups with six 
experienced General Practitioners (Elwyn, Edwards et al. 2000). The participants 
expressed positive attitudes to patient involvement, however they were concerned 
that this involvement should not be forced and that the patient’s right not to be 
involved should be respected.
A large study of 502 doctors in Germany investigated views towards shared decision­
making and compared these to patients (Floer, Schnee et al. 2004). The doctor 
sample comprised General Practitioners (28%) and specialists (73%), with 27% of the 
sample being female. Two thirds (67%) of doctors reported that decisions should be 
shared, 8% reported that patients should take the lead and 21% reported that doctors 
should make the decisions. Younger doctors (<45yrs) showed greater endorsement of 
shared decision-making. Differences between doctor disciplines were reported 
between the age groups. In the younger doctor groups, specialists reported that they 
preferred shared decision-making more than General Practitioners (38% compared to 
28%); in doctors aged 46-54 years 27% of specialists and 42% of General 
Practitioners preferred shared decision-making; and in doctors aged 55 years or over,
35% of specialists and 30% of General Practitioners preferred shared decision­
making.
62
Three studies investigating clinicians’ views of patient involvement in treatment 
decision-making have targeted health professionals specialising in breast cancer care. 
One of the earliest studies was undertaken in the United States (Beisecker, Helmig et 
al. 1994). Oncologists, nurses and patients were all asked to complete the 15 item 
Locus of Decisional Authority in Decision-making survey. For each item three 
responses were possible, 0= doctor should make the decision, 1 = doctor and patient 
should make the decision, 2= patient should make the decisions. A score of 15 
indicated that respondents felt all decisions should be shared. Total scores for the 
three groups were below 15, showing they felt that doctors should have overall 
decisional authority, with the doctors’ group mean score being the lowest, 10.23 
compared to 12.49 for the patient group and 13.74 for the nurses. Attitudes of the 
different clinician disciplines represented in the sample were also reported; surgical 
oncologists showed increased support for patient involvement compared to medical 
and radiation oncologists. No significant differences were found in attitude to patient 
involvement for patient age or physician gender, however a relationship was reported 
between older clinicians (both nurses and doctors) and reduced advocacy for 
increased patient involvement.
A qualitative study looked at understanding the doctor-patient relationship and the 
process of treatment decision-making over two years by observing 25 women
diagnosed with breast cancer at each encounter with one of 13 oncologists. 
Observation comprised recorded semi-structured interviews with patients and doctors 
(Freedman 2002). The researchers observed that doctors did offer patients choices, 
however sometimes the choices offered were those with which the particular clinician 
was familiar and/or were available within the health setting, while treatment options 
which may have been available through a different specialist were not mentioned. 
Also doctors reported only offering options which they felt were appropriate. 
However, there were instances where such assessments were based on psycho-social 
factors and/or age of the patients and perceived inability of the patient to manage 
certain treatments. The authors reported that in these instances, doctors clearly 
removed any active or shared role for patients in the decision-making process.
A Canadian study explored the views and understanding of surgeons and oncologists 
specialising in breast cancer (Charles, Gafni et al. 2004). This study comprised a 
cross-sectional survey inviting participants to report their use and comfort with 
shared decision-making and their perception of the mechanics of shared decision­
making as outlined in a framework described above (Charles, Gafni et al. 1997; 
Charles, Gafni et al. 1999). Semi-structured interviews were conducted initially with 
breast cancer patients to investigate their understanding and experience when making 
treatment decisions with their doctors (Charles, Whelan et al. 1998). The results of 
these interviews were then used to develop a draft questionnaire suitable for 
physicians. This was developed through separate focus groups of medical and 
radiation oncologists and breast surgeons, leading to a questionnaire identifying
physicians’ perceptions of shared decision-making and its meaning, their use and 
comfort with this consultation style and the existence of obstacles or aids to putting 
this approach into practice.
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Eighty-seven oncologists and 203 surgeons answered the open-ended question 
concerning what shared decision-making means, and the majority responded with 
definitions congruent with the principles of shared decision-making. A minority 
described shared decision-making as information transfer alone. More than a few 
respondents suggested that further discussion would be warranted if the patient’s 
preference and their own recommendation were not the same. The survey included 
illustrations of decision-making styles designed to depict the four common models; 
paternalistic, information sharing only, shared and informed. The survey asked the 
physicians to select the model which they thought described shared decision-making. 
The majority of surgeons (94%) and oncologists (87%) identified the example 
intended to describe shared decision-making as the one most like their own definition 
of shared decision-making. The example which described information sharing but 
clear retention of decisional authority by the doctor was selected by 28% of surgeons 
and 34% of oncologists as their interpretation of shared decision-making, while a 
similar proportion, surgeons (27%) and oncologists (21%), regarded the informed 
decision-making example as the most like shared decision-making. It is clear from 
these results that between a quarter and a third of respondents were unsure whether 
sharing responsibility between doctor and patient is indicative of a shared decision­
making experience.
The essential ingredients of shared decision-making were further explored by asking 
respondents to rate the importance of seven characteristics using a 5-point Likert 
Scale (1= not important, 5 = extremely important). Items which were rated with 
either a 4 or 5 were grouped together. Surgeons reported discussion of pros and cons 
(100%), giving information to the patient (99%) and agreeing on the treatment to be 
given (86%) as very/extremely important. In comparison, oncologists reported giving 
information to the patient (99%), discussion of pros and cons (96.9%), and agreeing 
on the treatment to be given (95%) as very/extremely important.
Survey participants were also asked to select which of the four decision-making 
styles was most akin to their usual style. Over half (56%) of oncologists and two- 
thirds, (69%) of surgeons stated that their approach to a decision-making consultation 
was most similar to the shared decision-making example and just under a third (27%) 
of oncologists and under a fifth (17%) of surgeons likened their approach to the 
information sharing style (Charles, Gafni et al. 2004). Less than 3% of both groups 
reported using a paternalistic approach and 8% reported embracing an informed or 
patient-led approach. A discrepancy was noted between these self reported use 
statistics and self reported comfort with each of the four styles. Both surgeons (89%) 
and oncologists (87%) stated they were very or extremely comfortable with the 
shared decision-making approach, a difference of 20% and 31% respectively to their 
reported use of this style.
Overall the studies in the general practice arena show support for involving patients 
in decisions about treatment, but less support of a patient controlled decision-making 
approach. They acknowledge that actual involvement of patients is not routine. 
Reasons why actual practice does not conform to the shared decision-making model 
include doctors not feeling comfortable with patients being assertive, wishing to 
respect the right of patients not wanting to be involved, and asserting that the role of 
the patient is minimal if only one reasonable treatment exists.
In the breast cancer setting, two recent studies report clinicians offering choice to 
their patients. However, the authors in the qualitative study stated that the choices 
offered were governed by the doctor, attesting that by this process the patient’s choice 
was limited to treatments already determined by the clinician. In the large Canadian 
study, self reported use of shared decision-making was high, with almost two-thirds 
of surgeons claiming this to be most like their own approach. The reason for this 
could be linked to the existence of treatment options and the acknowledgement of a 
clear treatment choice with similar survival outcomes e.g. mastectomy v. 
lumpectomy and radiotherapy. A number of these studies have reported some 
differences between specialties and physician age, with younger doctors in the 
German study reporting greater support for shared decision-making. This view was 
corroborated in the focus group of the pre-registration House Officers in the UK who 
believed shared decision-making and patient involvement to be a good idea, but they 
had seen little evidence of this approach during their practice placements, particularly 
in the acute hospital setting (Thistlethwaite and van der Vleuten 2004).
Many of the studies described above are small and do not offer a cross-sectional 
picture of clinician attitude or use of shared decision-making. Indeed, none of the 
studies reports the views of Australian clinicians although there are a number of 
Australian studies reporting the information preferences of patients.
1.14 SUMMARY
Shared decision-making can be viewed as the gold standard of decision-making in 
medicine generally, and specifically in the cancer context. While there is evidence 
for the benefits of this approach, available studies suggest that shared decision­
making is rarely implemented. Shared decision-making is, according to the theorists, 
suitable for many healthcare contexts. Much work in the oncology setting indicates 
cancer patients express desire for involvement in decision-making. Little evidence 
exists to show whether oncologists outside of breast cancer use such an approach or 
how comfortable they are with it. The survey by Charles et al (2004) provides an 
interesting insight into the views of breast cancer doctors, but it is unknown whether 
clinicians specialising in other cancers hold similar views. Additionally, a number of 
authors have asserted that shared decision-making is only appropriate in particular 
clinical situations, where doctors feel real treatment options exist. Little is known 
about doctor views on shared decision-making, its use, or the barriers and facilitators 
that might influence their use of this approach. No Australian data are available on
this issue.
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AIMS AND HYPOTHESES
This study aims to survey Australian oncologists to discover their understanding of 
the concept of shared decision-making, their level of comfort with shared decision­
making, whether and when they currently use it in their clinical practice and their 
perceptions of barriers and facilitators to shared decision-making. Predictors of 
attitudes and current practice will be explored, including demographic and practice 
variables. It is hoped that the results will inform the development of appropriate 
interventions to assist oncologists and patients to improve the quality of 
communication around decision-making.
Stage One: A questionnaire to identify the views and attitudes of cancer doctors 
to shared decision-making
Aims are to:
i. Develop a questionnaire to survey doctors treating breast, colorectal, 
gynaecological, haematological and urological cancers
ii. Retrieve information concerning consultation styles currently in practice
iii. Identify oncologist’s comfort levels with different decision-making styles
iv. Identify usual amount and type of information given to patients by cancer 
doctors
v. Identify perceived skills and qualities required to elicit shared decision­
making
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vi. Identify perceived barriers to shared decision-making in practice
vii. Identify perceived facilitators to shared decision-making in practice
viii. Identify support for interventions designed to encourage patient participation.
Stage Two: Semi-structured telephone interviews
Aims are to:
i. Elicit in more details views of doctors to involving patients in treatment 
decisions to explain and inform conclusions drawn from Stage One
ii. Investigate issues and influences experienced by cancer doctors when reaching 
treatment decisions with patients.
HYPOTHESES
• There will be a difference between breast cancer doctors and other cancer 
doctors in their attitudes to shared decision-making
• Medical oncologists in Australia will have more positive attitudes to shared 
decision-making than their surgical counterparts
• Younger doctors will have more positive attitudes to shared decision-making
• The practice setting will influence the attitude of doctors to shared decision­
making.
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CHAPTER TWO 
METHODS 
2.1 Introduction
This thesis incorporates both qualitative and quantitative methodology to collect and 
analyse data and is described as a mixed methods design (Teddlie and Tashakkori 
2003). The research follows a sequential, explanatory design, which places more 
emphasis on the quantitative component and then uses qualitative enquiry to delve 
deeper into the reasons or influences to explain findings from the quantitative data 
analyses (Morse 2003; Cresswell and Plano Clark 2007). Differences between 
quantitative and qualitative research methodology have been described as those of 
breadth versus depth (Patton 2002). Quantitative methods seek standardised and 
limited responses allowing comparison of cases and statistical analysis of the data and 
qualitative methods provide detailed information from a small sample. Mixed 
methods research has advantages over single method research in its ability to produce 
data that represents a superior breadth of views and therefore strengthens assumptions 
drawn (Teddlie and Tashakkori 2003). Mixed methods design is particularly suited 
to projects that seek to demonstrate relationships between variables and explore how 
or why that relationship exists. This thesis presents a quantitative study followed by 
a qualitative study. As described by (Morse 2003), the main drive of the quantitative 
component is deductive, to identify attitudes and behaviours of Australian cancer 
doctors to decision-making with patients, while the qualitative component is driven 
by findings of the quantitative study.
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2.2 Study One Survey of Australian cancer doctors.
2.2.1 Quantitative methodology
Quantitative methodology evaluates evidence and tests theories and hypotheses. 
Scientific methods used in quantitative research may include one or more of the 
following methods: the generation of models, theories and hypotheses; the 
development of instruments and methods for measurement; experimental control and 
manipulation of variables; collection of empirical data; modelling and analysis of 
data; and evaluation of results. The aims of this research project outlined in Chapter 
One lend themselves to quantitative research methodology to gather empirical data 
and conduct analysis and modelling to determine relationships and patterns to inform 
conclusions.
2.2.2 Aims o f quantitative stage
The initial aims of the first stage of this thesis were to gather information from 
practicing Australian oncologists concerning their usual approach and comfort with 
different approaches to decision-making when making treatment decisions with 
cancer patients. Secondary aims included eliciting information on:
• The type of information cancer doctors considered important to give to newly 
diagnosed or newly referred patients;
• Frequency of discussing patient participation in decision-making;
• Doctors’ perception of the role their patients wish to play in deciding on
treatment decisions;
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• Offering of patient choice;
• Giving treatment recommendations;
• Frequency of barriers and facilitators to decision-making process with 
patients; and
• Support of interventions to encourage patient involvement and reflection on 
treatment options prior to decision being made.
2.2.3 Development o f survey instrument
The survey instrument was based on a structured questionnaire developed by Charles 
and colleagues in Ontario, Canada in 1998 through focus groups and pilot-testing 
(Charles, Whelan et al. 2003; Charles, Gafni et al. 2004). The survey assessed the 
validity of the conceptual framework developed by Charles et al (1997; 1999), both in 
its description of the meaning of shared treatment decision-making (STDM) and in 
the agreement of practicing physicians to the key components. With permission, we 
used this questionnaire with some alterations. The survey presented unlabelled 
examples constructed from the conceptual framework presented by Charles and 
colleagues in earlier publications to reflect the following decision-making 
approaches; paternalistic, information-sharing only, informed and shared (Charles, 
Gafni et al. 1997; Charles, Gafni et al. 1999) (See Figure 1). Doctors were asked to 
select which of the examples best reflected their usual approach to treatment 
decision-making with their newly diagnosed or newly referred patients.
The survey included questions covering: use and comfort with decision-making 
approaches; usual information given; discussion of participation with decision-
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making; doctors’ perceived preferred roles of their patients; offering options and 
treatment recommendations; barriers and facilitators to decision-making.
Example 1 Paternalistic
After reviewing the medical records and examining the patient the doctor decides on a suitable 
treatment and presents this to the patient. The doctor gives information about the treatment including 
risks and benefits. The patient accepts the treatment that the doctor recommends.
Example 2 Information sharing only
After reviewing the medical records and examining the patient the doctor presents the available 
treatment options. Information about the risks and benefits of each option are given and discussed 
with the patient. The doctor then recommends a treatment that the patient accepts.
Example 3 Informed
After reviewing the medical records and examining the patient the doctor presents the available 
treatment options. Information about the risks and benefits of each option are given and discussed 
with the patient. The doctor asks the patient to decide on a treatment and states that s/he is the best 
person to make the decision. The patient decides and informs the doctor of the treatment s/he prefers.
Example 4 Shared
After reviewing the medical records and examining the patient the doctor presents the available 
treatment options. Information about the risks and benefits of each option are given and discussed 
with the patient. The doctor invites the patient to ask any questions. The doctor asks what his/her 
preferences for treatment are given his/her lifestyle and the issues that are important to him/her. 
Together they decide on a suitable treatment to implement.
Figure 1 Treatment decision-making examples
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2.2.3.1 Use and comfort with decision-making approaches
Doctors were asked to rate their comfort levels with each of the decision-making 
approaches on a five-point Likert scale, from not comfortable to extremely 
comfortable.
2.2.3.2 Usual information given
Ten items were listed and doctors were asked to indicate the amount of detail they 
usually provide from 1 = no information to 5 = a great deal of information on 10 
topics related to the benefits and risks of treatment option and the impact of treatment 
on the patient’s quality of life.
2.2.3.3 Discussion of patient participation
The survey asked doctors to report whether they had initiated a discussion of how 
much involvement their patients would want to play in the last six months, and if so, 
with what proportion of patients they had discussed this issue with.
2.2.3.4 Perceived preferred roles ofpatients
Doctors were asked what role they perceived their patients wanted to play in making 
treatment decisions. This was a three part question, with doctors reporting the 
proportion of patients who prefer the doctor to make the decision, those who prefer to 
share the decisions and those who prefer to make the decision themselves.
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2.2.3.5 Offering treatment options and recommendation
Two questions elicited ‘yes’ or 'no’ responses to whether doctors offered patients a 
choice when multiple options are available and whether, when options are available, 
doctors usually gave patients a recommendation.
2.2.3.6 Barriers and facilitators to decision-making process
Nineteen potential barriers were listed in the survey and participants were asked to 
rate how often they experienced these as barriers on a four-point Likert scale (never, 
sometimes, often and almost always). Six items considered helpful to the decision­
making process were listed and doctors were similarly asked to report how frequently 
they encountered these in their practice.
Three additional questions were included in the surveys administered to the breast 
and urological cohort. These elicited views concerning which components are 
important to a process of shared decision-making between clinician and patient, and 
support for a number of interventions and initiatives aimed to encourage patients’ 
participation and reflection on treatment decisions. Full versions of the surveys 
administered are presented in Appendices 3-6.
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2.2.4 Design and procedures
2.2.4.1 Participants
Medical and radiation oncologists and surgeons across Australia, whose practice is 
primarily in Oncology, and who specialise in managing people with one of five 
tumour types (breast, colorectal, gynaecological, haematological or urological 
cancers) were invited to participate in the study. Doctors were identified through the 
Australia and New Zealand Breast Cancer Trials Group, the Royal Australian College 
of Surgeons -  Breast Section, the Medical Oncology Group of Australia, the 
Colorectal Surgical Society of Australasia, Australian Society of Gynaecologic 
Oncologists, the Australasian Leukaemia and Lymphoma Group and the Urological 
Society of Australasia. The invitation letter clearly stated that the survey was 
intended for cancer doctors. Doctors who had retired from active practice were 
excluded from the study.
2.2.4.2 Procedures
This was a cross-sectional survey. Permission was sought to obtain contact details of 
all group members from each representative body. If this was granted, the research 
team sent each doctor a package through the mail which included a letter inviting 
their participation and outlining that the survey intended to identify views of cancer 
doctors; an information sheet; a consent form; a copy of the questionnaire; and a 
postage paid envelope. If contact details were not provided the packages were
distributed by the representative body. Written endorsement of the survey was 
sought and obtained from all representative bodies.
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Reminders were dispatched at six and 12 weeks if no response had been received. A 
modified Dillman approach was used to follow up invited participants (Dillman 
1978). The second contact was by mail and comprised a letter reminding the 
participant of the questionnaire and the value their input would bring to the study. 
The third and final contact included a second copy of the questionnaire with a return 
envelope, a letter outlining the aims of the survey and a further reminder of the 
importance of their contribution and the proportion of completed surveys that had 
been received so far. The returned surveys were de-identified. This study was 
approved by the University of Sydney Human Research Ethics Committee.
2.2.5 Data analysis
Demographics and characteristics of the sample were analysed using descriptive 
statistics. Statistical Package for the Social Sciences (SPSS) for Windows Version 14 
was used for all descriptive statistics and correlational analyses.
2.2.5.1 Predictors o f  usual approach to decision-making
Univariate analysis was completed to identify associations between variables and 
usual approach to decision-making and high comfort with shared decision-making. 
For the purposes of this study, identifying and predicting attributes which determine 
use of a shared decision-making approach were particularly noteworthy. Regression
analysis was used to predict usual approach of cancer doctors in our sample. 
Regression analyses are commonly used statistical techniques which seek to 
determine relationships between a dependent variable and a number of independent 
variables (Tabachnick and Fidell 1989). Generally, regression techniques seek to 
identify whether an independent variable is associated with the dependent variable.
Logistic regression analyses were completed with the usual approach, recoded as 
shared or not, and with comfort, recoded as low or high, as the dependent variables in 
multivariate analysis to identify predictors of use of and comfort with shared 
decision-making. Covariates for initial inclusion into the model were identified 
through univariate analysis: all those correlated p<0.25 were included in the model. 
To identify the final predictive factors for retention in the model, we applied 
multivariable logistic regression analysis. The likelihood ratio test in a backwards 
elimination process, with /?<0.05 for a covariate to be retained in the final model was 
used. The extent of model fit was assessed with Hosmer-Lemeshow goodness of fit 
tests. All analyses were performed using SPSS for Windows Version 14.
Multiple linear regression analysis was used to assess predictors of greater reporting 
of barriers to treatment decision-making where more than 2 variables emerged with 
p<0.2. A backwards elimination process, with /?<0.05 for a covariate to be retained in
the final model, was used.
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2.2.5.2 Factor analysis
Factor analysis was used to further explore the data collected concerning barriers to 
involving patients in reaching treatment decisions. To identify and explain 
relationships between variables Exploratory Factor Analysis (EFA) and Confirmatory 
Factor Analysis (CFA) were completed. Exploratory factor analysis allows 
conceptual thoughts to be tested and reveals loadings of items onto a number of 
factors, which can be more concretely classified conceptually and confirmed by CFA. 
Given the preliminary stage of this field it was felt appropriate to use this two-stage 
approach. Factor analysis was chosen as it seeks to discover whether the observed 
variables can be explained largely or entirely in terms of a much smaller number of 
variables called factors. Correlational analyses were conducted prior to all factor 
analyses, permitting inspection of any relationships between items. Factor analysis 
allows classification and description of the data collected, permitting comprehension 
of relationships between the independent variables and improved understanding of 
the information which cancer doctors regard as important in treatment decision­
making consultations with their cancer patients.
Exploratory Factor Analysis
Exploratory Factor Analysis was undertaken using the MS-DOS program Common 
Factor Analysis (COFA 87) (McDonald and Fraser 1987). Using exploratory as well 
as confirmatory analyses allows discovery of features of the data that other methods 
may ignore. Decisions taken during EFA were based on conceptual analysis initially, 
and then confirmed by inspection of the correlations. Three criteria were used to
guide judgments about model fit during EFA: (1) using the Promax oblique rotated 
factor pattern matrix -  all items with a factor loading of >0.3 were considered to be 
loading onto a factor (Tabachnick and Fidell 1989); (2) discrepancy values greater 
than 0.2 were considered indicative of need to revise the model; (3) the psychological 
significance of set of factors was considered.
Confirmatory Factor analysis
The MS-DOS program (CONFA) was used to perform Confirmatory Factor Analysis 
(McDonald and Fraser). Three indices were used to assess the model fit: (1) Steiger 
Lind Root mean square error of approximation (RMSEA), this is an indicator of 
unbiased absolute fit of a given model. A RMSEA value of less than 0.05 equals a 
good fit and a RMSEA value of 0.08-0.10 is considered an acceptable fit; (2) 
Goodness of fit index (GFI). This gives a measure of how well the model fits the 
data as a whole. A value of > 0.90 is considered an acceptable fit; (3) the sizes and 
distribution of the discrepancies between the sample correlations and the fitted 
values. Models are acceptable if the discrepancies are too small to support a more 
complex model (McDonald 1999).
Internal consistency and reliability
Internal consistency determines the certainty of factors within the variables and 
subsequently within the model (Tabachnick and Fidell 1989). This was measured 
using Cronbach’s alpha. A co-efficient alpha of 0.7 or more is considered to indicate 
high reliability of a scale (Streiner and Norman 1995). McDonald has asserted that
the coefficient alpha frequently underestimates factor reliability and suggests that the 
coefficient Omega gives a more accurate estimation of reliability (McDonald 1999). 
Therefore, the coefficient alpha and coefficient omega are reported to evaluate 
internal consistency and reliability of the factor analysis. Omega is based on the 
parameters of the items in the factor model. Omega is determined by summing the 
factor loadings; summing the unique variances; and then dividing the square of the 
summed loadings by itself and adding the sum of unique variances. As stated above, 
one of the research aims of the quantitative component of this thesis is to identify 
predictors of usual approach to treatment decision-making with cancer patients. 
Factors with low or moderate reliability coefficient loadings are considered useful for 
such purposes.
2.2.6 Sample size and power
A-priori sample size calculations were conducted based on the primary outcome of 
use or not of shared decision-making as participants’ usual approach to decision­
making. The study completed in Canada gave us an anticipated proportion of 
approximately 60% who would report shared decision-making as their usual 
approach. Sample size calculations were based on the precision required for point 
estimates within 95% confidence intervals of ± 5%. The following calculations show 
the workings for the sample size calculation for the survey.
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95% Cl = 
thus
SE(p)= 
that is
v
n—
ifp=60% 
n -
The minimum sample that would be expected to achieve the required accuracy is 369.
This study proposed to identify predictors of usual approach to decision-making. 
Sample size and power calculations were undertaken to allow for six potential 
predictors for the regression model. The following calculation was conducted to 
establish the required sample size for the proposed regression analyses. Guidelines 
recommended for the minimum number of events per variable for multivariate 
analysis suggest 10-20 events per variable (Peduzzi, Concato et al. 1996).
Reliability of a model is considered dependent on the sample size; a sample of 100- 
200 participants is recommended (Streiner and Norman 1995). Cohen (Cohen 1992)
p±1.96xSE(p) 
1.96 xSE (p) = 5
1.96
SE (p) = 2.55
/?(100-/7) =2.55
P{ 1 00~P) cc2=2.55 = 6.50
Ml 00-P) 
6.50
60x40
6.50 =369
provides guidance for small, medium and large effect sizes (ES) with Power =0.80 
and significant tests at a=.01, .05, and .10. He reports that for multiple regression 
analyses with 6 predictors using significance a=.01 for all tests requires a sample of 
134 for an expected medium ES.
Using the predicted prevalence of 60% of the dependent variable, used of shared 
decision-making or not, six potential predictors, and the 10 events per variable rule of 
thumb, the calculated sample required equals 150.
(6x10)x 100100-60
60x 10040 150
Results of the quantitative component of this thesis are presented in Chapters Three 
and Four.
2.3 Study Two: Qualitative interviews with cancer doctors
Mixed methods research is increasingly common in psycho-social research and 
proves itself to be a reliable method to investigate research issues. Strengths of a 
mixed methods approach to a research question include the ability to gain different 
perspectives of participants to an issue. Commonly, when using quantitative and 
qualitative methods, one approach supplements findings from the other (Morse 2003). 
For the purpose of this thesis, qualitative methodology was elected to explain and 
understand in more detail the findings of the quantitative component. Further, having 
collected data from a large sample of practicing Australian cancer doctors, it was
possible to select participants who reported divergent views and practices towards 
shared decision-making.
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2.3.1 Qualitative methodology
Qualitative methodology allows researchers to study the meanings which people 
ascribe to real situations, through collection of empirical data by observation or 
interviews or collection of written documents (Patton 2002). The three major 
approaches to qualitative research are ethnography, phenomenology, and grounded 
theory. Ethnography focuses on the study of a culture and is chiefly viewed as an 
anthropological approach, although a cultural group can be an organisation or club. 
Participant observation is a common example of the field work which occurs in this 
approach, where the researcher immerses him or herself in the community or culture 
to observe from within. Phenomenology focuses on the desire to understand the 
world through the experiences and descriptions of others, using participants’ 
subjective experiences. The grounded theory approach was established in the 1960s 
and research using this approach aims to generate theory from observation. Common 
features of qualitative research include a focus on meaning and understating, 
recognition of the role the researcher plays in the process, the concurrent collection 
and analysis of the data and the subsequent dynamic nature of the research design. 
The purpose of the research is important as this affects the selection of a design 
method, sampling and analysis. Decisions regarding those issues need to take into 
account whether the purpose is: to establish or contribute to knowledge or theory 
(basic research); to describe or bring attention to an issue (applied research); to
establish a program’s efficacy (summative evaluation); to improve a program 
(formative evaluation); or to find a solution to a particular problem (action research).
This study uses a phenomenological theoretical base, using the experiences of cancer 
doctors to understand when, why and how they involve patients in reaching treatment 
decisions.
2.3.2 Sampling strategy and participants
Purposeful sampling is appropriate where the research focus is to gain a detailed 
understanding and this underlines the difference between quantitative and qualitative 
methodologies (Patton 2002). Such sampling aims to achieve information rich data. 
Within purposeful sampling there are a number of strategies for identifying the 
participants or cases which will yield the most applicable results. Some researchers 
may be interested in the extreme or outlier cases to learn more about distinctive or 
unusual views or events. A similar strategy known as intensity sampling focuses on 
the information rich cases which best explain or give details of a particular issue, but 
do not represent extreme or outlier views. Other strategies focus on a particular 
subgroup to maximise homogeneity, or a snowball effect by eliciting from 
participants recommendation for the next person or case to be included in the sample.
Grounded theorists typically use theory guided by real world observations to examine 
the range of issues which a concept may encompass. In exploratory research where 
researchers are looking to identify new patterns, sampling can lead from the
exploratory to the confirmatory phase of pattern identification. Explanatory 
strategies include critical case sampling or criterion sampling, where criteria which 
must be met are identified. Maximum variation sampling seeks to elicit detail on 
certain key themes across a varied sample and is particularly useful where a larger 
sample is available from which a representative sample is sought. Heterogeneity can 
be achieved across the whole sample although stratification can be used to focus on 
key characteristics which researchers wish to ensure are represented and aims at 
achieving generalisation of the whole populations whilst allowing the possibility of 
statistically valid comparisons between characteristics such as gender or education 
level (Patton 2002).
The major question of this thesis is to identify doctor attitudes to involving cancer 
patients in treatment decisions. We used a purposeful sampling strategy to gather 
data from doctors who had reported in a previous national study (Shepherd, Tattersall 
et al. 2007) adopting as their usual style a variety of approaches (doctor-led, shared or 
patient-led) and who treated a variety of cancers (breast, colorectal, gynaecological, 
haematological and urological cancer). It was thought that these different treatment 
contexts might highlight contextual factors influencing attitudes to shared decision­
making.
Participants were purposefully selected using a stratified maximum heterogeneity 
strategy. Participants would each represent one of the three key approaches to 
decision-making and one of the five cancer specialties. This method would then
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ensure maximum heterogeneity of the collected qualitative data in terms of the 
reported different approaches to decision-making and cancer practice and allow 
identification of different views concerning when or where patients’ involvement was 
considered more or less appropriate.
A planned matrix was developed focusing on the usual approach and cancer types 
(see Figure 2). Where certain cells afforded numerous potential participants, 
attention was paid to the clinical discipline and gender of the participant, to maximise 
a representative sample for these additional attributes.
B R E A S T C O L O R E C T A L G Y N A E C O L O G IC A L H A E M A T O L O G IC A L U R O L O G IC A L
3 x  D r led 3 x  D r led 3 x  D r led 3 x  D r led 3 x  D r led
3 x  P t le d 3 x  P t le d 3 x  P t le d 3 x  P t le d 3 x  Pt led
3 x  Sh ared 3 x  Sh ared 3 x  Shared 3 x  Shared 3 x  S h ared
9 9 9 9 9
Figure 2 Proposed Sample Matrix
It was thought a priori that 15 participants in each decision-making group and 9 
within each cancer site group would be sufficient to allow saturation of themes; that 
is, that no new data would emerge after these numbers of participants were 
interviewed. Actual recruitment outcomes are described in the Results in Chapter
Five.
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2.3.3 Procedure
2.3.3.1 Data collection
Participants in our earlier quantitative study (Shepherd, Tattersall et al. 2007) who 
had agreed to a further qualitative interview were randomly contacted within the 
strata described above, to obtain consent to this stage of the study. Consenting 
doctors participated in a semi-structured telephone interview exploring their views 
about involving patients in decision-making. Research interviews are a common 
method to collect data and are described as a method of hearing the perspective of 
study participants with an underlying assumption that that perspective is sought, 
either due to the knowledge or experience or both of the participants and as a means 
to gather information and gain increased understanding of the research topic (Patton 
2002; Gillham 2003).
The decision to use semi-structured telephone interviews was based on a number of 
factors. First, the data collected from Stage One of this thesis identified a number of 
themes that seemed important to further explore. It was therefore necessary to ensure 
a level of standardisation across the proposed interviews to ensure that those themes 
were explored consistently and to allow comparison across groups.
Second, telephone interviews were primarily used as the geographical locations of the 
sample spanned the breadth of Australia. Furthermore it has been suggested that the 
anonymity that telephone interviews provide enhances the quality of data collected by
increasing participants’ willingness to speak openly and reducing social desirability 
bias (Carr and Worth 2001).
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Our questions probed a number of themes which emerged from the quantitative data 
we collected previously (Shepherd, Tattersall et al. 2007). The list of semi-structured 
questions is provided in Figure 3 and is included in the appendices (Appendix 9). 
The interviews were audio-recorded and fully transcribed. This study was approved 
by the University of Sydney Human Research Ethics Committee, approval no. 
HREC7575.
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1. Can you tell me what you think are the most important features of involving patients in decision making?
2. What do you think about involving patients in making treatment decisions?
• What about it is good or bad for the patient?
• What about it is good or bad for you?
• What about it is good or bad for the health system as a whole?
3. GPs have said that shared decision-making is useful in some situations (e.g. AF, menorrhagia, HRT,) but not in 
others. Do you think there are situations where shared decision-making is more appropriate than others? If so, 
what are they? Which clinical scenarios?
(If respond with “where there is clear choice”) How do you determine when there is clear choice?
4. How do you determine if the patient views this in the same way you do? E.g. patients may be interested in the 
no treatment option?
5. Do you think it is ever appropriate not to disclose a treatment option? For example, if it is expensive and you 
know the patient has a limited income?
6. Are there circumstances in which you either have not or might disclose a clinically relevant option to a 
particular patient?” (or might not disclose an option that you would sometimes mention to other patients with the 
same diagnoses)
7. Can you describe how you would normally present treatment options to your patients? Do you list them in 
order of your preference/recommendation? Do you present equal amounts of information on each? Do you spend 
more time on the ones you think are more appropriate?
8. In our survey doctors who treated breast and urological cancers were more positive about shared decision­
making than others. Why do you think that might be?
9. Some patients don’t want shared decision-making. To what extent do you think patients vary in terms of their 
preferences for shared decision-making?
10. Do you establish if your patients want to participate in decision making?
11. How do you establish whether your patient wants shared decision-making?
• In your experience what sorts of patients tend to like and dislike shared decision-making?
• In what senses do you think patients like/dislike shared decision-making? Or are there particular aspects 
which patients like/dislike?
12. Would you ever encourage passive patients to participate or do you simply accept their passivity? How do 
you decide which patients to push a little? How would you go about encouraging them to shared decision­
making?
13. In our survey, some doctors reported that some patients are incapable of shared decision-making because they 
are too anxious, or lack understanding of their disease status and/or the information they receive- do you agree?
• Can you give an example of a patient who could not share decision-making?
14. In your experience does shared decision-making take up extra time? Does it ever save time down the track?
15. Do you routinely offer a patient a follow-up consultation so they have time to think about the treatment 
choice?
• What might prohibit this approach?
16. How, if at all do you think shared decision-making impacts on your own and the patient’s responsibility for 
the decision? Does shared decision-making shift the ultimate decision responsibility? How easy or difficult is 
this for you and for the patient?
• For you? How?
• For the patient? How?
Figure 3 Questions for semi-structured telephone interviews
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2.3.4 Qualitative data analysis
Analysis of qualitative data requires researchers to make sense of large amounts of 
data, identifying data that are significant, in a similar vein to quantitative data 
analysis. Numerous guidelines for qualitative analysis exist, however there are 
minimal fixed rules, each study has unique elements, and interpretation by the analyst 
is governed by experience, skill and ability. According to Patton (2002) it is 
important to identify a framework for organising data, establishing whether findings 
are guided by an individual case and variation between individual cases (case 
analysis) or whether a topic is the main issue and answers and responses to questions 
or themes by individual cases are what will be reported (cross case analysis). 
Thematic analysis is described as a flexible analytical method which is able to 
provide a detailed and complex account of data (Braun and Clarke 2006). Thematic 
analysis can be inductive or theoretical depending on whether the researcher seeks to 
identify themes and patterns from the data alone (inductive) of whether the researcher 
is guided by theoretical or analytic interest (theoretical); however it is important to 
note that themes are guided by the researcher and more importantly by the research 
question. Cross case analysis can then be used to compare or contrast themes with 
experiences across individuals (Patton 2002).
In this study, a theoretical thematic analysis approach was used to identify key 
themes from the data. These themes were guided by intentions to answer questions 
which had emerged from stage one of this project. Following this thematic analysis 
approach, the data collected were analysed using cross case analysis, focussing on
doctors reported usual approach to decision-making and the type of cancer treated. 
The first four transcripts were read and themes and subthemes identified by the 
research team, HS, PB MT. These themes were discussed, differences in coding 
decisions were discussed until a common approach was agreed upon and a coding 
tree was developed. The remaining transcripts were coded (HS) by listening to the 
audio files and by reading the transcripts. Additional subthemes were coded and the 
final coding tree was discussed and reviewed by the research team. These themes 
were then described and compared across cases. All transcripts were then recoded in 
a different order to minimise possibility of coding fatigue on the last transcripts. Data 
were organised using NVivo7, an established computer program which assists 
management of large amounts of qualitative data. Finally the completed analysis was 
reviewed by HS and PB and small changes in coding were agreed upon.
Results of the qualitative component of this thesis are presented in Chapters Five, Six
and Seven.
SECTION TWO
STAGE ONE RESULTS AND 
DISCUSSION
Chapters Three and Four present the results of Stage One of this thesis and some 
discussion regarding their meaning and implications. Chapter Three, the results of 
surveying Australian cancer doctors regarding their usual approach to decision­
making and their reported comfort levels with different decision-making style, has 
been published in the British Journal of Cancer in 2007. The pdf document of this 
manuscript is included in the appendices (See Appendix 9).
Chapter Four presents the reported barriers and facilitators to involving patients in 
decision-making. These results have published in the Journal of Clinical Oncology in 
April 2008. (See Appendix 10).
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CHAPTER THREE
USUAL APPROACH AND COMFORT WITH SHARED 
DECISION-MAKING, AND INFORMATION EXCHANGE IN 
THE CONSULTATION
3.1 Sample
Of 1198 total surveys mailed, 136 were returned and regarded as being ineligible 
(doctor retired, deceased, not clinically active, overseas, incorrect address). From the 
remaining 1062 eligible participants, 632 surveys were returned, a response rate of 
59%. Eight respondents declined to participate. This response rate is comparable to 
the mean response rate of 54% for physician surveys (Asch, Jedrziewski et al. 1997). 
Twenty of the surveys were completed by clinicians who reported that they did not 
treat patients in the five targeted tumour groups; therefore these data were excluded 
from statistical analysis.
The response rate was higher in the groups where the researchers contacted the 
participants directly, perhaps because the mailing list being used by the professional 
society did not exclude retired or non-practicing doctors. Within the non­
respondents, tumour specialties were; breast 30%; colorectal 10%; gynaecological 
2%; haematological 9%; urological 42%, 7% unknown. The high non-responders in 
the urological cohort may reflect the mail out method in this group. Excluding the 
urological cohort on whom we had no information, 89% of the non-responders were
male. Comparison of these characteristics with the study sample reveals no notable 
differences.
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Table 1 shows the demographics of the 604 participating clinicians. Males (83%) 
made up the larger proportion of the sample. The mean age of the sample was 50 
years and the mean time since medical qualification was 26 years The majority 
(68%) worked >20 hours per week in direct patient care. The majority (59%) worked 
in community sizes of >500,000.
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Table 1 Demographics of sample
V ariab le N (% )#
C an cer typ e treated
B reast 3 0 8  (5 1 .0 )
C o lo re c ta l 7 9 ( 1 3 .1 )
G y n a e c o lo g ic a l 2 7  (4 .5 )
L e u k a e m ia /ly m p h o m a 83 (1 3 .7 )
U ro lo g ic a l 1 0 7 (1 7 .7 )
P h ysic ian  d iscip lin e
M e d ica l O n c o lo g is t 126 (2 0 .9 )
R a d ia tio n  O n c o lo g is t 51 (8 .4 )
S u rg e o n 3 5 4  (5 8 .6 )
H a e m a to lo g is ts 61 (1 0 .1 )
P a e d ia tr ic  O n c o lo g is t 1 2 ( 2 .0 )
G en d er
M a le 503  (8 3 .3 )
F e m a le 101 (1 6 .7 )
C ou n try  o f  m edica l sch oo l atten d ed
A u s tra la s ia 55 2  (9 1 .7 )
U K /E u ro p e /C a n a d a  &  S o u th  A fr ic a 4 0  (6 .6 )
A s ia /S E  A s ia /M id d le  E ast 1 0 ( 1 .7 )
D irect pt care per w eek
<  2 0 h rs 170 (3 1 .2 )
2 0 h rs  o r  m o re 375  (6 8 .8 )
C om m u n ity  size
< 1 0 0 ,0 0 0 41 (7 .5 )
1 0 0 ,0 0 0 -5 0 0 ,0 0 0 184 (3 3 .8 )
M o re  th a n  5 0 0 ,0 0 0 3 1 9 ( 5 8 .7 )
C aseload  o f  new  pts per m onth
0  to  6 313  (5 2 .3 )
7 + 2 8 5 (4 7 .7 )
M e d ia n 3-6  n ew  p ts  p e r  m o n th
A g e  - M ean 5 0 y rs  (3 2 -7 9 y rs )
Y e a rs  s in c e  g ra d u a tio n  - M ean 2 6 y rs  (4 -5 6 y rs )
percentages based on valid cases only; w ith specified cancer
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3.2 Usual approach to decision-making
The majority reported that their usual approach to decision-making with cancer 
patients was most like the shared decision-making approach (see Table 2). The 
paternalistic approach and the informed decision-making approach were selected by 
fewer doctors.
Table 2 Usual approach to decision-making and comfort levels with each 
approach
U s u a l
a p p r o a c h
N o t
c o m fo r ta b le
1
S o m e w h a t
c o m fo r ta b le
2
N e u tr a l
3
V e r y
c o m fo r ta b le
4
E x tr e m e ly
c o m fo r ta b le
5
N  (% ) N  (% ) N  (% ) N  (% ) N  (% ) N  (% )
P a te rn a lis t ic  
(E x a m p le  1)
6 ( 1 .0 ) 198 (3 7 .1 ) 144 (2 7 .0 ) 8 5 ( 1 5 .9 ) 6 0 ( 1 1 .3 ) 4 6  (8 .6 )
In fo rm a tio n  s h a r in g  
(E x a m p le  2 )
1 3 8 ( 2 3 .2 ) 3 9 ( 7 .3 ) 95  (1 7 .8 ) 135 (2 5 .3 ) 154 (2 8 .9 ) 1 1 0 (2 0 .6 )
In fo rm e d  
(E x a m p le  3 )
4 9  (8 .2 ) 7 3 ( 1 3 .7 ) 1 1 8 ( 2 2 .1 ) 1 1 5 ( 2 1 .5 ) 145 (2 7 .2 ) 8 3 ( 1 5 .5 )
S h a re d  
(E x a m p le  4 )
3 7 2  (6 2 .4 ) 1 1 ( 2 .1 ) 23  (4 .3 ) 4 9  (9 .1 ) 133 (2 4 .8 ) 3 2 0  (5 9 .7 )
N o n e  o f  th e s e 1 (0 .2 )
O th e r 3 0 ( 5 .0 )
Most doctors (82%) reported initiating a discussion about participating in decision­
making with their patients; however only 62% instigated this dialogue with more than 
half of their patients. Offering treatment options when available was almost
unanimously supported (98%).
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3.3 Comfort with different approaches to decision-making
Comfort levels with each of the four decision-making approaches are shown in Table 
2. The model with which most doctors (84%) reported being most comfortable was 
the shared decision-making approach, 37% reported being least comfortable with the 
paternalistic model.
3.4 Information giving
The amount and type of information doctors routinely gave to newly diagnosed or 
newly referred patients varied according to specialty (Table 3). Items which doctors 
gave the most information about were extent of disease, treatment procedures and 
benefits and risks. Items about which doctors gave the least information were effects 
of treatment on family, sexuality and mood. The amount of information given was 
scored out of 50; the mean score was 37.38, std. dev 5.372.
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Table 3 Amount of information given to new patients
N o A  li t t le S o m e Q u ite  a b it  o f G r e a t  d e a l  o f
in fo r m a t io n in f o r m a t io n in fo r m a t io n in f o r m a t io n in f o r m a t io n
1 2 3 4 5
N  ( % ) N ( % ) N  (% ) N  (% ) N  (% ) M e a n  (S D )
E x ten t o f  th e  d isea se 1 (0 .2 ) 4 ( 0 .7 ) 37  (6 .2 ) 233  (3 8 .8 ) 326  (5 4 .2 ) 4 .4 6  (0 .6 5 8 )
D etails  o f  tre a tm e n t 
p ro ced u re s
1 (0 .2 ) 0 ( 0 ) 2 2  (3 .7 ) 193 (3 2 .1 ) 385 (6 4 .1 ) 4 .6 0  (0 .5 7 8 )
B enefits  o f  tre a tm e n t 1 (0 .2 ) 0 ( 0 ) 1 8 (3 .0 ) 2 34  (3 9 .1 ) 34 6  (5 7 .8 ) 4 .5 4  (0 .5 7 3 )
R isks (s id e  e ffe c ts )  o f  
tre a tm e n t
1 (0 .2 ) 2 (0 .3 ) 36  (6 .0 ) 2 3 7 (3 9 .5 ) 32 4  (5 4 .0 ) 4 .4 7  (0 .6 4 0 )
Im p ac t o f  tre a tm e n t 
on  sex u a lity
34  (5 .7 ) 1 2 8 (2 1 .4 ) 189 (3 1 .6 ) 136 (2 2 .7 ) 111 (1 8 .6 ) 3 .2 7 (1 .1 5 8 )
C h an g e s  in 
ap p ea ra n c e  d u e  to  
tre a tm e n t
22  (3 .7 ) 6 3 (1 0 .5 ) 197 (3 2 .9 ) 2 1 8 (3 6 .4 ) 9 9 (1 6 .5 ) 3 .5 2 (1 .0 0 6 )
E ffec ts  o f  tre a tm e n t 
o n  m ood
41 (6 .8 ) 135 (2 2 .5 ) 24 7  (4 1 .1 ) 133 (2 2 .1 ) 45  (7 .5 ) 3.01 (1 .0 1 0 )
E ffec ts  o f  tre a tm e n t 
o n  fam ily
51 (8 .5 ) 179 (2 9 .8 ) 223 (37 .1 ) 1 0 7 (1 7 .8 ) 41 (6 .8 ) 2 .85  (1 .0 3 3 )
E ffec ts  o f  tre a tm e n t 
o n  so cia l a c tiv itie s
22  (3 .7 ) 1 1 4 (1 9 .0 ) 233  (38 .8 ) 178 (2 9 .7 ) 53 (8 .8 ) 3.21 (0 .9 7 2 )
E ffec ts  o f  tre a tm e n t 
o n  p a tie n ts ’ ab ility  to 
c a re  fo r th e m se lv e s  a t
1 5 (2 .5 ) 7 2 (1 2 .0 ) 194 (3 2 .4 ) 2 2 9 (3 8 .2 ) 8 9 (1 4 .9 ) 3.51 (0 .9 6 9 )
T o ta l in fo rm a tio n  
g iv in g  sco re
3 7 .3 8 (5 .3 7 2 )
SD : s tan d a rd  d ev ia tio n
Comparing the mean scores of amount of information given by clinicians according 
to their usual approach to decision-making revealed that doctors using shared 
decision-making gave significantly more information (mean score 38.27) than doctors 
who reported not using shared decision-making (mean 35.86), p<0.001. (See Figure 
4) This may reflect the emphasis on information exchange and attendance to patient 
preferences in shared decision-making, although the difference translates into less 
than one additional information item and is unlikely to have clinical implications.
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Approach to decision making
□ Doctor led ■ Shared □ Patient led
Figure 4 Information giving and usual approach to decision-making
3.5 Clinician perception of patient role preference
Forty-five percent of doctors reported that more than half of their patients preferred to 
share decision-making responsibility with their doctors (see Table 4). When this 
response was examined by specialty and doctor discipline, more urological (55.1%) 
and breast (53.4%) cancer doctors reported that more than half of their patients 
wanted to share responsibility than colorectal (33%), haematological (22%) and 
gynaecological (19%) cancer doctors. Similarly more medical oncologists (58%) 
than other disciplines reported that more than half of their patients wanted to share 
decision-making responsibility. The other disciplines stated that the majority of their 
patients wanted the doctor to take the decision-making responsibility. Very few
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clinicians (<10%) felt that the majority of their patients wanted to take the lead in this
process.
Table 4 Perception of patient preferred role (% of doctors who reported the role
>50% of their patients preferred)
D o c t o r  t a k e s  
f u l l
r e s p o n s ib i l i t y
N  ( % )
S h a r e
r e s p o n s ib i l i t y
N  ( % )
P a t i e n t  t a k e s  
f u l l
r e s p o n s ib i l i t y
N  ( % )
C h i  s q u a r e ^ ’ 
( d f )
C a n c e r  s p e c i a l t y / ( 4 ) = 1 7 . 1 6 "
B reast 80 (2 6 .8 ) 159 (53 .4 ) 4 ( 1 .3 )
C o lo rec ta l 41 (5 2 .6 ) 26  (3 3 .3 ) 1 (1 .3 )
L eu k aem ia  /  L y m p h o m a 43 (5 3 .8 ) 18 (2 2 .5 ) 1 (1 .3 )
G y n aeco lo g ica l 1 6 (6 1 .5 ) 5 (1 9 .2 ) 0 (0 .0 )
U ro lo g ica l 22  (2 0 .6 ) 59  (5 5 .1 ) 2 ( 1 .9 )
D r  T y p e f ( 4 ) = 3 1 .1 3 "
M edica l O n co lo g is ts 29  (2 4 .2 ) 70 (58 .3 ) 2 ( 1 .7 )
R ad ia tio n  O n co lo g is ts 22  (4 4 .0 ) 15 (30 .0 ) 0 (0 .0 )
H aem a to lo g is ts 31 (5 2 .5 ) 11 (18 .6 ) 0 (0 .0 )
P aed ia tric  O n co lo g is ts 5 (4 5 .5 ) 4 (3 6 .4 ) 1 (9 .1 )
S u rg eo n s 115 (3 3 .0 ) 167 (4 7 .9 ) 5 ( 1 .4 )
df: d eg rees  o f  freed o m , * /?<0.01
3.6 Predictors of usual approach to decision-making
The original 4 category response to usual approach to decision-making was collapsed 
into 2 categories, shared decision-making or not. This decision was taken as only 
example 4 describes shared decision-making fully, incorporating sharing of decision­
making responsibility, encouragement of patient involvement and discussion of 
patient preferences and values relevant to the situation.
We analysed the data using crosstabs and chi square to identify significant predictors 
of usual approach to decision-making. Univariate analysis results are presented in 
Table 5.
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More medical oncologists (66%) and surgeons (66%) reported using a shared 
approach than other doctors. The duration of direct patient care per week and the size 
of the community in which the doctors practiced did not influence approach to 
treatment decision-making. More doctors specialising in breast or urological cancer 
reported using a shared approach than doctors specialising in colorectal, 
gynaecological or haematological cancer. To further explore these results the 
clinicians were grouped into those treating cancers with well known preference- 
sensitive decisions and those where there are not. Breast and urology cancer doctors 
(prostate cancer) were combined to form the preference sensitive group (n=415) and 
colorectal, gynaecological and leukaemia/lymphoma doctors were grouped as the 
non-preference sensitive group (n=189). This variable was included in the 
multivariate analysis reported below.
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Table 5 Univariate analyses of usual DM approach by doctor characteristics.
N o n -S h a red
N (%)
S h ared
N (%)
C h i sq u a r e ^  
(d f)
D r ty p e
Medical Oncologists 42 (33.9) 82 (66.1)
X2(4)=l 5.240**
Radiation Oncologists 24 (48.0) 26 (52.0)
Surgeons 118 (33.8) 231 (66.2)
Haematologists 32 (52.5) 29 (47.5)
Paediatric Oncologists 8 (66.7) 4(33.3)
T u m o u r  ty p e
Breast 99 (32.9) 202 (67.1) X2(4)= 37.256**
Colorectal 42 (53.8) 36 (46.2)
Leukaemia / Lymphoma 44 (53.0) 39 (47.0)
Gynaecological 16(59.3) 11 (40.7)
Urological 23 (21.5) 84 (78.5)
C a n cer  sp e c ia lty
Breast and urological 122 (29.9) 286 (70.1) X2(l)=32.538**
Colorectal, gynaecology and haematology 102 (54.3) 86 (45.7)
G en d er
Male 198 (39.9) 298 (60.1)
X2(l)= 6.873**
Female 26 (26.0) 74 (74.0)
A ge
Under 40yrs 25 (29.4) 60 (70.6)
X2(2)=2.802
40-55yrs 125 (39.2) 194 (60.8)
Over 55yrs 73 (38.2) 118(61.8)
C o u n try  o f  m ed ica l tra in in g
Australia 195(36.4) 341 (63.6)
X2d )= 2.313
Other 27(46.6) 31 (53.4)
N ew  pt C a se lo a d  p er m on th
2 or less 38 (47.5) 42 (52.5)
X2(3)=l 0.345*
3-6 90 (39.6) 137(60.4)
7-10 56 (38.4) 90 (61.6)
11 + 37 (27.0) 100 (73.0)
D irect pt ca re  h rs/w eek
<20hrs 63 (38.0) 103 (62.0)
X2(l)=0.694
20hrs+ 127 (34.2) 244 (65.8)
C o m m u n ity  size
<100,000 12(30.0) 28 (70.0)
X2(2)=7.06
100,000-500,000 63 (34.8) 118(65.2)
500,000+ 115 (36.5) 200 (63.5)
(df) degrees of freedom * p<0.05, **¿><0.01
Binary logistic regression was performed of usual approach to decision-making 
(shared or non-shared) using independent variables with chi squares of p< 0.25. 
Variables entered in the model were cancer type (breast and urological doctors v. 
colorectal, gynaecological and haematological doctors, gender, age (3 groups), new 
patient caseload per month (2 or less, 3-6, 7-10 or >11) and country of medical 
training (Australia versus elsewhere). A backward stepwise likelihood ratio model 
was used; non-shared was the reference category of the dependent variable. The final 
model has a chi square of 51.31, df = 5, /?<0.001. Goodness of fit is supported by the 
Hosmer-Lemeshow Test; chi square 4.62, df =7, p=0.71.
Doctors practicing in breast or urological cancer were three times as likely to use a 
shared approach compared to colorectal, gynaecological or haematological doctors 
(/K0.001, OR 3.02, 95% Cl 2.08^4.37). Doctors reporting the highest numbers of 
new patients per month had 2.8 times the odds of using a shared approach (p<0.005, 
OR 2.81, 95%CI 1.54-5.16). Female doctors had 1.9 times the odds of using shared 
approach compared to their male colleagues (p<0.001, OR 1.87, 95%CI 1.13-3.10). 
Variables not independently associated with usual approach to decision-making were: 
country of medical training and age. (See Table 6)
Table 6 Multivariate logistic regression predicting usual approach to decision­
making
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Independent Variables (3 (SE) Wald chi square AOR (95%CI)
__________________________________________________________(X:)(dO_______________________
Age 0.00 (0.14) x2( 0  = o.oo 1.00 (0.75- 1.33)
Country of 
training
Australia 0.42 (0.30) X2 (1 )=  1-98 1.52(0.85- 2.74)
Other
Caseload 0-2 X2 (3) =11.33* 1-
3-6 0.53 (0.27) X2 ( 0  = 3.78 
X2 ( 0 - 3 .7 4
1.71 (1.00-2.92)
7-10 0.57 (0.29) 1.77 (0.99-3.14)
>11 1.03 (0.31) X2 (1) =11.23** 2.81 (1.54-5.16)
Cancer specialty Colorectal, Gynae 
& Haematological 
Breast & 
Urological
1.10(0.19) X2 (l)-3 3 .9 4 * * 3.02 (2.08- 4.37)
Gender Male 1-
Female 0.63 (0.26) X2 ( l ) -5 .9 9 * 1.87(1 .13-3 .10)
SE: standard error; df: degrees of freedom; AOR: adjusted odds ratio; 95%CI: 95% confidence 
interval
* p<0.05, **/3<0.01_________________________________________________________________
3.7 Predictors of comfort with shared decision-making
Univariate analysis was undertaken for high comfort with shared decision-making 
(See Table 7). Shared decision-making was rated with the highest comfort levels by 
doctors treating breast or urological cancers, (88%). Medical (89%) and radiation 
oncologists (78%) and surgeons (84%) reported being most comfortable with the 
shared approach.
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Table 7 Univariate analyses of high comfort levels with shared decision- 
making#
High comfort with SDM Chi square^ (df) 
________ N (%)______________________________
Dr type X2(4)=4.95
Medical Oncologists 105 (89.0)
Radiation Oncologists 39 (78.0)
Haematologists3 4 (66.7)
Paediatric Oncologists 9(81.8)
Surgeons 296 (84.3)
Cancer specialty
Breast and urological 360 (87.6) X2(l)=12.74"
Colorectal, gynaecology and 
haematology
93 (74.4)
Gender
Male 372 (83.0) r(2)=4.56*
Female 81 (92.0)
Age
Under 40yrs 65 (86.7) X2(2)=0.42
40-55yrs 241 (83.4)
Over 55yrs 146 (84.6)
Country of medical training
Australia 412(84.4) X2(1)=0.00
Other 39(84.8)
Caseload per month
2 or less 62 (81.6) X2(3)=6.65
3-6 162 (80.6) P=0.084
7-10 111 (86.7)
11 + 113 (90.4)
Direct pt care hrs/week
<20hrs 137(82.5) X2(l)=0.70
20hrs+ 315 (85.4)
Community size
<100,000 34 (85.0) X2(2)=1.27
100,000-500,000 158 (86.8)
500,000+ 259(83.0)
#
Percentages here represent respondents who reported comfort levels o f 4 or 5 on the 5 point Likert scale, 1 =not 
comfortable, 5 =very comfortable.
><0.05 *><0.01
3 An initial decision to shorten the survey for participants other than breast cancer specialists, excluding the question 
concerning comfort levels with each of the four decision making examples was reversed mid way through sending the 
survey to second cohort (haematologists) and explains the small number of responses in this group for these questions.
We performed binary logistic regression of comfort with shared decision-making 
(low comfort or high comfort) using independent variables with chi squares of < 0.25. 
Variables entered in the model were cancer type (breast and urological doctors v. 
colorectal, gynaecological and haematological doctors), doctor gender and new 
patient caseload per month. A backward stepwise likelihood ratio model was used; 
low comfort was the reference category of the dependent variable. The final model 
has a chi square of 23.55 df = 5, /?<0.001. Goodness of fit is supported by the 
Hosmer-Lemeshow Test; chi square 10.55, df=6, p=0.10.
In multivariate regression analysis doctors practicing in breast or urological cancer 
were 2XA times as likely to be very comfortable with shared decision-making 
compared to colorectal, gynaecological or haematological doctors (p<0.001, OR 2.53, 
95% Cl 1.52-4.24). Female doctors had 2.3 times the odds of being very comfortable 
with shared decision-making compared to their male counterparts (p<0.05, OR =2.31, 
95% Cl 1.01-5.27). Overall caseload did not produce a significant result however 
doctors reporting the highest numbers of new patients per month showed 2.3 times 
the odds of being very comfortable using shared decision-making (p=0.05, OR 2.33,
95%CI 0.10-5.44). (See Table 8)
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Table 8 Multivariate logistic regression predicting high comfort with shared 
decision-making
In d ep en d en t V a r ia b le s ß (SE) W a ld  chi 
sq u a re  ( x : ) (d f)
A O R  (9 5 % C I)
C a n cer Colorectal, Gynae &
sp ec ia lty Haematological
Breast & Urological 0.93  ( 0 .26 ) x2 ( 0  = 2.53  ( 1.52- 4 .24 )
12 .5 8 **
C a se lo a d 0-2
3-6 0 . 1 0 ( 0 .35 ) x2 ( 1) =  0.80 1.11 ( 0 .55 - 2 .22 )
7-10 0.56  ( 0 .40 ) X2 ( 1) =  1-95 1.76 ( 0 .80 - 3 .88 )
>11 0.84  ( 0 .43 ) X 2 ( 0  =  3.82 2.33  ( 1.00 - 5 .44 )
G en d er Male 1-
Female 0.84  ( 0 .42 ) X 2 ( 0  =  3 -97 * 2.311  ( 1.01- 5 .27 )
SE: standard error; df: degrees of freedom; AOR: adjusted odds ratio; 95%CI: 95% confidence interval 
* ¿><0.05, **/?<0.01____________________________________________________________________
The results show a discrepancy between reported usual practice of shared decision­
making and high comfort with that approach. This mismatch is highest in the 
gynaecological doctors (48%) and in the paediatric oncologists (53%). (See Table 9)
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Table 9 Discrepancy between high comfort level and reported use of shared
decision-making
U s u a l  a p p r o a c h
N  (% )
H ig h  le v e l  o f  
c o m fo r t
N  (% )
M is m a tc h
T u m o u r  ty p e
B reast 2 0 2  (6 7 .1 ) 2 6 6  (8 6 .9 ) 1 9 .8
C o lo rec ta l 3 6  (4 6 .2 ) 51 (6 7 .1 ) 2 0 .9
L eu k a em ia  /  L y m p h o m a 3 9  (4 7 .0 ) 18 (8 1 .8 ) 3 4 .8
G y n a e c o lo g ic a l 11 (4 0 .7 ) 2 4  (8 8 .9 ) 4 8 .2
U r o lo g ic a l 8 4  (8 1 .6 ) 9 4  (8 9 .5 ) 7 .9
D r  ty p e
M ed ic a l O n c o lo g is ts 91 (6 5 .0 ) 105 (8 9 .0 ) 2 4 .0
R ad ia tion  O n c o lo g is ts 2 6  (5 0 .0 ) 3 9  (7 8 .0 ) 2 8 .0
H a e m a to lo g is ts 2 9  (4 7 .5 ) 4  (6 6 .7 ) 19 .2
P aed ia tr ic  O n c o lo g is ts 4 ( 2 8 .6 ) 9 ( 8 1 .8 ) 5 3 .2
S u rg e o n s 231 (6 9 .2 ) 2 9 6  (8 4 .3 ) 15.1
3.8 DISCUSSION
We investigated usual practice and comfort levels with treatment decision-making 
across cancer care in Australia. Our expectation that differences would exist between 
tumour specialties and between doctor disciplines was supported. Since a clear 
treatment choice is available in the management of early breast cancer and because of 
the breast cancer consumer movement, we expected more positive attitudes to shared 
decision-making to be evident in surgeons treating this disease. Demographic 
differences were apparent in Australian clinicians’ approach to decision-making, not 
only in their usual practice but also in their comfort with the styles presented in the
survey.
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Comfort with and use o f shared decision-making
Respondents reported high levels of comfort with shared decision-making and 
discomfort with a paternalistic model. These results reflect the changes over recent 
years in the expectations and information preferences of patients and suggest that 
clinicians are responding to an increasingly consumerist model of healthcare. A UK 
study which used focus group interviews with General Practitioners also reported 
positive attitudes to patient involvement (Elwyn, Edwards et al. 2000). Doctor use of 
shared decision-making in our survey was associated with reported greater 
information giving compared to colleagues who did not use a shared approach.
Our hypothesis that doctors treating breast cancer would involve patients in decision­
making was supported. Breast cancer doctors in Australia strongly endorsed shared 
decision-making as found in Canada (Charles, Gafni et al. 2004). Indeed there were 
strong similarities between the decision-making practices of Australian and Canadian 
breast cancer doctors (Charles, Gafni et al. 2004), suggesting a similar culture 
surrounding treatment decision-making in the two countries. Shared decision-making 
was also strongly supported by the urological specialists. Conversely, support for 
shared decision-making was low in paediatric oncologists and haematologists. 
Paediatricians may feel parents of seriously ill children need to be informed of 
options, but led to the preferred treatment because of the extremely emotional 
context. Other clinicians however, may feel more able to share decision-making 
where a treatment decision is a real choice between two options with similar survival 
outcomes (Whitney, McGuire et al. 2003), such as mastectomy versus breast
conservation or radical prostatectomy versus hormone therapy and brachytherapy for 
prostate cancer. The surgical treatment options in breast cancer may explain the 
higher proportion of surgeons (who have a clear choice to offer) compared to medical 
oncologists (who may feel that systemic therapy is definitely indicated) who reported 
sharing decision-making with their patients. Similarly, colorectal, gynaecological 
oncologists and haematologists may also feel that their patients need more direction 
due to lack of treatment options available. This interpretation is supported elsewhere 
with family physicians asserting that shared decision-making is most appropriate 
when clinical equipoise exists (Elwyn, Edwards et al. 2000; Whitney, McGuire et al. 
2003). Respondents were not asked to identify a particular decision, nor did the 
questionnaire stipulate that the questions should be answered in contexts where 
equitable treatment options existed, yet our results indicate that context and existence 
of equitable treatment options may play a part in doctors’ comfort and readiness to 
use shared decision-making.
The consumer movement and public awareness of surgical treatment options in breast 
and prostate cancer may also have contributed to these results. The doctors in these 
specialties may be responding to this shift as their patients demand more information 
and a role in discussing and deciding about treatment. Breast and urological cancer 
doctors believe more of their patients wish to be involved in decision-making. 
Indeed, studies which have investigated the information and involvement preferences 
of patients demonstrate that breast cancer patients prefer a more active role than other
cancer patients (Beaver, Luker et al. 1996; Degner, Kristjanson et al. 1997; Bruera, 
Willey et al. 2002).
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The small differences according to caseload in support of shared decision-making 
may suggest a relationship with practice setting and multi-disciplinary relationships. 
Doctors who treat fewer patients with a particular cancer may be less comfortable 
with involving patients in decision-making due to their reduced familiarity with 
treatment options. Those with a large caseload are perhaps more likely to be a multi­
disciplinary team member where shared decision-making is fostered, and more likely 
to feel confident in offering a number of options.
Discrepancy between reported comfort levels and usual practice
The discrepancy in the reporting of comfort with shared decision-making and the use 
of this approach in practice mirrors the Canadian results. For all surveyed clinicians 
except those treating colorectal cancer, over 80% reported high levels of comfort with 
shared decision-making, yet, with the exception of the breast and urological cohorts, 
less than 50% reported using this approach for the majority of their patients. 
Interpretation of this discrepancy affords varying standpoints. Some commentators 
may interpret this discrepancy as evidence that in certain oncology clinical situations 
choice does not exist and therefore doctors would not use a shared decision-making 
approach. Whitney discusses the issue of no treatment as a non-viable option and 
cites the example of a life threatening gunshot wound and the inappropriateness of
shared decision-making in this context. Yet in oncology observation without 
treatment could be seen as medically reasonable in many instances where treatment 
reduces risk but does not eliminate it, and carries serious side effects. This 
interpretation opens up the debate on what constitutes a medically reasonable option 
and whether this always includes intervention. More generally however, these 
criteria for shared decision-making may be refuted by those who comment that shared 
decision-making is always appropriate even in circumstances where a treatment 
choice is obvious, as patients need to be involved in the decision to understand the 
logic. There may also be other barriers to implementation of shared decision-making 
which we as yet do not understand.
Similar discrepancies have been reported internationally. General Practitioners in the 
UK also professed support for shared decision-making but when their own 
consultations were analysed the participating doctors agreed components of shared 
decision-making did not occur (Stevenson, Barry et al. 2000). Braddock and 
colleagues analysed 1057 consultations of primary care physicians and surgeons in 
1993 and found that only 11% included discussion of alternative treatment options 
and just 8% included pros and cons (Braddock III, Edwards et al. 1999). An 
Australian study in 2001 of consultations with advanced cancer patients showed that 
only 27% of patients were offered a choice, and 44% were given information on an 
alternative course of action to anticancer therapy (Gattellari, Voigt et al. 2002). In a 
Dutch study of advanced cancer patient care acknowledgement of the medical 
oncology options of palliative chemotherapy or watchful waiting, occurred in half of
the consultations, with just 27% receiving extensive explanation of the watchful 
waiting option (Koedoot, Oort et al. 2004). These results lead us to conclude that the 
discrepancy between reported high comfort and actual shared decision-making 
practice may be greater than our self-reported data shows. It is important to explore 
barriers to implementation which might explain this discrepancy.
3.9 CONCLUSIONS
Despite shared decision-making being lauded as the gold standard for discussion of 
treatment options and reported high levels of comfort with shared decision-making, 
Australian clinicians are not currently reporting that this is their usual practice. 
Cancer specialty, clinician gender and higher caseload of new patients influence 
cancer doctors’ use of shared decision-making. Breast and urological cancer patients 
can expect a consultation where their involvement and information preferences are 
more likely to be explored. Clinician attitudes and use of shared decision-making can 
be influenced by the clinical situation in which they practice. Further work is 
required to establish whether clinicians in cancers other than breast and urological 
cancers recognize clinical scenarios where they support and use shared decision­
making.
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CHAPTER FOUR
PHYSICIAN IDENTIFIED FACTORS WHICH AFFECT 
PATIENT PARTICIPATION IN REACHING TREATMENT 
DECISIONS.
4.1 Sample
The sample for this analysis is identical to that reported above for Chapter Three.
4.2 Perceived barriers to treatment decision-making
Experience of items perceived as barriers to treatment decision-making is presented 
in Table 10 Response categories were on a four-point Likert scale; never, sometimes, 
often and almost always. Items experienced by the most physicians as difficulties 
‘almost always’ were; the physician having insufficient information to make a 
decision at the first consultation (7%); and insufficient time to spend with the patient 
(5%). Items perceived by the most physicians as ‘never’ a hindrance to treatment 
decision-making were; the doctor experiencing difficulty in framing the treatment 
options for the patient (48%); and the patient’s family overriding the decision-making 
process (44%). Most common difficulties reported ‘often’ or ‘almost always’ were; 
the physician having insufficient information to make a decision at the first 
consultation (29%); insufficient time to spend with the patient (28%); patient having 
other health problems (28%); patient having misconceptions about their disease or
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treatment (27%); patient being indecisive (24%); patient being too anxious (24%); 
and patient not understanding the information given (21%).
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T a b le  10 Item s ex p er ien ced  as d ifficu ltie s  or h e lp fu l to  d ecision --m akin g p ro cess
Item s exp erien ced  as d ifficu lties N ever Som etim es O ften A lw ays
N =604 N  ( % ) N  ( % ) N  ( % ) N  ( % )
I h a v e  in s u f f ic ie n t in fo rm a tio n  to  m a k e  a  d e c is io n  a b o u t 
tre a tm e n t a t th e  firs t c o n s u lta tio n .
5 8 (9 .6 ) 3 7 1 (6 1 .5 ) 1 3 4 (2 2 .2 ) 4 0 (6 .6 )
In su f f ic ie n t t im e  to  sp e n d  w ith  th e  p a tie n t 8 7 (1 4 .4 ) 3 4 5 (5 7 .2 ) 1 3 8 (2 2 .9 ) 3 3 (5 .5 )
T h e  p a tie n t h a s  o th e r  h e a lth  p ro b le m s . (E .g . h e a r t d ise a se ) 2 8 (4 .7 ) 4 0 6 (6 7 .4 ) 1 5 7 (2 6 .1 ) 11 (1 .8 )
T h e  p a tie n t h a s  m isc o n c e p tio n s  a b o u t th e  d is e a s e  o r 
tre a tm e n t.
1 1 (1 .8 ) 4 2 8 (7 1 .1 ) 1 5 4 (2 5 .6 ) 9 (1 .5 )
T h e  p a t ie n t  is in d e c is iv e . 2 2 (3 .7 ) 4 3 2 (7 2 .1 ) 1 3 9 (2 3 .2 ) 6 (1 .0 )
T h e  p a t ie n t  is  to o  a n x io u s  to  lis te n  to  w h a t I h a v e  to  say . 3 2 (5 .3 ) 4 2 8 (7 1 .1 ) 1 3 2 (2 1 .9 ) 10 (1 .7 )
T h e  p a tie n t d o e s  n o t u n d e rs ta n d  th e  in fo rm a tio n  1 h av e  
g iv en .
1 2 (2 .0 ) 4 6 7 (7 7 .4 ) 1 1 6 (1 9 .2 ) 8 (1 .3 )
T h e  p a tie n t h a s  d if f ic u lty  a c c e p tin g  s /h e  h a s  c a n c e r 9 6 (1 5 .9 ) 4 5 8 (7 6 .0 ) 4 3 (7 .1 ) 6 (1 .0 )
T h e  p a tie n t c o m e s  e x p e c tin g  a  c e r ta in  tre a tm e n t r a th e r  th a n  
a  c o n s u lta tio n .
1 1 5 (1 9 .1 ) 4 4 3 (7 3 .5 ) 4 3 (7 .1 ) 2 (0 .3 )
T h e re  a re  c u ltu ra l  d if fe re n c e s  b e tw e e n  th e  p a tie n t a n d  m e. 1 2 1 (2 0 .1 ) 4 4 0 (7 3 .1 ) 3 7 (6 .1 ) 4 (0 .7 )
T h e  p a tie n t h a s  re c e iv e d  c o n f lic t in g  r e c o m m e n d a tio n s  fro m  
v a r io u s  s p e c ia lis ts .
5 9 (9 .8 ) 5 0 5 (8 3 .7 ) 3 4 (5 .6 ) 5 (0 .8 )
T h e  p a tie n t r e q u e s ts  a  tre a tm e n t n o t k n o w n  to  b e  b e n e f ic ia l. 6 5 (1 0 .8 ) 5 0 0 (8 3 .3 ) 3 1 (5 .2 ) 4 (0 .7 )
T h e  p a tie n t b r in g s  to o  m u c h  in fo rm a tio n  to  d isc u ss . 1 3 0 (2 1 .6 ) 4 4 1 (7 3 .4 ) 2 8 (4 .7 ) 2 (0 .3 )
T h e  p a tie n t w a n ts  to  m a k e  a  d e c is io n  b e fo re  r e c e iv in g  th e  
in fo rm a tio n  fro m  m e .
2 4 3 (4 0 .3 ) 3 4 3 (5 6 .9 ) 1 4 (2 .3 ) 3 (0 .5 )
T h e  p a tie n t w a n ts  to  p a r tic ip a te  m o re  th a n  I w o u ld  like  
h im /h e r  to .
2 3 1 (3 8 .4 ) 3 5 7 (5 9 .3 ) 1 0 (1 .7 ) 4 (0 .7 )
I e x p e r ie n c e  d if f ic u l ty  k n o w in g  h o w  to  f ra m e  th e  t re a tm e n t 
o p tio n s  fo r  th e  p a tie n t.
2 9 1 (4 8 .3 ) 3 0 4 (5 0 .5 ) 7 (1 .2 ) 0 (0 )
T h e  p a t ie n t ’s fa m ily  o v e r r id e s  th e  d e c is io n -m a k in g  
p ro c e ss .
2 6 3 (4 3 .7 ) 3 3 2 (5 5 .1 ) 5 (0 .8 ) 2 (0 .3 )
T h e  p a tie n t re fu s e s  a  tre a tm e n t th a t  m a y  b e n e f it  h im /h e r . 3 0 (5 .0 ) 5 6 6 (9 3 .9 ) 3 (0 .5 ) 4 (0 .7 )
Item s exp erien ced  as helpfu l
T h e  p a tie n t tru s ts  m e. 0 (0 ) 1 1 (1 .8 ) 2 3 1 (3 8 .5 ) 3 5 9 (4 9 .7 )
T h e  p a tie n t h a s  so m e o n e  w ith  th e m  a t th e  c o n s u lta tio n . 0 (0 ) 5 1 (8 .5 ) 2 6 7 (4 4 .4 ) 2 8 4 (4 7 .1 )
P ro v id in g  w r it te n  in fo rm a tio n  to  th e  p a tie n t. 2 (0 .3 ) 1 1 7 (1 9 .4 ) 2 1 7 (3 6 .0 ) 2 6 7 (4 4 .3 )
T h e  p a tie n t w a n ts  to  p a r tic ip a te  in  m a k in g  th e  t re a tm e n t 
d e c is io n .
1 (0 .2 ) 1 0 7 (1 7 .8 ) 3 0 0 (4 9 .9 ) 1 9 3 (3 2 .1 )
T h e  p a tie n t is  e m o tio n a lly  re a d y  fo r  d e c is io n -m a k in g . 2 (0 .3 ) 1 3 4 (2 2 .2 ) 2 7 1 (4 4 .9 ) 1 9 6 (3 2 .5 )
T h e  p a tie n t is p re p a re d  (k n o w le d g e a b le  a b o u t d is e a s e  an d  
tre a tm e n t)  fo r  th e  c o n s u lta tio n .
4 (0 .7 ) 2 4 5 (4 0 .7 ) 2 3 1 (3 8 .4 ) 1 2 2 (2 0 .3 )
Based on conceptual analysis and the correlational findings, exploratory factor 
analyses were conducted. Two items, cultural differences and patient receiving 
conflicting recommendations, were removed due to statistical reasons. The items of 
insufficient information and patient co-morbidity were removed due to their relatively 
low factor loadings and as they did not fit conceptually with the other items loaded 
onto the patient difficulties factor. Confirmatory factor analysis produced a four 
factor model, conceptually defined as: patient difficulties; preference for a not 
recommended treatment; system difficulties; and agenda-setting patient. The patient 
difficulties factor included items which covered misunderstanding or lack of 
understanding, anxiety, denial, withdrawal and indecision. The patient preference for 
a not recommended treatment factor included items which indicated the patient did 
not want to accept the physician-recommended treatment, through refusal or request 
for another treatment. System issues included lack of time, misunderstanding of the 
nature of the consultation and the decision-making process and physician difficulties 
in framing options. The fourth factor included items which reflected a patient who 
was agenda-setting; either by bringing too much information or by wishing to be 
more involved than the doctor was comfortable with. The factor loadings for this 
analysis confirmed the four factor exploratory analysis. The analysis gave a X  of 
199.99 on 84 degrees of freedom, with a RMSEA of .05, a RMR of .04 and a GFI of 
.98. These values indicate that the model provides a good approximation to the data. 
Factor loadings are presented in Table 11.
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Table 11 Factor Analysis
Item 1 2 3 4 U n iq ue
varian ce
N M ean Std
D eviation
R ange
F actor 1 -  P atient d ifficu lties 596 1 2 .9 1.8 8-24
The patient does not understand the 
information I have given. .4 8 .77
The patient does not want to 
participate as much as I would like. .4 2 .82
The patient is indecisive. .5 0 .49
The patient has difficulty accepting 
s/he has cancer. .5 9 .66
The patient is too anxious to listen to 
what I have to say. .5 8 .66
The patient has misconceptions 
about the disease or treatment. .4 2 .82
F actor  2 -  P atien t prefers a not 
recom m en ded  treatm ent
600 3 .9 0.6 2-8
The patient requests a treatment not 
known to be beneficial. .71 .49
The patient refuses a treatment that 
may benefit her .6 2 .62
F actor  3 -  System  d ifficu lties 601 8 .8 1.7 5-17
Insufficient time to spend with the 
patient. .3 2 .90
The patient wants to make a decision 
before receiving the information 
from  m e
.5 8 .66
The patient’s family overrides the 
decision-making process. .5 8 .67
I experience difficulty knowing how 
to frame the treatment options for the 
natient
.3 8 .86
The patient comes expecting 
treatment rather than a consultation. .5 0 .75
600 3 .5 0.9 2-8
F actor  4 -  A gen d a-settin g  patient
The patient wants to participate more 
in deciding on his/her treatment than 
I would like him/her to.
.4 5 .80
The patient brings too much 
information to discuss. .7 8 .66
Note: All loadings for each item, are provided with the salient loadings in bold face
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4.3 Predictors of barriers to treatment decision-making.
To further explore the reported barriers, the variables relating to each factor were 
summed and a score was computed for each of the four factors. A higher score 
represented greater reporting of the factor as a difficulty. Mean scores are presented 
in Table 11.
Results of univariate analysis, comparing demographic and clinical characteristics 
with each of the factor scores are presented in Table 12. Urological cancer physicians 
had the highest mean score for the patient difficulties factor. Breast cancer 
physicians had the lowest mean score for the preference for a not recommended 
treatment factor. Haematologists and gynaecological physicians had the highest 
mean score for system difficulties. Surgeons reported the highest mean score for 
patient difficulties and haematologists reported the highest mean score for system 
difficulties. Mean scores for each of the factors were comparable regardless of 
physicians’ reported usual approach to decision-making. Physicians whose initial 
medical training was completed in Asia, SE Asia or the Middle East had higher mean 
scores for 3 of the 4 factors: patient difficulties; system difficulties; and agenda­
setting patient. Physicians reporting less direct patient contact per week and fewer 
new patients per month showed a higher mean score for the patient difficulties factor.
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Table 12 Univariate analysis of factor scores
F actor 1 F actor 2 F actor  3 F actor 4
Patient
P atien t prefers 
a not System
A g en d a­
setting
d ifficu lties recom m ended d ifficu lties
treatm en t
patient
Mean Std Mean Std Mean Std Mean Stddev dev dev dev
C ancer type treated
Breast 12.85 1.78 3.82*** 0.59 8.64** 1.69 3.41 0.82
Colorectal 13.05 1.64 3.96*** 0.44 8.72** 1.58 3.42 0.86
Gynaecological 13.04 1.51 4.04” * 0.98 9.11** 1.45 3.44 0.85
Haematological 12.78 1.42 3.98**’ 0.42 9.40" 1.60 3.62 0.70
Urological 13.26 2.48 4.14*” 0.70 8.92” 2.12 3.66 1.06
Breast and Urological 12.96 1.99 3.90+ 0.64 8.71* 1.81 3.47 0.89
Colorectal, Gynaecological & Haematological 12.93 1.52 3.97+ 0.54 9.07* 1.59 3.51 0.79
P hysician  d isc ip lin e
Medical Oncologist 12.59*** 1.42 3.98 0.51 9.09*” 1.44 3.50 0.81
Radiation Oncologist 12.12*** 1.18 3.94 0.31 9.27"’ 1.39 3.31 0.73
Surgeon 13.23*’* 2.07 3.90 0.70 8.55**’ 1.87 3.49 0.93
Haematologists 12.75**’ 1.42 3.95 0.47 9.51*** 1.60 3.52 0.72
Paediatric Oncologist 12.83*’* 1.59 4.00 0.00 8.73*" 1.74 3.75 0.45
P hysician  gen d er
Male 12.99 1.92 3.92 0.63 8.77f 1.77 3.50 0.87
Female 12.74 1.50 3.95 0.48 9.08+ 1.68 3.41 0.81
U sual ap p roach  to d ecision -m akin g
Doctor-led 12.81 1.67 3.93 0.60 8.82 1.71 3.58 0.79
Shared 12.96 1.88 3.92 0.59 8.83 1.75 3.47 0.84
Patient-led 12.85 1.43 3.88 0.56 8.78 1.82 3.44 0.97
M edical stu d en t tra in in g
Australasia 12.97 1.90 3.92 0.59 8.81 1.76 3.48 0.86
UK/Europe/Canada & South Africa 12.62 1.21 4.00 0.78 8.85 1.63 3.45 0.85
Asia/SE Asia/Middle East 13.50 1.65 4.00 0.67 9.20 2.39 4.00 1.12
Y ears o f  p ostgrad u ate  exp erien ce
<25yrs 12.84 1.76 3.95 0.57 9.15*** 1.63 3.42 0.88
>25yrs 13.04 1.93 3.90 0.64 8.53*** 1.81 3.54 0.84
N ew  p atient caseload  per m onth
<6 pts 13.03 1.87 3.86’ 0.62 8.75 1.80 3.48 0.84
>7 pts 12.86 1.83 3.99* 0.59 8.90 1.71 3.48 0.89
D irect pt care per w eek
< 20hrs 13.14+ 2.09 3.85+ 0.75 8.63 1.96 3.40+ 0.94
20hrs or more 12.89+ 1.80 3.96+ 0.55 8.84 1.67 3.52+ 0.84
C om m u n ity  size
<100,000 13.02 2.16 3.83 0.54 8.27+ 1.73 3.39 0.83
100,000-500,000 13.07 2.01 3.90 0.66 8.71+ 1.81 3.51 0.90
>500,000 12.90 1.79 3.95 0.60 8.88+ 1.74 3.47 0.87
fp<0.2, *p<.05, *><.01, ><.001,
Our data showed a high correlation between the variables age and years of experience 
(/?<.01) and physician discipline and type of cancer treated (/?<.01). We included 
only years of experience and type of cancer treated in regression analyses. Bivariate 
correlation of cancer, years of experience, doctor gender and community size showed 
significant correlation with system difficulties (See Table 12). New patients seen per 
month, cancer type treated and hours of practice per week showed significant 
correlation for the patient preference for a not recommended option.
Predictors of greater reporting of system difficulties were identified using linear 
regression. Three variables included had a significant association with a higher 
system limitation score. Variables included in the model were years of experience,
'y
cancer type treated and community size. The final model (R~ = .035) showed that 
physicians with less experience (/?<0.001) reported greater frequency of system 
difficulties as barriers to decision-making with patients.
Table 13 Linear Regression
M o d e l
Higher system difficulty score
R2
.035
d f
3,536
F -s ta t is t ic
7.536
p -v a lu e
0.000
In d iv id u a l p r e d ic to r s B SE P /7 -va lu e
Constant 9.291 .296 .000
No. of years qualified -.033 .008 -.174 .000
Breast & Urological vs. Colorectal, 
Gynaecological & Haematological .154 .178 .037 .385
Community size 100K, 100-500K, 
>500k .194 .120 .069 .105
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4.4 Facilitators to treatment decision-making
Six possible facilitators were listed and the frequencies with which physicians found 
these helpful obtained. As responses were skewed the original four categories on a 
Likert scale were collapsed into a dichotomous score. Those reported by physicians 
as experienced as helpful ‘never’ or ‘sometimes’ were recoded as not helpful, and 
those reported as experienced ‘often’ and ‘almost always’ helpful were recoded as 
helpful. The majority of physicians (98%) reported that the patient trusting them was 
helpful and that the patient being accompanied in the consultation (91%), the patient 
wanting to participate (82%), and providing written information were helpful (80%). 
(See Table 10)
4.5 Interventions to encourage patient involvement and reflection.
Most of the breast and urological cohort, (81%) supported offering patients written 
information concerning available treatment options; 69% supported a third person 
being at the consultation, and 50% endorsed input from a senior cancer nurse prior to 
the consultation. There was less support for six other interventions to encourage 
involvement. Three of six possible interventions for encouraging patient reflection 
after the consultation were well supported. A follow-up appointment to make the 
decision was supported by 96%, as was written information highlighting treatment 
options (90%) and encouragement for the patient to speak with the treatment team 
and their general practitioner (73%). Worksheets to assist the patient to articulate 
their values and preferences were supported by one fifth (19%). (See Table 14).
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Table 14 Interventions which physicians would support to encourage patient 
involvement and reflection.
N= 415*
Yes 
N (%)
Offering the patient written information about the treatment 
options available 321 (81.1)
Having a third person in the room 273 (68.9)
Input from Cancer Nurse Coordinator/CNC prior to consultation 196 (49.5)
Booklet explaining clinical decision-making. 135 (34.1)
Preparing patient for a greater role in decision-making, by offering 
question prompt lists prior to the consultation. 124 (31.3)
Booklet about patient roles explaining shared decision-making. 111 (28.0)
Access for medical practitioners to training to enhance skills in 
meeting patients’ preferences for SDM 99 (25.0)
Explicitly negotiating shared decision-making 89 (22.5)
Input from Cancer Nurse Coord inator/CNC post consultation 50(12.6)
Follow up appointment to make a decision 381(96.2)
Giving written information highlighting treatment options 356(89.9)
Encourage pt to talk to treatment team and general practitioner 288(72.7)
Worksheets for the patient to help him/her articulate what is 
important for him/her. 77(19.4)
Audio-taping consultation 64(16.2)
Telephone follow up to discuss treatment decision 54(13.6)
* Breast and urological cancer physicians only
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4.6 DISCUSSION
We examined the reported barriers and facilitators to treatment decision-making of a 
large sample of practicing cancer physicians across Australia. We hypothesized that 
physician characteristics including discipline and the type of cancer treated may 
influence experience and perception of factors as barriers to shared decision-making.
Lack of time was reported as one of the more frequently experienced barriers to 
treatment decision-making by Australian cancer physicians. Physicians with less 
experience reported system issues as difficult more often. This may be because 
physicians with greater experience are more patient-centred in their approach to 
consultations or have become skilled at overcoming system issues. A number of 
studies have reported that collaborative decision-making does not increase 
consultation time and may save time in the long run as thorough initial discussion 
enables subsequent consultations to be more succinct (Greenfield, Kaplan et al. 1985; 
Edwards, Elwyn et al. 2002; Say and Thomson 2003). Moreover addressing patient 
concerns may shorten initial consultations.
Patient misunderstanding was considered one of the key difficulties when reaching 
treatment decisions. Quirt et al (1997) explored the level of agreement between 
patients and their physicians about diagnosis, treatment aims, and risks and benefits. 
They reported that many lung cancer patients did not fully comprehend their situation 
and that this was underestimated by their physicians. If this discrepancy between the 
patient understanding and physician awareness of patient understanding is duplicated
in Australia, this barrier may be higher than reported by our participants. 
Participating physicians reported that patient anxiety and misconception of their 
disease or treatment were two of the most frequent barriers to sharing decision­
making. This is not surprising as emotion has a negative effect on many 
requirements for collaboration, making it more difficult for patients to take in 
information, and consider their options. In Gravel’s review of barriers to 
implementing shared decision-making in clinical practice, lack of applicability of the 
process due to patient characteristics, such as anxiety, and characteristics of the 
clinical situation, such as lack of any real choice, also featured strongly (Gravel, 
Legare et al. 2006).
Our data show cancer physicians’ perceptions of what assists them when making 
treatment decisions. Patients’ trust was regarded as the key facilitator. Patients also 
nominate trust in their physician as one of the most important factors when reaching a 
treatment decision (Salkeld, Solomon et al. 2004). As patient involvement and the 
consumer role in healthcare grows (Coulter 1999), the importance of physicians 
gaining the their patients’ trust may increase. Previous studies suggest that trust 
develops through excellent communication and by responding to patient preferences 
for information and involvement (Thom and Physicians 2001; Keating, Green et al. 
2002; Trachtenberg, Dugan et al. 2005). However, difficulties in defining and 
measuring trust complicate research into its effect on doctor decision-making style
(Entwistle 2004).
A patient being accompanied at the consultation was viewed as helpful. This may 
reflect recognition of the two-fold benefit a companion brings for the patient, as a 
second pair of ears and as emotional support. However the presence of a third person 
as a facilitator to patient involvement was supported less, implying that physicians 
are more comfortable with patients bringing a significant other to the consultation 
than having a third person present, perhaps a nurse or patient advocate. Perceived 
differences in the roles that a patient’s family or significant other might play 
compared to that of a nurse practitioner are unclear.
Perceived patient willingness to participate in the decision-making process was 
viewed by the majority of physicians as a facilitator and reflects the notion that for a 
shared approach both parties have to be willing to participate (Charles, Gafni et al. 
1997; Charles, Gafni et al. 1999).
Some written information given to patients is not balanced or complete (Braddock III, 
Edwards et al. 1999; Coulter 2003), yet our findings imply that patients and 
physicians may benefit from patients receiving written evidence-based information to 
reflect on the treatments being recommended.
We found little support for interventions designed to prepare patients to be involved 
in decision-making, with less than a third of respondents embracing booklets 
explaining clinical decision-making, patient roles in decision-making or use of 
question prompt lists (QPLs). Audio-recording consultations was supported by only
16% of physicians. A review of the effectiveness of providing consultation audio­
recording or written summaries showed the majority of patients found them to be 
very useful and that recall and satisfaction with information received were improved. 
Anxiety or depression were not influenced by receipt of an audio-recording or 
summary (Scott, Entwistle et al. 2001). Our findings suggest this review’s 
recommendation that physicians should consider offering patients audio-recordings 
appears not to have been adopted in Australia.
Translating research evidence into practice remains a challenge for researchers keen 
to implement effective communication tools. An investigation of barriers to uptake 
of patient decision aids in clinical practice reported that physicians’ lack of awareness 
and of the skills to use the tools effectively inhibited implementation (O'Donnell, 
Cranney et al. 2006). Training programs targeted at health professionals are 
recommended to address the issue of lack of familiarity (Charles, Gafni et al. 1997; 
Charles, Gafni et al. 1999; Gravel, Legare et al. 2006), yet our data reveal that 
Australian cancer physicians have minimal interest in access to training in order to 
meet patient preferences for shared decision-making.
The difficulties identified in our survey and the limited support for strategies and 
interventions echo the views of Entwistle and Watt (2006) who state that the 
clinician’s motivation to involve patients is influential and that success in facilitating 
involvement is inextricably linked to this. The difficulties we report emphasize 
system and patient attributes which prove challenging for physicians. Insight into the
difficulties which may be physician driven and reasons why physicians may be less 
supportive of patient involvement should be sought in further research. Changing 
established practice and successfully implementing evaluated communication 
interventions remains a challenge. Perhaps greater implementation success will be 
realized by aiming strategies at patients or at the system (Holmes-Rovner, Valade et 
al. 2000).
4.7 CONCLUSION
Our survey sought to identify physician perceived barriers and facilitators to the 
treatment decision-making process in cancer consultations and to explore support for 
interventions to increase patient involvement and reflection on treatment options 
presented to them.
What hinders? System issues, particularly time, are a barrier to shared treatment 
decision-making, particularly for less experienced physicians. Patients who refuse 
the recommended treatment or wish to pursue a treatment not considered optimal are 
also seen as a barrier to shared decision-making.
What helps? A patient trusting their doctor is important, although how to create and 
build trust is not clear. The value of the patient being accompanied during a 
consultation and being provided with quality written information is strongly endorsed 
by surveyed physicians.
Successful implementation of interventions to encourage patient involvement in 
decision-making is a challenge. Interventions which physicians support need to be 
developed, as well as increasing physician access to and awareness of interventions 
already available.
SECTION THREE
STAGE TWO RESULTS AND 
DISCUSSION
Chapters Five, Six and Seven present the findings from the qualitative interviews 
conducted with Australian cancer doctors treating breast, colorectal, gynaecological, 
haematological or urological cancer. As described in more detail in Chapter Two, the 
doctors were a subset of the larger sample from stage one, selected to give 
perspectives from doctors reporting each of the three different approaches to 
decision-making with their patients.
Chapter Five presents a detailed description of the sample as well as results and 
discussion concerning features of the cancer consultation which encourage or 
discourage doctors to involve patients in reaching treatment decisions.
Chapter Six describes the features which doctors identified as critical to involving 
patients in treatment decisions. The discussion of this chapter shows how these 
features reflect current models of shared decision-making in the literature.
Chapter Seven presents themes concerning the consequences for doctors and 
patients of patient involvement in decision-making; the effects on the consultation 
and changes that involvement brings about for the parties concerned.
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CHAPTER FIVE
FACTORS WHICH MOTIVATE CANCER DOCTORS TO 
INVOLVE THEIR PATIENTS IN REACHING TREATMENT 
DECISIONS
5.1 Participants
Forty-five doctors were invited to participate, nine treating each of five cancer types, 
and three within each set of nine who professed a doctor-led approach, three a shared 
approach and three a patient-led approach. Sixteen of the 45 agreed to participate. 
One of the 45 had since retired and therefore was excluded. A further 22 doctors 
were invited to participate; the researchers targeted the decision-making approaches 
and cancer types treated which were not represented in the matrix. Six of the 22 
doctors agreed to participate, giving a total of 22 interviews, an overall response rate 
of 34%.
The matrix with the final sample by usual decision-making approach and cancer 
treated is shown as Figure five. Seven doctors professed that their usual approach to 
decision-making was doctor-led, nine a shared approach and five a patient-led 
approach, one did not select a single usual approach. Doctor-led and shared usual 
approaches to decision-making were represented in each cancer type and a usual 
patient-led approach was represented in breast, urological and gynaecological cancer 
doctors. Only six colorectal doctors and one haematologist selected a patient-led as
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their usual approach in the original quantitative survey, all were invited to participate 
in the interviews and all declined or did not respond to the invitation. Nevertheless, 
theoretical saturation was apparent in the data, with no new themes emerging in the 
later interviews; thus it was felt to be reasonable to cease recruitment.
Dr led Shared Pt led Other
B r e a s t 3 (2 x M O . lx su rg e o n ) 1 (su rgeon ) 1 (su rgeon )
C o lo r e c t a l 2 (su rgeon ) 4  ( 1 xM O , 2 x su rg eo n )
G y n a e c o lo g ic a l 1 (su rgeon ) 1 (su rgeon ) 2 x  surgeon)
H a e m a t o l o g ic a l 1 (h a em a to lo g ist) 2 (M O *) 1 (h a em a to lo g ist)
U r o lo g ic a l 1 (su rgeon ) 1 (su rgeon ) 2 ( lx M O ,lx s u r g e o n )
MO= Medical Oncologist
Figure 5 Final sample matrix
The final sample consisted of 14 surgeons, six medical oncologists and two 
haematologists. Demographic and practice data are shown in Table 15. Ages ranged 
from 39 to 63 yrs (mean 50.3, SD 7.9 years). Number of years since graduation from 
medical school ranged from 12 to 40 years (mean 25.6 years, SD 9.0 years). Five 
participants (23%) were female, representative of the gender distribution of our larger 
survey. Five of the doctors worked less than 20hrs per week in direct contact with 
patients. Two doctors worked in communities of less than 100,000 and two doctors
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w o rk e d  in  c o m m u n it ie s  o f  1 0 0 ,0 0 0  - 
re p re s e n te d .
- 5 0 0 ,0 0 0 . A ll f iv e  m a jo r  s ta te s  o f  A u s tr a l ia  w e re
T ab le  15 D em ograp h ics o f  sam p le
V ariab le N (% )
Dr typ e
M edical O n co lo g is t 6 (27 .3 )
Surgeon 1 4 (6 3 .6 )
H aem ato log ist 2 ( 9 .1 )
G en d er
M ale 17 (77 ..3 ))
F em ale 5 (22 .7 )
A ge -  M ean 48. yrs (37-6  ly rs )
Y ears qualified  -  M ean 24yrs (10 -38y rs)
D irect pt care hrs/w eek*
< 20hrs 5 (26 .3)
20hrs+ 1 4 (7 3 .7 )
C om m u n ity  size*
< 100 ,000 2(10 .5 )
100 ,000-500 ,000 2(10 .5 )
500 ,000+
* n = 1 9 (3  m is s in g  v a lu e s )
15(78.9)
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5.2 Thematic analysis
In the telephone interviews we conducted with Australian cancer doctors (for 
Methods, see Chapter Two) we sought to further explore the discrepancy found 
between doctors reported comfort with shared decision-making and their reported use 
of this approach, as well as the barriers and facilitators they experienced when 
making treatment decisions with their cancer patients. A number of questions in the 
interview schedule (see Figure 3, Chapter Two) specifically sought responses from 
the participants regarding this topic:
■  GPs have said that shared decision-making is useful in some situations (e.g. 
AF, menorrhagia, HRT,) but not in others. Do you think there are situations 
where shared decision-making is more appropriate than others? I f  so, what are 
they? Which clinical scenarios?
■ (If respond with "where there is clear choice ”) How do you determine 
when there is clear choice?
■ How do you determine i f  the patient views this in the same way you 
do? E.g. patients may be interested in the no treatment option?
■ Do you think it is ever appropriate not to disclose a treatment option? 
For example, i f  it is expensive and you know the patient has a limited 
income?
■ Are there circumstances in which you either have not or might 
disclose a clinically relevant option to a particular patient?” (or 
might not disclose an option that you would sometimes mention to 
other patients with the same diagnoses)
■ Can you describe how you would normally present treatment options 
to your patients? Do you list them in order o f  your
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preference/recommendation? Do you present equal amounts o f 
information on each? Do you spend more time on the ones you think 
are more appropriate?
■ In our survey doctors who treated breast and urological cancers were more 
positive about shared decision-making than others. Why do you think that 
might be?
■ In our survey, some doctors reported that some patients are incapable o f  
shared decision-making because they are too anxious, or lack understanding o f 
their disease status and/or the information they receive-  do you agree?
■ Can you give an example o f a patient who could not share decision­
making?
■ In your experience does shared decision-making take up extra time? Does it 
ever save time down the track?
Four main themes emerged from the data regarding factors which influence when 
Australian cancer doctors considered it appropriate to involve patients in decision­
making appropriate. These were described as characteristics of the disease, the 
patient, the doctor and of society. Doctors described situations in regard to each of 
these themes referring to whether patients’ involvement was appropriate or not and
whether they encouraged it.
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5.3 Disease characteristics.
When discussing whether or not they involved patients in decisions doctors talked 
about five features of the disease: decision context; existence of treatment options; 
impact of treatment; disease culture; and stage of disease.
5.3.1 Decision context
A clear distinction was made between black and white decisions where there was 
only one treatment choice (where patients were less likely to be involved) and 
situations described as grey, where more than one option was considered potentially 
appropriate (where patient involvement was considered important). Clear cut 
decisions included those in an emergency situation or where the evidence for one 
treatment pathway was strong and the chance of success was high, the assumption 
being that patients wanted to live.
'I say look if you have appendicitis you are having your appendix out 
at 5 o ’clock today. Whether you ’re ready or not. Whether you’ve got 
meetings or other things on, we don't really care. You ’re having it out 
and the surgeon rolls her eyes at you if you think there's anything to 
discuss or so ... Urn, so there, there is no shared decision-making that 
thing. I t’s very black and white type of thing. ” (Medical oncologist)
“someone turning up with peritonitis, um and due to a ruptured 
appendix. I  mean, they really only have two alternatives. They ’re not 
very well ... to share in the decision, and there’s really not much 
sharing to be done. And ah, you know, so, so the sort o f urgent 
intervention ... i t ’s fairly irrelevant. ” (Breast surgeon)
“It depends on the disease so that i f  it's a disease where 1 think there’s 
a, clearly the best therapy. ... I ’ll probably even in some ways try to 
steer them against um sharing the decision because I would have made 
my mind up from the scientific evidence that is the best”. 
(Haematologist)
Examples of grey decisions were; low grade lymphomas, which involved deciding 
between a watch and wait approach or treatment; in more aggressive lymphomas 
deciding between stem cell transplantation or chemotherapy, (one with a higher 
chance of cure and an associated greater risk of morbidity/mortality); deciding about 
adjuvant chemotherapy in breast cancer, where the actual survival benefit is small; or 
in colorectal cancer deciding between different chemotherapy regimens.
5.3.2 Existence o f treatment options
Involving patients was considered important and more likely to happen where 
evidence for one treatment option compared to another was not conclusive. A key
indicator for involvement was described as options where survival is similar, such as 
the surgical options in early stage breast cancer, or in prostate cancer where 
contention surrounds the choice of surgical or radio-therapeutic intervention.
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“So there are many decisions o f the breast. Often, the fundamental one 
is O.K. we can do a, wide excision and radiotherapy ... or we can do a 
mastectomy. The results with many are pretty much equal in terms o f  
survival ... there is a, there’s a choice between the deformity o f the 
mastectomy, whilst avoiding 5 weeks o f daily radiotherapy which 
knocks them about bit and i t ’s totally disruptive o f  their life. ... And in 
almost every breast is a, a multi-choice discussion and then very few  is 
it cut and dried”. (Breast surgeon)
Existence of treatment options clearly featured highly although this was mitigated 
when patients' individual circumstances made some options inappropriate.
Treatments which were just as likely to result in death as they were to result in 
survival were not considered a real option, nor were treatments not based on 
evidence, or no treatment when treatment offered a significant advantage.
“It depends on the disease too you know. I f  i t ’s one where I think there 
are several options and very much needs the patient’s input into what's 
right for them (Haematologist)
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“Haematology’s a different kettle o f fish ... say i f  someone has a, a 
diagnosis o f acute leukaemia, their life expectancy without treatment is 
a month ...a  haematologist would not be sort o f  very keen to um, muck 
around too much, like spend too much time in making people have a 
have a chance to consider all their options, because there aren 7 very 
many. ” (Medical oncologist)
Some doctors mentioned established protocols or guidelines for disease management 
and that these prohibited discussion about options, whereas scenarios which included 
clinical trials added to the number of options and the need for discussion.
“And I suspect that, that management o f the lymphoma is more, is 
better than the management o f  the urology malignancy or the breast 
cancer, so you ve got a more defined treatment path (Haematologist)
The notion of uncertainty in breast, prostate and lymphoma treatment was often 
contrasted with the situation in colorectal or gynaecological surgery where contention 
was ruled out. For example, the contention surrounding prostate cancer options was
described as forcing doctors to involve patients and this made doctors more 
comfortable using this approach.
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“w e’ve been thrust into it that’s why, w e’re used to it. ... certainly in 
prostate I  mean ah, i t ’s an area where we just don’t know what the 
right answer is, so you have to involve the patient. You 're fool i f  you 
don’t. ” (Urologist)
However other issues clearly impacted on the doctors’ views that involvement was 
necessary.
5.3.3 Impact o f treatment on patient
The impact of a treatment option on a patient’s life style and self-image was often 
mentioned as influencing the appropriateness of shared decision-making. The more 
impact a treatment had, the more likely shared decision-making was to be supported. 
For example, many doctors felt patients should be involved in decision-making about 
potentially mutilating surgery for gynaecological and breast cancer, and treatments 
for prostate cancer which impact on sexual function. In these contexts doctors 
overwhelmingly supported involving patients in decisions.
“I  think that i t ’s a very personal thing for women when ... they’re 
having breast surgery and I  think that they do need to be involved in
what’s going on ... there are lots o f  different ways o f managing breast 
cancer in particular, reconstruction ... then they do have to be 
involved in the, in the treatment options, choices, because it does 
impact so much on their ... self identity. ” (Gynaecological oncologist)
“Sex. Yeah, ah so yes I'm being a bit provocative but I  mean the 
impact o f  um, of, o f  taking o ff a breast is significant to a woman and 
therefore, for me to disfigure, if, i f  I  were a breast surgeon, to disfigure 
somebody in that way I'd  have to have the support o f  the patient. They 
have to say; yes I  want my breast o ff I don’t want to feel that I ’ve 
imposed. And for a lot o f  prostate cancers and loss o f sexual function, 
the impotence and things like that, and fo r me to take that away from  
somebody I  think that probably I have to have them ask me to do it 
rather than me impose it on them ... that, crudely and maybe 
simplistic ally, [is] what I think it is. ” (Urologist)
Issues o f fertility were also included in this context. Some doctors clearly did not 
want to impose such decisions on their patients and found involving patients in these 
decisions beneficial.
“the advantage to us is that i t ’s shares a bit o f the burden because 
some o f our treatment decisions involve taking away fertility ... to do
that ah to a young woman is ah you know, fairly disastrous on their 
lifestyle ... i t ’s a big burden to carry without having them on board. ” 
(Gynaecological oncologist)
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5.3.4 Disease culture
Disease culture (the social, consumer and public profile of the disease)) was 
mentioned as influencing the appropriateness and likely use of shared decision­
making. This was raised in regard to breast cancer particularly, but also for prostate 
cancer. In both cancers, it was felt that the existence of active consumer groups 
encouraged patients to be more educated about their disease and to play an active role 
in treatment decisions. Involving patients was described as patient driven in these 
cancers, influenced by the amount of information in the public arena about treatment 
options.
“7 think the men with prostate have probably followed, less so than the 
breast, but have ... followed that lead ... empowering men, to have 
decision-making about their breast, about their prostate because 
there’s so much literature and publicity on it. ” (Haematologist)
"Breast cancer I  think was largely driven, there was probably more 
than any other cancer, there is an incredibly affective patient ah, ah, ah
patient focus and lobby group, telling doctors what they wanted, and I  
think the NBCC did a great job in that regard. ” (Medical oncologist)
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“I  mean i f  you take the adjuvant 2%, most ladies will say no to 
chemotherapy and that’s a right answer and some will say yes, that’s a 
right answer. ... so I  think in the type o f stuff I  do i t ’s ah, shared 
decision-making is, you know, I  think we actually do it without even 
really thinking... about it. ” (Medical oncologist)
In contrast to breast and prostate cancer, patients diagnosed with leukaemia often 
knew nothing about the disease and had no or far-fetched expectations of outcomes or 
what treatments would entail.
“when someone gets leukaemia well they ve often never heard o f it or 
hardly heard o f it and got all sorts o f strange preconceptions and i t ’s 
such a foreign entity that they ... say, and doctor I  don 7 know nothing 
about leukaemia but you tell me what to do. Whereas with breast 
cancer women and with prostate they might say yeah, um I  know a lot 
about this, i t ’s in the news... ” (Haematologist)
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5.3.5 Stage o f disease
Some doctors suggested that shared decision-making was more appropriate, or more 
beneficial for the doctor-patient relationship, at different stages of the disease. For 
example, some doctors suggested that shared decision-making facilitated the difficult 
discussion of the changing goals of treatment when disease progression had occurred, 
and withdrawing anticancer treatment had become an issue.
“The second scenario I  guess would be in advanced disease where 
often people have had a number o f treatments, and so the chances o f 
further treatments working is getting increasingly small ... the chance 
o f just feeling worst because o f side-effects is narrowing. ... the 
chances o f  benefit might be 10%, and chances o f getting some side- 
effects are 30 -  40%. And, i t ’s your call as to whether you just want us 
to treat symptoms as opposed to give you a treatment that may improve 
the disease but probably won t. ” (Medical oncologist)
One doctor commented that discussion around alternative treatment options, while 
discouraged in early disease was more common in advanced disease, where evidence- 
based medicine had little to offer.
“there are other diseases like um; refractory acute leukaemia’s that 
there’s really very little I  can do. And I ’ll, I ’ll even sometimes
encourage them to explore alternative health options. ”  
(Haematologist)
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Indeed, a doctor’s caseload, and the disease type and stages of the majority of his or 
her patients, were considered to often explain his or her approach to decision-making. 
The implication was that those doctors who work with patients whose prognosis is 
good will practice quite differently to those whose patients generally have a worse 
outcome.
“you might talk about people for whom minimal therapy will still end 
up with someone surviving decades. I t ’s quite different to someone 
who spends their time looking after acute leukaemia, particularly 
advanced acute leukaemia ” (Medical oncologist)
However, it was also noted that effective options for adjuvant and palliative 
chemotherapy in colorectal cancer have increased in recent years requiring more 
discussion and challenging perceptions that discussion is more suited to early stage or 
advanced stage or vice versa.
“before the options was really yes or no ... now with more options in 
the adjuvant setting a n d ... in the palliative setting it does require more 
discussion ”  (Medical oncologist)
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5.4 Doctor characteristics.
Characteristics of doctors themselves were grouped into four subthemes: practice area 
culture; communication styles; doctor perceptions; and support for involvement.
5.4.1 Practice area culture
Practice area culture (the norms and expectations which surround individual 
specialties) was also thought to influence attitudes to shared decision-making. For 
example, different specialties were thought to have different approaches to the issue 
of how long to continue anti-cancer therapy in the context of a poor prognosis. The 
image of haematologists was described as “fairly gung-ho” (haematologist), but not 
based on a cavalier-type attitude but rather the belief that the next treatment might be 
effective, or that this time an initial response to therapy might be sustained. This 
approach was thought to lead haematologists away from shared decision-making.
In a somewhat stereotypical response, surgeons were described as perhaps less likely 
to support patient involvement because their skills lay in manual dexterity rather than 
communication. One participant noted this was particularly true of those surgeons 
who,
“....just chop everything ... they are operators, not really oncologists”
(Gynaecological oncologist)
Breast and gynaecological surgeons were often described as an exception to this rule, 
in part because of the multidisciplinary approach to breast cancer care and their 
female clientele. One doctor described the difference they saw between surgeons 
working in breast and gynaecology and those working in the colorectal field as 
follows:
“people who go into gynaecology are ... more physician like than 
surgeon like ... colorectal surgeons tend to be more authoritarian" 
(Gynaecological oncologist)
Some doctors mentioned their awareness of the power of their own recommendation 
to influence patients’ decisions and thus limit patient involvement. This was often 
raised in the context of discussing expertise bias (another example of practice 
culture). Expertise bias is defined as a clinician’s preference for or stronger 
recommendation of a treatment or procedure which they commonly perform. 
Expertise bias was mentioned by some doctors as a strong influence on the 
recommendation or options they discuss with their patients. Some doctors stated that 
they make this clear to their patient, and some stated that perhaps this bias towards 
treatment or options they as practitioners felt more comfortable performing or 
administering was unconscious.
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“you tend to discuss the things that you think are treatments you can 
offer, or treatments, that you think you're good at, or you would be ... 
feel are appropriate. ... I  suppose that’s almost an unconscious thing 
that you may not mention treatments that are outside your ... area o f  
comfort. ” (Colorectal surgeon)
"I guess I ’m aware that you know I'm the surgeon and I ’m aware that I 
am biased towards surgery as a treatment option. I  think most people 
i f  they were honest would actually admit that they are probably biased 
towards the treatments that they use ” (Urologist)
5.4.2 Communication style
Doctors talked about their own ability to communicate with patients and the effect 
certain strategies can have in developing an environment where open discussion can 
occur.
“it ’s my ability to um communicate. ... You see, I  tell some people too 
much because they don’t want to know, they, they get upset when I  tell 
them everything, then other people ah, you can, you can never win, all 
you can do is your best. ” (Colorectal surgeon)
“ I ’m a great believer in trying to get the patient up to speed with, with 
what we ’re doing. And so I  um, 1 tend to be I  guess, a little brutal ah. 
Not brutal but, but I  believe honesty is the best policy. ... Say for  
example I've got someone who’s got a, ah comes with a breast lump I 
try and get the empathy going early on. ... I usually say to a patient at 
some stage during their first or second interview ... that it must be 
pretty frightening coming to see a surgeon with a breast lump. ... Or 
with rectal bleeding or whatever it might be. ... I  feel that openness ... 
and transparency gives us ah a good starting point to ah to then 
evaluate and to ah further investigations and also the discussion o f 
treatment ”. (Breast surgeon)
Communicating effectively to promote shared decision-making was described 
challenging with some patients, particularly those who are passive.
“ /  guess that’s the skill o f the consultation ... trying to work those 
people out ... whether you need to bring them back a couple o f times, 
whether you need to get other people involved or whether they 're truly 
just passive and happy to leave you be. I mean at the bottom, the 
bottom line is that, again I ’m confident with my advice, but I  want to 
know how they ’re going to react i f  it doesn ’t go well. So i f  they ’re 
gonna stay passive a n d ... accept the problems that are there, and keep 
going, well that’s fine, but i f  problems occur and they become
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aggressive and, and blameful, well then um, I'm going to push them to 
be much more ah active. [Mmm, Mmm] Ah now, God only knows how 
you sort that out. ... I  guess that’s seat-of-your-pants stuff sometimes 
isn ’t it? ” (Urologist)
5.4.3 Doctor perceptions
Many of the doctors alluded to their perception that ultimately cancer patients wanted 
treatment with the best chance of survival and that this mutual understanding 
overrode concerns about pushing patients to be more involved in any decision 
process.
“Now I must say most o f  these patients because they are malignant. ... 
most o f  them in our experience in gynaecology are not that keen to go 
away and give it a lot o f  thought. They want to plan and they want it 
dealt with. That's my impression. ” (Gynaecological oncologist)
“I ’m assuming that they want to survive and live and that there’s clear 
evidence with clinical trials, that this gives the best survival rate so I ’m 
not too worried if  they are so anxious they can’t under, they can’t make 
the, the appropriate decision.. Although, I ’ve made a judgement tha t... 
this is going to give them the best survival, based on the evidence ” 
(Haematologist)
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5.4.4 Support for involvement
Some doctors spoke about their own belief and support for involving patients in 
decision-making. At one end of the spectrum, some doctors believed that not 
allowing patients to make a decision if there is a choice is a sign of arrogance, while 
at the other extreme, some felt that shared decision-making mostly resulted in 
patients making the wrong decision. Some doctors stated that they would always try 
to involve patients, that it was important to do so and that by doing so they could 
reduce patient anxiety. Although they acknowledged that involving patients is not 
always easy and requires skills in negotiating how much patients want to know and 
what role they want to play.
“I  think most people have a view ... usually they express a preference 
fo r a particular course o f action ... i t ’s reassuring that yo u ’re 
embarking on a course ... they feel is appropriate fo r  them ” (Colorectal 
surgeon)
5.5 Patient characteristics
Doctors discussed eight key patient characteristics which influenced whether or not 
they involved patients in treatment decisions: anxiety; age; gender; cultural 
background; personality; occupation; understanding; and involvement preferences.
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5.5.1 Anxiety
Many of the doctors mentioned patient anxiety as a key barrier to involving patients 
in decisions and to patients’ understanding of the information they discuss in their 
consultations. Anxiety was described as preventing logical thought, recall, ability to 
prioritise and be objective, and ultimately to make the most appropriate decision.
"a lot o f my patients ... they’ve just been diagnosed with cancer ... 
taking in that one piece o f information on its’ own is difficult enough” 
(Urologist)
Some doctors talked about ways to manage this and that involving patients can in fact 
be helpful in reducing anxiety.
“anxiety paralyses a lot o f people but often i f  you engage in the 
decision process, sharing process that dissolves a lot o f  the anxiety” 
(Urologist)
“1 guess some people may argue that it creates undue stress etc. 1 
think that’s probably being overly paternalistic, and I don’t think 
patients are children, ... they need to be involved in their decision-
making” (Medical oncologist)
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5.5.2 Age
Many doctors mentioned age as a predictor of how much involvement patients would 
want in any decision-making. Older patients were often described as those who 
would ascribe to the “whatever you reckon Doc" (Medical oncologist) mantra. 
Younger patients were perceived to want more involvement particularly young 
female breast cancer patients, where the surgical options impact on appearance, self- 
image and may initiate concern of a partners’ reaction.
5.5.3 Gender
Gender appeared to override age in women with some doctors describing their older 
female patients as very assertive. As one medical oncologist noted,
"[...] they always tell me exactly what I can do with my chemotherapy 
or not" (Medical oncologist)
5.5.4 Cultural background
Patients’ culture often gave doctors a clue as to the amount of discussion they would 
want to have. Not telling some patients about their diagnosis due to the wishes of 
other family members was something which doctors found difficult and
uncomfortable.
Older patients with a Mediterranean or Central/Eastern European background were 
often identified as a group who prefer the doctor to make decisions, either because 
they expect the doctor to tell them what to do, or due to their lack of confidence in 
their ability to speak English.
“the culture o f  certain countries does vary enormously from Australia. 
What they expect o f  doctors, how they behave to doctors, how much 
respect they have fo r doctors ... will involve how much involvement 
they want in the decision-making ” . (Urologist)
5.5.5 Personality and occupation
A few doctors felt that personality features predicted involvement preferences. For 
example, patients with very little trust or those used to being in control were thought 
to prefer involvement, while those who lead busy professional lives or who have a 
medical background themselves were thought to be more likely to prefer non­
involvement. One doctor noted that the latter will often tell their doctors to “shut-up” 
(colorectal surgeon) and just tell them what to do.
5.5.6 Understanding
Cognitive impairment and psychiatric illness were described as situations where 
patients were not able to make decisions and so were not offered involvement. 
Patients described as of lower intelligence or limited educational background
sometimes caused the doctors some angst, as involving them was deemed impossible, 
or even detrimental.
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“I mean sometimes you 're worried even though you think you are using 
plain English they’re lost. I mean some people don’t know where their 
stomach is, I mean they 're really generally don 7 know where it is and 
then they’re kind o f embarrassed and i t ’s kind o f like how can they? ” 
[make a decision] (Medical oncologist)
Whereas doctors ensured they involved patients identified as educated, intelligent and 
questioning.
“I  would say more highly educated or more widely read people would 
prefer to be involved because they actually want to hear about — and 
often read a lot o f stuff”. (Medical oncologist)
5.5.7 In volvement preferences
Most o f the doctors alluded to the spectrum of involvement preferences they saw in 
their patients; those who wanted the doctor to make any decision, those who weren’t 
able to make decisions and those who came to the consultation armed with
information and a plan.
“most people um are obviously as you would be aware. You have a set 
o f people who say whatever you say doctor... another set who will um, 
ah very small subset who in cancer patients, who have their own plan. 
... You have to sort o f  present to them the options, and then i t ’s up to 
them, and then the ones in the middle who are very reasonable and you 
explain why you think a course o f action is the best and get them to 
come on board with it ” (Gynaecological oncologist.)
Working out the role patients want to play was described by some doctors as easy and 
by others as less obvious.
“Some people will do that (make a decision) very easily, 
people never do it. And ah you know, some patients are 
more um dependent. And so you just got to pick the patient, 
with it. ” (Breast surgeon)
And some 
very much 
... and run
“usually to be honest, usually patients will tell you what they want very 
quickly. They’ve already made decisions before they even come in to 
see y o u ” (Medical oncologist)
“I think i t ’s a ... bit o f mixture. It surprises you who says, I ’ll just try 
on what you think I  should do, and the people that say no, no, I  need, I
need all the information to make a decision. ... I  don’t think I  can say 
oh one group, I can’t generalise that well with them I don’t think”
(Medical oncologist)
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There was a general feeling that the patients who came with their own plan were in 
the minority however. Some doctors noted that despite patients being of the “I’m in 
your hands Doc” mentality, it was always possible to help them understand on some 
level. Doctors felt it was important that a certain amount of time was spent 
explaining what was happening and what would happen in terms of their illness and 
treatment to all patients regardless of their involvement preferences or their 
educational or comprehension ability.
“ I've got to explain it to you ... you may now or in the future want to 
understand a little bit more ... I don't want to upset you ... even i f  it was 
your car, yo u ’d ask me what was going on with it.” (Colorectal 
surgeon)
5.6 Society characteristics
Subthemes identified in doctors’ comments on the influence of society included, 
patient expectations of today’s healthcare, and the consumer and information driven
society.
Some doctors described the expectations of patients in today’s healthcare climate as 
necessitating involvement in decision-making. There was a general feeling that the 
days of paternalistic care are either long gone or certainly changing with the 
generations. Some doctors noted that involving patients was,
“the way things have to be these days ” (Breast surgeon).
Another doctor noted that:
“it’s the baby boomers who want control over everything’’ (Urologist)
Use of the term “consumers” was challenging for some doctors. Consumerist views 
were also thought to encourage 2nd and 3rd opinion seeking, as patients sought the 
answer they wanted to hear, rather than accepting a poor prognosis.
Others found it difficult when patients attended consultations having already 
identified available and preferred treatments (including alternative treatments) which 
may or may not be recommended, which prevents them from accepting any 
suggestion that their oncologist might make. This experience was described by
doctors as,
160
“they just come with an agenda and that is extraordinarily frustrating” 
(Breast surgeon)
“Well she didn't embrace the treatment which was quite clear that it 
would help her, because ... she had swallowed some line about 
alternatives, and you know, so there, there you go ” (Medical 
oncologist)
5.7 Subgroup differences
Despite our purposive sampling we found no consistent difference in opinions 
between doctors who reported different approaches to decision-making with their 
patients, or between doctors coming from different specialties. Tables 16 and 17 
show the number of issues covered by participants by reported usual approach to 
decision-making and cancer specialty.
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Table 16 Overview of themes vs. usual approach to decision-making
Usual decision-making approach
No. in each DM approach who mentioned 
theme
Themes Doctor
led
Shared Patient
led
Other
n = 7 n = 9 n = 5 n=l
Disease characteristics
•  D e c is io n  c o n te x t 5 7 2 1
•  E x is te n c e  o f  t r e a tm e n t  o p t io n s 7 9 4 1
•  I m p a c t  o f  t r e a tm e n t 6 7 3 1
•  D is e a s e  c u l tu r e 6 7 4 1
•  S ta g e  o f  d is e a s e 6 4 3 1
Doctor characteristics
•  P r a c t i c e  a r e a  c u l tu r e 6 7 3 1
•  C o m m u n ic a t io n  s ty le 2 4 4 1
•  D r  p e r c e p t io n s 6 3 5 1
•  S u p p o r t  f o r  in v o lv e m e n t 3 4 4 0
Patient characteristics
•  A n x ie ty  &  d is t r e s s 6 6 3 1
•  A g e 5 5 4 0
•  G e n d e r 1 2 0 0
•  C u l tu r e 4 4 4 1
•  P e r s o n a l i ty 4 3 4 1
•  O c c u p a t io n 1 3 0 0
•  U n d e r s ta n d in g 5 9 4 0
•  I n v o lv e m e n t  p r e f e r e n c e s 5 7 4 0
Society characteristics
•  H o w  h e a l th c a r e  is  n o w  - c u r r e n t  
e x p e c ta t io n s
3 3 1 0
•  I n f o r m a t io n  &  c o n s u m e r  d r iv e n  
s o c ie ty
5 2 3 0
•  F e a r  o f  l i t ig a t io n 0 1 0 0
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Table 17 Overview of themes vs. tumour specialty
Tumour specialty
No. in each specialty who mentioned theme
Themes B re a s t C o lo re c ta l G y n a ec o lo g ic a l H a e m a to lo g ic a l U ro lo g ica l
n=5 n=5 n=4 n=4 n=4
Disease characteristics
•  D e c is io n  c o n te x t 5 4 3 2 1
•  E x is te n c e  o f  o p t io n s 5 5 4 4 3
•  Im p a c t  o f  t r e a tm e n t 5 3 3 4 2
•  D is e a s e  c u ltu re 5 4 2 4 3
•  S ta g e  o f  d is e a s e 4 1 3 4 2
Doctor characteristics
•  P ra c tic e  a r e a  c u ltu re 4 4 2 4 3
•  C o m m u n ic a t io n  s ty le 3 2 2 3 1
•  D r p e r c e p tio n s 3 3 3 3 3
•  S u p p o r t  fo r  
in v o lv e m e n t
4 6 2 4 3
Patient characteristics
•  A n x ie ty  &  d is t r e s s 4 5 2 2 3
•  A g e 4 4 4 0 2
•  G e n d e r 2 0 1 0 0
•  C u l tu re 2 2 2 4 3
•  P e r s o n a l i ty 4 1 3 1 3
•  O c c u p a t io n 0 2 1 1 0
•  U n d e r s ta n d in g 5 5 3 2 3
•  I n v o lv e m e n t  
p re fe re n c e s
3 5 4 2 2
Society characteristics
•  H o w  h e a l th c a re  is  n o w 3 1 0 0 3
•  I n fo rm a t io n  &  
c o n s u m e r  so c ie ty
4 0 2 1 3
•  F e a r  o f  l i t ig a t io n 0 0 0 1 0
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5.8 DISCUSSION
This qualitative study of Australian cancer doctors sought to explain the differences 
found in the earlier study of clinician use of shared decision-making with their 
patients.
The existence of treatment options appeared to be the most influential factor over 
doctor support for involvement. Most doctors in our study commented that shared 
decision-making is most appropriate in situations of uncertainty or controversy, 
where there is no one right answer. These types of decision have been labelled 
preference-sensitive situations (Llewellyn-Thomas 2006). In contexts where clinical 
guidelines or protocols with a clear best option existed, they were less likely to 
involve patients. This finding reflects the views of Whitney et al (2004) where 
shared decision-making is considered appropriate in situations where two or more 
medically reasonable alternatives exist. Similarly, a qualitative study of academic 
and private primary care and surgical practice physicians in the United States found 
that situations with no clear best answer or with moral dimensions were considered 
particularly appropriate for increased or full patient decisional control while many of 
the physicians saw a reduced role for patients where there is only one reasonable 
medical choice (McGuire, McCullough et al. 2005). Llewellyn-Thomas (2006), 
noted that much of the research into both patient and doctor preferences has not made 
it clear to respondents whether they are answering the question in a preference 
sensitive situation or a clear-cut clinical scenario and this reduced the validity of the
findings.
Many doctors saw the impact of treatment on lifestyle and self-image as an indicator 
for involving patients in decision-making, particularly when the treatment would 
affect gender defining qualities. This may go some way to explain the differences 
found in the earlier study, where doctors treating breast and urological cancer were 
much more likely to use a shared decision-making approach than those treating 
colorectal and haematological cancers (Shepherd, Tattersall et al. 2007). Studies of 
the decision-making preferences of breast cancer patients have identified body image 
as one of the major influencing factors on which patients base their decisions 
(McVea, Minier et al. 2001). Similarly for prostate cancer patients, the majority 
wanted to play an active role in any decision-making and rated information on 
sexuality as important (Davison, Gleave et al. 2002). The comments of doctors in 
this study’s sample show that doctors are aware of and responsive to these concerns 
and allow patients to play a greater role when these situations occur.
The doctors in this sample did reflect prior findings in general practice and oncology 
that older people are less likely to want to be involved in decision-making either 
through their acceptance of the doctors’ authority or unfamiliarity with the notion of 
involvement (Blanchard, Labrecque et al. 1988; Wetzels, Geest et al. 2004). 
However the discussion of whether or not to have chemotherapy for older female 
patients was reported to evoke an assertive negative response, rather than a passive 
accepting one, suggesting that age did not always indicate a preference for non­
involvement. These comments reflect the findings of (Chouliara, Miller et al. 2004) 
that older people place equal importance on their quality of life when considering
whether or not to undergo cancer treatment. This example is illustrative of changing 
preferences patients have along their cancer journey and supports the need for doctors 
to reassess patients’ preferences regularly.
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In the quantitative study findings doctors’ support for and practice of involving 
cancer patients in decision-making differed between cancer contexts (Shepherd, 
Tattersall et al. 2007). Explanations of these findings in this qualitative work lead to 
the hypotheses that three factors are responsible for the increased use of a shared 
decision-making approach by breast and prostate cancer doctors. First, for both these 
cancers multiple treatment options are considered to be clinically equivalent. Second, 
treatments for both these cancers impact on gender issues and require patients to 
accept potential changes to either their sexual function or their body image. Third, 
both cancers are supported by high profile consumer groups who, particularly for 
breast cancer have raised the profile and expectations of cancer patients and 
empowered them to be active in their care, and which have increased knowledge of 
the general public about the treatment options available.
Meeting the preferences of patients was described as a challenge by many of the 
doctors in our study, particularly in light of the range of their patients. Doctors saw 
the need to identify the different personality types, anxiety levels and levels of 
understanding of their patients and acknowledged that this guided them in their 
encouragement to involve patients in decisions. Some doctors mentioned that their 
communication strategies or perceptions were often instinctive and not always right.
These sentiments are supported in the literature by a number of studies which report a 
mismatch between patients reported preferences for shared decision-making and 
doctors’ perceptions of patients preferences for shared decision-making (Bruera, 
Sweeney et al. 2001). It is these skills which may reduce the mismatch between 
patient involvement preferences and reported actual involvement often reported in 
both general practice and cancer consultations (Gattellari, Butow et al. 2001; Ford, 
Schofield et al. 2003).
Raised patient expectations for information and involvement and the increasingly 
consumer and information driven society were factors which all doctors 
acknowledged as increasing the involvement which patients expect in consultations 
and in treatment decisions. Explanations of information which patients have gathered 
from the internet or discussion to change a patient’s mind necessitated more 
consultation time. However in a similar vein to identifying patient characteristics 
which encourage or discourage doctors to involve patients, shared decision-making 
was portrayed by some as a method to allay patient anxiety rather than increase it. 
The identification of patient and doctor characteristics by this sample of doctors 
showed their awareness that both parties have a role and an influence on the 
communication and involvement in cancer consultations. Patients who are more 
active influence their doctors to display more patient-centred or partnership 
behaviours (Street, Krupat et al. 2003).
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5.9 CONCLUSION
Promoting shared decision-making as the optimum way of discussing treatment 
options with patients presents some challenges and contradictions for clinicians. 
Clearly in doctors’ views there have to be treatment options available, which is why 
this approach is more likely to occur in these situations. Added to this the impact of 
patients’ awareness of options increases the likelihood of doctors involving patients 
in decision-making. This is particularly true in breast cancer, where the consumer 
groups have motivated patients to take an active role in any treatment decisions. 
Prostate cancer appears to be a slightly different scenario, with the notion of 
controversy and uncertainty driving the doctors to acknowledge and encourage their 
patients to consider management options, which unlike in breast cancer surgery 
means referring their patients or informing their patients about an equivalent non- 
surgical option. What is common however for both these cancers is the impact of the 
treatments on the patients’ self image, with the potential of sexual function 
impairment due to mechanical complications or disfigurement to gender defining 
organs.
Australian cancer doctors are aware of the demand for involvement in decision­
making by cancer patients and comprehend a number of different factors which 
influence their consultation style with their patients. Clearly the clinical situation is 
of foremost importance, the patients’ perceived wish to survive and the existence of 
treatment options and consequent possibility of real choice is fundamental. There are 
however other issues of which cancer doctors are aware; particularly the emotive
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impact treatments may have, although the motivation to involve patients in these 
scenarios is unclear. It seems that patients can expect their cancer doctors to attend to 
their preferences in situations o f uncertainty or where treatment will have a severe 
impact on them.
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CHAPTER SIX
CRITICAL FEATURES OF INVOLVING PATIENTS IN 
DECISION-MAKING
6.1 Introduction
In the postal survey whose methods were described in Chapter Two, we identified the 
typical decision-making style of doctors, their comfort levels with different styles and 
key barriers which they encountered when attempting to share treatment decisions 
with their patients. These results are reported in Chapters Three and Four of this 
thesis and in the published manuscripts Shepherd et al (2007; 2008).
In the subsequent telephone interviews we conducted with Australian cancer doctors 
(for Methods, see Chapter Two) we sought to further explore these doctors’ 
perceptions regarding the key features of involving patients in decision-making. 
Doctors described what they felt involving patients required and what attributes it 
brought to consultations and how they managed this process and the issues that 
influenced the content of their consultations. A number of questions specifically 
sought responses from the participants regarding this topic:
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■ Can you tell me what you think are the most important features o f involving 
patients in decision making?
■ Some patients don’t want shared decision-making. To what extent do you think 
patients vary in terms o f their preferences for shared decision-making? Do you 
establish i f  your patients want to participate in decision making? How do you 
establish whether your patient wants shared decision-making?
■ In your experience what sorts o f patients tend to like and dislike 
shared decision-making?
■ In what senses do you think patients like/dislike shared decision­
making? Or are there particular aspects which patients like/dislike?
■ Would you ever encourage passive patients to participate or do you 
simply accept their passivity? How do you decide which patients to 
push a little? How would you go about encouraging them to shared 
decision-making?
6.2 THEMES IDENTIFIED
Three main themes emerged from the data regarding what doctors felt to be the 
critical features of involving patients in decision-making. These themes were; the 
doctor-patient relationship; eliciting preferences; and information exchange.
6.3 Doctor-patient relationship
Under this theme, doctors talked about how a good doctor-patient relationship was 
essential to shared decision-making, and vice-versa. Aspects of the doctor-patient
relationship raised in this context included trust, honesty, clarity of roles and a sense 
of being part of the same team.
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6.3.1 Openness, trust and honesty
Many of the doctors talked about developing an arena where open discussion was 
welcomed as a key feature of involving patients in decision-making. Having an open 
forum for many doctors engendered increased trust in them from their patients.
“I  feel that openness, and transparency gives us ah a good starting 
point ”
Trust was important to most doctors; with many stating that patients need to have 
confidence in their doctor and that a relationship built on trust then allowed both 
parties to be honest.
“7 think personally they should also have confidence o f the person with 
whom they are dealing, i.e. the doctor, has the expertise, has the 
credentials... to be able to guide them ah to a degree in what, what 
should be ah decided ”. (Urologist)
“by getting a trusting relationship going at least the patient can speak 
to you honestly about their concerns. I  think that’s, that’s where the 
advantage o f the shared decision-making is. Is that the patient does 
have a concern that you may not have come up with then they are more 
likely to talk to you about it., than in a, a more dogmatic sort o f  
approach (Surgeon)
6.3.2 A partnership role
Defining the role of the doctor in the relationship was important and a discussion 
where involvement and open discussion was supported allowed doctors to do this. 
Some doctors talked about their partnership with the patient, that they would 
accompany them on their cancer journey.
“7 think particularly with chemotherapy, you take a patient by the hand 
and say I  will take you in harms way. You know I  think you will get 
through, there are risks but I'll be with you through the journey. ” 
(Medical oncologist)
Shared decision-making and the relationship which then develops by using this 
approach was declared to be easier for doctors, illustrated by one participant,
“if you want to get their co-operation I guess i t ’s pretty important to 
have them on side isn 7 it And it, it um, it makes life so much easier 
dealing with people if you 're open and honest with them, then, and 
you ve got ah, an adult dialogue. ” (Gynaecological oncologist)
Other doctors noted that it was the feeling of sharing decisions that was important, 
not how informed or expert the patient had become. In other words, the impact 
shared decision-making had on the doctor-patient relationship and the patient’s sense 
of being part of a team was more critical than informed consent. One doctor stated 
that;
“..shared decision-making is, is not to get that patient up to the same 
level as understanding as you. Shared decision-making is about 
making the patient feel that they shared the decision. Now whether 
they do that with a little bit o f information or a lot o f information 
doesn 7 matter. ” (Urologist)
Other methods doctors suggested for enhancing an open discussion and subsequent 
involvement included using empathy and self-disclosure, for example talking about 
cancer experiences within the doctor’s own family.
"my eldest sister died o f rectal cancer at age 3 1... and my mother had 
colon cancer 5 years ago, I actually do quote that a lot ... because 
when 1 actually add that they then actually change and say oh he may 
actually have some idea h e’s not this, just the technician.. So I ’ve 
always noted it adds an extra dimension, and they almost tend to 
believe me a bit more... i t ’s incredible how when I  mention that. They 
go oh, so you're not just quoting from a textbook.’’ (Colorectal 
surgeon)
6.4 Eliciting preferences
Many doctors felt that eliciting and respecting patients’ preferences for decision­
making was an essential component of shared decision-making. When discussing 
identifying patient preferences for information and involvement doctors talked about 
four subthemes; identifying involvement preferences, skills and strategies to elicit 
treatment preferences; respecting preferences; and understanding preferences.
6.4.1 Identifying preferences
Knowing what level of involvement or information patients wanted was thought to be 
a critical part of shared decision-making by many of the doctors.
“7 mean you have to gauge what the person, the patient wants. Or, or 
is capable o f taking 1 think’’ (Haematologist)
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“we do make judgements about people all the time ... you make 
decision that there’s a seriously intelligent, questioning person ... 
sitting across the table. ... With those women I make absolutely 
certain I  involve them in everything. ” (Gynaecological oncologist)
Some doctors talked about it being easy to tell what level of involvement a patient 
would want, either because o f their own inherent skill;
“I  think you just get a feel for it. ” (Gynaecological oncologist)
“you get a feeling when people hit the door that they are inquiring. 
They often come with a lot o f information, they often tell you at the 
start, they ’ve read all about it. Or they come with extreme anxiety and 
those people need actually to have much more information. ” 
(Gynaecological oncologist)
Or because patients tell them what they want;
“Oh oh that’s easy. I  mean, you know, usually they tell you 
beforehand. Or often people come in and say you know I ’ve only come
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to see you because my Doctor made me come or my daughter forced  
me and I'm just letting you know that I ’ve had this done before and I 
don’t want to have it again. ...Some people are very upfront.” 
(Colorectal surgeon)
Some doctors noted that as they got to know their patients they picked up cues 
regarding how much involvement or information they would want to have.
“So I  think it often is apparent just as you're talking to people what, 
which type o f personality I  suppose, or what background, they bring 
and then when you talk, when you start talking to them about specifics. 
I  don’t think it ’s hard to tell people. People usually make it pretty 
apparent i f  they’re interested in participating or not.” (Colorectal 
surgeon)
“I  through the, you know, interview and you know history taking, I  try 
to work out how the woman feels about the whole thing. You know, and 
you will have different and every woman will be different. ” (Breast 
surgeon)
In contrast doctors mentioned those times when they find it impossible to tell what 
role their patients want to play;
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“God only knows how you sort that out. 1 can tell ya but... that’s seat- 
of-your-pants stuff sometimes isn 't it? ”  (Urologist)
“..there will be some patients where, you know occasionally where you 
know you couldn’t predict what they actually. You know what, they, 
they ’re just unreadable patients. You know, whatever you say it just 
they raise their eyebrows and you think oh God I'm not winning here at 
all. ”  (Breast surgeon)
6.4.2 Skills and strategies to elicit treatment preferences
Some doctors talked about specific language skills they used to help patients express 
preferences. These included use of the 3rd person to suggest how patients might feel 
about one option or another, using open questions to encourage patients to respond 
freely, or repeating pros and cons back to patients once they have been expressed.
Several doctors talked about the value of the patients being accompanied by a loved 
one in the consultation; that this helped patients feel more at ease with the situation, 
helped them to understand better the decision and treatment options but also allowed 
the doctor to make it clear that the patient’s voice needs to be heard. Some doctors 
also noted that decisions are rarely made just between the patient and doctor, 
particularly for patients with a spouse.
"I guess my observation is often i t’s the partner and the patient that 
have made the decision, rather than just the patient. ”  (Urologist)
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Other doctors mentioned the wider health team, General Practitioners, nurses, other 
specialists, as all having a role in treatment decisions.
Doctors’ awareness of patients’ reactions to information was mentioned by some 
doctors. Noting body language and responses to information gave good cues about 
where a patient might sit on the involvement spectrum; this skill was something 
which experience brought.
“at the end o f the day it comes down to a savvy operator, some savvy 
consultant. And that’s the difference between when I was 30 and now 
that I'm 50.’’ (Urologist)
6.4.3 Respecting preferences
Most doctors felt that it was important to respect a patient’s preferences for 
involvement, even if this did not accord with the doctor’s own views. For example, 
most doctors said they would respect a patient’s wish to play a passive role. Reasons 
included not wanting to raise anxiety of those already anxious, and discomfort with 
forcing their own ideas on patients. It seemed for some that forcing more 
involvement on patients than they wanted was similar to paternalism.
"I think you have to [accept a patient’s passivity] because again you're 
forcing your ideas on somebody else aren’t you? ” (Gynaecological 
oncologist)
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"I mean you must have come across these patients. I t ’s up to you 
doctor, whatever you reckon recommend. They do not wish to know, 
they want you to get on with it and make them better. And I think, you 
know, we, we have to. I think, I, I, I  have no problem with that 
actually. ” (Gynaecological oncologist.)
“I guess really you have to be ah aware that not all patients are going 
to react in the same way. ... so you really need to let them decide how 
much they want to do. And I think that really is the bottom line, forcing 
your ideas down somebody’s throat, um are the perfect way to end up 
um ah with poor satisfaction for both sides. ” (Gynaecological 
oncologist)
One doctor acknowledged he was happy to go ahead with treatment even if the 
patient had not taken in much information, justifying this action by his own expertise
and altruistic intent;
“/o me i t ’s a journey. ..., I've got no problems starting people on 
essential therapy i f  they don 7 know anything. As long as I know in my 
heart-of-hearts i t ’s the right thing for them ”. (Medical oncologist)
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Other doctors found it difficult to act in accordance with patient preferences, 
particularly for passivity. Some doctors felt shared decision-making helped them feel 
that their patients really understood the risks and benefits which certain treatment 
options presented, and that knowing that patients fully understood these helped the 
doctor to accept the option the patient wished to pursue. Such doctors were quite 
discomforted when patients preferred a passive role,
“occasionally a patient will say to me. You do whatever you think is 
best. And, and in some ways that’s, that’s then a difficult situation 
because I  usually like them to be involved. ” (Urologist)
6.4.4 Understanding preferences
Some doctors mentioned it was important to be aware of what was behind patients' 
preferences. This was particularly true for patients who stated they just wanted the 
doctor to get on with treatment, which was felt often to be based on fear of treatment 
or death, or previous experience with cancer, particularly having cared for a loved 
one, or just that patients weren’t familiar with a participatory style. Addressing these
issues allowed patients to play a greater role. As one doctor said about patients who 
say they don’t want to know anything,
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“I  say well yeah hang on that's fine. You know, look i f  you really don 7 
want to know, I ’ll look after you which ever way you want to do this, 
but you know, what it is you ’re frightened to know. And you know if  
you sit back and relax and ask that question. It usually comes out that 
they, and usually i t ’s fear o f dying, chemotherapy complications they 
nursed their husband who had a terrible experience. There’s 
something in that. ” (Medical oncologist)
Some doctors noted that understanding patient’s priorities helps explain their 
preferences.
“we can 7 judge for a person what may be important to them, that they 
may rather keep their hair and risk a couple o f  percent. ... And we 
can 't make a decision fo r them as to what their priorities are ... the 
person who’s having the treatment...knows their priorities better than 
anybody else. ” (Medical oncologist)
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6.5 Information exchange
The third important component of shared decision-making raised by doctors was 
information giving. This was divided into two main subthemes: discussing 
information with patients; and presenting options to patients.
6.5.1 Discussing information
Doctors raised four issues under this subtheme: the critical role information played in 
preparing patients for shared decision-making, the legal requirement embodied in the 
concept of informed consent for information giving, the external factors which 
enforce information exchange during medical consultations and the importance of 
distinguishing information giving and actual decision-making.
6.5.1.1 Provision o f information was considered fundamental to any notion of 
involving patients. Many of the doctors talked about their first goal being to transfer 
information and knowledge about the patient’s diagnosis and treatment options.
“basically they need to have enough knowledge to make a decision. ” 
(Gynaecological oncologist)
“I  think the single most important thing is providing them with 
adequate information ” (Urologist.)
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“I  think that it is important...because I  think for involvement you know 
they understand better the, the disease process and what’s happening. ” 
(Breast surgeon)
Doctors talked about ways in which they tried to ensure that they increased the 
likelihood of patients’ understanding the medical terminology.
“I  think when you first see them you have got to ask them what they 
really understand is going on. ” (Gynaecological oncologist)
Some doctors noted that when patients understood information shared decision­
making became easier.
“I  find  ... once the patient has sat down and gone through the 
information. You can actually come up with a shared decision” 
(Urologist)
6.5.1.2 Informed consent and medico-legal issues were mentioned by some doctors, 
with patient involvement in decision-making assisting doctors to meet legal 
requirements.
“We... have to lay the options out in front o f them. I t ’s a legal 
requirement, apart from anything else. ” (Breast surgeon)
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Not providing information to patients was seen as negligence, morally, ethically and 
legally.
“People need to be aware o f all o f  their options so that they can make 
an informed decision, and i f  you just give them one really you, morally, 
ethically and medico/legaily you, you haven 7 done the job you are 
meant to be doing. ” (Urologist)
6.5.1.3 Many doctors talked about external factors which enforced information 
exchange in consultations. Because information is much more available on the web 
and through the media, patients were often misinformed, and this required correction. 
The Internet was mentioned by many doctors, with some portraying it negatively and 
some positively. The negative sides included the confusion it may bring and the 
necessity then to spend time explaining why certain treatments are not appropriate.
“And the other thing is you are, I  sometimes find  that patients log on 
to the internet, look up I guess prostate cancer in particular find  there 
are 10,000 sites. And you get patients coming in with basically A4
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binders fu ll o f  information. Totally confused as to what they should be 
doing. ” (Urologist)
“They do a quick scan o f the Web or a couple o f  mates or, or they 
glean some sort o f information, and it maybe um about a context, it 
may be inapplicable to their particular situation, and they think they 
have become an authority, because the world is ah perpetuating this 
view that i f  you want to find  out anything. Well you can find  that 
information and, and you know, sort o f be in control o f your own 
destiny. ” (Urologist)
Some doctors also talked about the media, TV personalities and the fact that patients 
talk to each other, and that being armed with information prior to consultations has a 
similar effect as arriving with reams of paper from the internet.
‘'People very, people are very resourceful. 
They speak to people. They search the net. 
shows. They find  out information anyway, 
from us ” (Medical oncologist)
They find  out information. 
They you know, ring Chat 
I  think they should hear i f
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So, so ah we ’re pretty realistic about that [patients talk to each other] and 
answering questions about why they got this and I  didn 7. ” (Medical 
oncologist)
6.5.1.4 Some doctors noted that there is an important distinction between 
information exchange and actual decision-making. Some felt that the former was 
more critical to shared decision-making than the latter, while others felt that 
information giving alone was not enough.
“I  think, well. The, the most important aspect is ah to ensure that the 
patient has adequate information to participate in the discussion but 
not feel that they need to make a, ah life and death decision at any 
point. ” (Medical oncologist)
“[the patients] quickly say well I don’t want to talk about [the options], 
you do, I  wouldn’t call that shared decision-making...their decision is to 
leave it to me and take my preferred option, you know, I ’m penning my 
preferred option, so there’s still a sharing o f information but not 
decision ” (Breast surgeon)
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6.5.2 Discussing options
The idea of options available to cancer patients and how to discuss this featured 
frequently in the data we collected. Discussing options was seen as a vital part of 
shared decision-making and the doctors’ skills in doing so, critical also. On the other 
hand doctors discussed scenarios where they felt that open disclosure of all options 
was detrimental to patient well-being. Others felt it was important to reassure 
patients that while making them aware of different options the doctor would also 
make a clear recommendation to guide their thinking.
6.5.2.1 Presenting the idea o f options
Doctors felt that when treatment options existed, it was important to inform patients 
of them and involve them in decision-making.
“I  think in oncology especially there are lots o f um options to 
patients...and there may be two, three, four right answers o f  what to 
do....so I think fo r treatment options in oncology. It's ah, i t ’s very 
important that the patient is involved. ” (Medical oncologist)
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6.5.2.2 Strategies for presenting options
How doctors presented this idea to patients was explained by one doctor in the 
following way;
“..then we get to the point o f you know, options for care. And what's, 
what’s available and at that point I  usually tell them that there are two or 
three options for  [their] management. You can do nothing, you can have 
this, you can have this, this and that. And these are the relative ah 
advantages and disadvantages and then discuss it with them, you know, 
what do you feel about that? " (Gynaecological oncologist)
Some doctors talked about language strategies useful in presenting the idea of options 
to patients, such as giving patients examples of why some people might opt for one 
choice over another.
“I  present um, the options. And I  usually give them um my opinion. 
And where I  think you know, there are, you know there are two ways 
around it, I, I tell them that. Stating you know, I  think this could be 
approached ah via A or B...and the way I put it to them is um. Some 
people in your situation ah will be so against surgery that they will go - 
opt fo r  A, and some o f them will be so scared o f a second cancer or
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recurrence, so they will opt fo r B for treatment. ” (Gynaecological 
oncologist)
Some doctors were keen to communicate to their patients that they understood they 
had come to see them for an opinion, and that whilst they would present options to 
them they would also make a recommendation.
“7 do actually say to patients look yo u ’ve come here for my opinion. 
There are alternatives here, I  will tell you my opinion i f  I  can. I f  i t ’s a 
really grey area I 'll let you know that and we 'll decide that together. 
But I  find  most patients accept that. I don 7 accept the modern idea 
that...you try, like I  don 7 turn my patients into a haematologist ... in a 
1 hour initial consultation. " (Medical oncologist)
“I'll say look there isn’t a right way to manage this. These are the 
options. What do you think? And i f  they say I  really don 7 know. I ’ll 
say well my suggestion would be. ” (Breast surgeon)
6.5.2.3 Reasons fo r NOT presenting options
Doctors noted that there were a range of scenarios where they did not always disclose 
all treatment options.
The issue of whether or not to mention expensive or unfunded drugs was often raised 
in this context, with varying views expressed. Some doctors stated this was not an 
issue in their field of practice as all recommended or standard treatments were 
available to all patients.
“I guess the other question is where a treatment isn’t funded. I  mean
if  i f  i f  you can’t get the treatment because i t’s not available then i t ’s 
not a treatment option ... You can’t say, you know well this might 
work but we can 7 get it. ” (Medical oncologist)
“I think that’s in, very inappropriate...not to, not to give the patient all 
options. And I think w e’ve had a very good example o f that recently with 
Herceptin, a very expensive drug. ... Ife lt very strongly that we should 
discuss that with the patient whether they can afford it or not. In fact I, I 
think it, in my mind you are being negligent because [you are] assuming 
that that particular patient can 7 afford it. ” (Medical oncologist)
Some doctors talked about reasons other than expense for not disclosing all options to 
patients. These included treatments which the doctor believed would not work — and 
which they therefore did not feel were real options.
"I don’t go and talk about experimental treatment available in America 
... subject to tests through experiment. I  mean that’s not the go, but i f  
they say to me look what about this? I ’ll say well i t ’s not recommended 
in your cancer fu ll stop. ’’ (Gynaecological oncologist)
"I think it is completely appropriate not to disclose an unrealistic 
treatment option. ” (Medical oncologist)
Some doctors also talked about needing to talk about some options in order to dismiss 
them, as patients had expected to be told about a particular course of treatment and 
were surprised or confused when the doctor didn’t offer it to them. One doctor 
described explaining why surgical treatment for an 83yr old with prostate cancer was 
not appropriate,
“surgery is one option for select patients but you ’re not one o f those 
select patients buddy. Um, and so you can, you can mention to dismiss 
it. There are circumstances where you know, ah an option is not 
appropriate. And it will either not be mentioned or mentioned to 
dismiss it. ” (Urologist)
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6.6 FREQUENCY OF THEMES
While frequencies in qualitative studies cannot be interpreted in the usual quantitative 
sense, they can give an indication of majority and minority views and suggest 
possible group differences. The frequency with which different themes were raised 
by participants according to their reported usual decision-making approach is shown 
in Table 18 and by speciality in Table 19. Irrespective of usual approach to decision­
making, most doctors commented on patient understanding and information provision 
as key features of involving patients in decision-making. The issue of external 
influences and the dilemma of disclosing expensive options were raised by the more 
paternalistic and sharing doctors. All the doctors who had previously reported using 
shared decision-making as their usual approach gave a type of definition of what 
patient involvement meant for them.
Some differences were noticeable when looking at the spread of issues according to 
cancer specialty. The issue of expensive drugs was expanded on by doctors treating 
breast or haematological cancer, probably reflective in breast cancer of recent 
controversies in breast cancer related to the funding of Herceptin for patients.
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Table 18 Overview of themes vs. usual approach to decision-making
U s u a l  d e c i s io n - m a k in g  a p p r o a c h
N o . in  e a c h  D M  a p p r o a c h  w h o  m e n t io n e d  
t h e m e
T h e m e s D o c t o r
le d
S h a r e d P a t ie n t
le d
O t h e r
n = 7 n = 9 n = 5 n = l
D o c t o r /P a t ie n t  r e la t io n s h ip
•  O p e n n e s s ,  t r u s t  a n d  h o n e s ty 2 2 1 0
•  P a r tn e r s h ip  r o le 2 3 2 0
E l ic i t in g  p r e f e r e n c e s
•  R e s p e c t in g  p r e f e r e n c e s 4 5 3 0
•  U n d e r s ta n d in g  p r e f e r e n c e s 3 4 1 1
•  S k i l ls  &  s t r a te g ie s  to  e l ic i t  
p r e f e r e n c e s
7 8 4 1
•  I d e n t i f y in g  p r e f e r e n c e s 5 6 4 1
I n f o r m a t io n
•  I n f o r m a t io n  p r o v is io n 7 9 4 1
•  I n fo r m e d  c o n s e n t  &  le g a l i s s u e s 3 4 1 0
•  E x te r n a l  in f lu e n c e s 5 6 2 1
•  I n f o r m a t io n  p r o v is io n s  v s . D M 5 4 2 0
P r e s e n t in g  o p t io n s
•  P r e s e n t in g  id e a  o f  o p t io n s 7 9 4 1
•  S t r a te g ie s  f o r  p r e s e n t in g  o p t io n s 7 8 4 0
•  N o t  d is c lo s in g  o p t io n s 6 7 5 0
•  E x p e n s iv e  d ru g s 6 5 3 1
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Table 19 Overview of themes vs. tumour specialty
T u m o u r  s p e c ia lty
N o . in  e a c h  s p e c ia lty  w h o  m e n t io n e d  th e m e
T h e m e s B r e a s t C o lo r e c ta l G y n a e c o lo g ic a l H a e m a to lo g ic a l U r o lo g ic a l
n=5 n=5 n = 4 n = 4 n = 4
D o c to r /P a t ie n t
r e la t io n s h ip
•  O p en n ess , tru s t & 
hon esty
2 3 0 0 0
•  P a rtn e rsh ip  ro le 1 2 1 1 2
E lic it in g  p r e fe r e n c e s
•  R esp ec tin g  p re fe ren ces 2 2 3 2 3
•  U n d e rs tan d in g  
p re fe ren ces
1 3 1 4 0
•  S k ills  & s tra teg ies 5 4 3 4 4
•  Id en tify in g  p re fe ren ces 3 4 4 2 3
I n fo r m a t io n
•  In fo rm a tio n  p ro v is io n 5 5 3 4 4
•  In fo rm ed  c o n sen t/law 3 1 2 1 1
•  E x tern a l in flu en ces 1 4 3 3 3
•  In fo rm a tio n  vs. D M 4 2 1 3 1
P r e s e n t in g  o p t io n s
•  P resen tin g  id ea  o f  
o p tio n s
5 5 4 4 3
•  S tra teg ies 5 5 3 2 4
•  N o t d isc lo s in g  o p tio n s 4 4 4 3 3
•  E x p en siv e  d ru g s 4 3 2 4 2
6.7 DISCUSSION
The data collected in the interviews elicited some information about features doctors 
felt were critical to involving patients in reaching treatment decisions. Participants 
discussed three critical components of shared decision-making the doctor-patient 
relationship; eliciting preferences; discussing information.
For many it was difficult to separate the idea of the doctor-patient relationship from 
shared decision-making. In their explanation of what was important to involving
patients in decision-making doctors stated that patients being involved in a decision 
and an open transparent relationship are co-dependent. Models of shared decision­
making also place importance on communication between health professional and 
patients (Charles, Gafni et al. 1997; Siminoff and Step 2005). Qualities of a good 
doctor-patient relationship have been identified elsewhere and include elements of 
good manners, and courtesy, establishment of mutual trust, empathy, openness, 
transparency and honesty. Many of the themes common to the literature arose in our 
data.
A review of information giving and decision-making in advanced cancer patients also 
concluded that involving patients in decisions was helpful to the doctor-patient 
relationship (Gaston and Mitchell 2005). This two-way process suggests that it may 
be important to address both shared decision-making and general communication 
skills in programs designed to improve doctors’ skills in this arena. Focusing on one 
without the other may inhibit change.
The components of shared decision-making identified in this study mirror theories of 
shared decision-making and empirical data from other studies. Models of shared 
decision-making generally include five core components: partnership; information 
exchange; eliciting preferences; negotiation and agreement; and future planning 
(Charles, Gafni et al. 1999; Siminoff and Step 2005; Makoul and daym an 2006; 
Montori, Gafni et al. 2006). Table 20 compares the themes which our interviews
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elicited with core components in models of shared decision-making current in the 
literature.
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Table 20 Aspects of the SDM models which doctors discussed
C h a r le s  et al ( 1 9 9 9 ) M e n tio n e d  by 
A u s  d o c to rs
T w o  p e o p le  at le a s t are  in v o lv e d  in th e  d e c is io n  m a k in g  p ro c e s s
B o th  p a tie n t an d  d o c to r  ta k e  p art in th e  tre a tm e n t d e c is io n  m a k in g
T h e re  is a  tw o -w a y  flo w  o f  in fo rm a tio n  b e tw e e n  th e  c lin ic ia n  an d  th e  p a tie n t
A  tre a tm e n t d e c is io n  is m a d e  w h e n  b o th  th e  c lin ic ia n  an d  th e  p a tie n t ag re e  on th e  m o s t
a p p ro p ria te  tre a tm e n t.
M a k o u l an d  d a y m a n  ( 2 0 0 6 )
Y es
Y es
Y es
Y es
D efin e  e x p la in  p ro b le m  
P re s e n t o p tio n s
D isc u ss  p ro s  /c o n s  (b e n e fits /r is k s /c o s ts ) 
P a tien t v a lu e s /p re fe re n c e s  
D isc u ss  p a tie n t a b ility /se lf-e ff ic a c y
Y es
Y es
Y es
Y es
D o c to r k n o w le d g e /re c o m m e n d a tio n s  
C h e c k /c la rify  u n d e rs ta n d in g  
M ak e  o r e x p lic itly  d e fe r  d e c is io n  
A rra n g e  fo llo w -u p
Y es
Y es
Y es
Y es
R a tza n  ( 1 9 9 6 )  C o n flic t  r e so lu tio n s  sh a r e d  n eg o tia tio n  m o d el
Y es
C o m m u n ic a tio n
•  id e n tify  in te re s ts
•  e s ta b lish  an  a g e n d a
•  listen  an d  u n d e rs ta n d  o th e r  side
Y es
Y es
Y es
O p tio n s
•  b ra in s to rm
•  d ia lo g u e
•  s tre n g th e n  o p p o rtu n itie s
Y es
A lte rn a tiv e s
•  k n o w  y o u r b e s t a lte rn a tiv e s ,
•  e x p lo re  c o m p e titiv e  re a lis tic  id eas,
Y es
•  in fo rm  p a rtie s  o f  v a rio u s  a lte rn a tiv e s Y es
S ta n d a rd s
•  lo c a te  an d  sh a re  o b je c tiv e  c rite r ia Y es
T ru s t
•  b e  h o n e st an d  o p en ,
•  d e v e lo p  a  c o m p lia n c e - p ro n e  a g re e m e n t
Y es
•  b u ild  re la tio n sh ip s
S im in o ff  an d  S te p  ( 2 0 0 5 )  C o m m u n ic a tio n  M o d el o f  S h a red  d e c is io n - m a k in g
Y es
P a tie n t-P h y s ic ia n  C o m m u n ic a tio n  A n te c e d e n ts
•  so c io -d e m o g ra p h ic  c h a ra c te ris tic s
•  p e rs o n a lity
Y es
•  c o m m u n ic a tio n  c o m p e te n c e  
C o m m u n ic a tio n  C lim a te
Y es
•  In fo rm a tio n  an d  d e c is io n  p re fe re n c e s
•  D ise a s e  se v e rity
•  E m o tio n a l sta te
•  R o le  e x p e c ta tio n s
•  T re a tm e n t d e c is io n
Y es
Y es
Y es
Y es
Y es
These concepts also mirror some commonly used measures of decisional adequacy 
and difficulty, such as the Decisional Conflict Scale (O'Connor 1995). This measure 
includes subscales which cover information, uncertainty, values clarity, support and 
effective decision. It is perhaps fair to suggest that theses subscales do reflect the 
issues (doctor-patient relationship; eliciting preferences; information giving; and 
involving patients), which doctors identified as critical to the decision-making 
process. The uncertainty subscale touches on issues which concern doctors of 
overburdening patients with difficult decisions, the values clarity subscale teases out 
whether preferences have been explored and communicated, the support and 
information subscales reflect the importance placed on the quality of information that 
patients receive and the support patients receive both from their significant others and 
from the professional support they receive. The final subscale is the only one which 
does veer from the critical elements identified in the interviews, in that the wording 
implies that the patient makes the choice or decision, a view which most of the 
doctors felt was not vital to the notion of involving patients in treatment decisions. 
Perhaps these similarities may warrant the use of this scale as a measure of whether a 
patient has experienced a shared decision-making consultation in which they have 
been involved, rather than using measures designed to identify preferences, such as 
The Cassileth Information Styles Questionnaire (Strull, Lo et al. 1984), to measure 
the role the doctor or the patient played in the actual decision.
Doctors in our study suggested that these consultation skills come with experience. 
Competencies have been proposed by Towle and Godolphin (1999) and Elwyn,
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Edwards et al (2000) and Table 21 shows whether or not these competencies were 
discussed in the Australian data (see Table 21).
Table 21 Competencies for shared decision-making
Towle and Godolphin (1999)
D iscu ssed  by  
A u stra lia n  ca n cer  
d o cto rs
e s ta b l i s h in g  a  p a r tn e r s h ip , Y e s
e lic i t in g  p r e fe r e n c e s  fo r  in fo rm a t io n  a n d  in v o lv e m e n t , Y e s
a c k n o w le d g in g  a n d  re s p o n d in g  to  p a t i e n t ’s v ie w s , Y e s
o u t l in in g  c h o ic e s Y e s
p ro v id in g  th e  r e s e a rc h  e v id e n c e  to  s u p p o r t  o r  r e fu te  th e s e
d is c u s s io n  o f  p o s s ib le  o u tc o m e s ,  g o o d  a n d  b a d , Y e s
d e c is io n  n e g o tia t io n Y e s
fu r th e r  p la n n in g Y e s
D iscu ssed  by
Elwyn, Edwards et al (2000) A u stra lia n  ca n cer
d o c to rs
Im p lic i t  o r  e x p l ic i t  in v o lv e m e n t  o f  p a tie n ts  in  d e c is io n -m a k in g  p ro c e s s Y e s
E x p lo re  id e a s , fe a r s  a n d  e x p e c ta t io n s  o f  th e  p ro b le m  a n d  p o s s ib le  t r e a tm e n ts Y e s
P o r tra y a l  o f  c l in ic a l  e q u ip o is e S o m e
Id e n ti fy  p r e fe r r e d  fo rm a t
P ro v id e  t a i lo r  m a d e  in fo rm a t io n Y e s
C h e c k in g  p ro c e s s
■ u n d e r s ta n d in g  o f  in fo rm a t io n  a n d  r e a c tio n s Y e s
■ a c c e p ta n c e  o f  p ro c e s s  a n d  d e c is io n  m a k in g  ro le  p r e fe r e n c e Y e s
■ in v o lv in g  p a tie n ts  to  th e  e x te n t  th e y  d e s ir e Y e s
M a k e , d is c u s s  o r  d e f e r  d e c is io n s Y e s
A rra n g e  fo l lo w -u p Y e s
Whilst most of these were covered by doctors in the interviews, difficulties with them 
were noted. A qualitative study of General Practitioners, hospital doctors , academics 
and lay persons to explore their views of the key components of an evidence-based
patient choice consultation identified six key themes : establishing the nature of the 
problem; the doctor-patient relationship; the decision-making process; time issues; 
research evidence; and patient perspectives (Ford, Schofield et al. 2003). The three 
main themes which emerged from Australian cancer doctors (the doctor-patient 
relationship; eliciting preferences; information provision) reflect these earlier 
findings. Ford’s study also listed consultation skills which doctors require for 
evidence-based shared decision-making. Skills which were reported as the most 
difficult were, explaining complex information, keeping up to date with the latest 
evidence and according to the lay people in the sample, doctors’ ability to listen and 
not talk over patients.
Establishing and identifying patient preferences was a feature which most doctors 
identified as integral to facilitating patient involvement. Models of shared decision­
making include this as a core component (Charles, Gafni et al. 1997) and doctors 
surveyed in other studies have also identified this as a key feature of shared decision­
making. Over 93% of oncologists and surgeons in Charles et al study reported that 
they believed it to be very or extremely important for patients to communicate what 
issues were important to them for a shared approach to be evident (Charles, Whelan 
et al. 2003). Bruera et al 2002 concluded that doctors’ understanding of patients’ 
preferences has a positive effect on communication and outcomes such as patient
satisfaction with treatment decisions.
Our data shows that doctors sometimes find it difficult to identify the roles patients 
may wish to play. This is reflected in studies which report discrepancies between the 
roles doctors perceive patients want and the roles patients report they prefer. Other 
studies report wide discrepancies between doctors’ perceptions of what treatments 
patients would choose and the treatments patients report they would choose, 
suggesting that treatment preferences are also difficult for health professionals to 
identify.
Doctors placed value on knowing patient preferences; however there is scant 
evidence of how doctors elicit this information. In this study, many doctors saw this 
as an innate skill, while others suggested that these consultation skills come with 
experience. Some doctors felt that patients gave cues which doctors could perhaps be 
taught to recognise. This may a fruitful component of communication skills training 
programs in this area.
Information exchange and understanding is vital to patient involvement. Many 
doctors asserted that they aimed to assist patients to understand their situation and 
that without this, involvement in any decision was difficult. Additionally the 
consensus that information exchange is vital may reflect wide acceptance of the 
principle of informed consent, and legal rulings in recent years determining a 
minimum standard in information provision for patients prior to consent.
In discussions of involvement and decision-making, sharing information was clearly 
thought of as involvement on some level. This reflects the findings of the Canadian 
survey where approximately one third of participants identified an example of 
decision-making which included information sharing only, as a shared decision­
making approach (Charles, Whelan et al. 2003). Doctors often seemed to see shared 
decision-making as a process, rather than an outcome. Having both parties feel they 
were sharing information, views and preferences was the critical issue, the actual 
decision, or outcome, was not. This is also in accordance with studies of patient 
preferences which often report a high proportion of patients desiring maximum 
information but a much lower proportion of patients desiring active involvement in 
decision-making (Strull, Lo et al. 1984; Ende, Kazis et al. 1989; Degner, Kristjanson 
et al. 1997; Vick and Scott 1998). Whether patients need to be actually involved in 
decision-making for shared decision-making to be said to have occurred remains a 
contentious issue and one which should be explored further in future research.
Doctors also identified explicit discussion of treatment options as an important 
component of shared decision-making. However, doctors also commonly spoke of 
situations where disclosure of options might not be appropriate. As reported in the 
previous chapter, the existence of treatment options is an incentive for doctors to 
involve patients in reaching a treatment decisions. This issue is further explored in 
this chapter as doctors commented on what constitutes a realistic option. Most 
doctors felt that not disclosing unrealistic options was justified, especially those 
treatments whose efficacy has not been proved. Additionally many doctors pointed
out that whilst on the surface a number of options may seem appropriate, individual 
patient circumstances dictate those options that are realistic and that the doctors 
would recommend in a given situation. This view somewhat endorses the status of 
doctors as the experts, that patients seek medical advice and a treatment 
recommendation, and justifies occasions when doctors do not disclose all options. 
Further it could be commented that doctors are responding to the preferences of 
patients, for information but not necessarily control of decision-making. However 
not all doctors expressed this view with others raising the ethical dilemma of not 
disclosing options, regardless of their effectiveness, or their expense. These doctors 
suggested it was not their role to determine which options their patients should be 
told, that patients should have the right to decide whether or not they wanted to pay 
for an expensive treatment. This view was supported by doctors who suggest that 
patients find out about options anyway, either through talking to other patients or via 
the media and the Internet. Patients’ views about disclosure of expensive treatment 
options are unclear and research into this issue may assist doctors in deciding whether 
disclosure or not is the best option. Doctors’ views of when to disclose expensive 
options have not been extensively sought, although one study from the Netherlands 
reported that doctors would continue treating individual patients with a treatment they 
considered expensive when the average probability of success was less than 12% 
(Wouters, Timmermans et al. 1997). Other studies have shown that doctors often do 
not predict which treatment patients would opt for, placing more emphasis on 
survival than other consequences of treatment (Solomon, Pager et al. 2003), or poorly
predicting patients’ views on their wish to receive cardio-pulmonary resuscitation 
(Covinsky, Fuller et al. 2000).
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Shared decision-making suggests that patients should be made aware of all options, 
yet clearly doctors perceive options differently in different contexts, endorsing the 
views of Whitney (2003). Doctors’ motivations for disclosing options are equally 
diverse. Judging whether a patient has experienced shared decision-making is 
difficult in light of these conflicting views.
Interestingly, very few communication skills training programs have been reported 
which target both specific and general skills. A number of successful programs have 
been developed and evaluated which target generic skills in eliciting and responding 
to patient emotions and concerns (Razavi, Merckaert et al. 2003). Others have 
reported positive results from training programs designed specifically to improve 
shared decision-making (Elwyn, Edwards et al. 2004). Outcomes measured in these 
studies tend to reflect the focus of the training. It is still to be demonstrated whether 
targeting both specific and general skills results in much better patient and doctor 
outcomes.
Training programs have been developed and evaluated to develop doctors 
communication skills and improvements were noted; however sustained improvement 
beyond three months has only been reported in one study (Fallowfield, Jenkins et al.
2003). Given that many doctors discussed the difficulty of implementing shared 
decision-making, it is interesting that support for interventions such as decision aids, 
which are designed to assist patients to be more involved or more active in 
consultations and decisions (O'Connor, Drake et al. 1999), are not better supported by 
the medical profession. Support and use of these interventions was found to be 
limited in the survey reported in stage one of this thesis (Shepherd, Tattersall et al. 
2008).
In discussions of involvement and decision-making, sharing information was clearly 
thought of as involvement on some level. This reflects the findings of the Canadian 
survey where approximately one third of participants identified an information 
sharing example of decision-making, which included information sharing only, as a 
shared decision-making approach (Charles, Whelan et al. 2003). Studies which 
report patients’ experiences of treatment decision-making report recollection of who 
made the decision. Yet doctors appear to interpret information sharing as 
involvement, perhaps because for patients other than breast or prostate cancer 
patients, they are attending to the needs of patients which are generally reported to be 
high for information but less demanding for a major role in decision-making. 
Additionally the consensus that information exchange is vital may reflect the issue of 
informed consent and legal rulings in recent years concerning how much information 
patients need to be told prior to consent.
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6.8 CONCLUSION
According to the cancer doctors in this study involving patients in treatment decisions 
requires the development of a good relationship, the sharing of information and the 
eliciting of patients preferences, in line with models of shared decision-making. 
These findings show that doctors are aware of these core components and give some 
insights into how doctors go about achieving these when discussing treatment 
decisions. While specific strategies were presented by doctors, many had difficulty 
articulating exactly what they did, feeling that it was an innate skill, or somehow 
intuitive. This presents a challenge to those proposing to develop effective training 
programs in shared decision-making. Discussion of options was more controversial 
as a component of shared decision-making, and more research is required to
determine how critical this is.
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CHAPTER SEVEN
CONSEQUENCES OF INVOLVING PATIENTS IN DECISION­
MAKING
7.1 Introduction
In the postal survey whose methods were described in Chapter Two, key barriers 
were identified which cancer doctors encountered when attempting to share treatment 
decisions with their patients. These barriers are reported in chapter Four of this thesis 
and in the published manuscript (Shepherd, Tattersall et al. 2008).
In the subsequent telephone interviews with Australian cancer doctors (for Methods, 
see Chapter Two) these doctors’ perceptions regarding the consequences of involving 
patients in decision-making were further explored. A number of questions 
specifically explored this topic:
■ What do you think about involving patients in making treatment decisions
■ What about it is good or bad for you?
■ What about it is good or bad for the health system as a whole?
■ What about it is good or bad fo r the patient?
■ In your experience does shared decision-making take up extra time? Does it
ever save time down the track?
■ Shared decision-making involves sharing responsibility for the decision as well 
as information about the options and consequences o f these. Is this difficult?
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■ For you? How?
• For the patient? How?
■ How, if at all do you think shared decision-making impacts on your own and 
the patient’s responsibility for the decision? Does shared decision-making shift 
the ultimate decision responsibility? How easy or difficult is this for you and 
for the patient?
7.2 Themes identified
Four main themes were identified from the data: effects on decision responsibility; 
effects on doctors; effects on patients; and effects on the health system. We also 
gathered some information from doctors on strategies they employed to involve 
patients in decision-making.
7.3 Effects on decision responsibility
During the interviews doctors discussed the impact of involving patients in decision­
making on who accepted responsibility for the decision made. Doctors gave us 
instances where they felt that the patient took on the responsibility, where the 
responsibility was shared or where the responsibility remained with the doctor.
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7.3.1 Patients take on the responsibility.
A patient who has all the information was considered by some doctors to be 
responsible for the treatment decision.
‘'you know a fully informed patient makes their own decision, as it 
should be I  think, and i f  it's their decision, my responsibility is to give 
them correct advice, to ensure they understand it. The decision is their 
responsibility. I  am happier with that than the passive patient. ”  
(Breast surgeon)
Patient responsibility was considered particularly appropriate under three conditions; 
for grey decisions where no one right treatment path is obvious; when patients choose 
a path contrary to their doctor’s recommendation; and when the patient has time to 
fully consider the information and return at a later consultation with a decision.
“where there’s a grey area then ah all you can do is present the 
evidence and really give them the responsibility fo r the decision. ”  
(Gynaecological oncologist)
“I f  a patient says oh I, I, I  hear the two options but I  don t to loose my 
hair and I don’t that to happen. So neither option is possible. I will 
then say well there is may be a third option that’s even less effective. ... 
[If] the patient doesn’t want the recommendations; I ’ll make the next 
best recommendation. I  think then they have taken responsibility 
because they have declinedyour(my) recommendation, And so you then 
make your next best recommendation, but you tell them this isn't the 
optimal thing but within your (the patient’s) parameters o f  wanting this 
and that and not wanting the other ... i t ’s the optimal treatment.” 
(Medical oncologist)
“I  guess in my practice [responsibility does shift] because often I have 
spoken to patients about their diagnosis, given them the information to 
read and they will come back and say this is what I  want to have done, 
and then i t ’s just a matter of, making sure they 're fully informed about 
the decision they ’ve made and going ahead. So often it really does shift 
the decision in that the patient comes back having already made a 
decision as to what treatment they have. So it frequently does shift the 
decision ... and the responsibility to the patient.” (Urologist
Participants who felt that patients take on (or should take on) responsibility during 
shared decision-making saw their own role as one of advising.
“we are here to offer advice not decisions so this is what we advise. 
This is the reasons fo r it [the treatment] this is the pros, this is the 
cons. This is the alternatives. And you know, really i t ’s, i t ’s their 
decision, we ’re the ones who share it. ”  (Breast surgeon)
7.3.2 Responsibility is shared with the patient
Sharing the decision for some doctors did imply that responsibility was shared.
“if  we [the doctor and the patient] have the joint decision, we both 
decided to go down this path, and we both understood what this path 
could hold, and unfortunately, we have got a pot hole in the road, and 
you got an intermediate complication or a bad complication, well we 
both made the decision, we both know, knew we could get here, and we 
both take partial responsibility fo r having gotten here to a degree. So 
it does, it does sort o f  —  you spread the load o f responsibility, yes. ”  
(Urologist)
As demonstrated in the quotes above and below, in discussing the possibility of 
patients taking on some decisional responsibility, doctors did sometimes raise the 
notion of blame-sharing if things do not turn out as well as the doctor and the patient 
might have hoped. The degree to which such blame was shifted to the patient varied
amongst respondents.
“it’s not a matter o f  shifting it [the responsibility] to the sense that 
y o u ’re blaming them i f  they don't make a particular decision, but I ’ll 
write fo r  example, we discussed the nature o f this, that and the other, 
and Mr. So-and-so has indicated he does not wish to have this done at 
present. Or I've recommended a colonoscopy or I  discussed the 
options and he is not keen to have this procedure done but I ’ve 
encouraged to come, him to come back i f  his symptoms change. . . .  To 
me that implies that I ’m shifting some responsibility onto them and i t ’s 
not with the intent o f  blame. ... I  think people can make their own 
choices but I  certainly do feel then that afterwards I  can say to them if  
they come back well we did discuss this and as I  recall you know you 
weren’t keen to have such and such done at the moment”. (Colorectal 
surgeon)
“/ feel more comfortable i f  I  think the patient has been involved 
because I  guess to a degree it, it defers responsibility fo r that, to both 
o f us. You know, well we both decided this is the way to go. ”
(Urologist)
213
7.3.3 Doctors retain responsibility
Some doctors were clear that sharing a decision did not deflect responsibility away 
from them. Some saw themselves as the ‘‘captain of the ship” who would always be 
the one responsible.
“ultimately, lam  responsible fo r  the management o f that patient and as 
long as I ’m happy that they’ve made an informed decision and they 
understand the consequences o f  that. The responsibility is mine. ” 
(Gynaecological oncologist)
“I guess I  at the end o f the day, I 'm the captain o f the ship so, all the 
responsibility would have to fa ll on my shoulders. ” (I: So you
don 7 think it shifts the ultimate decision responsibility?) “No. ” 
(Medical oncologist
“I  make the analogy that they own a ship, they’ve employed me as the 
Captain. They can still basically decide where to go, but I ’m not going 
to let them o ff on a reef or do something like that and they know there ’s 
someone at the helm that they can trust. I  think that is still what people 
want, at least people in my practice. ” (Medical oncologist)
Others felt that even if they wanted to give away responsibility, patients would never 
be willing to accept it.
“I  think that i f  ... a patient is unhappy with the outcome they’ll put it 
back on to you. I  think that is because they are so unhappy as to what 
happened [they] will really not remember or really think that they were 
sort o f part and it all gets wiped out, because there is grief and 
someone’s got to be blamed. So because you 're the person who 
obviously knows more, I  think that you [the doctor] will be 
responsible. ” (Breast surgeon)
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The context of these discussions made this issue difficult for some doctors, with the 
nature o f cancer and the potentially life threatening nature of the disease influencing 
their views. One doctor used an example of deciding to withdraw treatment from a 
patient in intensive care to illustrate his understanding of shared decision-making and 
responsibility.
“We are going to turn this patient o ff because i t ’s the right medical 
thing to do but we wanted you to understand why we are doing it, and 
you can ask all the questions you like. To me that’s shared decision­
making but i t ’s not moving any o f the responsibility to make that 
decision. ’’ (Medical oncologist)
7.3.3.1 Doctors who felt they should retain responsibility for decision-making often 
reflected on their role as the expert who has responsibility fo r guiding patients to the 
‘right ’ decision.
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“I think one o f the problems is doctors these days too often abrogate 
our responsibility. They think patient decision making is, is a way to 
cop out o f  the hard decisions I  do actually say to patients look you ve 
come here for my opinion. ” (Medical oncologist)
“And so while shared decision-making works well, the patient will 
never have the, all the knowledge that someone like myself [has] 
accumulated in 30 years. ” (Breast surgeon)
“I  mean what I  would actually hate is i f  the patient [was] to make what 
I  thought was a wrong decision ... how would 1 feel fo r the patient then 
[to] carry that? I  think y o u ’ve got to steer the patient in the right 
direction ” (Colorectal surgeon)
“the young guy (who) says no to chemo, because he had advanced 
testicular cancer. I  still think the responsibility is mine ... I ’d  be rightly 
criticised i f  I  didn’t attempt to chase them down the corridor. Ring him 
at home and speak to the GP and speak to the urologist and speak to
the wife or the mother or the whatever. I would expect my colleagues 
to have shown that they tried more than just shrug their shoulders as he 
walked out the door. ” (Medical oncologist)
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7.3.3.2 Power to coerce
Some doctors noted that whether consciously or subconsciously, they did influence 
the choices patients made and therefore could not abdicate responsibility.
‘'you make a diagnosis, you, you lay out the options. I  might be 
selective in which options I  give because I think one is completely and 
utterly inappropriate fo r  this particular individual... I  probably would 
in some way bias some o f the options, to try and direct the choice. You 
know, let me make you make the choices that I think you should make. ” 
(Urologist)
“you know the bottom line is at the end o f the day, you know you can 
mould them (patients) whichever way you want” (Urologist)
“You can't help but add a personal bias to what yo u ’re saying yo u ’ll 
probably downplay some o f the side-effects o f one treatment option it 
may be consciously, may be subconsciously. At the end o f the day 
you ’ll have an idea o f what you think is best, you ’ll probably bias your
presentation o f that in such a way that will influence the individual. I 
think its both human nature and unavoidable. You either put them in 
order or you over or under emphasise particular consequences, to 
make it the obvious choice. ”  (Urologist)
“I  mean the whole thing ends up being the way you promote whatever 
you 're promoting in terms o f treatment to that patient. ”  
(Haematologist)
“ there's all sorts o f  literature showing how a doctor can spin 
information to actually make a patient give the answer you want to 
them to answer. ” (Medical oncologist)
“ I'll say on this side (...) these are the things against it and this is the 
things fo r  it, very keenly aware that I'm influencing the patient for the 
guise o f shared decision-making, ” (Colorectal surgeon)
“the whole process is extremely interesting ... we [doctors] can all 
think that we say things the same way but i f  the patient sees 3 different 
people they will come out making 3 different decisions. ” 
(Gynaecological oncologist)
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7.4 Effects on doctors of sharing decisions
During the interviews doctors mentioned issues which impacted negatively and 
positively on them as a consequence of involving patients in cancer treatment 
decisions. These included the impact of shared decision-making on their time, the 
increased complexity of discussions, the impact on patients’ confidence in their 
doctors, the challenge to the doctor’s authority, poor decision-making.
7.4.1 Negative effects
7.4.1.1 Time
Information sharing and explanation of options are core components of a shared 
decision-making approach and most of the doctors noted that this required increased 
consultation time.
“I think the single most important thing is providing them with 
adequate information, which, becomes difficult given the time 
constraints everyone has. It often takes ... two consultations and 
occasionally three or four consultations to come up with a decision that 
the patient is comfortable with. ” (Urologist)
"it may take a long time to explain to the patient and the relatives all 
the pros and cons ... and help them come to what we perceive is a 
correct decision. (Breast surgeon)
“it can be more time consuming, I mean that doesn’t matter, I ’m not 
saying i t ’s a negative thing. ... It can take longer to involve them, 
rather than saying I ’ve got all your results back and, and I  think that 
the best thing fo r you is to ... have you know, treatment A ’ rather than 
saying well we have all your results back and, yeah the options o f  
management are A, B, C and D. Let me tell you about A ’, let me tell 
you about B ’, let me tell about ‘C ’, let me tell you about D ’ and then 
together we can choose a pathway to manage your particular problem.
That’s certainly more time consuming and promotes more questions. ” 
(Urologist)
The negative impact of extra time depended on how much and how many 
consultations ensuring patient understanding and patient involvement took. Some 
doctors commented that they became frustrated when patients were unable to come to 
a decision and doctors felt they were having the same discussion over and over.
“I ’ve had some patient, making a decision over 6 months whether to 
have surgery or not have surgery or what to do ... and i t ’s very 
frustrating because you have the same consultation over and over. ” 
(Breast surgeon)
"patients are by and large pretty wilful. ... y o u ’ll involve them in 
certain, lead them gently over, say a long consultation, take an hour or
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so for a certain point o f  view, ah and then they ’ll come back and want 
to go through it again and come to a different conclusion” (Medical 
oncologist).
Some doctors noted that the extra time taken was not always without some benefit. 
Taking extra time initially and ensuring patients knew what treatment and what to 
expect made later discussions easier and possibly shorter.
in the big picture i t ’s time well spent, ... they do take long[er] but 1 
think in the bigger picture you can make decision(s) faster with them in 
the future. ” (Medical oncologist)
1 A. 1.2 Increased complexity
Many doctors stated that presenting different options and choosing between them 
requires extra skills on their part to establish what patients want to know and what 
preferences they may have, particularly when talking with patients who have no 
medical knowledge whatsoever.
“certainly when you are talking about different surgical approaches 
i t ’s sometimes very difficult to have people understand exactly what 
you mean and. what’s going to happen. ” (Gynaecological oncologist)
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"In general involving patients as a physician, tends to increase the 
work load and the time involved ... and is more demanding on 
explanatory powers I  guess. ” (Medical oncologist)
"To have shared decision-making you have got to be a good 
communicator and therefore it hones your skills in. good 
communication, you ’ll get feedback i f  you ’re not. ” (Haematologist)
"communication with patients is a bit like knowing what chemotherapy 
to give, i f  you don’t know how to do it, go and learn ... I've taken lots 
o f courses in communication ... you can [learn] there are efficient 
ways ” (Medical oncologist)
7.4.1.3 Reduced patient confidence in doctor expertise
Some doctors raised the issue that offering choice or discussing options occasionally 
led to patients questioning whether in fact the doctor was competent.
"Some patients interpret ... it that you [are] not sure o f  what they 
should have. I  think there ’s always a risk that the patient will go home 
and think gee, the doctor doesn ’t know what I  should have, what good 
is he? "(Urologist)
Further, with the increased access to information from the internet a couple of doctors 
asserted that they felt patients armed with pages of print out were challenging their 
expertise.
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‘'Someone comes in with a 200 page Internet printout and says, here 
this is what I  know, what do you know? And almost challenge you ” 
(Colorectal surgeon)
7.4.1.4 Challenge to the doctor’s authority
Some doctors noted that involving patients in treatment decisions and greater access 
to information increased their assertiveness and they can challenge the authority of 
the doctor. Doctors mentioned this with a note of amusement, but also with some 
concern that patients may be basing their view on poor quality information.
“people are wandering in to the clinic with their results tucked under 
their arm and saying, I  want treatment A ’ because I've heard i t ’s the 
best, and I ’ve seen it on the Web and you know I 'm informed and I ’m 
educated and I  know what I  want, and I think I  know what’s the best”
(Urologist)
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“They’ve come with their own agenda. They’ve got Channel 9 and the 
Age telling them what to do and we are just you know, putty in their 
hands. ” (Medical oncologist)
7.4.1.5 Poor decision-making
Involving patients in decisions allows patients to make decisions which doctors may 
not agree with. Doctors noted that this was their prerogative, but was sometimes hard 
to accept.
“Where there’s a large body o f expert opinion and evidence and the 
patients sometimes will bring along their internet gained opinions 
which may not have much credence ... there are people ... who will 
go away determined to try herbal remedies no matter what you say.
Then, ah you know that’s their prerogative.” (Gynaecological 
oncologist)
“people come along with preconceived ideas and they don’t 
understand the, the subtleties and consequences, and, and why this is 
not particularly appropriate for them. It can be quite a challenge to 
talk somebody out o f  a treatment they think that they ’ve decided they 
want to have done, i f  i t ’s not in their best interests. ” (Urologist)
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7.4.2 Better patient outcomes
A number of doctors felt that involving patients in treatment decisions produced 
benefits. These included benefits to their relationship with the patient, to their own 
practice, improved patient outcomes, and reduced fear of medico-legal issues.
7.4.2.1 Reassurance that the decision is the right one
Some doctors commented that involving patients in decisions reassured them that 
they had made the right choice with which the patients agreed. Additionally one 
doctor noted that shared decision-making required doctors to keep abreast of new 
advances in treatments.
"well good is the feeling that they are participants and that they're 
involved ... in their treatment and ... i f  you give people options
usually they express a preference for a particular course o f action ... /  
think it's reassuring that you 're embarking on a course o f action which 
they feel is appropriate fo r  them. So it affirms my own comfort with a 
recommendation. ” (Colorectal surgeon)
"It's good; it puts you on your toes. You make sure you have the latest 
information which is always difficult, but I  think it's generally a good 
thing. ... i t ’s good fo r doctor’s to know what they are talking about to
have the skills to explain things in detail to a patient. ” 
(Haematologist)
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Some doctors noted that understanding patients’ priorities helps explain their 
preferences.
“we can't judge for a person what may be important to them, that they 
may rather keep their hair and risk a couple o f  percent. ... And we 
can’t make a decision fo r them as to what their priorities are ... the 
person who’s having the treatment ... knows their priorities better 
than anybody else. ” (Medical oncologist)
7.4.2.2 Improves doctor-patient relationship
A number of the doctors suggested that they found involving patients in decisions 
was a pathway to a good relationship. They commented that sharing decisions was 
rewarding and allowed good relationships to build regardless of the how the cancer 
journey might continue.
“Involving a patient enhances the outcome because ... i t ’s very hard 
to manage a patient when there’s angst between you. ” (Medical 
oncologist)
‘'often i f  you engage in the decision process, sharing process that 
dissolves a lot o f the anxiety and they come on board. ”  (Urologist)
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"I guess the positive side [is] it does to give you a chance to actually 
develop good rapport with the patient, and give you a chance to . . .  
ensure that the patient is making the decision that hopefully is the right 
decision for them. ”  (Urologist)
“I  may not have expressed that very well. I  like to be very close to 
them (patients) and to have them trust me and I like the idea that we 
solve problems and work together. ” (Colorectal surgeon)
“I  think my patients need to understand what the intention o f ah our 
treatment is, I  think from a decision point o f view, i f  the patient is on 
the same wavelength from an intention point o f view that I  am, then it 
goes much smoother over the rest o f  the relationship. ” (Medical 
oncologist)
7.4.3 Reduced fear o f medico-legal issues
Some doctors asserted that involving patients in decisions about treatment was 
advantageous in ensuring patients understood the reasons for treatment and reducing 
the risk o f medico-legal complications.
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“when there are other situations where a doctor’s uncertain about a 
treatment, i f  the patient’s keen, this concept that i t ’s their decision, 
doctors find  sometimes that it might give some medico-legal protection 
i f  things go wrong. ” (Haematologist)
‘’You make [a] decision that there’s a seriously intelligent, questioning 
person sitting across the table. With those women I  make absolutely 
certain 1 involve them in everything. So there’s no question, they can 
come back later on and say well you didn 7 tell me about this. ” 
(Gynaecological oncologist)
“should a patient have chemotherapy for adjuvant breast cancer or not 
the benefit might be 2% ... so, i f  a patient said look this is what I  want 
to do, I really think i t ’s worth doing. I ’ll kind o f say that back to them 
so i t ’s a confirmation you know you are going ahead because you 
believe 2% is worth doing. And then you kind o f make it like a 
declaration in front o f  the family. And I  jo t that down in a letter saying 
that they were keen, so when they die o f  a septic shock a month later, I  
guess that theory makes life a little bit easier. ” (Medical oncologist)
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7.5 Effects on patients
Doctors felt that shared decision-making could have both positive and negative 
effects on patients themselves.
7.5.1 Difficult decisions for patients to make
A number of the doctors talked about the difficult decisions which cancer patients 
face. Uncertain outcomes, weighing up pros and cons, and complex survival and 
recurrence risks are difficult issues to understand, quite independent o f the emotional 
burden of a new diagnosis.
“7 think it is hard fo r people to make decisions. ... the first time 
they ve heard it (their diagnosis) and they 're being asked to consider ... 
a very complex thing, that even people who are very familiar with the 
issues find  difficult. I  mean, pre-operative radiotherapy is a great 
example and rectal cancer, practitioners argue about it. How can you 
expect a patient in 10 minutes, when they're dealing with their cancer 
diagnosis and the thought o f everything else happening in their life to, 
to really appreciate the issues. ” (Colorectal surgeon)
"Where there are no black and white, right and wrong decisions and 
there are often 3 or 4 treatment options all with similar out comes, it
becomes quite difficult I  think for the patient to know what decision to 
make. ” (Urologist)
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7.5.2 Patient anxiety
Eleven of the doctors noted that involving patients in decisions can raise anxiety and 
that this was something to be avoided. In these instances doctors would often reduce 
options offered and make clear recommendations. These doctors stated that they 
could recognise patients who did not want autonomy and preferred their doctor to 
make their decisions.
“there are people who get thrown into a bit o f  a spin by actually being 
offered a choice. So that’s the bad side I guess ... when they've said 
they ’re uncomfortable with deciding and they ’d rather have my hand 
than pushing them into it [deciding]. 1 think [ it’s] not going to help i t ’s 
just going to increase or create anxiety i f  they are already anxious ” 
(Medical oncologist)
One doctor talked about how he managed those patients who became anxious when 
asked to share in the treatment decision.
“I  think it can increase their anxiety and um, I  um then tend to shift 
over to a more directive role. But you try and do it cleverly, not
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sneakily but cleverly. You try and direct them more perhaps but still 
keep them involved in the process. ” (Urologist)
Others asserted that involvement can reduce anxiety and saw this as a positive 
outcome of a move away from paternalism.
“often i f  you engage in the decision process, sharing process, that 
dissolves a lot o f  the anxiety and they come on board. ”  (Urologist)
“it will save angst and I  think that’s an important aspect, particularly 
when you 're dealing with very ill people. ” (Medical oncologist)
7.5.3 Increases confusion and overwhelms patients
Many of the doctors talked about the increased likelihood of confusing patients with 
detailed information about risks and benefits of treatment. For most cancer patients 
treatment decisions are made at the beginning of the cancer journey when many feel 
overwhelmed by their diagnosis. The amount of information accessible to patients 
was also highlighted as contributing to the confusion that patients feel.
“I  really do think that we have not learnt to control the information 
revolution in medicine, and what you can end up doing is confusing the 
life out o f  patients. ”  (Medical oncologist)
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7.5.4 Patients can make the wrong decisions
Three of the doctors expressed the view that some patients are not able to make the 
right decisions for themselves due to the circumstances they find themselves in. One 
was quite clear that involving patients in decision did not give good outcomes.
“I t ’s more frustrating, it leaves people to fuck up their lives good and 
proper sometimes, i.e. to die.’’ (Medical oncologist)
7.5.5 Decisional regret
Some doctors felt that patients who were involved in decisions might be vulnerable to 
later regret. That is, if something went wrong, patients may feel it was their own 
mistake which had led them to that pass. A distinction was drawn between 
participation and decision-making, where regret was seen as a possible consequence 
of actually making the decision, but not of participation.
" . . .  i f  it's thrust upon them they 'll always then look back later, well not 
always, but often and say you know was that the right thing? Was that 
necessary and did I  do the best thing etc? ” (Breast surgeon)
“some people are happy to be guided and do get scared about having 
to choose in case ... they choose the wrong thing. ... They find  it ’ s a 
testing question that they are being asked to choose the best treatment
and i f  it doesn’t work, [that] may be because they made the wrong 
decision. ” (Medical oncologist)
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“the important thing is avoiding future regret, and i f  there really is a 
decision to be made then you must clearly flag that to the patient ” 
(Medical oncologist)
However others suggested that by involving patients in decisions patients would have 
less reason to wonder why they had undergone a particular treatment.
“the good aspects o f  it [shared decision-making/ are that, that there's, 
there should never be a question at the end about why a particular 
treatment pathway was made and there’s never the possibility of, I 
would never have done that had I  known ... that’s the most positive 
aspect. ” (Medical oncologist)
7.5.6 Increases understanding, autonomy and empowerment
A number o f doctors talked about involving patients as empowering patients and 
giving them some control in the consultation. These doctors saw this as a positive 
attribute as it enabled patients to better understand their disease and its’ treatment.
“I  think the positive side o f  it is that most patients actually feel involved 
in their care. And that gives them some form o f control over a situation 
where they can otherwise feel fairly helpless. Ah they just sort o f  in 
some ways you know, you almost feel as i f  they 're along for the ride, 
rather than being involved in their care. So I  think the positives are it 
gives them a chance to be involved in their care to make a decision. 
And also be informed about what they 're doing. ” (Urologist)
“I  think i f  they understand why they're having something done and 
have been part o f  that process, they don't feel disenfranchised when 
something happens to them, [they won ’t] say well I  didn t realise that 
was going to happen " (Gynaecological oncologist)
“given the complexity you know, o f modern medicine the decisions can 
be quite difficult, they are not always black and white and patients 
themselves have increasing knowledge o f their diseases. But on the 
other hand ... their expectation is there’s a clear black and white 
answer and they want certainty and reassurance that nothing will 
happen. 1 think that involvement in the decisions makes them 
understand the process better. ” (Breast surgeon)
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7.5.7 Increased patient satisfaction
A few doctors noted that they felt patients were more satisfied with their care when 
they were given more information and were more involved in decisions.
“So they feel really happy that they’re actually part o f it and they feel 
that ... they did make a decision even though indirectly it was 
predetermined. So I  think it, it enhances patient care. ” (Breast 
surgeon)
“patients (who) are better informed are generally more satisfied 
afterward, and accepting (when) complications occur ... rather than 
being very un-accepting and potentially very unhappy fo r lots o f  
reasons. ” (Urologist)
“They’d think well gee that doctor listened to me and. he seemed to 
present me all the options and I  felt as though I was involved in the 
decision making. I  guess that’s the positive thing. ’’ (Medical 
oncologist)
A number of doctors also suggested that greater patient empowerment resulting from 
shared decision-making was beneficial to the doctor-patient relationship and 
subsequently increased patients’ tolerance and compliance with treatment regimens.
“the good part for the patient is ... that they feel involved in their care 
and they are more likely to comply, that’s the upside o f  it. ” 
(Gynaecological oncologist)
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“if  they share in the decision making they share in the progress o f  
their illness, I think they feel more empowered. Um, they’re more 
likely to um be open with their problems. ” (Urologist)
7.6 Effects on health system
The main impacts on the health system that doctors commented on was linked to the 
issue of consultation time, that involving patients in decisions demands more 
consultation time. A further consequence alluded to by some doctors was the 
possibility of increased costs as patients may choose options which cost the health 
service more, even though a cheaper option may have an equivalent outcome.
“even though the outcome may not be better, a more resource 
consuming option maybe chosen, because that’s what the patient wants 
to do ... there is a possibility that that more empowerment, that we, if  
you want to look at it that way, more, more involvement or 
empowerment o f  the patient may end up in the consumption o f  more
resources. ’’ (Urologist)
Some doctors noted that understanding patients’ priorities helps explain their 
preferences.
“we can’t judge fo r a person what may be important to them, that they 
may rather keep their hair and risk a couple o f  percent. ... And we 
can’t make a decision for them as to what their priorities are ... the 
person w ho’s having the treatment...knows their priorities better than 
anybody else. ” (Medical oncologist)
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7.7 DISCUSSION
From the qualitative interviews with Australian cancer doctors some insights into the 
effects of involving patients in treatment decision- making were elicited. A key issue 
was the effect that sharing decisions has on the responsibility for the decision. Does 
giving patients more control over which treatment they have shift the responsibility 
for that treatment choice and the outcome of that choice to them?
Decision responsibility
Most doctors in our sample asserted that they were ultimately responsible for their 
patients' welfare if they were prescribing the treatment. However a shift of some 
responsibility to patients occurred when patients chose independently or when they 
opted for a treatment which was not the treatment preferred by the doctor. There is 
minimal commentary in the literature of shared decision-making concerning the 
effect sharing decisions or patients leading decision-making has on decisional 
responsibility. Entwistle and Watt (2006) outline a broader conceptual framework of
patient involvement in decision-making beyond preferences and doctor-patient 
communication, and the issue of responsibility appears to fit within the two domains 
which reflect the clinician’s and patient’s feelings about their role.
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The end of medical paternalism has been championed in healthcare, with patient- 
centred care heralded as the way forward. Shared decision-making has come to the 
fore and is founded upon the notion of the doctor and patient as partners in the 
consultation, with information exchange, and negotiation leading to mutually agreed 
decisions (Charles, Gafni et al. 1999). Description of the modern patient ascribes 
attributes of autonomy and self-responsibility, reflective of human rights, although 
the reality for patients is that this idealised image is set in an environment of illness 
(Dieterich 2007).
The doctors in our sample gave a variety of consequences of involving patients in 
decisions. It is not clear that patients accept that being more involved in decisions 
and in some instances making the decision, signals that the doctor is absolved of 
decision responsibility. Nor is it clear whether doctors think patients should take on 
some responsibility. Some doctors stated they recorded when patients chose a 
different treatment option so that they could remind patients of this if and when 
circumstances changed. How these consultations play themselves out is unknown as 
the doctors talked about these conversations in a hypothetical manner.
Differing motivations for involvement, such as benevolence or self protection, are 
suggested by Entwistle and Watt (2006) in their discussions of the conceptual 
framework for involving patients in treatment decisions. They suggest that patients’ 
experience of involvement may vary in these different contexts. The consequences of 
involving patients in treatment decisions appeared to suggest some different 
motivations of the Australian cancer doctors. Some doctors expressed a view of 
deflecting responsibility, some saw involvement as reassurance that they had selected 
or recommended the treatment with the best fit for their patients, while a third 
motivation was the benefit from the subsequent improved relationship involvement 
engenders. It is perhaps in understanding the motivation of doctors that answers the 
question of whether involvement increases patients’ responsibility.
Does encouraging patients to be more autonomous affect decisional responsibility 
and absolve doctors of ultimate responsibility? Edwards et al (2006) propose that 
clinicians should pay attention to the decisional responsibility preferences of patients 
as well as involve patients in the process. Their data suggest that when responsibility 
preferences are not matched patients are less satisfied. The opinions of the patients 
interviewed qualitatively in their study reflect the views expressed by the doctors in 
our study, that the process and the decision are separate entities. These findings 
support the notion that a shared decision-making consultation can result in a doctor- 
led, shared or patient-led decision, while the process itself reflects the components of 
shared decision-making models (Elwyn, Edwards et al. 1999). However the term 
decision responsibility in this study refers to the decision maker and does not appear
to imply responsibility beyond this. The motivation of doctors to involve patients, 
particularly those doctors who seek to deflect responsibility perhaps suggest that in 
the context of treatment decision-making responsibility may well imply that the 
decision-maker is responsible for the decision and the subsequent outcome?
Does it make a difference if the treatment decision is in a preference-sensitive or grey 
context as opposed to choosing between a standard or alternative treatment, or if 
patients are choosing not to have treatment when an option with documented 
effectiveness exists? And does this issue of responsibility only matter when things do 
not go according to plan? Little is known about patient views on this issue, and this 
would be a fruitful area for future research.
Involvement to help patients choose or to disclose uncertainty?
Some doctors expressed concern that discussing options and asking patients to be 
more involved was sometimes interpreted by patients as a sign that doctors did not 
know the ‘right’ answer and were therefore incompetent. This interpretation may 
reflect more about doctors own discomfort in discussing uncertainty with patients 
than patients’ responses (Katz 1984). Alternatively this concern may stem from poor 
communication between doctors and patients about the role patients can have in 
treatment decisions. In the first stage of this thesis we asked doctors how often they 
had discussions with patients about the role they wished to play in decisions and 37% 
reported that they have this discussion with half or less of their patients. We also 
asked the breast and urological doctors whether they felt patients receiving a booklet
explaining their role in treatment decisions would be useful, but only 28% agreed 
with this approach.
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Disclosing uncertainty
Admitting to patients that the outcome of their diagnosis or treatment is uncertain is 
an uncomfortable scenario. Ideally doctors wish to cure the sick; not being able to do 
this challenges that ethos. It might be expected that doctors who choose a career in 
oncology would accept the notion of uncertainty early in their careers. Further it 
might seem reasonable to believe that communicating uncertainty would be a skill 
honed in cancer specialists. Equally, despite patients rationally knowing that their 
disease may not be curable, they expect to hear from doctors that they will be cured 
or that if they have treatment ‘x ’ it will result in outcome iy ’. More importantly that 
outcome ‘y’ is a certainty. Modern medicine however is not that simple, and today’s 
cancer care has many treatment options which offer varying degrees of effectiveness, 
risks, benefits and a variety of side effects. For patients, their families and doctors 
survival is the number one priority, if that is guaranteed then that is the option that 
patients will take. When treatment options offer no guarantees the value which 
people place on other issues of body image, sexual function, and components which 
affect quality of life become more influential, and the importance of the doctor and 
patients sharing this information is paramount.
Communication of risk and benefits to patients is fundamental in involving patients in 
decisions. How to communicate uncertainty as suggested by Griffiths et al (2005)
should be highlighted in existing risk communication training modules. Disclosing 
uncertainty and subsequent discussion of all possible options and side effects does not 
imply that patients will make bad decisions; rather it prepares patients and their 
families for the road ahead. Concern about overburdening cancer patients with 
difficult decisions prompted consideration of when shared decision-making is 
appropriate. Some feel it is appropriate only in chronic illness, where different 
treatment options with equivalent outcomes exist, and where outcomes are uncertain 
(Whitney 2003), while others disagree. Discussing options does not preclude the 
giving of a recommendation, indeed most patients want their doctors to recommend 
the treatment and most patients follow their doctor’s recommendation, but this does 
not suggest that discussing other options is a waste of time.
Patient involvement or patient-led decision-making
This issue raises the definition of shared decision-making and its interpretation by 
clinicians. Is shared decision-making about who makes the decisions or about how 
the decision is made; is asking patients to make difficult decisions a problem or do 
doctors think simply informing them of the options adds too much burden? It has 
been suggested that distinguishing between the decision and the process needs more 
exploration (Edwards and Elwyn 2006) and this was supported by the confusion 
evident in some answers in the current data set. A recent qualitative study of diabetic 
patients’ interpretation of the meaning of involvement by Entwistle et al (2008) 
reported that the majority wanted to hear and accept a doctors’ recommendation, even
those who spoke of making decision themselves appreciated guidance from their 
doctor towards the best decision.
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Increased consultation time was the most common negative effect conveyed in this 
study, supporting our findings from the larger survey and mirroring findings in other 
studies on barriers to or problems with shared decision-making (Charles, Gafni et al. 
2004; Gravel, Legare et al. 2006; Thistlethwaite, Heal et al. 2007; Shepherd, 
Tattersall et al. 2008). A number of studies have reported that collaborative decision­
making does not increase consultation time and may save time in the long run as 
thorough initial discussion enables subsequent consultations to be more succinct 
(Edwards, Elwyn et al. 2002). Views that involving patients in decisions may save 
time down the track were proposed, however there is no evidence to confirm or deny 
this assertion. Data on consultation time over the long term would assist this 
controversy.
Positive effects reported in our interviews included better patients outcomes including 
requiring doctors to keep abreast of latest treatment advances, and the development of 
therapeutic trusting relationships where the doctor is reassured that the patients is 
informed and understands why a treatment is being given or not. This is in line with 
quantitative findings showing that the majority of doctors are in fact comfortable 
with, and regularly use shared decision-making (Charles, Gafni et al. 2004; Shepherd,
Tattersall et al. 2007).
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7.8 CONCLUSION
Cancer patients’ preferences for information and involvement in treatment decisions 
require cancer doctors to shift toward using shared decision-making. This shift 
requires some changes in the way doctors manage their consultations and raises some 
questions about decision responsibility. Strategies which may assist doctors to 
manage the negative effects they experience and to enhance consultation skills to 
foster patient involvement in the process need to be developed and evaluated.
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CHAPTER EIGHT 
SYNTHESIS OF RESULTS
The focus of this thesis was to elicit information from practicing Australian cancer 
doctors concerning their attitudes towards involving patients in treatment decision­
making. Data to support discussion were gained using a mixed methods approach, 
namely surveying a nationwide sample of cancer specialists, followed by in depth 
qualitative interviewing of a purposeful subset of the larger participant sample. This 
thesis gives empirical data on the reported practice of Australian cancer doctors and 
raises issues which impinge on doctors’ support and practice in relation to involving 
cancer patients in treatment decisions.
Are doctors comfortable with shared decision-making and do they report using 
shared decision-making as their usual approach?
The primary outcome of stage one of this thesis is the reported usual approach of 
Australian cancer doctors treating one of five cancers (breast, colorectal, 
gynaecological, haematological and urological) to making treatment decisions with 
cancer patients.
The data show that the majority report high levels of comfort with a shared decision­
making approach, irrespective of their cancer speciality or their discipline. 
Differences were noted in the reported use of a shared decision-making approach, 
with breast and urological cancer doctors being significantly more likely to report 
using shared decision-making than the other specialists. This finding supported the
hypothesis that there will be a difference between breast cancer doctors and other 
cancer doctors in their attitudes to shared decision-making. Breast cancer doctors 
are more likely to use a shared decision-making approach, yet it identified that 
urological cancer doctors are equally as supportive of this approach. In the 
discussion of Chapter Three these findings were supported by other commentators on 
the appropriateness of patient involvement in treatment decisions as being aligned to 
the existence of more than one treatment option considered clinically reasonable for a 
given clinical situation(McNutt 2004; Whitney, McGuire et al. 2004). The surgical 
options in early stage breast cancer and the options in prostate cancer suggest that 
cancer doctors practicing in these contexts have embraced shared decision-making 
because there are treatment options with similar outcomes. Additionally the data 
elicited from the telephone interviews completed in stage two of this thesis and 
reported in Chapter 5 suggest that the existence of treatment options, where one 
treatment is not considered superior to another, is a strong motivator for doctors to 
encourage patient involvement.
The impact of treatment is a further issue which arose from the qualitative findings, 
as doctors voiced their unwillingness to impose treatments with consequences 
affecting sexual function or gender specific body image, without the full support and 
understanding of patients. These concerns are especially relevant in the treatment of 
breast and prostate cancer, but include gynaecological cancer.
The qualitative findings also endorsed the original thoughts guiding the hypothesis 
above in the support breast and prostate cancer patients gain from high profile 
consumer groups. This raised profile and raised expectation of cancer patients 
encourages and empowers them to participate in decisions about their care as well as 
increasing general knowledge of the treatment options available.
The remaining hypotheses o f younger age and practice setting influencing doctors’ 
attitudes towards use and comfort with shared decision-making were not supported 
by the data, despite belief that doctors trained more recently in an era of patient- 
centred medicine would be more comfortable and therefore more likely to use this 
approach. Perhaps the confidence and communication skills which develop with age 
are also important contributors to the likelihood of practising shared decision-making.
Do doctors discuss involvement in treatment decisions with their patients and do 
they know which patients want to be involved and which don’t?
To establish whether Australian cancer doctors discussed decisional participation 
with their patients in consultations, doctors were directly asked about their practice in 
stage one of this thesis. The results showed that most doctors reported discussing 
decision participation with their patients, yet a large minority (37%) did this with less 
than half of their patients. Similarly, most doctors were very comfortable with the 
notion of shared decision-making (84%) but far fewer reported that this was their
standard approach (62%).
According to the findings in Stage Two, a number of issues feed into this decision to 
limit open invitations to participate in decision-making to only some patients. 
Doctors reported that certain patient attributes motivated them to seek their patients’ 
involvement in reaching a treatment decision, namely younger age, female gender, 
perceived higher intelligence or education level, personality traits and certain 
occupations. Such patients were seen as capable of sharing decisions and likely to 
desire such involvement. Other patients were seen as less likely to want involvement 
in decision-making, and more likely to be harmed by such an approach. Whether 
doctors can make such judgements accurately in determining who to encourage and 
who not to encourage to share decisions is difficult to determine. Certainly there is a 
large literature reporting significant disparities between doctors’ estimates of 
patients’ preferences and patients’ reports of the same preferences (Solomon, Pager et 
al. 2003).
Doctors practising medical oncology were more likely to predict that their patients 
wanted a more active role. These findings support the hypothesis stated in the 
introduction that medical oncologists in Australia will have more positive attitudes to 
shared decision-making than their surgical counterpart. However the stereotypical 
view of surgeons as being the most paternalistic and the worst communicators 
amongst the medical professions was challenged in these findings, since surgeons 
were more likely than many other disciplines to support shared decision-making.
The qualitative findings suggest that rather than being profession based, views on 
shared decision-making were rather influenced by the disease scenarios in which 
doctors worked. Doctors who treated diseases in which real treatment options with 
similar outcomes existed were more likely to support shared decision-making. The 
data also suggested that doctors in these clinical areas are responding to the 
increasing information and involvement expectations of their patients.
Where few treatment options existed and where the patients’ prognoses were 
generally poor, doctors were less likely to embrace shared decision-making. 
Haematologists and paediatric oncologists for example, who were the least likely to 
report using shared decision-making as their usual approach talked about the lack of 
options for their patients and their hope that the next treatment might give a sustained 
response. In such a scenario, doctors and patients are more likely to collude to 
maintain hope by avoiding information exchange. Thus avoidance of share decision­
making is motivated by ‘caring too much’ perhaps, rather than ‘caring too little’ and 
refusing to give up power.
In the qualitative interviews indentifying patients’ preferences for information and 
involvement was noted as a key component of involvement. Doctors identified that 
making the right judgement was a skill which they developed with increasing 
consultation experience, but was one that was difficult to master as individual 
patients do not always fit within generalisations.
What stops doctors from involving patients in treatment decision-making?
System issues, particularly time, were the most frequently nominated barriers to
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involving patients in decision-making in the quantitative findings and were reiterated 
in the qualitative interviews, supporting findings elsewhere (Charles, Gafni et al. 
2004; Gravel, Legare et al. 2006). Whether extra time at initial consultations is time 
well spent has not yet been proved or disproved. Views of doctors on this matter are 
conflicting despite some work concluding that collaborative decision-making may 
save time later (Edwards, Elwyn et al. 2002). Doctors voiced that addressing patients 
concerns and thereby reducing anxiety is beneficial to the doctor-patient relationship, 
and involvement fosters this. It may perhaps be worth investigating whether it is the 
time point in the consultation where a treatment decision is agreed that is delayed 
rather than the actual length of the consultation which is increased. Perhaps the 
energy doctors expend to negotiate or coerce is greater giving the impression of more 
time spent.
Patient anxiety and concerns about how to manage this featured in both stages of this 
study as obstacles to involving patients in treatment decisions. Patients being overly 
anxious during consultations and the possibility of increasing anxiety by discussing 
options pushed some doctors towards involving their patients less. Anxiety does 
hinder patients’ understanding, however as some doctors noted, giving patients more 
information and taking the time to explain things more clearly and helping them to 
understand their situation can reduce anxiety and make the consultation and ensuing 
relationship more effective. Offering a treatment recommendation was a strategy
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which was used by some to overcome the concern that by asking patients to become 
involved would overburden them with responsibility and imply that the doctor did not 
know what to do. The notion of decisional regret came up as a potential concern for 
doctors. Doctors are care-providers and their reluctance to overburden patients was 
communicated as protective, a caring rather than paternalistic standpoint.
Very few doctors expressed difficulty in framing options for patients in the 
quantitative data, suggesting that doctors did not find explaining complex information 
about risks and benefits, communicating evidence or explaining differences between 
treatment options, a barrier to involving patients in treatment decisions. However, 
the need to transfer information to patients and ensure understanding was considered 
vital to patient involvement and a challenge.
Inexperience featured as a predictor of greater difficulties with system issues 
explained in detail in Chapter Four and was somewhat supported in comments made 
during the in depth interviews. The ability to determine what information or 
involvement patients might want to play appears to increase with consultation 
experience, explained perhaps by learning from mistakes or reflecting on what 
worked and what didn’t. Equally with experience some doctors talked about 
strategies they used to assist their patients to participate; offering handwritten 
summaries, dictating letters in front of the patients are some examples.
The data documented limited doctor support for interventions which aim to 
encourage patient participation. Changing established practice is difficult, yet doctors 
do respond to changing patient expectations, as illustrated in the differences noted 
between the breast and urological cancer doctors compared to other doctors in the 
sample. Responding to patient expectations not only triggers this difference, but also 
demonstrates where interventions should be aimed; it is perhaps easier to change 
doctors by changing patient expectations than attempting to change doctors directly.
What things encourage doctors to involve their patients in decisions?
As mentioned above and explained in more detail in Chapters Four and Five of this 
thesis, the most significant motivators and facilitators to doctors involving patients in 
treatment decisions found in this project are trust in the doctor, the impact of 
treatment on the patient and specifically issues of body image and sexual function, 
and the role that significant others play in the decision and consultation process.
Trust is pivotal; doctors clearly want their patients to believe them to be trustworthy, 
a quality they hope their communication, reputation and expertise conveys. Patients 
who trust their doctors are easier to guide to the best treatment and on occasions 
allow doctors to prescribe or to commence treatment prior to patients fully 
comprehending their situation. Elements of shared decision-making according to 
Australian cancer doctors assist development of a trusting relationship. Two-way 
communication permits both parties to know what motivates the other; whilst 
obviously survival is important, other values elicited during consultations where
doctors elicit preferences helps doctors to know which treatment might be preferred 
and to understand why a patient may refuse a particular treatment.
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Many doctors saw the impact of treatment on lifestyle and a patient’s self-image as an 
indicator for involving patients in decision-making, particularly when the treatment 
would affect gender defining qualities. These issues clearly prompted doctors to 
discuss the options and outcomes of treatment in more depth, ensuring that patients 
understood and that patients agreed to the doctor recommended treatment, that the 
doctors were not seen to be imposing mutilating surgery without informed consent.
Does involving patients in treatment decisions change doctors’ and patients’ 
behaviour?
Shared decision-making fosters patient involvement in treatment decisions. The 
tenets of shared decision-making demand that doctors pay heed to the preferences 
their patients have. Shared decision-making does not dictate that patients make 
decisions. In the interviews with doctors, interpretation of shared decision-making or 
patient involvement often pointed to the process of the consultations rather than to 
who made the decision. Indeed most doctors felt that patients wanted the doctor to 
make the decision or at the very least to make a clear recommendation and doctors 
felt comfortable with this. The notion that the patients could take on the doctor’s 
expertise in one or two consultations was not supported.
Involving patients requires new skills from doctors and in this way affects the way 
doctors behave. Knowing how to elicit preferences was a skill which the doctors 
knew they needed to have, yet most of them did not have a clear strategy to achieve 
this end. Asking patients what treatment they prefer is an easy method, yet many 
doctors stated this question may cause anxiety or bring their own expertise into 
question. Communication skills training was rarely mentioned by our participants 
and when asked in stage one whether access to such training would be helpful, the 
vast majority answered in the negative. Patients’ preferences to receive detailed 
information are high, preferences for involvement are high too, but lower for wanting 
to make any decisions alone (Vick and Scott 1998; Jenkins, Fallowfield et al. 2001; 
Levinson, Kao et al. 2005). However doctors are the ones with control, authority and 
familiarity in consultations and their endorsement or not of patient involvement is 
influential.
The rise of consumer involvement in healthcare has also had an effect on doctors. 
The results of this study show that patients from communities who expect to play an 
active role have forced the doctors to change their behaviour to accommodate this. 
This change is reflected in the higher reported use of shared decision-making and 
reflected in the interviews where doctors described how patients are given the 
information, given time to think about the options with their families and then return 
to the doctor with a decision. The comments concerning documentation of this event 
to make these discussions transparent in medical notes suggests that some doctors
consider it important, as a reminder and level of protection on a legal, moral and 
ethical level in case of poor outcomes.
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Uncertainty also features in doctors attitudes to patient involvement. In the case of 
prostate cancer, the acknowledged uncertainty in the medical fraternity of the best 
treatment is transferred to the patients by their use of shared decision-making and 
their actively seeking the patient’s input into their selected treatment.
Moves to promote patient involvement in treatment decision-making have emerged 
from patient-centred medicine, reflecting autonomy and patients rights. With this, 
other issues arise, as found in this thesis, such as the concept of decision 
responsibility. Doctors gave conflicting responses to this issue and conclusions 
drawn from the small amount of data gathered indicate that this idea deserves more 
thought and study. If patients are making decisions are they taking on the 
responsibility for the outcome? As doctors encourage patients to be more active due 
to pressure from consumer movements, do they retain ultimate responsibility or pass 
on some level of responsibility to the patients too?
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CONCLUSIONS
Shared decision-making is considered to be the gold standard approach to reaching 
treatment decision with patients. Despite this, many Australian cancer clinicians 
have not adopted this approach as their usual practice. Context, particularly medical 
specialty matters as does clinician gender, higher caseload of new patients, and the 
existence of reasonable treatment options.
Doctors support patient involvement but interpret involvement as participation in the 
decision process, not necessarily the decision. According to doctors, patients want 
their doctor to recommend a treatment and doctors want to do this. Involving patients 
in the decision process assists doctors to steer their patients towards that ‘right’ 
decision, and ensures that information is given explaining treatment, risks and 
benefits and likely outcome.
Involving patients is not always easy; doctors need excellent communication skills to 
draw out preferences from patients who are not familiar with this type of 
consultation. Our survey demonstrated that doctors are unfamiliar or reluctant to use 
interventions which assist patients to be more active.
Lack of time to involve patients fully, particularly by less experienced physicians, 
influences doctors to avoid this approach.
Involving patients in reaching decisions has both negative and positive consequences 
for doctors and patients. Extra time is required for patients to absorb increasing 
amounts of information but strategies, such as use of clinic nurses and individualised 
take home information to manage this can and are being used by some. Patients 
making decisions may affect the understanding of who is responsible for the 
outcome. How this plays out legally, ethically and morally is unclear.
LIMITATIONS
The studies in this thesis have a number of limitations. First the self-report nature of 
the survey means that it is impossible to verify whether participating clinicians 
actually practice as they reported. There is the potential for social desirability bias to 
have influenced the responses given by participants, with participants reporting their 
usual practice to be aligned with shared decision-making approach knowing the 
patient-centred ethos of modern healthcare. Further we asked doctors about their 
usual or general approach to treatment decision-making with their newly diagnosed 
or newly referred patients, without specifying a clinical scenario and did not allow 
them to indicate how they would respond in different situations, although many 
commented that they would vary their approach. Identification of participants was 
undertaken through professional societies and some eligible clinicians may not have 
received an invitation to participate if they were not registered members of the 
professional societies approached.
The data concerning the barriers and facilitators to treatment decision-making 
represent cancer physicians’ perceptions; the data do not necessarily represent the 
importance physicians place on these barriers and facilitators.
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The 59% response rate to the postal survey presents some limitation to the 
generalisability of the data. A further potential bias may be that the responders may 
be more interested in treatment decision-making approaches used with patients than 
non-responders. Consequently the reported experience of difficulties to involving 
patients in decision-making may be underreported and support for shared decision­
making may be over representative of the situation in practice.
The data collected from the qualitative interviews also offer a potential for bias in the 
results as responders may be more interested in patient involvement in treatment 
decision-making than non-responders. Participants may have acceded to a social 
desirability bias and been reluctant to express negative views concerning involving 
patients in decision-making. Effort was made to assure participants that we were 
interested in their own views to gain insight into how patient involvement in 
decision-making works in practice and not an idealistic view on how it should work.
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FUTURE RESEARCH
This thesis has raised more questions than it has answered and there are a number of 
issues which warrant future research.
Australian doctors report differences in involving patients in decision-making or 
shared decision-making and the context in which they encourage their patients to be 
involved appear to be dependent on a number of issues. Further work should seek to 
identify what these issues are and identify clinical scenarios where patients and 
doctors benefit from shared involvement in reaching a treatment decision.
In the data presented on barriers and facilitators to treatment decision-making with 
patients, trust was endorsed as vital to a shared process. As patients are encouraged 
to ask more questions of their doctors, doctors may feel that their patients trust them 
less. Identifying what trust means to patients and what doctor behaviours engender 
trust may provide a fruitful research ground, and assist in the development of a 
measure which reflects and assists doctors to gain their patients trust.
The role or impact of the presence of a third person in a consultation, a family 
member or other health professional, gave some food for thought. Is having a cancer 
nurse present in the consultation helpful to patients and/or a hindrance to doctors? In 
both the interviews and the postal survey a number of doctors supported the idea of 
patients being accompanied at the consultation, although support differed depending
on whom that person may be, a loved one or another healthcare professional such as 
cancer nurse. Many doctors endorse the value of cancer nurses to assist patients with 
understanding after their consultation yet the value of the nurse being present in the 
consultation may be a strategy which is helpful to both patients and doctors. Patient 
anxiety was frequently voiced as a barrier to patient involvement which is often 
reduced when patients understand what is going on. The role loved ones play in 
reducing anxiety by their presence in the consultation and the value of the presence of 
a patient advocate or nurse merit investigation.
The use of communication strategies and tools such as audio-recordings, question 
prompt lists and decision aids were not well supported by Australian doctors, indeed 
they were rarely mentioned in the interviews. Establishing why doctors are ignorant 
of or reluctant to use these methods is worth pursuing, as research developing and 
evaluating such tools, falls down if, despite positive results, doctors do not implement 
such strategies in their usual practice. Research investigating and targeting different 
implementation issues is therefore worthwhile.
Educating doctors about competences required to involve patients in reaching 
treatment decisions has been advocated. Once again developing strategies which 
doctors support is difficult. A number of training programs have been developed, 
however combining general communication skills and these competences merit 
exploration. Training programs need to identify and produce outcomes which doctors
value.
The data from this thesis show that doctors find establishing and identifying patient 
involvement preferences difficult, yet did not have clear ideas as to how they could 
better predict or establish patients preferences. Further work might examine how 
doctors identify patient preferences or how patients can be encouraged to voice 
preferences in cancer consultations.
The consequences of involving patients in treatment decisions also raised the issue of 
who then takes responsibility for the treatment outcome. Further work with patients 
and doctors could explore this issue morally, ethically and legally.
Finally this thesis has highlighted some issues where doctors’ interpretation of shared 
decision-making and its reality in consultations differed from the ideals put forward 
in models. Further work should focus on the idea of shared decision-making being a 
process rather than evaluation concentrating on the decision. Studies which report 
what patients’ experience should evaluate the elements of the process, instead of 
reporting who made the decision. The OPTION scale developed by Elwyn et al 
(2003) goes someway to target the competences put forward by the models; using 
these methods to evaluate consultation practice may be more accurate in reporting 
whether patients experience a shared decision-making consultation.
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Heather Shepherd, Research Assistant, 02 9036 5419 
Phyllis Butow, 02 9515 7097 
Martin Tattersall, 02 9351 3675.
Any person with concerns or complaints about the conduct of a research 
study can contact the Manager for Ethics Administration. University of 
Sydney on (02) 9351 4811,__________________________________________
Thank you for considering this information. This information sheet
is yours to keep.
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Appendix 2. Consent form for postal survey
MPRU
M e d i c a l  P s y c h o l o g y  R e s e a r c h  U n i t
T it Cnrfrtdtv  Ilf '«  A liy
Specialising in
RESEARCH STUDY INTO SHARED TREATMENT DECISION MAKING: A research into
SURVEY OF CANCER DOCTORS' VIEWS AND ATTITUDES ACROSS psycho-oncoloqv
AUSTRALIA- and health
communication
PARTICIPANT CONSENT FORM
I, ............................................................................................................. [name]
have read and understood the information for participants on the above 
named research study.
I freely choose to participate in this study and understand that I can 
withdraw without compromise at any time.
Medical Psychology Research 
Unit Blackburn Building. D06
The University of Sydney 
NSW 2006 ’
AUSTRALIA
Ph -61 2 951Î 6580 
Fax: -61 2 9515 5697 
E medpsych Smail usyd.edu au
DIRECTORS
Professor Phyllis Butow
I understand that the research study is strictly confidential. Ph -e i  293512859
Fax: -61 2 9036 5292 
E phyllisb'gpsvch usvd.edu.au
I hereby agree to participate in this research study.
Professor Martin Tatter sail 
Ph -61 2 9351 3675 
F a x -6 1  2 93514317 
E mtatt Smed.usyd.edu.au
Signature:
Name:
Date:
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Appendix 3. Survey sent to breast cancer specialists
Medical Psychology Research Unit
ID No. ____
Date / /
Treatment Decision-Making Study
A Research Project Of The Medical Psychology Research Unit And The 
Department Of Cancer Medicine, University Of Sydney
CONFIDENTIALITY
We would like to ask you to complete the following questionnaire. All the 
information will be treated as s tr ic t ly  con fid en tia l and your identity will never be 
revealed in any reports. The completed questionnaires will be kept separately 
from any information that could identify you and will be kept securely under lock 
and key. There is no need for you to write your name on this questionnaire.
INSTRUCTIONS:
There are no right or wrong answers. Just tick ( ✓ )  those answers that most 
apply to you.
When you have completed the questionnaire, please return it in the enclosed 
reply paid envelope and post it within the next seven days if possible.
Thank you very much for your help in this study
A5
Caseload of women with newly diagnosed early stage breast cancer
1) How many newly diagnosed early stage breast cancer patients (stage 1 or 2) do you see on 
average in a one-month period?
(✓ one box only)
□ 2 or less
□ 3 to 6
□ 7 to 10
□ 11 to 15
□ 16 to 20
□ 21 +
Your approach to providing information to women with newly diagnosed early 
stage breast cancer.
2) Using a rating scale of 1 to 5, where 1= No information, 5= A great deal of information, to 
what extent do you give information to cancer patients about:
For each item circle one number only
A Extent of the disease 1 2 3 4 5
B Details of treatment procedures 1 2 3 4 5
C Benefits of treatment 1 2 3 4 5
D Risks (side effects) of treatment 1 2 3 4 5
E Impact of treatment on sexuality 1 2 3 4 5
F Changes in appearance due to treatment 1 2 3 4 5
G Effects of treatment on mood 1 2 3 4 5
H Effects of treatment on family 1 2 3 4 5
I Effects of treatment on social activities 1 2 3 4 5
J Effects of treatment on patients' ability to care for 1 2 3 4 5
themselves at home
A 6
Your approach to treatment decision making with women with newly diagnosed 
early stage breast cancer.
To answer the following questions please look at examples below. Each example 
shows a different way in which a decision about treatment can be made with a 
patient. Now think about your approach to decision-making with cancer patients 
over the last 6 months:
¡¡f Example 1 «
in After reviewing the medical records and examining the patient the doctor 1,1
in decides on a suitable treatment and presents this to the patient. The doctor 
in gives information about the treatment including risks and benefits. The patient
1.1 accepts the treatment that the doctor recommends.
1.1 Example 2
1 After reviewing the medical records and examining the patient the doctor ,|,
'' presents the available treatment options. Information about the risks and w 
„ benefits of each option are given and discussed with the patient. The doctor m 
in then recommends a treatment that the patient accepts. 1,1
in 1,1
i„ Example 3 «
in After reviewing the medical records and examining the patient the doctor 1,1
in presents the available treatment options. Information about the risks and
1.1 benefits of each option are given and discussed with the patient. The doctor
1.1 asks the patient to decide on a treatment and states that s/he is the best
!' person to make the decision. The patient decides and informs the doctor of m 
„ the treatment s/he prefers. m
in ***|(| Example 4 m
After reviewing the medical records and examining the patient the doctor w
in presents the available treatment options. Information about the risks and 1,1
in benefits of each option are given and discussed with the patient. The doctor
in invites the patient to ask any questions. The doctor asks what his/her
1.1 preferences for treatment are given his/her lifestyle and the issues that are
¡1 important to him/her. Together they decide on a suitable treatment to m
implement. m
3) My approach is
□
□
□
□
□
□
usually more like: (✓  one box only)
Example 1
Example 2
Example 3
Example 4
None of these
Other, please specify_________
3
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4) On a scale of 1 to 5, indicate your level of comfort in using each of four approaches to 
treatment decision-making described in the examples above 
(For each example, circle one number only)
Not Extremely
comfortable *  *  comfortable
A Example 1 1 2 3 4 5
B Example 2 1 2 3 4 5
C Example 3 1 2 3 4 5
D Example 4 1 2 3 4 5
Comment:
5) In the last 6 months have you initiated a discussion with any of your newly diagnosed 
breast cancer patients about how much they wish to participate in deciding on their 
treatment?
( • / Yes or No)
Yes If yes, with what percentage of patients did you
es have this discussion?
(✓ one box only)
□  □  
<10% 10-25%
□
26-50%
□
51-75%
□
>75%
□ z o
a) What percentage of patients preferred that you take full responsibility for making a 
decision about treatment?
(✓ one box only)
□  □  
<10% 10-25%
□
26-50%
□
51-75%
□
>75%
b) What percentage preferred that you and the patient share making a decision about
treatment?
( /  one box only)
□ □ □ □ □
<10% 10-25% 26-50% 51-75% >75%
c) What percentage preferred that the patient take full responsibility for making a decision
about treatment?
(■/ one box only)
□ □ □ □ □
<10% 10-25% 26-50% 51-75% >75%
4
7) When treatment options are available for your newly diagnosed breast cancer patients do 
you usually give them a choice of treatment options?
(✓ one box only)
□  Yes
□  No
8) When treatment options are available for your newly diagnosed breast cancer patients do 
you usually give them a specific treatment recommendation?
(✓ one box only)
□  Yes
□  No
9) How important are the following to a process of “shared" treatment decision-making 
between clinician and patient?
(For each statement circle one n u m b e r only ) Not Extrem ely
im portant Im portant
A The doctor gives information (about the disease, the 
risks and benefits of treatment options) to the 
patient.
1 2 3 4 5
B The patient gives information to the doctor about 
what is important to him/her 1 2 3 4 5
C The doctor shows care and understanding. 1 2 3 4 5
D The doctor gives a treatment recommendation to the 
patient. 1 2 3 4 5
E The patient alone decides on the treatment. 1 2 3 4 5
F The doctor insists that the patient accept the 
recommended treatment 1 2 3 4 5
G The patient and the doctor discuss the pros and 
cons of the treatment options. 1 2 3 4 5
H The doctor and patient together agree on the 
treatment to be given 1 2 3 4 5
1 Only the doctor and the patient are involved when 
deciding on treatment. 1 2 3 4 5
J The doctor, patient and others (such as family or 
spouse) are involved when deciding on treatment. 1 2 3 4 5
K Other, please specify 1 2 3 4 5
A9
There are many factors that influence how treatment decisions are made. Some factors 
make decision-making difficult and can be a barrier to the process. Other factors are 
helpful and enable decision making to happen more easily.
10)To what extent do you experience the following as difficulties during the treatment decision­
making process?
(For each statement circle one number only.) 
A Insufficient time to spend with the patient.
Never Sometimes Often Almost
always
1 2  3 4
B The patient does not understand the information I 
have given.
C I have insufficient information to make a decision 
about treatment at the first consultation.
D The patient does not want to participate in treatment 
decision making as much as I would like her to.
E The patient wants to participate more in deciding on 
her treatment than I would like her to.
F The patient is indecisive.
2 3 4 
2 3 4 
2 3 4 
2 3 4 
2 3 4
G There are cultural differences between the patient and 
me.
FI The patient has received conflicting recommendations 
from various specialists.
I The patient requests a treatment not known to be 
beneficial
J The patient refuses a treatment that may benefit her
K The patient has difficulty accepting she has breast 
cancer.
L The patient is too anxious to listen to what I have to 
say.
M The patient brings too much information to discuss.
N The patient has other health problems (Eg. heart
disease)
O The patient wants to make a decision before receiving 
the information from me.
P The patient’s family overrides the decision making 
process
Q The patient has misconceptions about the disease or 
treatment.
R I experience difficulty knowing how to frame the 
treatment options for the patient.
S The patient comes expecting a certain treatment 
rather than a consultation.
T Other, please specify _______________________
6
11 )To what extent do you experience the following as helpful during the treatment decision­
making process?
(For each statement circle one number only )
Never Sometimes Often
Almost
always
A Providing written information to the patient.
1 2 3 4
B The patient wants to participate in making the 
treatment decision.
1 2 3 4
C The patient is prepared (knowledgeable about 
disease and treatment) for the consultation. 1 2 3
4
D The patient has someone with them at the 
consultation 1 2 3 4
E The patient is emotionally ready for decision-making 1 2 3 4
F The patient trusts me 1 2 3 4
Al l
Communication skills
12) If the patient wants less involvement than you think is optimal, how can this be addressed? 
(Please ✓  any of the following suggestions that you would support)
_  Preparing patient for a greater role in decision-making, by offering
— question prompt lists prior to the consultation.
□  Booklet explaining clinical decision-making.
□  Booklet about patient roles explaining shared decision-making
_  Access for medical practitioners to training to enhance skills in
— meeting patients' preferences for Shared decision making
□  Having a third person in the room
□  Explicitly negotiating shared decision making
□  Input from breast care nurse/CNC prior to consultation
_  Offering the patient written information about the treatment 
“  options available to her
□  Other,_______________________________________________
13) When you believe that there is no medical reason why a treatment decision needs to be 
made on the first consultation, how do you think pts should be encouraged to reflect on the 
treatment options before making a decision?
(Please ✓  any of the following suggestions that you think would be valuable)
□  Follow up appointment to make a decision
□  Giving written information highlighting treatment options
□  Audio-taping consultation
□  Encourage pt to talk to treatment team and general practitioner
□  Telephone follow up to discuss treatment decision
_ Worksheets for the patient to help her articulate what is important 
“  for her
□  Other,_______________________________________________
8
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Demographic information
14) Are you:
□  Male
□  Female
15) In what year were you born?
16)ln what year did you qualify as a doctor?
17)At which university did you complete your medical school training?
18) ln what setting do you perform most of your clinical activity?
(✓  all that apply: if several please indicate most activity with an asterisk)
□  Private practice
□  Public Hospital
□  Cancer Centre
□  University affiliated practice
□  Other setting, please specify______________________________
19) On average how many hours a week do you devote to direct patient care in oncology? 
(✓  one box only)
□  Less than 20 hours per week
□  20 hours or more per week
20)What is the size of the community where you perform most of your clinical duties? 
(✓  one box only)
□  Less than 100,000
□  100,000 to 500,000
□  More than 500,000
Thank you very much for completing this questionnaire. Your contribution to 
this research is greatly appreciated.
To ensure you do not receive a reminder please return the questionnaire in the 
postage paid envelope provided.
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Appendix 4. Survey sent to urological cancer specialists
MPRU
M e d i c a l  P s y c h o l o g y  R e s e a r c h  Un i t Th-[inwrtxiK at NTdnty
Treatment Decision-Making Study
A Research Project Of The Medical Psychology Research Unit And The Department 
Of Cancer Medicine, University Of Sydney
CONFIDENTIALITY
We would like to ask you to complete the following questionnaire. The completed 
questionnaires will be kept separately from any information that could identify 
you and will be kept securely under lock and key. There is no need for you to 
write your name on this questionnaire.
INSTRUCTIONS:
There are no right or wrong answers. Just tick (✓ ) those answers that most 
apply to you.
When you have completed the questionnaire, please return it in the enclosed 
reply paid envelope and post it within the next seven days if possible.
Thank you very much for your help in this study
A14
Caseload of patients with newly diagnosed cancer
1)
a) Which of the following types of cancer does the majority of your caseload 
represent? (✓ one box only)
□  Colorectal/Gastrointestinal
□  Leukaemia/lymphoma
□  Head and Neck
□  Lung
□  Gynaecological
□  Prostate/urological
□  Other, please specify__________________________
b) How many newly diagnosed cancer patients of the type indicated in Q1 
above do you see on average in a one-month period? (✓ one box only)
□ 2 or less
□ 3 to 6
□ 7 to 10
□ 11 to 15
□ 16 to 20
□ 21 +
2) Your approach to providing information to patients with newly diagnosed cancer.
Using a rating scale of 1 to 5, where 1= No information. 5= A great deal of information, to what 
extent do you give information to cancer patients about: For each item circle one number only
A Extent of the disease 1 2 3 4 5
B Details of treatment procedures 1 2 3 4 5
C Benefits of treatment 1 2 3 4 5
D Risks (side effects) of treatment 1 2 3 4 5
E Impact of treatment on sexuality 1 2 3 4 5
F Changes in appearance due to treatment 1 2 3 4 5
G Effects of treatment on mood 1 2 3 4 5
H Effects of treatment on family 1 2 3 4 5
I Effects of treatment on social activities 1 2 3 4 5
J Effects of treatment on patients' ability to care for 1 2 3 4 5
themselves at home
Your approach to treatment decision making with patients with newly diagnosed 
cancer.
To answer the following questions please look at examples below. Each example shows 
a different way in which a decision about treatment can be made with a patient. Now 
think about your approach to decision-making with cancer patients over the last 6 
months:
» s a a a s a a s e s s a e a a a a B a a e a a a a a e s a e s a s a a e a e e a *  
■ Example 1 ■
“ After reviewing the medical records and examining the patient the doctor decides on a " 
¡j suitable treatment and presents this to the patient The doctor gives information about |‘ 
„ the treatment including risks and benefits. The patient accepts the treatment that the „ 
u doctor recommends. u
1 Example 2 1
|J After reviewing the medical records and examining the patient the doctor presents the ¡J 
„ available treatment options, information about the risk.s and benefits of each option are „ 
„ given and discussed with the patient The doctor then recommends a treatment that the „ 
h patient accepts •
|| Example 3
u After reviewing the medical records and examining the patient the doctor presents the ,, 
„ available treatment options, information about the risks and benefits of each option are „ 
it given and discussed with the patient The doctor asks the patient to decide on a » 
» treatment and states that s/he is the Dest person to make the decision The patient »
» decides and informs the doctor o f the treatment s/he prefers “
ni h
,i Example 4 »
» After reviewing the medical records and examining the patient the doctor presents the n 
m available treatment options, information about the risks and benefits of each option are » 
given and discussed with the patient The doctor invites the patient to ask any questions « 
" The doctor asks what hi&her preferences for treatment are given his/her lifestyle and the 11 
|| issues that are important to him/her. Together they decide on a suitable treatment to || 
„ implement.
3) My apprcacn is usually more like: i /  one box only)
□  Example 1
□  Example 2
□  Example 3
□  Example 4
□  None of these
□  Other, please specify_________________________________
4) On a scaie of 1 to 5 indicate your level of comfort in usng each of four approaches to 
treatment decision-making descited in the examoles aoove. [For each example circle
one number only)
Not Extremely
comfortabie # ...... ' comfortable
A Example 1 1 2 3 4 5
B Example 2 1 2 3 4 5
C Example 3 1 2 3 4 5
D Example 4 1 2 3 4 5
3
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5) In the last 8 months nave you nitiated a dscussicn wth ary of your career patens 
about how much they wtsn to p a te  pate in deeding on their treatment?
( /  Yes or No)
If yes, with wnat percentage of patents did you 
es nave this discussion’’
( /  one box only)
C □  □  □  □
<10% 10-25% 20-50% 51-75% >75%
No
0 }
a) A'hat percentage of patents preferred that you take full resoonsibi ¡ity for 
making a cecision about treatment’’
( /  one box only)
□ □ □ □ □
<10% 10-25% 26-50% 51-75% >75%
b) A'hat percentage preferrec that you and the patient share making a dec.son 
about treatment?
( /  one box only)
□ □ □ □ □
<10% 10-25% 26-50% 51-75% >75%
o) 'A'hat percentage preferrec that the patent take full responsib ity for making 
a decision about treatment1’
(✓ one box only)
□ □ □ □ □
<10% 10-25% 26-50% 51-75% >75%
7) 'A'hen treatment options are availaole for your cancer patients, co you usually g ve tnem a 
cnooe of treatment options’7 < / one box only)
□  Yes
□  No
8) 'A’hen treatment opt ons are 3vailaole for your cancer patients, co you usual V g ve tnem a 
specie treatment recommendation"7 i /  one box only)
□  Yes
□  No
4
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9) H o * important are the V iew ing to a p-ocess of ‘shared’ treatment cecision-mak ng 
oetweer clinician and patient'7
(For each statement, circle one number only.) Net Extreme,.
Npottrt mporarr
A The dccto1, gives informal)or (about the disease, the 
risks and benefits c* treatment options) to  the oatient.
i 2 3 4 5
B The patent gives information to the doctor about wnat 
is important to h m'ner. 1
2 3 A 5
C The doctor shows care and unde-stanc nc. i 2 3 A 5
D The doctor gives a treatment recommendation to the 
patient 1
2 3 A 5
E The patent alone decides on the treatment t 2 3 A 5
F The doctor nsists that the patent accept the 
reoommendec treatment. 1 2 3 A 5
G The oatent ard tne coctor discuss the oros anc cons 
of tne treatment options.
1 2 3 A 5
H The doctor and oatient together agree on the 
treatment to be given. 1 2 3 A 5
1 Only tne doctor 3nc the patient are involved when 
cecic ng on treatment
1 2 3 A 5
J The doctor, patient and otners (such as family or 
spouse i 3re involved wher aecic ng on t-eatment 1 2 3 A 5
K Other, please specify. 1 2 3 A 5
10)To wnat extent do you expenence the V o w in g  as helpful during the treatment deos on- 
making process?
(For each statement, circle one number only.) S ev r Scmett’nei Oner Almostai*iyx
A Providinc w itten  information to the oatient. 1 2 3 4
B The patent wants to part cipate n mak ng the treatment 
decision 1 2 3 4
C The 03ten: is oreoared (kncwiecqeable about disease 
anc treatment) for the consultation 1 2 3 4
D The patent has someone with them at the consultation
1 2 3 4
E The oatent is emotionally ready for decision-mak np. 1 2 3 4
F The oatient tr js ts  me.
1 2 3 4
5
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There are many factors that inftuence how treatment decisions are made. Some factors 
make decision-making difficult and can be a barrier to the process. Other factors are helpful 
and enable decision making to happen more easily.
11 )To what extent do you experience the follow ng as difficulties during tne treatment 
decson-making process?
(For each statement, circle one number only.) se.er Sa-nwme* Otle-i Ornate a »ays
A insufficient t  me to scene with the oatient . 2 3 A
B The pat ent coes not understand tne information 1 have 
given. 2 3 A
C ! have insufficient nformation to make a decision about * 
treatment at the first consultation 2 3 A
D The patent Coes not want to participate in treatment 
decision making as much as 1 would ke himvher to.
9 3 A
E The patent wants to participate more in decidno on - 
his/her treatment than wou d like him/her to. 2 3 A
F The patent is indecisive. 3 A
6 There are cultural differences between tne patient ana * 
me. 2 3
A
H The patert has received conflicting recommendations 
'rom various speo alists 2 3 A
1 The pat ent requests a treatment not known to oe - 
beneficia. 2 3
A
J The patent refuses a treatment tnat may bereft her 2 3 A
K The patent has difficulty accepting she has cancer - 2 3 A
L The patent is too anxious to l isten to what nave to say. 2 3 A
M The patent br ngs too much information to discuss. 2 3 A
N The patient has otner healtn problems /Eg hear 
disease: 2 3 A
O The patert wants to make a decision be'o-e receiving 
the information from me. 2 3
A
P The parent's family overrides the decision making 
process. 2 3 A
G The pat ent has m sconoeptions about tne c sease or 
treatment. 2 3
A
R 1 expenence difficulty knowing how to frame the 
treatment options for tne pat ent
2 3 A
S The patert comes expecting a ce-tair treatment rathe- 
thar a consultation. 2 3
A
T Other, please specifv . 2 3 A
A19
Communication skills
12) If the patent wants less involvement than you think is optimal now can this be adc-essed'’ 
(Please /  any of the following suggestions that you would support!
n
c
n
a
c
□
n
c
c
^reoar ng patient for a greater role n dec s on-making, by offer ng qjestion prompt lists 
prio' to the consultation
3ook et explain ng clinical deasion-makirg
Book et about patent roes exp aining shared cecision-mak ng.
Access for medical practitioners to training to enhance sk.lls in meeting oatients1 
presences for Shared aeoision making
Having a third person in the room
Explicitly negotiating snarec decision making
Input from Cancer Nurse Coorcnator.’CNC poor to consultation
Offering tne patent wrtten information about tne treatment options avarabe to ner
Othef, ___________________________________________________
13) Wnen you believe tnat tnere is no medical reason why a treatment deason needs to be 
mace on the first consultation, now do you think pts should be encouraged to reflect on tne 
treatment options before making a decision?
(Please /  any of the following suggestions that you think would oe va uable i
C Poilow up apoo ntment to make a decision 
C Giving written information highlignting treatment options 
C Aud o-taping consultation
□  Encourage pt to talk to treatment team ana general practitioner
□  Te ephone fol<ow up to discuss treatment decision
Worksheets for the patent to help her articulate what is mportart 
for him-’her
□  Otner.___________________________________________________
7
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14) Are you:
Demographic information
□  Male
□  Femate
15) In wnat year were you bom0
16) In wnat year did you qualify 3S a coctor?
17) A: which university dio you complete your medical school :ra ning?
18) Are you a: (S one box only)
□  Mec cal Oncologist
□  Radiation Oncologist
□  Surgeon
□  Other, please specfy________________________
19) In wnat setting do you perform most of your clinical activity?
( /  ail that apply: if several p ease indicate most activity wtn ar asterisk)
□  Pnvate practce
□  Puolic Hospital
□  Cancer Centre
□  University affil ated practice
□  Other setting, pease specify_____________________________
20) On average how many hours a week do you devote to direct patient care in oncology? 
( /  one box only)
□  Less than 20 hours per week
□  20 hours or more per week
21) What is the size of the community woere you perform most of your clinical duties?
( /  one box only)
□  Less than 100.000
□  100.000 to 500.000
□  More than 500,000
Thank you very much for completing this questionnaire. Your contribution to 
this research is greatly appreciated.
To ensure you ao not receive a reminder please return the questionnaire in the 
postage paia envelope provided.
3
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Appendix 5. Survey sent to colorectal, haematologists, gynaecological specialists
M e d i c a l  P s y c h o l o g y  R e s e a r c h  U n i i
Treatm ent Decision-Making Study
A Research Project Of The Medical Psychology Research Unit And The Department 
Of Cancer Medicine. University Of Sydney
CONFIDENTIALITY
We would like to ask you to complete the following questionnaire. The completed 
questionnaires will be kept separately from any information that could identify 
you and will be kept securely under lock and key. There is no need for you to 
write your name on this questionnaire.
INSTRUCTIONS:
There are no right or wrong answers. Ju st tick (/") those answers that most 
apply to you.
When you have completed the questionnaire, please return it in the enclosed 
reply paid envelope and post it within the next seven days if possible.
Ikr l «ninth at m JiiiY
Thank you very much for your help in this study
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Caseload of patients with newly diagnosed cancer
D
a) Which of the 'o lowing types of cancer does the majority of your case oad 
represent? (✓  one box only)
□  Coiorecta./Gastrointestinal
□  Leukaemia/lympnoma
□  Head and Neck
□  Lung
□  Gynaecoiogical
□  Prostate
□  Other please specify________________________
b) How many newly diagnosed cancer patients of the type indicated in Q1 
above do you see on average in a one-month period'7 ( /  one box only)
□ 2 or ess
□ 3 to 6
□ 7 to 10
□ 11 to 15
□ 16 to 20
□ 21 +
2) Your approach to providing information to patients with newly diagnosed cancer
Using a rating scale of 1 to 5, where 1= No information, 5= A great deal of information, to what 
extent do you give information to cancer patients about For each item circle one number only
A Extent of the d sease 1 2 3 4 5
B Details of treatment procedures 1 2 3 4 5
C 3ene1ts of treatment 1 2 3 4 5
D Risks (side effects) of treatment 1 2 3 4 5
E Impact of treatment on sexuality 1 2 3 4 5
F Changes m appearance due to treatment 1 2 3 4 5
G Effects o' treatment on mood 1 2 3 4 5
H Effects of treatment on 'amily 1 2 3 4 5
I Effects of treatment on social activites 1 2 3 4 5
J Effects of treatment on patients' ability to care for 1 2 3 4 5
themseves at home
A23
Your approach to  treatm ent decision making w ith patients w ith newly diagnosed 
cancer.
To answer the following questions please look at examples below. Each example shows 
a different way in which a decision about treatment can be made with a patient Now 
think about your approach to decision-making with cancer patients over the last 6 
months:
!.. Example 1 ¡¡|
in After reviewing the medical records and examining the patient the doctor ll( 
in decides on a suitable treatment and presents this to the patient. The doctor 
gives information about the treatment including risks and benefits. The patient m 
w accepts the treatment that the doctor recommends. '»•
I» in
1.1 Example 2 m
1.1 After reviewing the medical records and examining the patient the doctor m 
|J| presents the available treatment options. Information about the risks and 1,1
benefits o f each option are given and discussed with the patient. The doctor |J| 
in then recommends a treatment that the patient accepts
in hiExample 3
hi After reviewing the medical records and examining the patient the doctor 
in presents the available treatment options. Information about the risks and w 
benefits of each option are gr/en and discussed with the patient. The doctor m
1.1 asks the patient to decide on a treatment and states that s/he is the best «• 
¡¡| person to make the decision. The patient decides and informs the doctor of 1,1 
... the treatment s/he prefers111 III
IJI Example 4 1,1
After reviewing the medical records and examining the patient the doctor ¡J|
in presents the available treatment options. Information about the risks and ¡,J 
hi benefits o f each option are given and discussed with the patient. The doctor 
"i invites the patient to ask any questions. The doctor asks what his/her m
1.1 preferences for treatment are given his/her lifestyle and the issues that are '«
1.1 important to him/her. Together they decide on a suitable treatment to 1,1 
implement.
s s s ss-ss-ssit*fss!9s* =
3) My aooroach is usually more like ( /  one box only)
□ Example 1
□ Example 2
□ Example 3
□ Example 4
□ None of these
□ Other, please specify
3
A24
4) On a scale of 1 to 5, indicate your level of comfort in using each of four approacnes to treatment 
decision-making descnbed in the examples above 
(For each example, circle one number only)
Not Extremely
comfortable *  *  comfortable
A Example 1 1 2 3 4 5
B Example 2 1 2 3 4 5
C Example 3 1 2 3 4 5
D Example 4 1 2 3 4 5
Comment
5) In the last 6 montns have you initiated a discussion with any of your cancer patients about how 
much they wish to participate in deciding on their treatment7
(✓ Yes or No)
□  Yes
(✓ one box oniy)
□ □
<10% 10-25%
If yes, with wnat percentage of patients did you 
have this discussion7
□
26-50%
□
51-75%
□
>75%
□  No
6)
a) Wnat percentage of patients preferred that you take full responsibility for 
making a decision about treatment?
(✓ one box only)
□ □ □ □ □
<10% 10-25% 26-50% 51-75% >75%
b) What percentage preferred that you and the patient share making a decision 
about treatment7
(✓ one box oniy)
□ □ □ □ □
<10% 10-25% 26-50% 51-75% >75%
c) What percentage preferred that the patient take full responsibility for making 
a decision about treatment7
( /  one box only)
□ □ □ □ □
<10% 10-25% 26-50% 51-75% >75%
4
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7) When treatment options are available for your cancer patients do you usually give them a 
choice of treatment options7
(✓ one box only)
□  Yes
□  No
8) When treatment options are avai able for your cancer pat ents do you usually give them a 
specie treatment recommendation7
(✓ one box only)
□  Yes
□  No
9) How important are the fol owing to a process of 'shared" treatment decision-making between 
clinician and patient?
(For each statement circle one number only.) sot Exrenetv
iTpcrtant mponar:
A The doctor gives information (about the d sease. the 
risks and benefts of treatment options) to the pat ent. 1 2 3 4 5
B The patient gives information to the doctor about what 
is important to hinVher. 1 2 3 4 5
C The doctor shows care and understanding. 1 2 3 4 5
D The doctor gives a treatment recommendation to the 
patient 1 2 3 4 5
E The patent alone decides on the treatment 1 2 3 4 5
F The doctor insists that the patent accept the 
recommended treatment. 1 2 3 4 5
G The patent and the doctor discuss the pros and cons 
of the treatment options. 1 2 3 4 5
H The doctor and patent together agree on the 
treatment to be given. 1 2 3 4 5
1 Only the doctor and the patient are involved when 
deciding on treatment. 1 2 3 4 5
J The doctor, patient and others (such as family or 
spouse) are involved when deciding on treatment. 1 2 3 4 5
K Other, please specify
1 2 3 4 5
5
A26
There are many factors that influence how treatment decisions are made. Some factors 
make decision-making difficu lt and can be a barrier to the process. Other factors are helpful 
and enable decision making to happen more easily.
10)To what extent do you experience the following as difficulties during the treatment decision­
making process?
{For each statement circle one number only.) Never Sometimes Otter AIT051always
A Insufficient time to spend with the patent . 2 3 4
B The patient does not understand the information 1 have . 
given.
2 3 4
C 1 have nsufficient information to maxe a decision about 
treatment at the first consultation 2 3 4
D The patient does not want to participate in treatment 
decision making as much as 1 would like him/her to. 2 3 4
E The patient wants to oartic pate more n decid ng on 1 
his/her treatment than I would ike him/her to. 2 3 4
F The patient is indecisive , 2 3 4
G There are cultural differences between the patient and 1 
me. 2 3 4
H The patient has received conflicting recommendations - 
from various specialists. 2 3 4
1 The patient req jests a treatment not known to be 
beneficial. 2 3 4
J The patient reuses  a treatment that may benefit her. 2 3 4
K The patient nas difficulty accept/ng s/he has cancer. 1 2 3 4
L The patient is too anxious to listen to what i have to say. 2 3 4
M The patient brings too much information to discuss 2 3 4
N The patient has other health problems. (Eg. heart 
disease) 2 3 4
0 The patient wants to make a decision before receiving 
the information from me. 2 3 4
P The patient s family overrides the decision making 
process.
2 3 4
Q The patient has misconceptions about the disease or 
treatment. 2 3 4
R I experience difficulty knowing how to frame the 
treatment options for the patient. 2 3 4
S The patient comes expecting a certain treatment rather 
than a consultation. 2 3 4
T Other please specify 2 3 4
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11 ) To wnat extent do you experience the *o lowing as helpful during the treatment decision-making 
process?
(For each statement circle one number only.) N e ve r S o n n e t l r « Ohen A m c * :always
A Providing wrtten nformation to the patient.
1 2 3 4
B The patent wants to participate in making the treatment 
decision. 1 2 3 4
C The patent is prepared (know edgeabie about disease 
and treatment) for the consultation. 1 2 3 4
D The patent has someone with them at the consultation.
1 2 3 4
E The patient is emotona ly ready for decision-making.
1 2 3 4
F The patent trusts me.
1 2 3 4
12) Are you:
Demographic information
G Male 
C Female
13) In what year were you bom?
14) In what year did you qua ify as a doctor?
15) At which university did you complete your medical school training?
16) Are you a:
(✓  one box only)
G Medica> Oncologist 
C  Radiation Oncologist 
G Surgeon
□  Other, please specify_______________________
17) In what setting do you perform most of your clinical activity?
(✓  all that apply: if several please indicate most activity with an asterisk) 
G Private practice 
G Public Hospital 
C Cancer Centre 
C University affil.ated practice 
G Other setting, please specify_________________
Please Turn Over
7
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18) On average how many hours a week do you devote to direct patient care in oncology7 
(✓ one box oniy)
□  Less than 20 hours per week
□  20 hours or more per wee<
19) What is the size of the community where you perform most of your ciin cai duties? 
(✓ one box only)
□  Less than 100,000
□  100,000 to 500,000
□  More than 500,000
Thank you very much for completing this questionnaire. Your contribution to 
this research is greatly appreciated.
To ensure you do not receive a reminder please return the questionnaire in the 
postage paid envelope provided.
S
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Appendix 6. Survey sent to paediatric oncologists
MPRU
M e d i c a l  P s y c h o l o g y  R e s e a r c h  U n i t/  C  v
The [ htv^ iK  «f Sydney
Treatment Decision-Making Study
A Research Pro ject O f The Medical Psychology Research Unit And The Department 
O f Cancer Medicine, University O f Sydney
CONFIDENTIALITY
We would like to ask you to complete the following questionnaire. The completed 
questionnaires will be kept separately from  any information that could identify  
you and will be kept securely under lock and key. There is no need fo r  you to 
w rite your name on th is questionnaire.
INSTRUCTIONS:
There are no right or wrong answers. Ju s t t ick  ( / )  those answers tha t most 
apply to you.
When you have completed the questionnaire, please return it in the enclosed 
reply paid envelope and post it within the next seven days if  possible.
Thank you very much fo r  your help in th is study
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Caseload of patients with newly diagnosed cancer
D
a) Which of the following types of cancer does the majority of your case oad 
represent? (✓ one box only)
□  Leukaemia/lympnoma
□  Sarcoma
□  Neurological
□  Other, please specify__________________________
b) How many newly dagnosed cancer patients of the type indicated in Q1 
above do you see on average in a one-month period'? ( /  one box only)
□ 2 or ess
□ 3 to 6
□ 7 to 10
□ 11 to 15
□ 16 to 20
□ 21 +
2) Your approach to providing information to patients, or their parent/guardian, with newly 
diagnosed cancer
Using a rating scale of 1 to 5, where 1 = No information, 5= A great deal of information, to what 
extent do you give information to cancer patients about For each item circle one number only
A Extent of the d sease 1 2 3 4 5
B Details of treatment procedures 1 2 3 4 5
c Benents of treatment 1 2 3 4 5
D Risks (side ejects) of treatment 1 2 3 4 5
E Impact of treatment on sexuality 1 2 3 4 5
F Changes in appearance due to treatment 1 2 3 4 5
G Effects o' treatment on mood 1 2 3 4 5
H Effects of treatment on 'amily 1 2 3 4 5
I Effects o' treatment on social activit es 1 2 3 4 5
J Effects of treatment on patients’ ability to care for 1 2 3 4 5
themselves at home
2
A31
Your approach to treatment decision making with patients with newly diagnosed 
cancer.
5  s
III
To answer the following questions please look at examples below. Each example shows 
a different way in which a decision about treatment can be made with a patient. Now 
think about your approach to decision-making with cancer patients over the last 6 
months:
(||= S s s à B s s 5 9 s s 3 S « S 9 s a s s B S 9 s s 9 S 5 S f i s S
1 Example 1
in After reviewing the medical records and examining the patient the doctor l(l 
decides on a suitable treatment and presents this to the patient. The doctor ,« 
gives information about the treatment including risks and benefits. The patient m
accepts the treatment that the doctor recommends. >«
in
Example 2 «
After reviewing the medical records and examining the patient the doctor •« 
presents the available treatment options. Information about the risks and 
benefits o f each option are given and discussed with the patient. The doctor 
then recommends a treatment that the patient accepts
Example 3
After reviewing the medical records and examining the patient the doctor 
presents the available treatment options. Information about the risks and 
benefits of each option are given and discussed with the patient. The doctor 
asks the patient to decide on a treatment and states that s/he is the best •« 
person to make the decision. The patient decides and informs the doctor of 
the treatment s/he prefers
Example 4
After reviewing the medical records and examining the patient the doctor ¡|| 
presents the available treatment options. Information about the risks and 
benefits of each option are given and discussed with the patient. The doctor n, 
invites the patient to ask any questions. The doctor asks what his/her m 
preferences for treatment are given his/her lifestyie and the issues that are ■« 
important to him/her. Together they decide on a suitable treatment to 
implement.
9 9 9 9  = 9 9 9 * 9 3  = 9 = 9 = = 99 = 9 = = = 9 S * 9 9 9  = * = 99 =
3) My aoproach is usually more like: (✓  one box only)
□ Example 1
□ Example 2
□ Example 3
□ Example 4
□ None of these
□ Other, please specify
3
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4) On a scale of 1 to 5, indicate your level of comfort in using each of four approaches to treatment 
decision-making described in the examples above 
(For each example, circle one number only)
Not Extremely
comfortable *  *  comfortable
A Example 1 1 2 3 4 5
B Example 2 1 2 3 4 5
C Example 3 1 2 3 4 5
D Example 4 1 2 3 4 5
Comment:
5) In the last 6 months have you initiated a discussion with any of your cancer oatients: or their 
parent/guardian. about how much they wish to participate in deciding on their treatment7
(✓ Yes or No)
Y If yes, with wnat percentage of patients did you
1 s have this discussion7
(✓ one box only)
□ □ □ □ □
<10% 10-25% 26-50% 51-75% >75%
□  No
6)
a) Wnat percentage of patients, or their parent/g jardian, preferred that you take 
full resoonsibility for making a decision about treatment7
(✓ one box only)
□ □ □ □ □
<10% 10-25% 26-50% 51-75% >75%
b) Wnat percentage preferred that you and the oatient, or their parent/guardian, 
share making a decision about treatment7
(✓ one box oniy)
□ □ □ □ □
<10% 10-25% 26-50% 51-75% >75%
c) Wnat percentage preferred that the patient or their parent/guardian, take full 
responsibility for making a decision about treatment7
( /  one box on y) 
C
< 10%
□
26-50%
□
10-25%
4
□
51-75%
□
>75%
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7) When treatment options are available for your cancer patients do you usually give them, or their 
parent/guardian, a choice of treatment options?
(✓ one box only)
□  Yes
□  No
8) When treatment options are available for your cancer patients do you usually g*ve them, or their 
parent/guardian, a specific treatment recommendat on?
(✓ one box only)
□  Yes
□  No
9) How important are the fol owing to a process of ‘shared” treatment decision-making between 
clinician and patient?
(For each statement circle one num ber only.) Sot Ecremelv
irr portarli nporar:
A The doctor gives information (about the dsease, the 
risks and benefts of treatment options) to the patent. 1 2 3 4 5
B The patient gives information to the doctor about what 
is important to him/her. 1 2 3 4 5
C The doctor shows care and understanding.
1 2 3 4 5
D The doctor gives a treatment recommendation to the 
patient and their parent/guardian. 1 2 3 4 5
E The patient alone decides on the treatment.
1 2 3 4 5
F The doctor insists that the patient accept the 
recommended treatment.
1 2 3 4 5
G The pat ent and the doctor discuss the pros and cons 
o f the treatment op tons.
1 2 3 4 5
H The doctor and pa ten t or their parent/guardian, 
together agree on the treatment to be given. 1 2 3 4 5
1 Only the doctor and the patient are involved when 
deciding on treatment. 1 2 3 4 5
J The doctor, patient and others (such as family or 
soouse) are involved when deciding on treatment.
1 2 3 4 5
K Other, please specify
1 2 3 4 5
5
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There are many factors that influence how treaunent decisions are made. Some factors 
make decision-making difficult and can be a barrier to the process. Other factors are helpful 
and enable decision making to happen more easily.
10) To what extent do you experience the following as difficulties djrmg the treatment decision­
making orocess?
M
(For each statement circle one number only.)
Insufficient time to spend with the patent and their 
parent-guardian.
The oatient, or their parent'guardian. does not 
understand the information I nave g;ven.
I have nsufficient information to maxe a decision about 
treatment at the first consultation.
The oatient does not want to participate in treatment 
decision making as much as I would like him/her to 
The patient, or their parent'guardian. wants to participate 
more in deciding on his/her treatment than I would ke 
nim/her to.
The patient, or their parent/guardian is indecisive
There are cultural differences between the oatient, or 
their parent/guardian. and me.
The oatient, or their parent/guardian. has received 
conflicting recommendations from vanous specialists 
The patient, or their parent'guardian, requests a 
treatment not xnown to be beneficial.
The patient, or their parent'guardian, refuses a treatment 
that may beneflt him/her.
The oatient, or their parent/guardian has difficu ty 
accepting s/he has cancer
The oatient, or their parent/guardian, is too anxious to 
isten to wnat I have to say.
The oatient, or their parent'guardian brings too much 
information to discuss.
The oatient has other health prob ems. (Eg heart 
disease)
The oatient, or their parent'guardian. wants to maxe a 
decision before receiving the information from me.
The patient s family overndes the decision making 
pipe— .
The patient, or their parent'guardian. has 
misconceptions about the d sease or treatment.
I experience difficulty knowing how to frame the 
treatment options for the patient, or their 
parent/guardian.
The oatient, or their parent'guardian, comes expecting a
certain treatment rather than a consultai on
Other please specify_______________________
Never So ned nee Oder AlTOSlalways
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
6
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11 ) To wnat extent do you experience the Allowing as helpful during the treatment decision-makmg 
process?
(For each statement circle one number only.) N e v e Som etlrres o n e i A i n o Ka rra ys
A Providing written nformation to the patient.
1 2 3 4
B The pat ent or their oarent/guardian, wants to partic pate 
in rrvak ng the treatment decision. 1 2 3 4
C The patent or their oarent/guardian, s prepared 
(know edgeab e abojt disease and treatment) 'or the 
consu tatior.
1 2 3 4
D The patent or their oarent/guardian, has someone with 
them at the consj tation. 1 2 3 4
E The patient, or their oarent/guardian, is emotionally 
ready for decision-making. 1 2 3 4
F The patent or their oarent/guardian, trusts me.
1 2 3 4
12) Are you:
Dem ographic information
□  Male 
G Female
13) In what year were you bom?
14) In what year did you quarify as a doctor?
15) At which university did you complete your medical school training?
16) Are you a:
(✓ one box only)
□  Medical Oncologist 
C Radiation Oncologist
□  Surgeon
□  Other, please specify__________________________
17) In what setting do you perform most of your clinical activity?
(✓ all that app y: if several please indicate most activity with an asterisk)
C Private practice 
G Public Hospital 
C Cancer Centre 
G University affiliated practice
G Other setting, please specify________________________________
Please Turn Over
7
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18) On average how many hours a week, do you devote to direct patient care in oncology" 
(✓ one box only)
□  Less than 20 hours per week
□  20 hours or more per week
19) What is the s,ze of the community where you perform most of your cimcai duties?
(✓ one box only)
□  Less than 100,000
□  100,000 to 500,000
□  More than 500,000
Thank you very much for completing this questionnaire. Your contribution to 
this research is greatly appreciated.
To ensure you do not receive a reminder please return the questionnaire in the 
postage paid envelope provided.
8
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Appendix 7. Information sheet for telephone interview participants.
MPRU
M e d i c a l  P s y c h o l o g y  R e s e a r c h  U n i t
Hit CnñcTóh Sritity
Research in psycho­
oncology and health 
communication
RESEARCH STUDY INTO SHARED TREATMENT DECISION MAKING: A SURVEY OF CANCER 
DOCTORS’ VIEWS AND ATTITUDES ACROSS AUSTRALIA.
PARTICIPANT INFORMATION STATEMENT
Recently you participated and completed our survey identifying cancer doctors' views about and 
attitudes to shared treatment decision making across Australia. The results from this postal survey 
suggest that some doctors believe that shared decision-making is appropriate in some but not all 
clinical situations. We are now exploring further the characteristics of situations in which doctors feel 
shared decision making is appropriate or not. It is hoped that the results will guide the development of 
training materials and resources which target the clinical situations where shared decision making is 
most likely to be used.
In order to achieve this we are conducting telephone interviews with a number of respondents to our 
survey. If you agree to participate in this second stage of the study you will be contacted by telephone 
at a time convenient for you and asked to participate in a semi-structured interview exploring clinical 
situations where different decision-making approaches are acceptable to clinicians. The interview will 
last approximately 15 minutes and will be audio-taped so that no information is lost. Included is a 
consent form with a stamped self-addressed envelope for its return. If you are happy to participate, 
please indicate on the consent the best time(s) for the research co-ordinator to phone you. All 
information you provide will be strictly confidential and only the investigators named below will have 
access to the data. All audiotapes and computer data will be identified only by an ID number, and will 
be destroyed after 7 years, as required by NHMRC. A report of the study may be submitted for 
publication, but individual participants will not be identifiable.
Participation in this study is entirely voluntary: you are not obliged to participate and - if you do 
participate - you can withdraw at any time.
The study is being conducted by Heather Shepherd, and will form the basis for the degree of Doctor of 
Philosophy in the School of Psychological Medicine at the University of Sydney under the supervision 
of Professors Phyllis Butow and Martin Tattersall.
If you would like to know more at any stage, please contact: 
Heather Shepherd, Research Assistant, 02 9036 5419 
Phyllis Butow. 02 9351 2859 
Martin Tattersall. 02 9351 3675.
Any person with concerns or complaints about the conduct of a research study can contact the Senior 
Ethics Officer, Ethics Administration. University of Sydney on (02) 9351 4811 (Telephone); (02) 9351 6706 
(Facsimile) or gbriody@mail.usyd.edu.au (Email).
This information sheet is for you to keep
Approved 26/10/2006
Page 1 of 1
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Appendix 8. Consent form for telephone interviews
MPRU
Medical Psychology Research Unit Du Cnírtióh »r S»dmrResearch in psycho- 
oncology and health
communication
RESEARCH STUDY INTO SHARED TREATMENT DECISION MAKING: A SURVEY OF 
CANCER DOCTORS’ VIEWS AND ATTITUDES ACROSS AUSTRALIA.
PARTICIPANT CONSENT FORM (semi structured telephone interviews)
In giving my consent I acknowledge that:
I............................................................... give consent to my participation in the research project
Name (please print)
TITLE:..........................................................................................................................................
1. The procedures required for the project and the time involved have been explained to me. 
and any questions I have about the project have been answered to my satisfaction.
2. I have read the Participant Information Statement and have been given the opportunity to 
discuss the information and my involvement in the project with the researcher/s.
3. I understand that I can withdraw from the study at any time, without affecting my 
relationship with the researcher(s) now or in the future.
4. I understand that my involvement is strictly confidential and no information about me will 
be used in any way that reveals my identity.
Signed:
Name:
Date:
My contact telephone number is __________________________________
Please suggest a time that would be convenient for us to contact you. Or circle a time below. 
The most convenient time/s to reach me by telephone are: ______________________
Monday Tuesday Wednesday Thursday Friday
9am 9am 9am 9am 9am
11am 11am 11am 11am 11am
3pm 3pm 3pm 3pm 3pm
5pm 5pm 5pm 5pm 5pm
Approved 26/10/2006
Page 1 of 1
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Appendix 9 Questions for telephone interviews
Project Title" Shared Treatment Decision Making: A survey of cancer doctors' views and attitudes across
Australia. HREC Approval Number 7575
Questions for semi-structured telephone interviews
1) Can ycu tell me what ycu tnn< are tne rrcs: inrecrtart Satires cf involving patents n decision making'5
2) What *  you 7> nk about nvovtng patients in making treatment deoscns?
a. Whait abcut t s gcod cr cao for tne patent0
z. Wnat abcut f s gcod cr Md for you0
c. Wnat abcut it s gcod cr Md for the nealtn system as a whole?
3) 3Ps have said that SDM is useful n  some situatcns (e.g. AF nenor~agia. HRT,) out not in others Do yo- think 
there are stuations »ne'e SDM s mo» acprcpriate tnan others'5 tf so; what a» they0 Whicn clinical scenarcs?
a. {If respond with 'where there s cear choice'} Hew do yo- determine when Ihere is clea' choice"
b. How do you determ'» f  the patient views this in tne same way you do0 E.g. patents may be 
"»rested n the nc treatment ootion?
c. Do you think n s ever accrcpnate net tc dsdese a t-eatmen: epten0 Fcr example, f it  is expensive 
and you knew tne patient has a limited income'1
d. A» there crc-mstances in wmch you either have not cr m iy: disclose a clinically Levant opten to a 
particular patient0' (or might not asdose an option that ycu worn seme: Ties mention to other 
patients with the same diagnoses)
e. Can ycu »escribe how you would normally present treatment ootions to yo-' patients? Do ycu list 
them n Oder of you* oreference rexmmendatcn0 Dc you present eaual amo-nts of information on 
eacn? Do ycu spend more t me on the ones yo- think a» more apprxrate?
4) In cur survey acctcrs who treated breast and iroicgioai cancers were mere pcs trve abcut SDM than others Why 
do ycu tnnx mat mght be51
5) Some patients don t wart SDM. To what extent do ycu thinx m * ents vary n  terms of their preferences fcr SDM° 
Do you establish if your patients want to oancipate n decision maxing? mow do yo- establis" whether you' patient 
wants SDM°
a. In you' experience what sorts cf patents tend to like ana dislike SDM°
b. In wnat senses ac you think patents like.'dslixe SDM? Or a» Ihere particular aspects which patients 
xe'dislike?
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c. Wouo ycu eve' encourage oasEive oatients tc cert cioate cr x  you s noty acceot their passvity7 Hew 
do ycu decoe ’/inch patents to push a lltte? Hew would yo- go abo-t encouraging thetr tc SOM7
6) In cur survey sane fosters reooned tnat sane patients are incapable of SOM ceca-se trey are toe anxious, o' 
aek -rderstansng of ther dsease status andor the infornaten they *eceve- do you ag-ee"1
a. Can ycu g ve an example of a oatient ’«no oculd net share deasen-maxing?
7) In your experience does SOM take up extra tine7 D o es: ever sa'/e t ire  down the track?
8) Oo yo- routiney effer a eatien; a follow-up ocnsJtation sc they nave t ne  to think accut r e  treatrent chcice?
a. Wnat nK?iiprohibt this approach7
9) How if at al do ycu tninx SOM ireacts or ycur cw  ana the oatent s ’esterselity for the decision7 Ooes SOM 
shift tre utinate decision restcnsibility7 How easy a  dfficut is this fb' you and f<y the catiert7
10) SDM rvo  ves shar rg resoorsib ty for the deci&cn as well as information about the ootions and consequences cf 
these Is this d fficu t7
a. For you7 Hew?
b. For the oatient7 How7
C
linical Studies
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Appendix 10. Published manuscript
British Journal of Cancer (2007) 97, 6 13
C> 2007 Cancer Research UK All rights reserved 0007 0920/07 $3000
www.bjcancer.com
The context influences doctors' support of shared decision­
making in cancer care
H L Sh ep h erd *1, MHN Tattersall' and PN Butow 2
'Medical Psychology Research Unit, faculty of Medicine, Blackburn Building, University of Sydney. N S W  2006, Australia; 2Medical Psychology Research 
Unit. School of Psychology. Griffith Taylor Bullring University of Sydney. N S W  2006. Australia
M ost cancer patients in westernised countries now  want all information about their situation, good o r  bad, and many wish to be 
involved in decision-making. The attitudes to and use of shared decision-making (SD M ) by cancer doctors is not well known. 
Australian cancer clinicians treating breast colorectal, gynaecological, haematological. o r  urological cancer were surveyed to identify 
their usual approach to decision-making and their comfort with different decision-making styles when discussing treatment with 
patients. A  response rate o f 5996 resulted in 624 complete surveys, which explored usual practice in discussing participation in 
decision-making providing information, and perception of the role patients want to play. Umvanate and multivariate analyses were 
performed to identify predictors o f use o f SD M . M ost cancer doctors (62.496) reported using S D M  and being most comfortable with 
this approach. Differences were apparent between reported high comfort with S D M  and less frequent usual practice. Multivariate 
analysis showed that spedalisation in breast o r  urological cancers compared to other cancers (A O R  3.02), high caseload of new 
patients per month (A O R  2 8 1) and female gender ( A O R  1.87) were each independently assodated with increased likelihood of use 
of SDM . Barriers exist to the application o f S D M  by doctors according to dinical situation and dinidan characteristics.
British Journal of Cancer (2007) 97, 6 -  13. doi: 10. l038/sj.bjc.660384l www.bjcancer.com 
Published online 5 June 2007 
©  2007 Cancer Research U K
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Shared decision-making (SDM) is perceived by many as the 
preferred way for health professionals and patients to approach 
treatment decisions. Public expectation to be fully informed about 
healthcare and available options has increased over recent years 
and there is decreasing acceptance of paternalism, highlighted in 
references to patients as consumers in the medical ethics and 
healthcare literature (Shotton, 1997). Meeting the involvement 
preferences of patients has positive effects on outcomes such as 
increased patient satisfaction and reduced decisional conflict and 
improved concordance with treatment regimens (Anderson et al. 
1995; jahng et al, 2005).
Shared decision making lies between paternalism and informed 
decision-making and can be considered an important component 
of patient centred care (Edwards et al, 2003). Shared decision 
making involves two steps: presentation of facts about treatment 
options and discussion of preferences, with the doctor's and 
patient’s values together determining the final decision (Eddy, 
1990). The challenges for the clinician are to minimise patients’ 
misunderstanding and misinterpretation of risks or benefits of 
treatment and to avoid imposing his or her own treatment 
preferences onto the patient.
From the clinician’s perspective, SDM is a useful way of presenting 
to patients the reality that outcomes in medicine arc not certain. 
Shared decision making is particularly appropriate in instances where 
there is more than one clinically reasonable treatment option or 
where there is a reasonable degree of uncertainty in the outcome of a 
particular intervention (Whitney et al, 2003; Kaplan, 2004).
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The literature suggests that SDM is not always achieved, 
although it is not clear whether patient or doctor barriers are 
more important. The preferences of cancer patients in this area 
have been widely studied (Say et al, 2006) but information is 
limited on the attitudes and practise of cancer clinicians when 
discussing treatments.
We surveyed cancer clinicians across Australia from August 
2004 to May 2006 to document their views on SDM and discover 
whether their views differed systematically according to doctor 
characteristics. We aimed to gain an expansive understanding of 
use and support of the different approaches to decision-making 
when discussing treatment options and did not identify particular 
clinical situations in the survey instrument. We hypothesised that 
certain factors may influence the support and use of SDM such as 
doctor specialty, clinician practice, practice setting, and patient 
caseload. As younger doctors have been educated in evidence 
based medicine and during the rise of medical consumerism, we 
also expected more positive attitudes to SDM in this age group. 
Other doctor characteristics might also influence attitudes and 
practise. Because of reduced access to some treatments and 
therefore reduced choice for patients in rural areas, we thought 
that doctors practising in rural communities might favour a SDM 
approach less than their colleagues in urban practices.
MATERIALS AND METHODS 
P articipan ts
Medical and radiation oncologists and surgeons practising mainly 
in oncology across Australia specialising in managing people with
A42
five tumour types (breast, colorectal, gynaecological, haematolo- 
gical, or urological cancers) were invited to participate in the 
study. Doctors were identified through the Australia and New 
Zealand Breast Cancer Trials Group, the Royal Australian College 
o f Surgeons -  Breast Section, the Medical Oncology Group of 
Australia, the Colorectal Surgical Society of Australasia, Australian 
Society of Gynaecologic Oncologists, the Australasian Leukaemia 
and Lymphoma Group, and the Urological Society of Australasia. 
The invitation letter clearly stated the intended participants as 
cancer doctors. Doctors who had retired from active practice were 
excluded from the study.
Questionnaire
The survey instrument was based on a structured questionnaire 
developed by Charles et al (2003, 2004) in Ontario, Canada in 1998 
through a process of focus groups and pdot-testing. With 
permission, we used this questionnaire with some alterations. 
The survey presented unlabelled examples constructed from the 
conceptual framework presented by Charles et al (1997, 1999)in 
earlier publications to reflect the following decision-making 
approaches: paternalistic, information-sharing only, informed, 
and shared (see Figure 1). Doctors were asked to select which of 
the examples best reflected their usual approach to treatment 
decision making with their newly diagnosed or newly referred 
patients. Doctors were asked to rate their comfort levels with each 
of the decision-making approaches on a five-point Likert scale, 
from not comfortable to extremely comfortable. Doctors also 
indicated with what percentage of their patients they usually 
initiated a discussion concerning participation in decision making, 
whether they routinely offered a treatment recommendation, and 
which role they felt their patients wanted to play: passive, shared, 
or active. Finally, doctors indicated the amount of detail they 
usually provide from 1 no information to 5 =  a great deal of 
information on 10 topics related to the benefits and costs of 
treatment options.
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body. If this was granted, the research team sent each doctor a 
package through the mail which included a letter inviting their 
participation and outlining that the survey intended to compare 
views of cancer doctors, an information sheet, a consent form, a 
copy of the questionnaire, and postage-paid envelope. If contact 
details were not provided, the packages were distributed by the 
representative body. Written endorsement of the survey was 
sought and obtained from representative bodies. Reminders were 
dispatched at 6 and 12 weeks if  no response had been received. A 
modified approach by Dillman (1978) was used to follow up 
invited participants. The second contact was by mail and 
comprised a letter reminding the participant o f the questionnaire 
and the value their input would bring to the study. The third and 
final contact included a second copy of the questionnaire with a 
return envelope, a letter outlining the aims of the survey, and a 
further reminder o f the importance of their contribution and the 
proportion o f completed surveys that had been received so far. The 
returned surveys were anonymous.
Data analysts
Demographics and characteristics of the sample were analysed 
using descriptive statistics. Univariate analysis was completed to 
identify associations between variables and usual approach to 
decision making and high comfort with SDM. Logistic regression 
analyses were completed with usual approach, recoded as 
shared or not, and with comfort, recoded as low or high, as the 
dependent variables in multivariate analysis to identify predictors 
of use of and comfort with SDM. Govariates for initial inclusion 
into the model were identified through univariate analysis 
(P$0.25). To identify the final predictive factors for retention in 
the model, we applied multivariable logistic regression analysis. 
We used the likelihood ratio test in a backwards elimination 
process, with P <  0.05 for a covariate to be retained in the final 
model. Model fit was assessed with Hosmer-Lemeshow goodness 
o f fit y2 tests. All analyses were performed using SPSS for Windows 
Version 14.
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Design and procedures
This was a cross-sectional survey. Permission was sought to obtain 
contact details of all group members from each representative
Example 1 Paternalistic
After reviewing the medical records and examining the patient, the doctor 
decides on a suitable treatment and presents this to the patient The doctor 
gives information about the treatment including risks and benefits The patient 
accepts the treatment that the doctor recommends
Example 2 Information sharing only
After reviewing the medical records and examining the patient, the doctor 
presents the available treatment options Information about the risks and 
benefits of each option are given and discussed with the patient The doctor 
then recommends a treatment that the patient accepts
Example 3 Informed
After reviewing the medical records and examining the patient, the doctor 
presents the available treatment options. Information about the risks and 
benefits of each option are given and discussed with the patient The doctor 
asks the patient to decide on a treatment and states that she/he is the best 
person to make the decision. The patient decides and informs the doctor erf the 
treatment s/he prefers
Example 4 Shared
After reviewing the medical records and examining the patient, the doctor 
presents the available treatment options. Information about the nsks and 
benefits of each option are given and discussed with the patient The doctor 
invites the patient to ask any questions The doctor asks what his/her 
preferences for treatment are given his/her lifestyle and the issues that are 
important to him/her. Together they decide on a suitable treatment to 
implement.
Figure I Treatment decision making examples.
RESULTS
Participants
Of 1198 total surveys mailed, 136 were returned and regarded as 
being ineligible (doctor retired, deceased, not clinically active, 
overseas, and incorrect address). From the remaining 1062 eligible 
participants, 632 surveys were returned, a response rate of 59%. 
Eight respondents declined to participate. Twenty of the surveys 
were completed by clinicians who reported that they did not treat 
patients In the five targeted tumour groups; therefore, these data 
were excluded from statistical analysis. The response rate was 
higher in the groups where the researchers contacted the 
participants directly, perhaps because the mailing list being used 
by the professional society did not exclude retired or non 
practising doctors. Within the non-respondents, tumour special­
ties were breast 30%, colorectal 10%, gynaecological 2%, 
haematologica! 9%, urological 42% and 7% unknown. The high 
non-responders in the urological cohort may reflect the mail out 
method in this group. Excluding the urological cohort on whom we 
had no information, 89% of the non-responders were male. 
Comparison of these characteristics with the study sample reveals 
no notable differences.
Table 1 shows the demographics of the 604 participating 
clinicians. Males (83.3%) made up the larger proportion of the 
sample. Mean age of the sample was 50 years and mean number of 
years medically qualified was 26 years. The majority (68.8%) 
worked >20h  per week in direct patient care. The majority 
(58.7%) worked in community sizes of >500 000.
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Table I Demographics of sample
Variable N(X)*
Cancer type
Breast 308 (51.0)
Colorectal 79 (13.1)
Gynæco logeai 27 (4.5)
Leukaemia/lymphoma 83 (13.7)
Urological 107 (17.7)
Doctor type
Medical oncologist 126 (20.9)
Radiation oncologist 5! (84)
Surgeon 354 (58.6)
Haematologst 61 (10.1)
Pac-dathc oncologist 12 (20)
Gender
Male 544 (83.3)
Female 101 (16.7)
Medica trarvng
Australia 544 (90.4)
Other 58 (96)
Direct poüent core per week
<20h 170 (31.2)
20 h o r more 375 (68.8)
M an  piace of clncal work
Private hospital 217 (39.8)
Public hospital 165 (30.3)
Cancer centre 43 (7.9)
University affiliated 8 (1.5)
Public/prr/ate 5(y50 111 (20.4)
Other 1 (Û2)
Communty are
<100000 41 (7.5)
100000-500000 184 (33.8)
>500000 319 (58.7)
Caseoad of new patients per montfiD
2 or less 81 (I3.S)
3 -6 232 (38.8)
7 -1 0 147 (24.6)
11 -  IS 69 (11.5)
16 20 37 (62)
21 + 32 (54)
Median 3 -6  new patients per month
Age (mean) 50 years (32 - 79 years)
Years qualified (mean) 26 years (4 56 years)
‘ Percentages based on valid cases only. 'W ith  specified cancer.
Usual approach to decision-making
The majority reported that their usual approach to decision­
making with cancer patients was most like the SUM approach (see 
Table 2). The paternalistic approach and the informed decision­
making approach were selected by fewer doctors.
Most doctors (82.1%) reported initiating a discussion about 
participating in decision making with their patients; however, only 
62.5% instigated this dialogue with more than half of their patients. 
Offering treatment options when available was almost unan­
imously supported (98.5%).
Comfort with different approaches to decision-making
Comfort levels with each of the four decision-making approaches 
are shown in Table 2. The model with which most doctors (59.7%)
reported being most comfortable was the SDM approach; 37.1% 
reported being least comfortable with the paternalistic model.
Information giving
The amount and type of information doctors routinely gave to 
newly diagnosed or newly referred patients varied according to 
specialty (Table 3). Items that doctors gave the most information 
about were eitent of disease, treatment procedures, and benefits 
and risks. Items about which doctors gave the least information 
were effects of treatment on family, sexuality, and mood. The 
amount of information given was scored out of 50; the mean score 
was 37.38, s.d. 5.372.
Comparing the mean scores of amount of information given by 
clinicians according to their usual approach to decision-making 
revealed that doctors using SDM gave significantly more informa­
tion (mean score 38.27) than doctors who reported not using SDM 
(mean 35.86), P = 0.00.
Clinician perception of patient role preference
Forty five per cent of doctors reported that more than half of their 
patients preferred to share decision-making responsibility with 
their doctors (see Table 4). When this response was examined by 
specialty and doctor discipline, significantly more urological 
(55.1%) and breast (53.4%) cancer doctors reported that more 
than half of their patients wanted to share responsibility (P = 0.00, 
d.f. =  4, OR 42.35). Significantly more medical oncologists 
(P 0.00, d.f. -  4, OR 32.94) than other disciplines reported that 
more than half of their patients wanted to share decision-making 
responsibility. The other disciplines stated that the majority of 
their patients wanted the doctor to take the decision-making 
responsibility. Very few clinicians ( < 10%) felt that the majority of 
their patients wanted to take the lead in this process.
Predictors of usual approach to decision-making
The original four category response to usual approach to decision­
making was collapsed into two categories; SDM or not. This 
decision was taken as only example 4 describes SDM fully, 
incorporating sharing of decision making responsibility, encour­
agement of patient involvement, and discussion of patient 
preferences and values relevant to the situation.
We analysed the data using crosstabs and yl  to identify 
significant predictors of usual approach to decision making. 
Univariate analysis results are presented in Table 5.
More medical oncologists (66.1%) and surgeons (66.2%) 
reported using a shared approach than other doctors. The duration 
of direct patient care per week and the size of the community in 
which the doctors practised did not influence the approach to 
treatment decision-making. More doctors specialising in breast or 
urological cancer reported using a shared approach than doctors 
specialising in colorectal, gynaecological, or haematological 
cancer. To further explore these results, we grouped the clinicians 
into those treating cancers with well-known preference-sensitive 
decisions and those where there are not. Breast and urology cancer 
doctors (prostate cancer) were combined to form the preference 
sensitive group (« =  415) and colorectal, gynaecological, and 
leukaemia/lymphoma doctors were grouped as the non-preference 
sensitive group (« =  189). This variable was included in the 
multivariate analysis reported below.
We performed binary logistic regression of usual approach to 
decision making (shared or non shared) using independent 
variables with y~ of <0.25. Variables entered in the model were 
cancer type (breast and urological doctors vs colorectal, gynaeco­
logical, and haematological doctors, gender, age (three groups), 
new patient caseload per month (2 or less, 3 -6 , 7-10, or >11), 
and country of medical training (Australia vs elsewhere). We used
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T a b le  2 Usual approach to decision-making and com fort levels with each approach
U sual approach
N  (% )
N o t  com fortable  
N ( % )
Som ew hat com fortable
N ( % )
Neutral
N ( % )
Very com fortable  
N ( % )
Extrem ely  
com fortable  N  (% )
Paterr.alistJC (example i) 6(1.0) 198 (37.1) 144 (27.0) 85 (15.9) 60 (1 1 3 ) 46 (86)
Information sharing (example 2) 138 (23.2) 39(7.3) 95 (17.8) 135 (25.3) 154 (28.9) 110(20 6)
Informed (example 3) 49 (8.2) 73(13.7) 118 (22.1) I I S  (21.5) 145 (272) 83(15.5)
Shared (example 4) 372 (62.4) I I  (21) 23 (4.3) 49 (9.1) 133 (248) 320 (59.7)
None of these 1 (0.2)
Other 30(5.0)
T a b le  3 Am ount o f information given to new patients
N o A  little So m e Q uite  a bit of Great deal of
inform ation inform ation inform ation inform ation inform ation
N ( % ) N ( % ) N < % ) N<%> N ( % ) M ean (s.d.)
Extent of the disease 1 (02) 4(0.7) 37 (6.2) 233 (388) 326 (54.2) 4.46 (0658)
Details of treatment procedures 1 (02) 0 (0 ) 22 (3.7) 193 (321) 385 (64.1) 4.60 (0578)
Benefits of treatment 1 (02) 0 (0 ) 18 (3.0) 234 (39.1) 346 (57.8) 4.54 (0573)
Risks (side effects) of treatment 1 (0.2) 2 (0 3) 36 (6.0) 237 (395) 324 (54.0) 4.47 (0640)
Impact o f treatment on sexuality 34 (5.7) 128 (214) 189 (31.6) 136 (227) 111 (18.6) 3.27 (1.158)
Changes in appearance due to treatment 22 (3.7) 63 (105) 197 (329) 218 (36.4) 99(16.5) 3.52 (1.006)
Effects of treatment on mood 41 (68) 135 (225) 247 (41.1) 133 (22.1) 45(7.5) 3.01 (1.010)
Effects of treatment on family 51 (85) 179 (298) 223 (37.1) 107 (178) 41 (68) 2.85 (1.033)
Effects of treatment on soaal activities 22 (3.7) 114 (19.0) 233 (38.8) 178 (29.7) 53 (88) 3.21 (0972)
Effects of treatment on patients' ability to care for 
themselves at home
15 (2 5 ) 72 (12.0) 194 (324) 229 (382) 89(14.9) 151 (Q969)
Total information gving score 37.38 (5.372)
T a b le  4 Perception o f patient preferred role
D o c to r takes full 
responsibility N  (% )*
Share  responsibility 
N ( % ) *
Patient takes full 
responsibility N  (% )* I 2 (d.f.)
Cancer specialty 
Breast 80 (26.8) 159 (514) 4(11)
.^(4) = 17.16«
Colorectal 41 (526) 26 (313) 1 (11)
Leukacma^ymphoma 43 (53.8) 18(225) 1 (11)
Gynaccologcal 16 (61.5) 5(19.2) 0 (0.0)
Urological 22 (20.6) 59 (55.1) 2(1.9)
Doctor type
Medical oncologists 29 (24.2) 70 (583) 2 (1.7
^(4) =31.13«
Radiation oncologists 22 (44.0) 15 (300) 0 (00)
Haematologsts 31 (525) 11 (186) 0 (00)
Paediatric oncologists 5 (45.5) 4 (364) 1 (9.1)
Surgeons 115 (33.0) 167 (47.9) 5(1.4)
d.f =  degrees of freedom, ••f’ <0 .0 1 ' %  o 'doctors who reported the role > 5 0 %  of their patients preferred.
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a backward stepwise likelihood ratio model; non shared was the 
reference category of the dependent variable. The final model has a 
y1 of 51.31, d.£ = 5, P =  0.00. Goodness of fit is supported by the 
Hosmer-Lemeshow test; y1 4.62, d.f. = 7, P — 0.71.
Doctors practising in breast or urological cancer were three 
times as likely to use a shared approach compared to colorectal, 
gynaecological, or haematological doctors (P<0.001, OR - 3.02, 
95% Cl 2.08-4.37). Doctors reporting the highest numbers of new 
patients per month had 2.8 times the odds of using a shared 
approach (P<0.005,OR -2.81, 95% Cl 1.54-5.16). Female doctors 
had 1.9 times the odds of using shared approach compared to their 
male colleagues (PcO.001, OR ~ 1.87, 95% Cl 1.13-3.10). Vari­
ables not independently associated with usual approach to 
decision-making were country of medical training and age (see 
Table 6).
Predictors of comfort with SUM
Univariate analysis was undertaken for high comfort with the SDM 
(see Table 7). Shared decision-making was rated with the highest 
comfort levels by doctors treating breast or urological cancers 
(87.6%). Medical (89.0%) and radiation oncologists (78%) and 
surgeons (84.3%) reported being most comfortable with the shared 
approach.
We performed binary logistic regression of comfort with SDM 
(low comfort or high comfort) using independent variables withy" 
of <0.25. Variables entered in the model were cancer type (breast 
and urological doctors vs colorectal, gynaecological, and haema­
tological doctors), doctor gender, and new patient caseload per 
month. We used a backward stepwise likelihood ratio model; low 
comfort was the reference category of the dependent variable. The
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T a b le  5 Univariate analyses o f usual DM  approach by doctor 
characteristics
Non-sharcd
N (% )
Shared
N(%) * <«U)
Doctor type
Medical oncologists 42 (33.9) 82 (66.1) y2(4) = 15.240“
Radiation oncologists 24 (48,0) 26 (52.0)
Surgeons 118 (33.8) 231 (66.2)
Haematologists 32 (52.5) 29 (47.5)
Paedatric oncologists 8 (66.7) 4 (33.3)
Tumour type
Breast 99 (32.9) 202 (67.1) / (4 ) = 37.256“
Colorectal 42 (53.8) 36 (46.2)
Lcukacmia/lymphoma 44 (53.0) 39 (47.0)
Gynaecobgcal 16 (59.3) II  (40.7)
Urological 23(21.5) 84 (78.5)
Cancer speoaity
Breast and urological 122 (29.9) 286 (70.1) y2( l) = 32.538«
Colorectal, ¡ynaecolojÿ. 102 (54.3) 86 (45.7)
and haematology 
Gender
Male 198 (39.9) 298 (60.1) *3(0  =6.873“
Female 26 (26.0) 74 (74.0)
Age
Under 40 years 25 (29.4) 60 (70.6) * '(2 ) = 2802
40-55 years 125 (39.2) 194 (60.8)
O /er 55 years 73 (38.2) 118 (61.8)
Country of medicai tranng
Australia 195(36.4) 341 (63.6) * '(0  = 2313
Other 27(46.6) 31 (53.4)
New parent caseload per month
2 or less 38 (47.5) 42 (52.5) / (3 )=  10345*
3-6 90 (39.6) 137 (60.4)
7-10 56 (38.4) 90 (61.6)
11 + 37 (27.0) 100(73.0)
Direct patient care per week
<20hrs 63 (38.0) 103 (62.0) * J (1) = 0694
20+hrs 127 (34.2) 244 (65.8)
Communty size
<100000 12 (30.0) 28 (70.0) / (2 ) = 7.06
i 00 000 500000 63 (34,8) 118 (65 2)
500000+ 115 (36.5) 200 (63.5)
d.f = degrees of freedom. *P<0.05. “ P <0,01
final model has a y2 o f 23.55, cL£ =  5, P =  0.00. Goodness o f fit is 
supported by the Hosmer - Lemeshow test; y1 10.55, d.f. =6 , 
P = 0.10.
In multivariate regression analysis, doctors practising in breast 
or urological cancer were 2 i times as likely to be very comfortable 
with SDM compared to colorectal, gynaecological, or haematolo- 
gical doctors (PcO.OOl, OR =  2.53 , 95% Cl 1.52-4.24). Female 
doctors had 2.3 times the odds o f being very comfortable with 
SDM compared to their male counterparts ( P c 0.05, OR 2.31, 
95% Cl 1.01 -5.27). Overall caseload did not produce a significant 
result; however, doctors reporting the highest numbers o f new 
patients per month showed 2.3 times the odds o f being very 
comfortable using SDM (P  =  0.05, OR =  2.33, 95% Cl 0.10-5.44) 
(see Table 8).
Our results show a discrepancy between reported usual practice 
o f  SDM and high comfort with that approach. This mismatch is 
highest in the gynaecological doctors (48.2%) (see Table 9).
T a b le  6 Multivariate Logistic Regression predicting usual approach to 
decision-making
Independent variables P  (» e .) W a ld  ( y 1)  (d .f.) A O R  (95% C l)
Age 0.00 (Oil 4) ** (0  = 000 1.00(075-1.33)
Country of training 
Australia 0 42 (Û30) *J( 0 = '  98 1.52 (085 2.74)
Other
Caseload
0-2 z X 3) =1133» 1—
3-6 0.53 (027) **(0=3.78 1.71 (1.00-2.92)
7-10 0.57 (029) / ( O  = 374 
* ( 1 ) = 1 1.23“
1.77 (0.99 3.14)
>11 1.03 (Q3I) 281 (1.54-5.16)
Cancer specialty
Colorectal, gynaecology, 
and haematological 
Breast and urologcal 1.10(019) *3(0  = 33.94“ 3.02 (208 4.37)
Gender
Mde
Female 0.63 (0.26) ** (!) = 5.99*
1 —
1.87(1.13-3.10)
AO R = adjusted odds ratio: d.f. = degrees of freedom; 9556 0 = 9 5 %  confidence 
interval. "P<0.05. “ P<0.0l.
DISCUSSION
We investigated usual practice and comfort levels with treatment 
decision making across cancer care in Australia. Our expectation 
that differences would exist between tumour specialties and 
between doctor disciplines was supported. Since a clear treatment 
choice is available in the management o f early breast cancer and 
because o f  the breast cancer consumer movement, we expected 
more positive attitudes to SDM to be evident in surgeons treating 
this disease. Demographic differences were apparent in Australian 
clinicians’ approach to decision making, not only in their usual 
practice but also in their comfort with the styles presented in the 
survey.
Comfort with and use of SDM
Respondents reported high levels o f comfort with SDM and 
discomfort with a paternalistic modeL These results reflect the 
changes over recent years in the expectations and information 
preferences o f  patients and suggest that clinicians are responding 
to an increasingly consumerist model o f  healthcare. A UK study 
that used focus group interviews with general practitioners also 
reported positive attitudes to patient involvement (Elwyn ef a/, 
2000). Doctor use o f SDM in our survey was associated with 
reported greater information giving compared to colleagues who 
did not use a shared approach.
Our hypothesis that doctors treating breast cancer would 
involve patients in decision making was supported. Breast cancer 
doctors in Australia strongly endorsed SDM as found in Canada 
(Charles et al, 2004). Indeed there were strong similarities between 
the decision making practices o f Australian and Canadian breast 
cancer doctors (Charles et al, 2004), suggesting a similar culture 
surrounding treatment decision-making in the two countries. 
Shared decision-making was also strongly supported by the 
urological specialists. Conversely, support for SDM was low in 
paediatric oncologists and haematologists. Paediatricians may feel 
that parents o f  seriously ill children need to be informed o f 
options, but led to the preferred treatment because o f the 
extremely emotional context. Other clinicians, however, may feel 
more able to share decision making where a treatment decision is
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T ab le  7 Univariate analyses o f high comfort levels with S D M *
H igh  com fort with S D M  N  (% ) Z2 (d-f.)
Doctor type
7 ^ ) =  4.95Medical oncologists 105 (89.0)
Radiation oncologists 39 (78.0)
Hacmatologsts” 4 (66.7)
Paediatric oncologists 9(81.8)
Surgeons 296 (84.3)
Cancer specialty
/ ( I )  =  12.74“Breast and urological 360 (87.6)
Colorectal, gynaecology 
and haematology
93 (74.4)
Gender
Male 372 (83.0) * 2(2) =  4 5 6 *
Female 81 (92.0)
Under 40 years 65 (86.7) X \ l )  =0.42
4 0 -5 5  years 241 (83.4)
Over 55 years 146 (84.6)
Country of medical tramng
r 2(i)= o .o oAustral a 412 (84.4)
Other 39 (84.8)
Caseload per month
* '(3 )  =  6.652 or less 62 (81.6)
3 - 6 162 (80.6) P =  <1084
7 -1 0 111 (86.7)
1 1 + 113 (90.4)
Drect paOent care per vveek
7^1) =0.70<20 h rs 137 (825)
20+hrs 315 (85.4)
Community size
< 1 0 0000 34 (85.0) 7 ^ )  =  1-27
100000 500000 158 (86.8)
500000+ 259 (83.0)
• P < 005  **P<0 .0 l. “Percentages here represent respondents who reported 
comfort levels of 4 or S on the S-poimt Liken scale. I — not comfortable. 5 -  very 
comfortable. “An initial decision to shorten the survey for participants other than 
breast cancer specialists, excluding the question concerning comfort levels with each 
of the four decision making examples was reversed mid-way through sending the 
survey to second cohort (haematologists) and explains the small number of 
responses n  this group for these questions.
a real choice between two options with similar survival outcomes 
(Whitney ef al, 2003), such as mastectomy vs breast conservation 
or radical prostatectomy vs hormone therapy and brachytherapy 
for prostate cancer. The surgical treatment options in breast cancer 
may explain the higher proportion of surgeons (who have a clear 
choice to offer) compared to medical oncologists (who may feel 
that systemic therapy is definitely indicated) who reported sharing 
decision making with their patients. Similarly, colorectal gynae 
cological oncologists, and haematologists may also feel that their 
patients need more direction due to lack of treatment options 
available. This interpretation is supported elsewhere with family 
physicians asserting that SDM is most appropriate when clinical 
equipoise exists (Elwyn ef al, 2000; Whitney ef al, 2003). 
Respondents were not asked to identify a particular decision, 
nor did the questionnaire stipulate that the questions should be 
answered in contexts where equitable treatment options existed; 
yet our results indicate that context and existence of equitable 
treatment options may play a part in doctors’ comfort and 
readiness to use SDM.
T a b le  8 Multivariate logistic regression predicting high comfort with 
S D M
Independent variables ft (s.e.) W a ld  (* 2) (d.f.) A O R  (95% C l)
Cancer speoalty
Colorectal, gynaecolo^.
and haematological
Breast and urological 0.93 (026) * 2( l ) = ! 2 5 8 ~ 253  (152 4.24)
Caseload
0 - 2
3 - 6  0.10 (035) 
7 - 1 0  0.56 (040) 
>  11 0.84 (043)
72d )  =  080  
X2( l)  =  l.95 
X2( l)  =  382
l.l 1 (055-2.22) 
1.76 (080 3 88) 
233 (1 0 0 -5 4 4 )
Gender
Male
Female 0.84 (042) A 0  =  3.97*
1 -
2.31 (1.01-5.27)
A C R  =  adjusted cxids ratio: d.f. -  degrees 
Interval. *P<0.05. **P<0 .0 l.
of freedom: 95%  G =  95%  confidence
T a b le  9 Discrepancy between high comfort level and reported use of 
S D M
Usual approach  
N ( % )
H igh level of 
com fort N  (% ) M ism atch
Tumour type
Breast 202 (67.1) 266 (869) 198
Colorectal 36 (462) 51 (67.1) 20.9
Lcukaemiaflymphoma 39 (47.0) 18 (81.8) 348
Gynaecologcal 11 (407) 24 (88.9) 482
Urological 84 (81.6) 94 (89.5) 7.9
Doctor type
Medical oncologists 91 (650) 105 (89.0) 24.0
Radiation oncologists 26 (500) 39 (780) 28.0
Haomatologsts 29 (47.5) + (667) 192
Pacdiatnc oncologists 4 (286) 9 (81.8) 532
Surgeons 231 (69.2) 296 (84.3) 15.1
The consumer movement and public awareness of surgical 
treatment options in breast and prostate cancer may also have 
contributed to these results. The doctors in these specialties may 
be responding to this shift, as their patients demand more 
information and a role in discussing and deciding about treatment. 
Breast and urological cancer doctors believe more of their patients 
wish to be involved in decision making. Indeed, studies that have 
investigated the information and involvement preferences of 
patients demonstrate that breast cancer patients prefer a more 
active role than other cancer patients (Beaver ef al, 1996; Degner 
ef al, 1997; Bruera ef al, 2002).
Differences according to caseload in support of SDM may be 
related to practice setting and multi-disciplinary relationships. 
Doctors who treat fewer patients with a particular cancer may be 
less comfortable with involving patients in decision-making due to 
their reduced familiarity with treatment options. Those with a 
large caseload are perhaps more likely to be a multi-disciplinary 
team member where SDM is fostered, and more likely to feel 
confident in offering a number of options.
Discrepancy between reported comfort levels and usual 
practise
The discrepancy in the reporting of comfort with SDM and the use 
of this approach in practice mirrors the Canadian results. For all
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surveyed clinicians except those treating colorectal cancer, over 
80% reported high levels o f comfort with SDM; yet, with the 
exception o f the breast and urological cohorts, less than 50% 
reported using this approach for the majority of their patients. 
Interpretation o f this discrepancy affords varying standpoints. 
Some commentators may interpret this discrepancy as evidence 
that in certain oncology clinical situations choice does not exist 
and therefore doctors would not use an SDM approach. Whitney 
discusses the issue o f no treatment as a non-viable option and cites 
the example o f  a life-threatening gunshot wound and the 
inappropriateness o f SDM in this context. Yet in oncology, no 
treatment could be seen as medically reasonable in many instances 
where treatment reduces risk but does not eliminate it, and carries 
serious side effects. This interpretation opens up the debate on 
what constitutes a medically reasonable option and whether this 
always includes intervention. More generally, however, these 
criteria for SDM may be refuted by those who comment that 
SDM is always appropriate even in circumstances where a 
treatment choice is obvious, as patients need to be involved in 
the decision to understand the logic. There may also be other 
barriers to implementation o f SDM, which we as yet do not 
understand.
Similar discrepancies have been reported internationally. 
General practitioners in the United Kingdom also professed 
support for SDM but when their own consultations were analysed 
the participating doctors agreed components of SDM did not occur 
(Stevenson et al, 2000). Braddock et al (1999) analysed 1057 
consultations o f  primary care physicians and surgeons in 1993 and 
found that only 11.3% included discussion o f alternative treatment 
options and just 7.8% included pros and cons. An Australian study 
in 2001 o f  consultations with advanced cancer patients showed 
that only 27% o f patients were offered a choice, and 44% were 
given information on an alternative course o f action to anticancer 
therapy (Gattellari et al, 2002). In a Dutch study o f advanced 
cancer patient care, acknowledgement o f the medical oncology 
options o f palliative chemotherapy or watchful waiting occurred in 
half o f the consultations, with just 27% receiving extensive 
explanation o f the watchful waiting option (Koedoot et al, 2004). 
These results lead us to conclude that the discrepancy between 
reported high comfort and actual SDM practice may be greater 
than that our self-reported data shows. It is important to explore 
barriers to implementation that might explain this discrepancy.
CONCLUSIONS
Despite SDM being lauded as the gold standard for treatment 
options discussion and reported high levels o f comfort with SDM, 
Australian clinicians are not currently reporting that this is their 
usual practice. Cancer specialty, clinician gender, and higher 
caseload o f new patients influence cancer doctors’ use o f SDM. 
Breast and urological cancer patients can expect a consultation 
where their involvement and information preferences are more 
likely to be explored. Clinician attitudes and use o f SDM can be 
influenced by the clinical situation in which they practice. Further 
work is required to establish whether clinicians in cancers other 
than breast and urological cancers recognise clinical scenarios 
where they support and use SDM.
LIMITATIONS
A limitation o f  this study is the self-report nature o f the survey; 
therefore, we cannot verify whether participating clinicians 
actually practise as they reported. There is the potential for social 
desirability bias to have influenced the responses given by 
participants, with participants reporting their usual practise to 
be SDM knowing the patient-centred ethos o f modern healthcare. 
Finally, we asked doctors about their usual or general approach to 
treatment decision-making. This did not allow them to indicate 
how they would respond in different situations, although many 
commented that the)’ would vary their approach. Identification o f 
participants was undertaken through professional societies and 
some eligible clinicians may not have received an invitation to 
participate if they were not registered members o f the professional 
societies approached.
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Physician-Identified Factors Affecting Patient Participation 
in Reaching Treatment Decisions
Heather L  Shepherd, Martin H..\r. Tattersall, and Phyllis N. Baton-
A B S T R A C T
Purpose
Cancer physicians report high comfort with shared decision making but a lower frequency of using 
this approach in practice. Information regarding physicians' perceptions of what helps and what 
hinders patient involvement in decision making may facilitate understanding of this discrepancy. 
Methods
We surveyed 604 Australian cancer physicians treating breast, colorectal, gynecologic, hemato­
logic, or urologie cancer to investigate barriers and facilitators to reaching treatment decisions with 
their patients and their support o f strategies to encourage patient involvement and reflection on 
treatment options. Factor analysis and regression analyses were used to investigate relationships 
between variables and identify predictors of greater reporting of barriers to sharing treatment 
decisions w ith patients.
Results
Insufficient information at the first consultation (28.9%) and insufficient time (28.4%) were the most 
frequently reported barriers to reaching treatment decisions with patients. Multivariate analysis 
revealed that less experienced physicians more commonly reported system barriers (P =  .00). Patients 
trusting their physician and being accompanied at the consultation were most helpful to reaching a 
treatment decision. Providing written information about treatment options, making a further appoint­
ment to reach a decision, encouraging the patient to speak with their family physician and treatment 
team, and the presence of a third person during the consultation were felt to encourage involvement 
and reflection on treatment decisions.
Conclusion
Cancer physicians experience difficulties when reaching treatment decisions w ith their patients. 
Interventions and strategies that physicians support are required to enhance patient involvement 
in reaching a treatment decision.
J  Clin Oncol 26:1724-1731. © 2008 by American Society of Clinical Oncology
INTRODUCTION
Involving patients in discussion about treatm ent op­
tions and reaching a treatm ent decision is increas­
ingly com m on. Cancer patients report wanting to be 
involved in treatm ent decision making; however, 
this preference is often not achieved when consult­
ing with their cancer physicians.1"* Public expecta­
tion to be fully informed about health care and 
available interventions lias increased over recent 
years, alongside decreasing acceptance o f medical 
paternalism.* Patients who are involved in reaching 
a treatm ent decision report increased satisfaction, 
reduced decisional conflict, and improved compli­
ance with treatm ent.6-7
\Ve surveyed cancer clinicians across Australia 
from August 2004 to May 2006 to document their 
comfort with and use of different decision-making 
approaches and their attitudes toward treatment de-
cision making w ith patients. We found cancer phy­
sicians in Australia are comfortable with shared 
treatm ent decision making (STDM ), b u t their re­
ported use of this approach is considerably less than 
their com fort with this co n c ep t8 This article reports 
tiie perceived barriers and facilitators to treatment de­
cision making identified by cancer physicians when 
consulting with newly referred or newly diagnosed 
cancer patients. We hypothesized that factors such as 
type of cancer treated; physician discipline, age, and 
experience; and patient caseload may influence experi­
ence o f barriers to STDM. Interventions are pro­
posed that may assist physicians to  encourage patient 
involvement and reflection on treatm ent options.
METHODS
Participant recruitment and procedures are reported in 
full elsewhere.8 Medical and radiation oncologists, he­
matologists. pediatric oncologists, and cancer surgeons
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practicing in Australia, managing people with five cancer sites (breast, colo­
rectal, gynecologic, hematologic, or urologic), were invited to participate. 
Professional representative bodies were contacted to gain permission to incite 
group members to participate in this study. If this was granted and the ad­
dresses were provided, the research team mailed each physician a package 
mcluding an invitation to participate in the survey intended to compare views 
of cancer physicians, an information sheet, a consent form, the questionnaire, 
and postage paid envelope. In the urologic cohort contact details were not 
provided, but the representative body sent the package to their members. The 
survey instrument was based on a structured questionnaire developed by 
Charles et a!*-10 in Ontario, Canada, in 1998 through focus groups and pilot 
testing. The survey assessed the validity o f the conceptual framework devel­
oped by Charles et al,11,u both in its' description of the meaning of STDM and 
in tire agreement of practicing physicians to the key components. With per­
mission. we used this questionnaire with some alterations. The questionnaire 
presented four examples of a treatment decision-making scenario, each one 
representing one of the following approaches: paternalistic, mformation shar­
ing only, informed, and shared. The survey did not define shared decision 
making (SDM). This was a cross-sectional survey. Participants were asked to 
rate on a four-point Likert scale to what extent they experienced selected items 
as barriers or facilitators to decision making. Physicians treating breast or 
urologic cancer were also asked to report their support tor a range of listed 
uiterventions to encourage patient mvolvement and reflect on treatment op­
tions during the decision-making process.
Data Analysis
Demographics and characteristics of the sample were analyzed using 
descriptive statistics. To identify and explain relationships between variables, 
exploratory factor analysis was completed using the MS-DOS program COFA 
87 (R.P. McDonald, News South Wales, Australia). K.xploratorv Factor Anal­
ysis allows conceptual thoughts to be tested and reveals loadings of items onto 
a number of factors, which can be more concretely classified conceptually and 
confirmed by Confirmatory Factor Analysis using the MS-DOS program 
CONFA. Given the preliminary stage of this field, it was fett appropriate to use 
this two-stage approach. Multiple linear regression analysis was used to 
assess predictors o f greater reporting of barriers to treatment decision 
making where more than two variables emerged with P <  .2. We used a 
backwards elimination process, with P <  .05 for a covariate to be retained in 
the final model. Descriptive statistics and correlational and regression analyses 
were undertaken using SPSS tor Windows Version 14 (SPSS Inc, Chicago, II.).
RESULTS
Participants
O f 1,062 eligible physicians approached, 624 completed survey's 
were returned, representing a response rate of 59%. This low response 
rate is comparable to the mean response rate of 54% tor physician 
surveys.1* Twenty surveys completed by clinicians who reported they 
did not treat patients in tire five targeted tumor groups were excluded 
from statistical analysis. Within the nonrespondents, tumor special­
ties were as follows: breast, 309b; colorectal, 10%; gynecologic, 2%; 
hematologic, 9%; urologic, 42%; and unknown, 7%. The high nonre­
sponder rate in the urologic cohort may reflect the mailout method in 
this group. Excluding the urologic cohort on whom we had no sex 
information, 8996 of the nonresponders were men. Comparison of 
this characteristic with the study sample reveals no notable differences.
Table 1 shows the demographics of the 604 participating clini­
cians. M;ile clinicians (83.3%) made up the larger proportion of die 
sample. Mean age was 50 years, and mean time since medical qualifi­
cation was 26 years.
Table I. Dem ograph ics o f Sam ple
Variable No. ».•
Cancer type treated
Breast 308 51.0
Colorectal 79 13.1
Gyneco log ic 27 4.5
Leukem ia/lymphoma 83 13.7
Urologic 107 17.7
Physician discip line
M edica l oncologist 126 20.9
Radiation onco log ist 51 8.4
Surgeon 354 58.6
Hem atologist 61 10.1
Pediatric oncologist 12 2.0
Sex
Male 503 83.3
Fem ale 101 16.7
Country of m edical school attended
Australasia 652 91.7
United Kingdom/Europe/Canada and 
South Africa
40 6.6
Asia/Southeast A s ia /M idd le  East 10 1.7
D irect patient care  per week, hours
< 20 170 31.2
2  20 375 68.8
Com m unity  size
<  100.000 41 7.5
100,000-500,000 184 33.8
> 500,000 319 58.7
Caseload o f new  patients per month t
0 to  6 313 52.3
7+
Median
285
^ 6
47.7
Age. years
Mean 50
Range
Years s ince graduation
32-79
Mean 26
Range 4-56
•Percentages are based on valid cases only 
tW ith  specified cancer.
Perceived Barriers to Treatment Decision Making
Experience of items perceived as barriers to treatment decision 
making is presented in Table 2. Response categories were on a four- 
point Likert scale; never, sometimes, often, and almost always. Items 
experienced by die most physicians as difficulties almost always were 
as follows: the physician having insufficient information to make a 
decision at die first consultation (6.69o) and insufficient time to spend 
with the patient (5.59o). Items perceived by the most physicians as 
never a hindrance to treatment decision making were as follows: the 
doctor experiencing difficulty in framing the treatment options for the 
patient (48.3%) and the patient’s family overriding the decision­
making process (43.7%). Most common difficulties reported often or 
almost always w'ere as follow's: die physician having insufficient infor­
mation to make a decision at the first consultation (28.99o), insuffi­
cient time to spend with the patient (28.496), patient having otiier 
healdi problems (27.9%), patient having misconceptions about dieir 
disease or treatment (27.1%), patient being indecisive (24.2%),
h 'h  w. jco.org O 2008 by American $oa*tv of Clinical Onco*o^ 1725
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Table 2. Items Experienced as Difficulties or as Helpful to the Treatment Decision-Making Process (N =  604)
Never Sometimes Often Always
Item No. %  No. % No. % No. %
Items experienced as difficulties dunng treatment decision making 
I have insufficient information to make a decision about treatment 58
at the first consultation
Insufficient time to spend with the patient 87
The patient has other health problems (eg heart disease) 28
The patient has misconceptions about the disease or treatment 11
The patient is indecisive 22
The patient is too anxious to listen to what I have to say 32
The patient does not understand the information I have given 12
The patient has difficulty accepting she/he has cancer 96
The patient comes expecting a certain treatment rather than a 115
consultation
There are cultural differences between the patient and me 121
The patient has received conflicting recommendations from 59
various specialists
The patient requests a treatment not known to be beneficial 65
The patient brings too much information to discuss 130
The patient wants to make a decision before receiving the 243
information from me
The patient wants to participate more than I would like him/her to 231 
I experience difficulty knowing how to frame the treatment 291
options for the patient
The patient's family over-rides the decision-making process 263
The patient refuses a treatment that may benefit him/her 30
Items experienced as helpful to treatment decision making 
The patient trusts me 0
The patient has someone with them at the consultation 0
Providing written information to the patient 2
The patient wants to participate in making the treatment decision 1
The patient is emotionally ready for decision making 2
The patient is prepared (knowledgeable about disease and 4
treatment) for the consultation
9.6 371 61.5 134 22.2 40 6.6
14.4 345 572 138 22.9 33 5.5
4.7 406 67.4 157 26.1 11 1.8
1.8 428 71.1 154 25 6 9 1.5
3.7 432 72.1 139 23.2 6 1.0
5.3 428 71.1 132 21.9 10 1.7
2.0 467 77.4 116 19.2 8 1.3
15.9 458 7 6 0 43 7.1 6 1.0
19.1 443 73 5 43 7.1 2 0.3
20.1 440 73.1 37 6.1 4 0.7
9.8 505 837 34 5.6 5 0 8
10.8 500 833 31 5.2 4 0.7
21.6 441 73.4 28 4.7 2 0.3
40.3 343 56.9 14 2.3 3 0.5
38.4 357 59.3 10 1.7 4 0.7
48.3 304 50 5 7 1.2 0 0
43.7 332 55 1 5 0.8 2 0.3
5.0 566 9 3 9 3 0.5 4 0.7
0 11 1.8 231 38.5 359 49.7
0 51 8.6 267 44 4 284 47 1
0.3 117 19.4 217 36.0 267 44.3
0.2 107 17 8 300 49.9 193 32.1
0.3 134 22.2 271 44.9 196 32.5
0.7 245 4 0 7 231 38.4 122 20.3
patient being too anxious (23.6%), and patient not understanding the 
information given (20.6%).
O n  the basis ofconceptu.il analysis and the correlational findings, 
exploratory factor analyses were conducted. Two items, cultural dif­
ferences and patient receiving conflicting recommendations, were 
removed because of statistical reasons. The items of insufficient infor­
mation and patient comorbidity were removed because o f their rela­
tively low factor loadings and because they did not fit conceptually 
with die other items loaded onto the patient difficulties factor. Con­
firmatory factor analysis produced a four-factor model, conceptually 
defined as follows: patient difficulties, preference tor a not recom­
mended treatment, system difficulties, and agenda-setting patient. 
The patient difficulties factor included items that covered misunder­
standing or lack of understanding, anxiety, denial, withdrawal, and 
indecision. The patient preference tor a not recommended treatment 
factor included items that indicated the patient did not want to accept 
the physician-recommended treatment, through refusal or request for 
another treatment. System issues included lack o f time, misunder­
standing of file nature of the consultation and the decision-making 
process, ¿ind physician difficulties in framing options. The fourth 
factor included items that reflected an agenda-setting patient, either by 
bringing too much information or by wishing to be more involved 
than the doctor was comfortable with. The factor loadings for this
analysis confirmed the four-factor exploratory analysis. The analysis 
gave a x2 of 199.99 on 84 degrees o f freedom, with a Steiger Lind root 
mean square error o f approximation of 0.05, a root mean residual of 
0.04, and a goodness of fit index of 0.98. These values indicate that the 
model provides a good approximation to the data. Factor loadings are 
presented in Table 3.
Predictors of Barriers to Treatment Decision Making
To further explore the reported barriers, the variables relating to 
each factor were summed and a score was computed for each of the 
four factors. A  higher score represented greater reporting of the factor 
as a difficulty. Mean scores are presented in Table 3.
Results o f  univariate analysis are presented in Table 4. Urologic 
cancer physicians liad the highest mean score for the patient difficul­
ties factor. Breast cancer physicians had the lowest mean score for the 
preference for a not recommended treatment factor. Hematologists 
and gynecologic physicians had the highest mean score for system 
difficulties. Surgeons reported the highest mean score for patient 
difficulties, and hematologists reported the highest mean score for 
system difficulties. Mean scores for each of the factors were compara­
ble, regardless of physicians' reported usual approach to decision 
making. Physicians whose initial medical training was completed in 
Asia, Southeast Asia, or the Middle East had higher mean scores for
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Table 3. Factor Analysis
Item 1 2 3 4
Unique
Variance No. Mean SD Range
Factor 1 : Patient difficulties 596 12 9 1.8 8-24
The patient does not understand the information I have given 0 48 0.77
The patient does not want to participate as much as I would 
like him/her to
0 4 2 0.82
The patient is indecisive oso 0.49
The patient has difficulty accepting she/he has cancer 0 5 9 0.66
The patient is too anxious to listen to what 1 have to say 0 68 0.66
The patient has misconceptions about the disease or treatment 0 4 2 0.82
Factor 2: Patient prefers a not recommended treatment 600 3 9 0.6 2-8
The patient requests a treatment not known to be beneficial 0 71 0.49
The patient refuses a treatment that may benefit her 0 6 2 0.62
Factor 3: System difticulties 601 8 8 1.7 5-17
Insufficient time to spend with the patient 0.32 0.90
The patient wants to make a decision before receiving the 
information from me
0 5 8 0.66
The patient's family over-rides the decision-making process 0.58 0.67
1 experience difficulty knowing how to frame the treatment 
options for the patient
0 3 8 0.86
The patient comes expecting a certain treatment rather than a 
consultation
0 5 0 0.75
Factor 4, Agenda-setting patient 600 3 5 0.9 2-8
The patient wants to participate more in deciding on his/her 
treatment than 1 would like him/her to
0 4 5 0.80
The patient brings too much information to discuss 0 78 0.66
NOTE All loadings for each item are provided with the salient loadings in bold. 
Abbreviation: SO, standard deviation.
three of the tour factors: patient difficulties. system difficulties, and 
agenda-setting patient. Physicians reporting less direct patient contact 
per week and fewer new patients per month showed a higher mean 
score for rite patient difficulties factor.
Our data showed a high correlation between the variables o f age 
and years o f experience (P <  .01) and physician discipline and type of 
cancer treated (P <  .01). We included only years o f experience and 
type of cancer treated in regression analyses. Bivariate correlation of 
cancer, years of experience, doctor sex, and community size showed 
significant correlation with system difficulties (Table 4). New patients 
seen per month, cancer type treated, and hours of practice per week 
showed significant correlation for the patient preference tor a not 
recommended option.
Predictors o f greater reporting o f system difficulties were identi­
fied using linear regression (Table 5). Three variables included had a 
significant association with a higher system limitation score. Variables 
included in the model were years of experience, cancer type treated, 
and community size. The final model (R:  =  0.035) showed that 
physicians with less experience (P =  .000) reported greater frequency 
of system difficulties as barriers to decision making with patients.
Facilitators to Treatment Decision Making
Six possible facilitators were listed and the frequencies with 
which physicians found these helpful obtained. As responses were 
skewed, the original four categories on a Likert scale were collapsed 
into a dichotomous score. Those reported by physicians as experi­
enced as helpful never or sometimes were recoded as not helpful, 
and those reported as experienced often and almost always helpful 
were recoded as helpful. The majority o f physicians (98.2% ) re-
h-h >w. ico.org
ported that the patient trusting them was helpful and that the 
patient being accompanied in the consultation (91.5% ), the pa­
tient wanting to participate (82.0% ), and providing written infor­
mation were helpful (80.3% ; Table 2).
Interventions to Encourage Patient Involvement 
and Reflection
Most (81%) of the breast and urologie cohort supported oliering 
patients written information concerning available treatment options; 
69% supported a third person being at the consultation, and 50% 
endorsed input from a senior cancer nurse before the consultation. 
There was less support for six other interventions to encourage in­
volvement. Three o f six possible interventions for encouraging patient 
reflection after the consultation were well supported. A follow-up 
appointment to make the decision was supported by 96.2%, as was 
written information highlighting treatment options (89.9%) and en­
couragement for the patient to speak with the treatment team and 
their general practitioner (72.7%). Worksheets to assist the patient to 
articulate their values and preferences were supported by one fifth 
(19.4%; Table 6).
DISCUSSION
We examined the reported barriers and facilitators to treatment deci­
sion making of a large sample of practicing cancer physicians across 
Australia. We hypothesized that physician characteristics, including 
discipline and the type o f cancer treated, may influence experience and 
perception of factors as barriers to SDM.
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Table 4. Univariate Analysts of Factor Scores
Factor 2: Patient 
Prefers a Not
Factor 1 : Patient Recommended Factor 3: System Factor 4: Agenda-
Difficulties Treatment Difficulties Setting Patient
Parameter Mean SD Mean SD Mean SD Mean SD
Cancer type treated
Breast 12 85 1.78 3.82* 0.59 8.64t 1.69 341 0.82
Colorectal 13.05 1.64 3.96* 0.44 8.72f 1.58 3.42 0.86
Gynecologic 13,04 1.61 4.04* 0.98 9.1 I t 1.45 3.44 0.85
Hematologic 12.78 1 42 3.98* 042 9.40t 1 60 3.62 0.70
Urologie 13.26 2.48 4.14* 070 8.92t 2.12 366 1.06
Breast and urologie 12.96 1.99 3.90* 064 8.71* 1.81 347 089
Colorectal, gynecologic, and hematologic 12.93 1.52 3.97* 0.54 9.07! 1.59 3 51 0.79
Physician discipline
Medical oncologist 12.59* 1.42 3.98 0.61 9.09* 1.44 3.60 0.81
Radiation oncologist 12.12* 1.18 3.94 0.31 9.27* 1.39 3.31 0.73
Surgeon 13.23* 2.07 3.90 0.70 8.65* 1.87 3.49 0.93
Hematologist 12.75* 1 42 3.95 047 9.51* 1.60 3.52 0.72
Pediatric oncologist 12.83* 1.59 4.00 0.00 8.73* 1.74 3.75 0.45
Physician sex
Male 1299 1 92 3.92 063 8.77* 1.77 3.50 0.87
Female 12.74 1.50 3.95 0.48 9.08* 1.68 3.41 0.81
Usual approach to decision making
Doctor led 12.81 1.67 3.93 060 8.82 1.71 358 0,79
Shared 12.96 1.88 3.92 0.59 8.83 1.75 3.47 0.84
Patient led 12.85 1.43 3.88 0.56 8.78 1.82 344 0.97
Medical student training
Australasia 12.97 1.90 3.92 0 59 8.81 1.76 3.48 0.86
United Kingdom/Europe/Canada and South Africa 12.62 1.21 4.00 0.78 8.85 1.63 345 0.85
Asia/Southeast Asia/Middle East 13.50 1 65 4.00 067 9.20 2.39 4.00 1.12
Years of postgraduate experience
< 25 12.84 1.76 3.95 0.57 9.15* 1.63 3.42 0.88
i  25 13.04 193 3.90 064 8.53* 1.81 3.54 0.84
New patient caseload per month
a  6 13.03 1.87 3.86* 0.62 8.75 1.80 3.48 0.84
i  7 12.86 1.83 399* 0 59 8.90 1.71 348 0.89
Direct patient care per week, hours
< 20 13.14* 2.09 3.85* 0.75 8.63 1.96 3.40* 0.94
£  20 12.89* 1 80 3.96* 0 55 8.84 1.67 3.52* 0.84
Community size
< 100,000 13.02 2.16 3.83 0.54 8.27* 1.73 3.39 0.83
100.000-500,000 13.07 2.01 3.90 0.66 8.71* 1.81 3.51 0.90
> 500,000 12 90 1 79 3.96 060 8.88* 1.74 347 087
Abbreviation: SD, standard deviation. 
*P <  .001. 
tP <  .01.
*P < .2.
*P <  .05.
Lack of time was reported as one of the more frequently experi­
enced barriers to treatment decision making by Australian cancer 
physicians. Physicians with less experience reported system issues as 
difficult more often. This may be because physicians with greater 
experience are more patient-centered in their approach to consulta­
tions or have become skilled at overcoming system issues. A number 
of studies have reported that collaborative decision making does not 
increase consultation time and may save time in the long run, because 
thorough initial discussion enables subsequent consultations to be 
more succinct14"16 Moreover, addressing patient concerns may 
shorten initial consultations.
Patient misunderstanding was considered one of the key difficul­
ties when reaching treatment decisions. Quirt eta l17 explored the level 
of agreement between patients and their physicians about diagnosis, 
treamient aims, and risks and benefits. They reported that many lung 
cancer patients did not fully comprehend their situation and that this 
was underestimated by their physicians. If this discrepancy between 
the patient understanding and physician awareness of patient under­
standing is duplicated in Australia, this barrier may be higher than 
reported by our participants. O ur data showed that physicians re­
ported that patient anxiety and misconception of their disease or 
treatment were two of the most frequent barriers to sharing decision
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Talil« 5. Linear Regression
Parameter R2 B a SE
F
Statistic 0 P
Model
Higher system difficulty score 0 035 3.536 7 536 000
Individual predictor
Constant 9.291 0.296 .000
No. of years qualified -.033 0008 -.174 .000
Breast and urologie v colorectal, gynecologic, and hematologic 0.154 0.178 0.037 385
Community size: 100,000, 100,000-500,000, >500,000 0.194 0.120 0.069 105
making. This is not surprising, as emotion lias a negative effect on 
many requirements tor collaboration, making it more difficult for 
patients to take in information and consider their options. In the 
review of Gravel et aJ1* of barriers to implementing SDM in clinical 
practice, lack of applicability of the process owing to patient charac­
teristics. such as anxiety, and characteristics of the clinical situation, 
such as lack of any real choice, also featured strongly.
Our data show cancer physicians’ perceptions of what assists 
them when making treatment decisions. Patients’ trust was regarded 
as the key facilitator. Patients also nominate trust in their physician as 
one of the most important factors when reaching a treatment deci­
sion.1'* As patient involvement and the consumer role in healthcare 
grows,20 tiie importance of physicians gaining their patients’ trust may 
increase. Previous studies suggest that trust develops through excellent 
communication and by responding to patient preferences for infor­
mation and involvement.2I'2’ However, difficulties in defining and 
measuring trust complicate research into its’effect on doctor decision­
making style.24
T»Me s. Interventions That Physicians Would Support to Encourage Patient 
Involvement and Reflection (n -  415)
Intervention No %
Offering the patient written information about the 
treatment options available
321 81.1
Having a third person n the room 273 68.9
Input from cancer nurse coordinator before consultation 196 49.5
Booklet explaining clinical decision making 135 34.1
Prepanng patient for a greater role in decision making by 
offenng question prompt lists before the consultation
124 31.3
Booklet about patient roles explaining stared decision 
making
111 28.0
Access for medical practitioners to tranng to enhance 
skills in meeting patients' preferences for SDM
99 25.0
Explicitly negotiating shared decision making 89 22.5
Input from cancer nurse coordinator post consultation 50 12.6
Follow-up appointment to make a decision 381 96.2
Giving written information highlighting treatment options 356 89.9
Encourage patient to talk to treatment team and general 
practitioner
288 72.7
Worksheets for the patient to help hirrvher articulate what 
is important for him/her
77 19.4
Audiotapng consultation 64 16.2
Telephone folow-up to discuss treatment decision 54 13.6
NOTE Breast and urologic cancer physicians only 
Abbreviation SOM shared decision making
Patients’ being accompanied at the consultation was viewed as 
helpful. This may reflect recognition of the two-fold benefit a com- 
panion brings for die patient (asa second pair of ears and as emotional 
support). However, the presence of a third person as a facilitator to 
patient involvement was supported less, implying that physicians are 
more comfortable with patients bringing a significant other to the 
consultation than having a third person present, perhaps a nurse or 
patient advocate. Perceived differences in the roles that a patient’s 
family or significant other might play compared with that of a nurse 
practitioner are unclear.
Perceived patient willingness to participate in the decision­
making process was viewed by the majority of physicians as a facilita­
tor and reflects the notion that tor a shared approach, both parties 
have to be willing to participate."-12
Some written information given to patients is not balanced or 
complete,25-2® yet our findings imply that patients and physicians may 
benefit from patients receiving written evidence-based information to 
reflect on the treatments being recommended.
We found little support tor interventions designed to prepare 
patients to be involved in decision making, with less than one third of 
respondents embracing booklets explaining clinical decision making, 
patient roles in decision making, or use of question prompt lists. 
Audio recording of consultations was supported by only 16% of phy­
sicians. A review of the effectiveness of providing consultation audio 
recording or written summaries showed that the majority' of patients 
found them to lie useful and that recall and satisfaction with informa­
tion received were improved. Anxiety or depression were not influ­
enced by receipt of an audio recording or summary.27 Our findings 
suggest this review’s recommendation that physicians should consider 
offering patients audio recordings seems not to have been adopted 
in Australia.
Translating research evidence into practice remains a challenge 
for researchers keen to implement effective communication tools. An 
investigation of barriers to uptake of patient decision aids in clinical 
practice reported that physicians’ lack of awareness and of the skills to 
use the tools effectively inhibited implementation.2* Training pro­
grams targeted at health professionals are recommended to address 
the issue of lack of familiarity,"-12-18-28 yet our data reveal that Austra­
lian cancer physicians have minimal interest in access to training to 
meet patient preferences tor SDM.
The difficulties identified in our survey and the limited support 
for strategies and interventions echo the views of Entwistle and Watt,24 
who state that the clinician’s motivation to involve patients is influen­
tial and that success in facilitating involvement is inextricably linked to
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this. The difficulties we report emphasize system and patient attributes 
that prove challenging for physicians. Insight into the difficulties that 
may be physician driven and reasons why physicians may be less 
supportive of patient involvement should be sought in further re­
search. Changing established practice and successfully implementing 
evaluated communication interventions remains a challenge. Perhaps 
greater implementation success will lie realized by aiming strategies at 
patients or at the system.30
In conclusion, our survey sought to identify physician-perceived 
barriers and facilitators to die treatment decision-making process in 
cancer consultations and to explore support for interventions to in­
crease patient involvement and reflection on treatment options pre­
sented to them.
What hinders? System issues, particularly time, are a barrier to 
shared treatment decision making, particularly for less experienced 
physicians. Patients who refuse the recommended treatment or wish 
to pursue a treatment not considered optimal are also seen as a barrier 
to STDM.
What hell's? A patient trusting their doctor is important, al­
though how to create and build trust is not clear. Tire value of the 
patient being accompanied during a consultation and being provided 
with quality written information is strongly endorsed by sur­
veyed physicians.
Successful implementation o f interventions to encourage patient 
involvement in decision making is a challenge. Interventions that 
physicians support need to be developed, as well as increasing physi­
cian access to and awareness of interventions already available.
This study presents self-reported survey data on cancer phy­
sicians’ perceived barriers and facilitators to treatment decision 
making with their patients; the data does not necessarily represent
the importance physicians place on these barriers and facilitators. 
The 59% response rate presents some limitation to the generaliz- 
abiliry o f the data. There is potential for bias to have influenced the 
results, because responders may be more interested in treatment 
decision-making approaches used with patients than are nonre­
sponders. Consequently, the reported experience of difficulties to 
SDM may be under-reported, and support tor SDM may be over­
representative o f the situation in practice. The survey did not detail 
specific decisions contexts, and physicians were asked to consider 
their approach to decision making with their newly referred or 
newly diagnosed cancer patients.
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Abstract
This paper describes tfie current position of shared deasion-making (SDM) 
within the Australian health care system. Australian health care includes a 
mixture of public and private practice governed by both regional and 
national policy. Support for SDM exists through guidelines and support for 
interventions to increase participation. However, there is no dear overall 
policy framework for SDM in Australia. The result is recognition that 
consumer involvement is important yet there are limited resources and
infrastructure, and no dear strategy to support implementation. Barriers to 
SDM at the macro, meso and micro levels of health care are described. 
Efforts to support consumer involvement to  date have been targeted to 
the supply side of health care. There is now awareness of the need to 
target the demand side by educating consumers to ask for information 
and involvement in their health care
Key words: Patient participation, patient information, shared decision-making, health care system, Australia 
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Partizipative Entscheidungsfindung in Australien
Zusammenfassung
Diese Arbeit beschreibt den derzeitigen Stand der Partizipativen Entschei­
dungsfindung (PER im australischen Gesundheitssystem Das australische 
Gesundheitssystem besteht aus einer Mischung von öffentlichen und 
privaten Gesundheitseinrichtungen, die von regionaler und nationaler 
Politik geführt werden. Unterstützung für PEF existiert durch Leitlinien und 
durch Interventionen, die Patientenbeteiligung erhöhen Jedoch gibt es 
keinen klaren politischen Rahmen für PEF in Australien Daraus folgt die 
Erkenntnis, dass die Einbeziehung von Patienten zwar wichtig ist,
allerdings sind die Ressourcen und die Infrastruktur begrenzt und es gibt 
keine klare Strategie die Umsetzung der PEF zu unterstützen. Es werden 
die Hürden für PEF auf Makro-, Meso- und Mikroebene beschrieben. Die 
derzeitigen Anstrengungen, die Patientenbeteiligung zu unterstützen, 
beziehen sich auf die Angebotsseite der Gesund heitsversorgung. Mittle­
rweile wurde erkannt, dass die Seite der Nachfrage durch Patientenschu­
lungen zur Inanspruchnahme von Information und Einbeziehung in die 
Gesundheitsversorgung angezielt werden sollte
Schlüsselwörter: Patientenbeteiligung, Patienteninformation, Partizipative Entscheidungsfindung, Gesundheitssystem, Australien 
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Australia has a population of approxi­
mately 20 million people, living in eight 
States and Territories (regions) in an 
area approximately the size of Western 
Europe. The Australian health care 
system is directed and funded at both 
a national and regional level, and 
includes a mixture of public and private 
health service delivery. The State and 
Territory governments fund a broad 
range of regional health services. The 
Commonwealth (or Federal) govern­
ment fund most medical services out 
of hospital and most health research 
nationally. The Commonwealth pro­
vides non-directed funds to the State 
and Territories to administer public 
hospitals. Both the Commonwealth 
and the State and Territory govern­
ments variously fund community care 
for aged and disabled persons. General 
practice (GP) services are provided on a 
fee-for-service basis with an 85% 
rebate provided through Medicare. 
Medicare is the Commonwealth fun­
ded Australian health insurance system 
that provides universal access to health 
services. Private health insurance covers 
fees for private hospitals and selected 
doctors in public hospitals, in addition 
to allied health services, optical and 
dental care. This paper describes the 
current position of shared decision 
making (SDM) within Australian health 
care system.
1. Level of patient 
participation in macro, 
meso and micro levels
The Australian Government Depart­
ment of Health & Ageing receives 
advice and recommendations from the 
National Health & Medical Research 
Council (NHMRC) which involves con­
sumers via appointment of consumer 
representatives to committees and con­
ducting public consultations before 
making regulatory recommendations 
or issuing guidelines. In 2002, the 
NHMRC together with the Consumers' 
Health Forum of Australia (see further 
details below) published the Statement 
on Consumer and Community Partici­
pation in Health and Medical Research, 
guidelines for consumer participation
at all levels and across all types of 
health and medical research in Austra­
lia [1], The statement includes some 
principles of partnership of consumers 
and researchers in order to shape 
decisions about research priorities, spe­
cific research questions and design of 
research projects in a way that recog­
nises and responds to the rights of all 
voices to be heard.
Australia has seven national health 
priorities receiving targeted funding; 
asthma, cardiovascular disease, dia­
betes, cancer control, injury prevention, 
arthritis and mental health. Several of 
these have programs for patient self­
management. The Australian Govern­
ment also has an extensive consumer 
health information website called 
"Health Insite" [www.nealthmsite.go- 
v.auj whose strategic plan specifically 
aims to involve consumers in the devel­
opment and evaluation of the site. State 
Health Departments also have policies 
supporting consumer and community 
involvement in decision-making, plan­
ning, development and evaluation of 
services. The Western Australia (WA) 
Department of Health and the Health 
Consumers' Council of WA [http:// 
www.hccwa.global.net.au/pages/pol- 
icy_comment.html] have recently signed 
a state Consumer Participation Policy 
that require all levels of healthcare 
administration, from local public hospi­
tals to Clinical Networks and decision­
making committees to include at least 
one consumer representative.
The Consumer's Health Forum of Aus­
tralia [http://www.chf.org.au] is an 
independent member-based non-gov­
ernment organisation which is funded 
by the Australian Government. It nomi­
nates and supports consumer represen­
tation with government, industry and 
professional organisations. A number 
of condition-specific non-government 
organizations (NGOs) also have key 
advocacy roles and these also involve 
consumers. NGOs include the National 
Breast Cancer Centre, Diabetes Austra­
lia, Cancer Australia and Cancer Coun­
cils in each state, Beyond Blue (mental 
health), Arthritis Foundation, and 
National Heart Foundation. Australia 
hosts the Cochrane Collaboration's 
Consumer and Communication Group.
2. Present state of SDM 
im plem entation in the 
Australian Health Care 
System
Shared decision-making is espoused in 
many policy and strategic direction 
documents, such as the NHMRC series 
of booklets on doctor-patient commu­
nication. Making decisions about tests 
and treatments; Principles for better 
communication between healthcare 
consumers and healthcare profession­
als http://www.nhmrc.gov.au/publica- 
tions is a new toolkit intended to assist 
health professionals with optimising 
communication when discussing treat­
ment options with consumers. On p. 1, 
it states:
"Whenever possible, people seeking 
health advice should have opportunities 
to explain and discuss their values and 
preferences, so that the decisions 
reached can take these into account".
The Australian Council for Safety and 
Quality in Health Care have also pro­
duced a document, W Tips for Safer 
Health Care, [httpV/www.safetyand- 
quality.gov.au/internet/safety/publish- 
ing.nsf/Content/10-tips] available in 15 
languages, which aims to help people 
be more actively involved in their own 
healthcare [2]. A draft Cancer Services 
Standards Framework has also been 
developed stating that [3]
"all cancer patients are involved in 
decisions concerning their care to the 
extent that they wish" p. 172.
While there is apparent support for 
SDM m Australia, implementation is 
limited. A survey of Australian oncolo­
gists found that 80% were comfortable 
with SDM but only 53% reported it as 
their usual approach, and many stated 
that they used it only with some 
patients [4] (Fig. 1).
Brown et al. [5] audited SDM in 59 
consultation audio-recordings of 10 
oncologists seeking consent to clinical 
trials. Doctors only introduced the 
concept of joint decision-making about 
treatment in 24% of consultations and, 
where it was discussed, it was rated as 
poor in 75% of cases. Information
Z.arrtl. Fortb ild . Qual.Gesundh.wes. 101 (2007) 205-211 Wjf 
www.elsevier.de/zaefq îü '-’ î206 BS51
A59
Fig. 1. Australian Mammography Decision Aid Trial, http7/ww w health usyd.edu au/shdg/resources/ 
decision_aids.php
preferences were checked in 40%  o f 
the consultations w ith 66%  o f these 
receiving a poor rating. The doctors 
invited patient questions and com­
ments in 61%  of the consultations; 
however, 70% o f these were rated as 
poor. Uncertainty of treatment benefit 
was acknowledged m 54% of consul­
tations. Patients were, however, com­
monly offered the option of delaying 
their decision about trial participation 
(78% of consultations). Thus, many 
aspects o f SDM were rarely observed in 
this sample o f oncology consultations. 
Focus group interviews and participant 
observation methods explored nurses' 
approaches to working w ith patients to 
support patients' participation in health 
care [6]. The authors noted a sharp 
contrast between the ideas nurses 
expressed and their actions observed 
in practice. Nurses said they supported 
consumer participation, yet observa­
tional data revealed nursing practices 
that excluded active participation by 
consumers. In conclusion, evidence for 
the implementation of SDM is sparse, 
and the few studies that have been 
conducted do not support optimism 
about the uptake of these ideas.
3. Mechanisms and 
institutions which support 
SDM in practice
Support for shared decision-making in 
Australia exists through guidelines and
support of interventions which aim to  
increase participation. Three NHMRC 
publications specifically promote 
patient involvement in decision making 
as part o f optimal care [7-9] http:// 
www.nhmrc.gov.au/publications.
The Royal Australian College of General 
Practitioners (RACGP) document Shar­
ing Health Care: Chronic C ondition 
Self-M anagem ent Guidelines also 
asserts that,
“When treatment is jointly planned and 
negotiated, and information is shared 
between doctor and patient, the patient 
is assisted to exercise autonomy and 
follow an agreed plan" [ 10]
h ttp ://w w w .racgp .org .au /gu ide lm es/ 
sharing healthcare
These publications are complemented 
by a number of other consumer-led 
initiatives. The Patient Charter pro­
duced by the Victorian State Govern­
ment states that;
“You should be fully involved in deci­
sions about your care and be given the 
opportunity to ask questions and dis­
cuss treatments so you understand 
what is happening. "
h ttp ://w w w .health .v ic .gov.au/patien t- 
charter/pa tien t.h tm
Tip One of The Australian Council for 
Quality and Safety in Health Care
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document states, "Be actively involved 
in your own healthcare". [2]
Pamphlets produced by consumer 
groups, particularly in the oncology 
setting, promote patients' active parti­
cipation in their healthcare, (e.g. M y 
Journey K it, developed by Breast Can­
cer Network Australia httpV/www. 
bcna.org.au/). Cancer Voices Australia 
also links advocacy groups across the 
country and aims to  ensure cancer 
consumers are involved in decision 
making regarding treatment, research, 
support and care throughout their 
cancer journey.
Implementation of tools and interven­
tions to increase patient participation 
Decision Aids: In Australia decision aids 
(DAs) have been developed for a num­
ber o f different settings.
•  Health screening
•  Genetic counselling
•  Disease prevention
•  Cancer early and advanced stage 
treatment decisions
•  Clinical trial participation
Only one DA has been implemented 
nationally. The NHMRC commissioned 
the Sydney Health Decision Group 
(SHDG) to produce a DA fo r women 
considering hormone replacement 
therapy. Copies were distributed to 
GPs across Australia and can be down­
loaded from the internet [http:// 
www.nhmrc.gov.au/publications] [11] 
(Fig. 2).
Question Prom pt Lists (QPL): Question 
prompt lists aim to  aid the patient in 
obtaining the information s/he may 
w ant by listing questions pertinent to 
their situation [12-16]. The Cancer 
Institute New South Wales is funding 
a project to evaluate the implementa­
tion of QPL fo r cancer patients consult­
ing a surgeon, radiation or medical 
oncologist or a palliative care doctor in 
New South Wales. Palliative Care Aus­
tralia has disseminated a QPL for 
patients consulting a palliative care 
doctor [httpV/www.pallcare.org.au].
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Fig. 1  NHMRC. Making Decisions: Should I use hormone replacement therapy?
Audio-recording consultations:
The value of audio-taping has been 
explored and has proven of value in 
allowing patients to clarify details of 
previous consultations, as well as to 
give further opportunity to absorb the 
plethora of information given in any 
consultation. [17,18] The Cancer Insti­
tute NSW has recently funded a system 
in two public hospitals in Sydney which 
enables recording of the consultation 
and instant transfer to a CD which 
patients can take home.
4. Barriers to SDM in 
Australia
There is little research in Australia 
identifying barriers to implementation 
of a SDM approach. In a systematic 
review (1990-2006) of health profes­
sionals' perceptions of barriers to SDM 
practice, only one of the 28 identified 
studies was conducted in Australia 
[19].
System related barriers 
In the recent Guide to effective parti­
cipation o f consumers and communi­
ties in developing and disseminating 
health inform ation [20], the following 
system barriers to effective consumer 
participation were identified: i) the 
infrastructure of organisations often
does not support sufficient consumer 
participation, ii) organisations may lack 
skill and confidence in collaborating 
with consumers, iii) consumers may 
need skills in presenting and advocacy, 
iv) vulnerable groups may have little 
opportunity for input, v) there may 
be weak links between health informa­
tion developers and consumers and 
community organizations, and vi) 
dissemination of health information 
often occurs without consumer input. 
Equity, transparency and good commu­
nication skills relating to purpose and 
process have been identified as key 
strategies in overcoming these barriers 
[20],
The most commonly cited barrier to 
implementation of a SDM approach in 
Australia has been time constraints, 
identified as a critical issue in nursing 
and general practice [6], Other repor­
ted system barriers are division of 
labour and difficulties in relinquishing 
power [6], excessive administrative 
requirements [21], lack of broad con­
sultation in developing materials and 
patient preferences for clinician-provi­
ded advice rather than self-adminis­
tered decision aids [22],
A particular challenge in the implemen­
tation of SDM in Australia is the 
equitable provision of services for 
patients in rural and remote areas 
[23], A key issue was "geographical 
isolation from centres o f evidence- 
based practice, lim ited choice o f health 
care practices for referral, and fewer
resources, compared to the urban 
clinical practice".
In total, many of the SDM initiatives 
that have occurred have done so in the 
absence of any clear, overall policy 
framework [24], Consequently, there 
are gaps in specific clinical areas that 
are not covered by existing guidelines 
[25],
Health professional barriers 
The NHMRC document, Communicat­
ing w ith Patients: Advice for Medical 
Practitioners [8], identifies doctor-rela­
ted obstacles to adequate communica­
tion. Research with oncologists also 
reports barriers to SDM including lack 
of time, perception that patients mis­
understand the treatment/disease, con­
cerns about increasing patient's anxiety, 
and not having sufficient evidence 
about the efficacy of specific treat­
ments [4],
Studies indicate that the doctors' con­
sultation style is an important compo­
nent of the decision-making process 
[26,27] and varies among practitioners. 
These findings suggest that communi­
cation skills training in university med­
ical curriculae would be beneficial. The 
Oncology Education Committee of the 
Cancer Council Australia recently laun­
ched the Ideal Oncology Curriculum for 
medical schools: Knowledge, skills and 
attitudes o f medical students at gra­
duation; in which communication skills 
are identified as one of the core skills 
and competencies in oncology that
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graduating medical students should 
possess. The Australian Medical Coun­
cil's Accreditation Standards for Medi­
cal Schools (2002) advise that all med­
ical graduates should involve patients in 
formulating a management plan, and 
should be good listeners and able to 
provide information in a manner that 
allows patients and families to be fully 
informed.
Culturally diverse communities have 
varying perceptions of information 
exchange and decision making which 
may pose an important barrier to SDM 
[28-30], Goldstein et al. [28] found 
that a Greek community in Australia 
preferred a greater involvement of the 
family in decision-making and a more 
paternalistic style in their doctor. A 
study of Aboriginal consumers reported 
they wanted GPsto spend more time in 
consultations to get to know them and 
to foster a relationship with the Abori­
ginal community outside of the GP-pa- 
tient encounter [31], In general, com­
munication is facilitated when the 
health professional is aware of, respect­
ful of, and sensitive to, the back­
ground, emotional and cultural needs 
of each individual patient. Most doctors 
lack skills in this area [32].
Consumer/patient related barriers 
A number of barriers have been identi­
fied, anxiety, embarrassment or denial 
about the medical condition; being 
inexperienced in identifying and 
describing symptoms; being intimida­
ted by healthcare settings, being over­
awed by the doctor's perceived status, 
being disadvantaged by differences in 
language and culture; being confused 
by the use of medical jargon; being 
reluctant to ask questions; or being 
concerned about taking up too much 
time [8].
Low literacy skills are another impor­
tant barrier. Data from 1996 by the 
Australian Bureau of Statistics indicate 
that almost half the Australian popula­
tion is likely to have some, or consider­
able, difficulty with written information 
materials [33]. There have been no 
attempts to develop tools or materials 
to facilitate SDM with low literacy 
groups in Australia.
5. Influence o f patient 
rights on SDM 
im plem entation
There is no national patient charter or 
patient rights statement in Australia 
such as exists in the UK (NHS Patients 
Charter http://www.pfc.org.uk/node/ 
633) and elsewhere. In 1993 the 
NHMRC issued general guidelines for 
medical practitioners on providing 
information to patients (updated in 
2004) [7], The guidelines hold no 
legislative power, rather they are seen 
to reflea the Australian common law 
right of legally competent patients to 
make their own decisions about med­
ical treatment and their right to grant, 
withhold or withdraw consent before 
or during and examination or treat­
ment (NHMRC 2004 p7).
Mental health policy and legislation has 
demonstrated a rights-based approach 
to patient participation which has been 
explicitly incorporated into the Mental 
Health Act (1990) and the Mental 
Health Legislation Amendment Act 
(1997). Individual state and area based 
health services (e.g. Viaorian and WA 
State Governments (see weblmks pre­
viously listed), North Coast Area Health 
Service NSW, http://www.ncahs.nsw.- 
gov.au/support/), and some hospitals 
(Royal Children's Hospital, Queensland, 
http://www.health.qld.gov.au/qhppc/ 
documents/QHPPCbooklet.pdf have 
voluntarily established their own indivi­
dual patient charters. Health Care 
Agreements between the federal and 
state governments have meant that 
states must develop and implement 
systems to ensure that patients give 
informed consent. However patient 
participation in decision-making is lim­
ited by a serious deficiency in the 
understanding of healthcare practition­
ers and administrators as to what 
information constitutes informed con­
sent, how and when it should be 
provided, and what decision-making 
support patients (and clinicians) require 
[34],
Consumer activism has played an 
important role in campaigning for 
change in Australia [35]. Groups 
formed by patients of failed healthcare
treatments or those with specific health 
conditions have raised the profile of 
patient rights [36], Identity based con­
sumer groups such as Aboriginal 
groups and women's groups also play 
an important role [37,38], as have large 
NGOs and national consumer organisa­
tions described in Seaion 1.
6. Present SDM-research 
and research funding
Researchers and Research groups 
A small number of research groups and 
individuals are working in the area of 
SDM or patient choice. Nevertheless 
Australian research has made some 
important contributions, for example 
in patient-doaor communication 
[5,15,26,39,40], risk communication 
[41,42], consumer and patient prefer­
ences [43,44] and evidence based 
patient choice [43-46],
Research goals and priorities 
The Australian government has articu­
lated four National Research Priorities, 
one of which pertains to health. Within 
health the specific research priorities 
are described as follows:
• A healthy start to life
• Ageing well, ageing productively
• Preventive healthcare
• Strengthening Australia's social and 
economic fabric
[ http ://www. dest. gov.au/sectors/ 
research _sector/policies_issues_re- 
views/key_issues/national_research_ 
p rior ities/prio rity_goa Is/p romoti ng_ 
a nd_ ma i nta i m ng _good_ hea Ith. 
htm#4#4]
However, none of these include provi­
sion for a research priority relating to 
SDM or patient choice.
Research funding
The NHMRC funded 853 grants 
amounting to $500 million to com­
mence in 2007. Only two specifically 
addressed patient choice: Gattellari 
et al., DESPATCH Delivering Stroke
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Prevention in Atrial Fibrillation: assisting 
evidence based choice in primary care 
($524,653), and McCaffery et al., a 
randomized controlled trial of a bowel 
cancer screening decision aid for adults 
with low education and literacy 
($229,500), demonstrating a compara­
tively low commitment to funding SDM 
research in Australia.
7. Future perspectives of 
SDM in Australia
The legal system and consumer advo­
cacy groups have influenced develop­
ment of various policies for the sharing 
of information and decision-making 
between doctors and patients. The 
result is an unsystematic approach 
across Australia to the patients to being 
informed and involved in decision­
making. Many doctors are still unaware 
of the minimum legal obligation to 
inform patients [34], Consequently, 
there is a long way to go to ensure 
patients are both informed and 
involved in decisions about their health. 
To date all efforts at advancing the 
issues of patient rights and information 
have been targeted towards the supply 
side of health care, encouraging clin­
icians to adopt best-practice models in 
informing patients and shared decision­
making, with mixed results. In the 
future consumer groups will need to 
target the demand side by educating 
consumers as to the questions to ask 
their clinicians to ensure that they get 
sufficient information to participate in 
decision-making and make decisions 
that will maximize their individual 
health outcome.
In 2005, the Australian government 
established a new health policy initia­
tive called Strengthening Cancer Care. 
Increased research funding for cancer 
was announced as well as the estab­
lishment of a new health agency called 
Cancer Australia. Although none of 
their current research priorities expli­
citly include SDM, cancer patients have 
been a very powerful advocacy group 
in recent years and it is possible that 
they will influence the research prio­
rities of this new initiative embracing
shared decision making and patient 
choice.
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